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Abstract
Efficient parameter estimation is increasingly recognised to be essential in fitting
epidemic models to data. This thesis primarily explores parameter estimation
methods as applied to data generated from an experimental infection with foot
and mouth disease (FMD) virus in sheep. Data were generated from two ex¬
periments involving four groups of sheep, housed under restricted mixing, where
sheep in the initial group were inoculated with type O FMD virus. The aim of
the analysis is to investigate the presence of any trend in the infection rate with
increased generation.
The infection process of FMD virus in sheep can be modelled using chain binomial
models and generalized linear models. However, application of these methods
requires that the epidemic chain of infection pathways be known. The set of
true pathways is an unobservable quantity and, in general, infectious disease data
will be incomplete because the infection process is only partially observed. One
proposed strategy is subjectively to assign an epidemic chain to the data and to
analyse it on this basis. This approach is evaluated.
An alternative to modelling the FMD infection process for individual sheep is
to consider the transmission among groups of sheep, thus avoiding the need to
make inference about individual infection pathways. Martingale methods and
maximum likelihood estimation methods are used to estimate the typical infection
rate /3 applying to groups of sheep where the aim is to investigate whether the
infection rate changes across groups. The expected total infection exposure for
each group is estimated. This entails knowledge of the time of infection, the
latent period and the infectious period for each infected sheep. Parameters for
the latent period and infectious period distributions are estimated from the data.
A joint distribution of time to infection and latent period is formulated from which
expected values for time to infection and the latent period for each infected sheep
are estimated. The expected infectious period is estimated by fitting the infectious
period distribution to the observed data. Estimates of these expectations and of
j3 are calculated iteratively using an analogy of the Expectation Maximization
(EM) algorithm until convergence occurs.
Trends in estimates across groups are summarised using weighted linear regres¬
sion and their significance is tested using bootstrap methods. The power of
the methodology is explored using simulated data from a Susceptible-Latent-
Infectious-Removed (SLIR) model that reflects the design of the experiments.
In the final part of the thesis, the properties of the confidence interval based on
asymptotic likelihood theory are compared with those of the percentile confidence
interval generated by parametric and semi-parametric bootstrap methods. Boot¬
strap calibration is applied to each of these methods. Simulated data are used
to explore the coverage properties of different confidence intervals for the basic
reproduction ratio (Rq) of a SIR infection process.
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Efficient parameter estimation is increasingly recognised to be essential in fitting
epidemic models to data. This thesis explores parameter estimation methods as
applied to infectious disease data, in particular, data about infectious diseases
of animals. Animals are a well defined source of a number of infectious diseases
in humans. It is known that infectious diseases can easily cross from animals to
humans and a sizeable volume of literature exists on the subject. Taylor et al.
(2001), in their review involving 1415 species of infectious organisms known to
be pathogenic to humans, identified 61% as zoonotic i.e. they can be transmitted
between humans and animals. According to Weiss (2001), animals have been a
major source of human infectious diseases since time immemorial. The author
gives examples of infections such as rabies which are caused by direct animal-to-
human transmission or of variant Creutzfeldt-Jacob disease (vCJD) which arose
from bovine spongiform encephalopathy (BSE) a recent example of direct zoono¬
sis. BSE is caused by prions and was first observed in 1986 in Great Britain.
It was presumably spread by trade in feed containing the infectious agent and
there is a strong evidence that both the previously unknown human prion dis¬
ease, new vCJD and BSE are caused by the same agent (Donnelly et ah, 1999;
Kretzschmar and Lederer, 2002). According to Borchers (2002), there is evidence
that in Great Britain by the end of March 2001, 97 young people acquired vCJD
due to consumption of food that contained bovine risk material. Erstad (2002)
emphasises that ingestion of prion-infected beef remains the only known cause of
new vCJD. Weber et al. (1997) and Donnelly et al. (1999) point out that public
concern in Great Britain and Northern Ireland remains focused on the probable
link between BSE infection in cattle and new vCJD in humans.
Escherichia coli 0157 (E.coli 0157) is another pathogen responsible for the de¬
velopment of a number of syndromes in humans. E.coli 0157 is found regularly
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in faeces of healthy cattle (Synge et ah, 2000) and is transmitted to humans
through contaminated food, water and direct contact with infected people or an¬
imals (Pennington Group, 1997; Shinoda et ah, 1997; Mead and Griffin, 1998).
E.coli 0157:H7 is often a cause of serious disease in humans with asymptomatic
animal carriers cited as a reservoir of infection (Clifton-Hadley, 2000). Vari¬
ous authors, for example, Richter et al. (1997); Heuvelink et al. (1998); Hu et al.
(1999) and Osek (1999) believe that cattle are the main carriers of the pathogenic
bacteria, with food of animal origin (especially beef and milk) being important
sources of infection. Other zoonoses apart from BSE and E.coli 0157, mainly
transmissible from animal to man through contaminated food are: salmonellosis,
listeriosis and campylobacteriosis (Ganiere et ah, 2001). Jemmi et al. (2000) point
out that the risk of zoonotic disease transmission when handling livestock or ani¬
mal products is substantial. The authors further point out that in industrialised
countries, diseases such as salmonellosis and campylobacteriosis which can cause
serious disease in humans have become a major public health problem.
Companion animals are also a potential route of infection from animals to man.
According to Ivolarova et al. (2002), the development of close contacts between hu¬
mans and animals that served humans for meat and as guardians encouraged the
exchange of microflora between species. By inhalation of aerosol from animal hair
or scales and especially by consumption of animal meat, eggs and milk, humans
became subject to the natural circulation of animal microorganisms. Geffray and
Paris (2001) point out that domestic pets can transmit numerous bacterial, par¬
asitic, fungi and viral infections and the authors highlight the need to improve
knowledge about the epidemiology of pet-transmitted zoonoses.
According to Thrusfield (1995), Chapter 20, in western countries, government
veterinary services are increasingly required to justify their budgets, as the role
of the public sector diminishes. Also, as the importance of agricultural output
declines in these countries, the economic justification for animal disease control is
queried more closely. With rising incomes and changing social values, attention in
the western countries has widened from the initial (relatively narrow) evaluation
of disease in farm livestock to address both qualitative aspects of food produc¬
tion and diseases of companion animals. However, diseases of farm livestock, in
addition to being sources of infection to humans, are barriers to international
trade. There is a current drive to liberalise world trade through the world trade
organisation (WTO) and to the problem of livestock diseases has become even
more acute. For instance an exporter of infected product may face higher tariff
7
than would otherwise be the case (Paarlberg and Lee, 1998). The problem of
spread of diseases also impacts upon the harmonisation of trade in the EU which
requires free movement of commodities (Zwingmann and Fiedler, 2001). In gen¬
eral, animal diseases have economic as well as biological impact on humans. As
already noted above, disease in a livestock population poses a risk to humans as
a result of consumption of contaminated animal products (Cornick et ah, 2000;
Phillips et ah, 2000; Bouvet et ah, 2001; Chapman et ah, 2001; Cobbold and
Desmarchelier, 2001; Watson, 2001). Disease in livestock population also reduces
the quality and/or quantity of livestock products available for human consump¬
tion and export. More importantly, from the economic point of view, disease in
livestock populations deters people from consuming associated animal products.
According to Baker and Ridley (1996), following a report of 10 cases of new vCJD
which precipitated alarm throughout Europe, the beef trade in the UK collapsed.
The 2001 UK foot-and-mouth disease epidemic, is the most recent example of the
effect of animal diseases on the economy. This epidemic had vast impact on the
agricultural and tourism industries. Thompson et ah (2002) estimated losses to
agriculture arising from the epidemic at about 3.1 billion pounds. The authors
indicate that the majority of the costs were met by government through compen¬
sation for slaughter and disposal as well as clean-up costs. Nevertheless, farmers
will have suffered losses which the authors estimated at 355 million pounds, repre¬
senting 20% of the estimated income from farming in 2001. Taylor (2002) points
out that the restrictions imposed for more than 10 months throughout the coun¬
try in 2001 to control and eradicate FMD had damaging effects on tourism and
rural businesses. The decision to eradicate the disease by slaughter rather than
vaccination saw a huge number of animals destroyed. Davies (2002) estimates
that over 4 million animals were slaughtered from 2000 herds and flocks while
Scudamore et al. (2002) put the number of slaughtered animals at 6.5 million of
which over 4 million were removed as a direct result of the disease, while a fur¬
ther 2.5 million were slaughtered on welfare grounds. Mepham (2001) questions
the ethical validity of the procedure i.e. the slaughter of millions of animals, to
eradicate the disease. According to Cassagne (2002), FMD has devastated animal
husbandry in the Netherlands frequently in the past and still constitutes a threat.
The author points out that in 2001, the FMD outbreak proved very disruptive
to the wider rural economy, such as the recreational and tourism sectors. Garner
et al. (2002) in their study of the economic aspects of FMD in Australia empha¬
size that an outbreak of FMD would have severe economic consequences on the
economy. The authors estimate that in an outbreak lasting six months, real gross
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domestic product in Australia would fall by an estimated 3.5 billion Australian
dollars and point out that much of the impact would be due to loss of export
markets. Undoubtedly, the biological and economic problems that result from
infections in animals both serve to emphasize the importance of understanding
the mechanisms underlying the spread of diseases in animals.
For some diseases e.g. E.coli 0157, it is very difficult to identify the virulent
strains, Karakulska and Nawrotek (1999) emphasize that it is very important to
work out diagnostic methods which will detect the pathogens in the environment
quickly and effectively. For FMD, there are variations in the indicators of dis¬
ease, for instance clinical signs may be observed only after viraemia has already
commenced (Hughes et ah, 2002b) and there is a high risk of infected animals,
especially sheep, being misdiagnosed (Dekker and Terpstra, 1999; Blanco et ah,
2002). For such a disease it is vital that laboratory diagnostic tests are very sen¬
sitive. Molecular biologists, for instance in Paton and Paton (1998); Karakulska
and Nawrotek (1999); Reid et al. (2002) and Reid et al. (2003), are carrying out
research to try to perfect diagnostic tests.
Mathematical and statistical modelling has been used in efforts to try to un¬
derstand the spread of diseases and to estimate parameters of biological impor¬
tance. Mathematical modelling has been widely used to understand the spread
of diseases in human populations. Mathematical modelling in epidemiology was
pioneered by D. Bernoulli in 1760 in his work demonstrating the effectiveness of
the technique of variolation against smallpox (Anderson and May, 1991, Section
1.2; Valleron, 2000). Mathematical modelling in human disease has investigated
infectious diseases such as HIV infection (e.g. Coutinho et al. (2001); Greenhalgh
and Hay (1997); Salomon and Murray (2001)), Prion diseases (Ferguson et al.,
1997), amongst others, as well as non-infectious diseases such as cancer (Valleron,
2000). le Corfec et al. (2000) argue that mathematical models have contributed
to a better understanding of the pathogenesis of AIDS.
Mathematical and statistical models are now being used to help understand the
dynamics of infectious diseases in animals. For example Anderson et al. (1996)
use epidemic models to investigate the transmission dynamics and epidemiology
of BSE in British cattle. Ferguson et al. (1999) use models in the estimation of
the basic reproduction number of BSE in British cattle. Stringer et al. (1998)
formulate a mathematical model to assist in the interpretation of field data fol¬
lowing an outbreak of scrapie in a single sheep flock. Woolhouse et al. (1998) use
a mathematical model to explore the expected course of an outbreak of scrapie in
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a sheep flock and the potential impact of different control measures. Matthews
et al. (2001) and Woolhouse et al. (1999) use a mathematical model to understand
the epidemiology and population dynamics of scrapie following an outbreak in a
flock of Cheviot sheep. MacKenzie and Bishop (2001) use a stochastic model to
describe disease transmission dynamics on a pig farm, van Nes et al. (2001) use
mathematical and statistical models to analyse an outbreak of pseudorabies virus
in a vaccinated sow herd. Nodelijk et al. (2000) use stochastic models to analyse
observational data of porcine reproductive and respiratory syndrome virus in a
Dutch breeding herd. Stegeman et al. (1999) use a model to estimate the period
when classical swine fever virus had been introduced into herds where the infection
started in the breeding section during the 1997/98 epidemic in The Netherlands.
Jalvingh et al. (1999) use spatial-temporal and stochastic simulation models to
evaluate the impact of events and control measures in the 1997/98 classical swine
fever epidemic in The Netherlands. Woolhouse et al. (1996) use models to evalu¬
ate the effectiveness of vaccination in preventing persistent outbreaks of FMD in
Saudi Arabian dairy cattle herds. Durand and Mahul (2000) use what they term
an extended state-transition model to study FMD epidemics in France. Dexter
(2003) uses stochastic models to explore how stochastic variation in the popu¬
lation dynamics of feral pigs in the Australian semi-arid rangelands affects the
probability of persistence of an FMD outbreak and its impact on the density of
feral pigs. During the 2001 UK foot-and-mouth disease epidemic, mathematical
models were used to guide the disease control policy (Woolhouse, 2003). Ferguson
et al. (2001b) and Ferguson et al. (2001c) used models to analyse the transmis¬
sion intensity and impact of control policies on the epidemic. Morris et al. (2001)
used a spatial simulation model to evaluate alternative control policies for the
epidemic. Keeling et al. (2001) used an individual farm-based model to explore
different options of vaccination in advance of a FMD outbreak following the 2001
UK FMD epidemic.
The importance of modelling was underlined in the Royal Society of London's
report on the 2001 UK foot-and-mouth disease epidemic, which stated: " Quan¬
titative modelling is one of the essential tools both for developing strategies in
preparation for an outbreak and for predicting and evaluating the effectiveness of
control policies during an outbreak" (Royal Society, 2002). This report empha¬
sises that more work is required to refine the existing models. When investigating
disease transmission in animals, surveys and experiments have an important role
as they provide quantitative data enabling statistical analyses to be carried out.
However, there is a need for more refined analytical techniques which could utilise
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smaller numbers of animals in experiments in line with the UK government policy
encouraging the 3Rs of refinement, reduction and replacement (Hay, 1998). In
the wake of the 2001 UK foot-and-mouth disease epidemic, the UK government
has come to appreciate the importance of animal experiments in trying to under¬
stand the mechanisms of infectious diseases. Government agencies now believe
that animal experiments have a valuable contribution to make in understand¬
ing epidemic mechanisms and in developing control strategies (Matfield, 2002;
Anonymous, 2003).
1.1 Infectious diseases in animals
An infectious disease is one in which an animal is invaded by a foreign organism
such as a virus, bacterium or parasite from another infected animal. Some infec¬
tious diseases require intermediary vectors in order to spread from one animal to
another. For instance, equine infectious anaemia of horses can only be spread from
one animal to another by blood-sucking biting flies (Hunter, 1996). Infectious dis¬
eases can also spread between animals without any intermediary agent and these
are sometimes referred to as contagious diseases. Contagious diseases can be
spread by direct or indirect transmission. Direct transmission occurs mainly with
viruses that do not survive long in the environment. Infection in this case only
occurs when there is close contact between diseased and healthy animals. Some
organisms can infect animals via the skin, usually by contamination of cuts and
abrasion. For example, in bovine farcy, a chronic disease of cattle characterised
by lesions under the skin, infection occurs via contamination of skin wounds from
tick bites and thorn bushes (Hunter, 1996). Indirect transmission occurs in cases
where the infectious organism can survive outside the animal and hence be picked
up from the environment. Susceptible animals may become infected by ingestion
of contaminated food and water (Hinton, 1993). This is an important route of
transmission for many infectious organisms. The longer the organism survives in
the environment, the greater the chances of susceptible animals becoming infected
through this route. For instance FMD spreads rapidly because infected animals
discharge large amounts of the infecting virus in saliva, milk, faeces, semen, urine
and exhaled breath to the environment where it may survive for several months
(Dekker and Terpstra, 1999). The E.coli 0157 organism can survive in faeces for
a long time (Chapman et ah, 1993; Pennington Group, 1997). Other infectious
diseases may be transmitted through bedding, vehicles, and harness. This route
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of infection is referred to as infection from formites (Bartely et al., 2002). For
example in sheep and goat pox, animals can become infected by rubbing against
contaminated formites such as sheep pens, as the virus can survive for many
months in the environment.
Some infectious diseases are associated with environmental and husbandry factors
(the way animals are managed by their owners). It is therefore important to
understand the nature of livestock management when designing disease control
programmes. For example, mastitis in the modern dairy herd is relatively rare
in cows which suckle their calves naturally but it is a very serious problem in
high producing dairy cows milked by machine (Kruze, 1998). If not carried out
properly with high standards of hygiene, the process of machine milking can
lead to bacterial infection of the udder and hence to mastitis (Barkema et ah,
1999). Another example of infectious diseases triggered off by environmental
or husbandry factors are clostridial toxaemias in which animals are poisoned by
toxin produced by infecting clostridial bacteria (Hunter, 1996). These bacteria
are widespread in nature, being found in soil, organic matter and are natural
inhabitants of the intestines of livestock (Levett, 1986; Alsaif and Brazier, 1996).
Although infections with these organisms are normally harmless, in the presence
of certain predisposing factors e.g. a sudden improvement in nutrition or tissue
damage, they can multiply rapidly and produce large quantities of toxins which
poison the animal. Tetanus is a good example of such an infection; the causative
organism, Clostridium tetani localises and multiplies in contaminated cuts and
wounds producing a toxin which affects the nervous system. Bruggemann et al.
(2003) warn that tetanus is one of the most dramatic and globally prevalent
diseases of humans and vertebrate animals, and has been reported for over 24
centuries. The authors point out that the main manifestation of the disease,
spastic paralysis, is caused by the second most poisonous substance known, the
tetanus toxin, with a human lethal dose of approximately Ing/kg. Fortunately,
the disease can be successfully controlled through immunization with tetanus
toxoid (Bruggemann et ah, 2003).
In general there are many different routes by which an organism may pass from
an infected individual to a non-infected one. Knowledge of these routes is essen¬
tial in devising methods to prevent infection. It is essential to understand the
agents that cause infectious diseases in order to appreciate better the process by
which diseases occur. Micro-organisms are defined as being pathogenic and often
referred to as pathogens when they cause a range of pathological changes to tis-
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sues once they have invaded an animal. In nature there are thousands of different
types of micro-organisms but only a small proportion are pathogenic. Infection
due to a particular organism can be diagnosed using a number of criteria, which
include clinical signs and symptoms, detection of specific agents, reaction to diag¬
nostic tests and identification of lesions (Dekker and Terpstra, 1999; Reid et ah,
2001; Hughes et ah, 2002b).
With the "reaction to diagnostic tests" criterion, test reactions may be observed,
for example, the reading of antibody titres in serological tests. Serological meth¬
ods involve investigation of disease and infection in animals by measurement of
variables present in serum: for instance, the specific antibody activity of im¬
munoglobulin. Antibodies provide evidence of current and previous exposure to
the infectious agent. However, because most commonly used diagnostic tests are
neither 100% sensitive nor 100% specific, animals may be misdiagnosed. Animals
may be recorded as having an infectious agent present or having had exposure to
infectious agent when actually no such exposure has occurred. This constitutes
a false positive record. Alternatively, an animal may be recorded as having no
infectious agent present or not having had exposure to infectious agent when ac¬
tually the converse is true. This constitutes a false negative record. Such errors
lead to misclassification of infected and non-infected animals. There is therefore
a need to validate diagnostic tests. Sensitivity, the proportion of true positives
that are detected by the test, and specificity, the proportion of true negatives
that are detected by the test are indicators of the validity of diagnostic tests. In
Figure 1.1, extracted from Hughes et al. (2002b), where the FMD virus infection
in sheep was examined experimentally, it is observed that detection of infected
sheep would highly depend on the diagnostic criterion used. For instance using
virus isolation from blood as the diagnostic criterion yielded a higher proportion
of infected sheep than the criterion of antibody detection in serum and that of
clinical signs. The results of these experiments have implications for the diagnosis
and control of FMD virus infections and estimation of sensitivity and specificity
is another important aspect of veterinary infectious disease data.
1.2 Foot-and-mouth disease
Foot-and-mouth disease (FMD) is a very important and extremely infectious vi¬
ral disease of cloven hoofed animals and occasionally man (Hunter, 1996). FMD
virus can be spread via saliva, milk, semen, faeces, urine and exhaled air as well as
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Figure 1.1: Graph illustrating the epidemiology of experimental FMD virus infec¬
tion is sheep: graph extracted, with permission, from Hughes et al. (2002b).
Days post exposure
being released directly from ruptured vesicles. The virus is extremely infectious
and susceptible animals may be infected by inhalation or ingestion of the virus by
various means e.g. from nearby infected animals, a virus contaminated environ¬
ment or in feed, notably uncooked swill containing animal tissues such as lymph
nodes, bone marrow and viscera. The virus can also be transferred from location
to location on vehicles or clothing, and in cool humid conditions the virus can
become wind-borne for long distances. According to Sanson (1994), FMD may
well be the most contagious disease known in the animal kingdom. The author
attributes this property to the ability of FMD to gain entry and initiate infection
through a variety of sites, its small infective dose, short incubation period, the
release of virus before the onset of clinical signs, the massive quantities of virus
excreted from infected animals, its ability to spread large distances due to air¬
borne dispersal and the persistence of the virus in the environment. The author
warns that the above features plus the ability of the virus to be disseminated
through movements of animals, animal products, people, plants and equipment
all make the disease very difficult to control.
There are seven serotypes of FMD virus, namely A, O, C, SAT 1, SAT 2, SAT 3
and ASIA I and within each serotype there are further sub-types. The disease is
enzootic in many parts of the world. In Africa types A, O, SAT 1 and SAT 2 are
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widespread while type C is rare and type SAT 3 is mainly present in Southern
Africa and Sudan. FMD is absent from North and Central America, Australia,
Pacific Islands and most of Europe but endemic in countries bordering continental
Europe (Hunter, 1996). Before the 2001 outbreak of FMD in the UK, there had
been recent outbreaks in various parts of the world including EU countries (e.g.
Greece in 1996) Hughes (2001).
Through global trade links, there is always a risk of the virus being exported
to virus free countries. Gallagher et al. (2002) on estimating the risk of impor¬
tation of FMD into Europe concluded that the illegal importation of livestock
was the most likely route of introduction of FMD into Europe. Moennig and
Kramer (2002) warn that EU member states face a high risk of introduction of
FMD through increasing trade and tourism but also through the illegal impor¬
tation of animals and animal products from all over the world. The 2001 UK
FMD epidemic is a concrete example of the disease breaking out in a country
after several decades of freedom from FMD. Animal feed is another important
source of FMD, for instance the feeding of swill to pigs not only creates a risk of
introducing classical swine fever but also of introducing FMD. Indeed, according
to Alexandersen et al. (2003), during the 2001 UK FMD epidemic, the first out¬
break was at an abattoir which specialised in the processing of culled sows and
boars followed by confirmation of the disease at a pig farm fed on waste food. As
reported in Bruckner et al. (2002), in 2000 South Africa lost its designation as a
zone free from FMD without vaccination in domestic stock attained in 1995 due
to the re-introduction of FMD in domestic livestock when the first ever recorded
case of serotype O in South Africa was diagnosed in a piggery after the illegal
feeding of untreated swill. FMD virus can be moved a big distance by airplanes
and boats into a disease free country (de Clercq, 2002).
Moennig and Kramer (2002) highlight that during the 2001 UK FMD epidemic, a
rapid spread of the disease became possible through trans-species infection from
pigs to sheep. As FMD symptoms are less pronounced in sheep compared to
cattle and pigs, this resulted in a late detection of the disease. This factor and the
intense trade in animal open markets coupled with numerous long distance animal
transports caused the rapid spread of FMD over the country and the export of
infection to France and The Netherlands. Moennig and Kramer (2002) also point
out that the inadequate hygiene management prevalent in most cattle operations
might facilitate the spread of FMD infection, warranting the establishment of
legal rules to define an adequate hygiene status for cattle holdings, equivalent to
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those criteria implemented for the pig industry. Although not formally confirmed
during the UK outbreak, FMD can be transmitted through contact with wildlife
(Bruckner et ah, 2002). Donaldson (1997) suggests that in the early stages of
an outbreak, in a country which is normally free of FMD, before disease control
measures have been implemented, FMD can be spread through untreated milk
because cattle are not routinely vaccinated.
In endemic areas, the disease in indigenous livestock may follow a mild course with
animals recovering in a few days but susceptible animals {e.g. exotic cattle) may
be severely affected. Although the lesions heal fairly rapidly, convalescence can
be prolonged, causing significant losses in milk and meat production and through
infertility. Also, draught buffaloes and oxen may be unable to work. Although
the disease is generally extremely infectious, less than 5% of affected animals die
(Hunter, 1996). FMD causes both clinical and subclinical infection, depending on
the natural or acquired immunity of the host. Hutber et al. (1999) point out that
within vaccinated dairy herds, FMD may appear as an acute, mild or subclinical
infection, depending upon the immune status of the herd, the level of challenge
and the efficacy of the vaccine used. The FMD virus can survive outside the
infected host for up to several months if not subjected to heat or change in pH,
for example, the virus can survive for fifteen weeks on hay and straw (Bartely
et ah, 2002). In frozen carcasses, the virus can survive for prolonged periods in
lymph nodes, viscera and bone marrow.
It is evident from the literature that there is enormous concern about animal
diseases, especially those diseases which affect humans medically, socially or eco¬
nomically. It is therefore important that the epidemiology of animal diseases be
studied to facilitate the design of control measures. This thesis will investigate
statistical inferential techniques as applied to veterinary infectious disease data.
It will incorporate a practical component where various inferential methods will
be applied to data describing experimental infections of FMD virus in sheep. As
discussed earlier in this section, FMD is a highly important disease, and hence it
is crucial that the properties of the virus are investigated.
1.3 The foot-and-mouth disease experiments
In this thesis inference will be performed on data generated from experiments in¬
fecting sheep with FMD virus. The experiments were inspired by earlier studies
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of type O FMD epidemics, which produced unexpected results (Hughes, 2001).
These studies followed the outbreaks of FMD in Greece in 1994 and in Tunisia
in 1989-90. Results from these studies suggested a marked progressive reduction
in the infection potential. The observations made in these studies would suggest
that FMD outbreaks could be self-limiting in sheep for some virus strains. The
observed epidemiology of the natural outbreaks certainly suggested that some
strains of FMD virus were weakly maintained in sheep populations under cer¬
tain conditions. Such a suggestion if true, would have important implications
for the design of FMD control programmes in outbreaks involving sheep as the
predominant hosts.
The experiments described in this section were an attempt to assess transmis¬
sion of the virus through the infection of sequential groups of sheep in a well
defined experimental situation. It was crucial to the design of the experiments to
ensure a consistent exposure period for sequential groups of sheep. Preliminary
experiments (Hughes, 2001) were performed using one animal room within an
isolation unit. During these experiments, a group of sheep were initially infected
with FMD virus and further susceptible groups of sheep were introduced after the
earliest definitive sign of FMD. Analysis of these experiments suggested that due
to the early (pre-clinical) excretion of FMD virus by infected sheep, a consider¬
able proportion of the viral excretion was lost before the new susceptible groups
of sheep were introduced to the room. Thus it was difficult to expose recipient
groups of sheep to the total viral excretion of the donor group while ensuring that
the total viral load from these animals is shed in the presence of their (further)
recipient group. Subsequent experiments were therefore designed in such a way
as to ensure that each recipient group was exposed to the same proportion of the
total virus excreted by the donor group. The exposure period was set at 24 hours
following another set of preliminary experiments which demonstrated that a 12
hour exposure period was not sufficient to allow transmission to occur beyond the
second group. All contact groups of sheep were to be exposed to virus for 24 hours
by moving 'up-stream' and following this period, spend 24 hours 'down-stream'
potentially donating virus. To ensure that at least some sheep in group 1 had
reached peak infectivity when group 2 was brought into contact, inoculation of
group 1 was staggered.
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1.3.1 Design and objective of experiments
Two identical experiments were carried out within a high security isolation unit at
the Institute of Animal Health in Pirbright. The experiments involved four groups
(G1-G4) of eight sheep, each group housed in a different room for three days prior
to the start of the experiments. All sheep in group 1 were inoculated with the
virus, inoculation being staggered in time to ensure a wider distribution of peak
infectiousness. Half of group 1 sheep (denoted group la) were inoculated on day
0 while the other half (group 16) were moved to a separate room and these were
inoculated 24 hours later. All group 1 sheep were inoculated with 105 TCID50
of FMD virus type O Greece 23/94 in 2ml of M25 buffer intranasally using a 2
inch-length of sterile rubber tubing. Groups of sheep were moved between rooms
repeatedly after 24 hours had passed. The movement of groups between rooms
are shown in Figure 1.2.
Figure 1.2: Pattern of movements of groups of sheep in the FMD experiments.
MIXING GROUPS
DAY Rooml Room2 Room3 Room4
0 G1 G2 G3 G4
1 G1&G2 G3 G4
2 G1 G2&G3 G4
3 G1&G2 G3&G4
4 G1 G2&G3 G4
5 G1&G2 G3&G4
6 G1 G2&G3 G4
Odd Day G1&G2 G3&G4
Even Day G1 G2&G3 G4
24 hours after the inoculation of group la sheep, group 2 sheep are moved into the
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group 1 room and stay there for 24 hours. They are subsequently moved back to
their room and joined by sheep from group 3 for 24 hours. Group 3 sheep are then
taken back to their room and joined by group 4 sheep for 24 hours; at the same
time group 2 sheep are moved back to the group 1 room where they all remain
for 24 hours. After the movement of animals has commenced, sheep repeatedly
spend 24 hours in their own room and 24 hours in the preceding room except for
group 1 sheep: these remain in their own room throughout the experiment. This
process continues until there are no shedding sheep in any groups (7 days after
viraemia ceased, see Section 1.3.2 below) and sufficient time had been allowed for
any infected but pre-patent animals to become apparent (10 days). All uninfected
sheep were challenged at the end of each experiment by intranasal inoculation of
10° TCID50 of FMD virus type O Greece 23/94 in 2ml of M25 buffer to confirm
that they were susceptible to infection.
All sheep movements took place at the same time each morning. Groups of sheep
were moved along a 'dirty' corridor, starting with the highest group number.
The corridor was disinfected thoroughly after each movement. This ordering
should ensure that, should disinfection fail, animals would be typically exposed
to virus from a higher passage than that to which they are exposed in their rooms.
Following movement, all sheep were sampled, starting with the lowest group. All
staff were disinfected thoroughly before moving to a different room.
The main hypothesis to be tested is whether there is an intrinsic diminution
in the infectivity of infected animals during the course of successive naturally
transmitted infections of FMD virus.
1.3.2 Sampling
On each day of the experiments, blood samples were taken for serology and FMD
virus isolation (details found in Hughes (2001)). Throat swabs were also taken
every day and were tested for presence of FMD virus using polymerase chain
reaction (PCR) (Reid et ah, 2001). All sheep were examined daily for clinical signs
of FMD in the mouth and on all four feet. Rectal temperatures were recorded
daily. Oesophageal-pharyngeal fluid (OPF) was taken from every animal on days
estimated as 30 and 33 post-infection for the first experiment and 35 and 38 days
post-infection for the second experiment. Animals that did not develop clinical
disease at the end of the epidemic were tested for immunity. Processing of samples
is described in Hughes (2001).
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1.3.3 Observed data from FMD experiments 1 and 2
The observed data as obtained from the experiments is presented in Figures 1.3
and 1.4 for experiments 1 and 2 respectively. The data are viraemic periods,
indicating days of detected virus shedding. The 'red' region indicates days when
sheep tested positive to FMD virus. For example sheep number 1 from experiment
1 tested positive on days 2, 3 and 4. Methods developed in this thesis will be
applied to these data.
Figure 1.3: Viraemic periods for sheep during serial passage experiment 1. The
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1.4 Infectious disease data
Infectious disease data are usually obtained from epidemics occurring in nature
rather than from planned experiments. This fact makes it difficult to accumulate
precise and detailed data and often infectious disease data are incomplete due to
partial observation of the infection process. For instance, it might be that only
the initial and final states of the epidemic are observed or that the data consist
of initial values and continuous observation of the removal process, as infected
animals are either identified or removed from the population. The number of
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Figure 1.4: Viraemic periods for sheep during serial passage experiment 2. The
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infective and susceptible individuals is not observable at all time points during
the period of the epidemic. Usually it is impossible to observe the time at which
infections occur or to know which infected individual is responsible for transmit¬
ting the disease to a particular susceptible. For some diseases one can hope to
have the times at which infected individuals show certain symptoms, this is the
most reliable information one can collect about the physical infection process. In
practice, one is usually aware of infectives only when they show symptoms but
it is sometimes possible to deduce, at least approximately, the times at which
infections have occurred and when infected individuals are infectious. For exam¬
ple, Becker (1995) points out that the measles rash erupts about 14 days after
infection with relatively little variation and it is reasonable to assume that indi¬
viduals are infectious during the period immediately prior to the eruption of the
rash. However, in the case of animals, it is often not easy to tell if an animal is
infected until it finally breaks down or exhibits clinical signs. This is true of FMD
in sheep (Sanson, 1994; Hughes et al., 2002b). This makes veterinary infectious
disease data even more difficult to analyse. In summary, analysis of these data
requires special attention because of the following difficulties:
1. The spread of infection through a community is only partially observable.
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2. Dependence in the data usually leads to a likelihood function with an ana¬
lytically intractable form.
3. Relatively little is known about characteristics that are not directly observ¬
able such as the duration of the latent period, which makes it difficult to
fit parametric models for the entire progression of the disease as is required
for most likelihood-based inference methods.
1.4.1 Issues in the analysis of infectious disease data
The analysis of infectious disease data presents new statistical challenges because
standard methods of inference such as those based on likelihood are often too
complicated to implement (Becker, 1995). The complexities arise because the
infection process is only observed partially leading to the introduction of many
integrals into the likelihood function to integrate over unobserved variables. These
likelihoods are difficult to analyse and cannot be simplified. Statisticians have
devised a number of ways to overcome these difficulties. In human epidemics,
for instance, one approach is to restrict the analysis to data summarising out¬
breaks in households with the assumption that the households are independent
e.g. in Becker (1968, 1979, 1981), Becker and Hopper (1983) and Becker and Dietz
(1995). Further methods to analysis data from independent outbreaks in house¬
holds are detailed in Bailey (1975), Chapter 14 and Becker (1989), Chapters 2
and 3.
Another way to tackle the difficulties in the likelihood methods is to make ad¬
ditional assumptions which enable the times of infection and the durations of
latent and infectiousness periods to be deduced, likelihood methods can then be
applied. Another approach has been to use non-likelihood methods. Martingale
methods are one such method derived from the theory of martingales. The work
of Becker (1989), Chapter 7 highlights that this method has found considerable
success in the epidemic context and Becker has applied the method in various
papers e.g. Becker (1993a), Becker and Hasofer (1997) and Becker and Britton
(2001). A more recent approach is the use of Markov Chain Monte Carlo (MCMC)
methods where unobservable quantities are estimated along with the desired pa¬
rameters. Examples where MCMC methods have been applied in the epidemic
context are Gibson (1997) for plant epidemics, O'Neill and Roberts (1999) for a
smallpox outbreak and O'Neill et al. (2000) for household outbreaks of influenza
and measles.
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In this thesis inference will be performed on data collected from experiments in¬
volving FMD virus in sheep. The rate of infection acting upon groups of sheep
will be estimated using martingale and maximum likelihood methods. Estima¬
tion will be carried out using an iterative procedure similar to the Expectation-
Maximization (EM) algorithm (Dempster et al, 1977; McLachlan and Krishnan,
1997, Section 1.5) to calculate estimates for the unobserved times of infection,
times of start of infectiousness, and times of end of infectiousness for infected
individuals.
1.5 Thesis outline
In this chapter the main theme of the thesis has been introduced. Biological and
socio-economic reasons for interest in infectious diseases in animals have been
provided along with an overview of infectious diseases in animals. Particular
attention has been paid to FMD virus. A detailed description of the FMD virus
infection experiments in sheep has been provided. Some motivation on the use of
mathematical and statistical models has also been given.
Chapter 2 presents a review of epidemic models and simulation models. Specific
epidemic models such as the general epidemic model and the susceptible-latent-
infectious-recovered (SLIR) are described and their application to the experimen¬
tal FMD design is explored. The simulation models which will be used to generate
data for use in other parts of the thesis are described. In addition, the EM algo¬
rithm, an inferential method that will be developed later in the thesis to analyse
the data is introduced.
Chapter 3 explores specific methods for modelling the FMD experimental infec¬
tion process on the basis of the infection generation of individual sheep. Chain
binomial models suitable for modelling the infection process using infection path¬
ways are described and their application in relation to the FMD experimental
data is discussed. Generalized linear models are used to make inference about
the generational rate of infection by assigning infection generations to infected
individuals. The generalized linear model approach is evaluated using simulated
data.
In Chapter 4, methods of parameter estimation using models of the infection
process based on average infection rates applying to groups of sheep rather than
individual sheep are described. These include maximum likelihood and martingale
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methods of estimation. All of these methods require observations which are not
available from the experimental data. Hence these estimation methods are to
be used within an iterative procedure similar to the EM algorithm to estimate
unobserved quantities and hence estimate the rate of infection acting upon groups
of sheep.
In Chapter 5, emphasis is placed on modelling the infectiousness period given the
observed number of viraemic days without taking into account the time of infec¬
tion and latent period or the force of infection. This will be referred to as partially
modelling an infection process as opposed to fully modelling the entire infection
process. If an epidemic does not exhaust the susceptible population in a group of
animals, this information will suffice to allow the use of a martingale estimator
to estimate the rate of infection parameter. In this chapter, parameters for the
estimated distribution of the infectiousness period are estimated based on the
observed number of viraemic days. Also estimated is the expected infectiousness
period for each infected individual given the number of viraemic days. Martin¬
gale estimates for the average rate of infection acting upon groups of sheep are
calculated once the expected infectiousness periods for infected individuals have
been estimated.
In Chapters 6 and 7, infection process characteristics i.e. the time of infection,
latent period and infectiousness period are estimated in addition to the rate of
infection in what is referred to as a model of the entire infection process. In Chap¬
ter 6, distributions for these three infection process characteristics are introduced.
From these, expected values of the characteristics are to be estimated. This is
achieved directly for the latter variable, while calculations for the expected time
to infection and latent period are more complex. These are estimated by consider¬
ing temporal partitions of constant hazard and then summing up the components
from all partitions. The distribution parameters for the latent period distribu¬
tion are estimated based on the data defining the number of days that group 1
individuals tested negative after inoculation prior to the first positive test result.
Also estimated are the average rates of infection applying to groups of sheep.
The rates of infection are estimated using martingale (Chapter 6) and maximum
likelihood (Chapter 7) estimation methods. The trend in the rate of infection
is then summarised. The maximum likelihood estimation methods are carried
out to give both unrestricted and restricted estimates for group rates of infec¬
tion. The estimates for rates of infection and estimates of expected infection
process characteristics are calculated alternatingly within an iterative procedure.
In Chapter 7, comparisons are made between the martingale, unrestricted and
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restricted maximum likelihood based estimates. The statistical significance of the
trend in the rate of infection is tested using bootstrap methods.
In Chapter 8, the methods developed in Chapters 6 and 7 are evaluated using
simulated epidemic data. Estimation methods based on both martingale and
maximum likelihood for the rate of infection are assessed with regard to an exist¬
ing trend in the rates of infection to investigate if the methods are able to detect
the trend. The properties of martingale based methods are further assessed with
regard to size of decrease in the rate of infection, size of R0 and group size.
Chapter 9 is concerned with the exploration of coverage properties of confidence
intervals for the reproduction ratio estimated from realisations of a susceptible-
infectious-removed (SIR) infection process. Confidence intervals for which the
properties depend on asymptotic likelihood theory are evaluated with regard
to their appropriateness in situations of small populations and small outbreaks.
Asymptotic likelihood theory is shown to give poor results in such situations and
therefore ways of improving maximum likelihood estimate statistic based confi¬
dence limits are discussed. Bootstrap approaches to the construction of confidence
intervals are proposed and evaluated. A bootstrap calibration process is applied
to each of the methods with the objective of improving the basic asymptotic
likelihood and bootstrap confidence intervals.
In Chapter 10, results derived in the thesis are summarised and possible areas of
further work are outlined.
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Chapter 2
Epidemic models and simulation
modelling
2.1 Introduction
Mathematical and statistical methods have been widely used to contribute to the
understanding of the mechanisms underlying the spread of infectious diseases.
This has largely been done via the use of epidemic models. Modelling involves
the mathematical representation of the physical and biological processes which
control infections. The modelling of the processes facilitates the representation
of events in quantitative mathematical terms, allowing predictions to be made
about future or hypothetical events. Thus epidemic models allow an increased
understanding of patterns of disease occurrence. Progress in understanding the
nature of epidemic processes has assisted in the prevention of infectious diseases
(Anderson and May, 1991, Section 1.3).
In epidemiology, models have been constructed to attempt to predict patterns
of disease occurrence and what is likely to happen if specific control strategies
are adopted. The modelling of infectious diseases dates back to the 18th cen¬
tury, where Daniel Bernoulli applied a simple life table to French smallpox data
(Thrusfield, 1995, Chapter 19). Early models described natural epidemics of
human infectious diseases. Thrusfield (1995), Chapter 19, points out that only
within the last 30 years has serious attention been paid to the modelling of animal
diseases. Early work on the dynamic behavior of theoretical models (for both hu¬
man and animal diseases) made little attempt to fit models to observational data
and was therefore of little direct value to disease control campaigns. However,
there has been a trend for subsequent modelling work to become more realistic,
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incorporating the effects of control techniques such as vaccination and immuniza¬
tion for human diseases (Halloran et ah, 1992; Becker and Hall, 1996; Becker and
Utev, 1998). Recent formulations have incorporated the effect of economic con¬
straints and examined the cost-benefit implications of different strategies. Given
the trend of increasing computing power, many studies have used computers to
simulate situations rather than depending on analytical results. Models can only
give useful results if they are biologically valid. Epidemic models therefore should
seek to ensure that all known determinants that influence disease occurrence are
included, that these factors can be quantified and estimated with accuracy and
that the model is biologically meaningful. Mathematical models of the dynamics
of communicable diseases have often had a direct bearing on the choice of an
immunization programme, the optimal allocation of scarce resources or the best
combination of control or eradication techniques (Remme et ah, 1995). Most re¬
cently, this has been illustrated by the use of mathematical models to drive the
governmental response to the 2001 UK FMD epidemic (Green and Medley, 2002).
The epidemic theorem is probably the most important result derived in the the¬
ory of epidemic models (Becker, 1989, Section 1.4.1). This theorem quantifies
the distribution of the final size of an outbreak of a disease in large closed pop¬
ulations in terms of a parameter R0 and other aspects of the infection process.
By referring to the early stages of an epidemic, R0 may be loosely defined as the
mean number of susceptible individuals infected by a single infected individual
introduced into a susceptible population at the beginning of the infected indi¬
vidual's infectious period. R0 is commonly referred to as the basic reproduction
number. The threshold phenomenon frequently associated with R0 can help ex¬
plain aspects of disease spread when the disease is endemic in a community. In
general terms, where Ro < 1, there is zero probability at the infection giving rise
to a major outbreak, affecting the majority of individuals in a population. Where
Ro > 1, there is a finite probability, equal to 1 — of such an outbreak occurring
(Bartlett, 1949).
Mathematical epidemic models which are sufficiently simple to provide analytical
results may be said to be simplistic and unrealistic, but they can generate useful
qualitative predictions about possible modes of behavior (Renshaw, 1991, Section
10.2). Becker (1989), Section 1.4, argues that it is wrong to reject such models on
the grounds of their simplicity since therein lies a considerable part of their value.
A simple model is more likely to yield to mathematical analysis and hence reveal
important characteristics more clearly than a complex model. For example, in a
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simple model it is more straightforward to extract estimates of parameters which
measure the infectiousness of the disease, the mean duration of the period between
infection and infectiousness and similar epidemiologically important parameters.
Bailey (1975), Chapter 1, gives an account of different ways in which mathemat¬
ical modelling can provide scientific insight into the mechanics of epidemic and
endemic processes. Mathematical and statistical studies have an essential role to
play in shedding light on the life-cycle of a parasite, the transmission and spread
of an infectious disease, the nature of threshold population densities above which
an epidemic can flare up and the methods of optimal immunization and control
(Renshaw, 1991, Section 10.1).
de Jong (1995) emphasizes that modelling is a useful tool for studying complex
phenomena such as the population dynamics of infectious agents, reasoning that
models allow disparate measurements to be seen as manifestations of a single
underlying process, but warns that a careful choice of model is important. During
the UK 2001 foot and mouth disease outbreak government agencies relied heavily
on the advise given to them by modellers in the effort to combat the epidemic
(Ferguson et ah, 2001a; Keeling et al., 2001; Woolhouse, 2003). The importance of
modelling during this outbreak in forming efforts to control the epidemic cannot
be overestimated.
In the past, it may have been necessary for researchers to develop mathemati¬
cal models, driven more by the need for mathematical simplicity than biological
realism, while the effective fitting of these models to data was sometimes rudi¬
mentary. However, research is now being carried out in inferential statistics with
the objective of estimating parameters for infectious disease systems e.g. in Fer¬
guson et al. (1997, 1999); O'Neill and Roberts (1999); Nodelijk et al. (2000) and
Caley and Ramsey (2001). In this thesis, emphasis will be placed on parameter
estimation methods as applied to experimental foot-and-mouth disease virus in
sheep.
2.2 Types of models
Thrusfield (1995), Chapter 19, points out that veterinary modelling has been
focused on infectious diseases. Following earlier work, he classifies infectious
agents into two groups according to their generation dynamics. These groups are
micro-parasites (e.g. viruses and bacteria) and macro-parasites (e.g. helminths
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and arthropods). These two different groups are associated with two different
modelling approaches. One is the density model approach that considers the
absolute number of infectious agents in each host, commonly used for macro-
parasitic infections where the numbers of infectious organisms can be estimated
either in the host or in the environment. A classical example of this approach to
modelling is the schistosomes model of MacDonald (1965). The second type is the
prevalence model, which is used to model micro-parasites. Since the enumeration
of absolute numbers of micro-parasites is usually impracticable, these systems
cannot be readily modelled by density models, and so are modelled by prevalence
models that consider the presence or absence of infection in the host. Density and
prevalence models can be formulated either deterministically or stochastically.
In deterministic models, results obtained do not take account of random varia¬
tion. It is assumed that the future state of the epidemic process can be determined
precisely given the initial numbers of, for example susceptible and infectious in¬
dividuals as well as the model parameters such as the rate of infection, recovery
rate, birth rate or death rate. Stochastic models, however, describe processes or
events subject to random variation so that there exists a space of possible epi¬
demic histories, each of which can occur with a certain probability. These models
exist within a mathematical structure which allows meaningful confidence inter¬
vals to be associated with estimates of model parameters of interest. In this
thesis, which is aimed at modelling the infection process of FMD virus in sheep,
stochastic models are considered. The model formulations explored are: the gen¬
eral epidemic model, where the infection process is defined in terms of susceptible,
infectious and removed/recovered states (SIR), assuming no latent period (the pe¬
riod when an infected individual is not yet infectious after acquiring the infection
(Anderson and May, 1991, Section 2.1); a susceptible-latent-infectious-recovered
(SLIR) model where infected individuals exhibit a latent period before becoming
infectious and then recovering; chain binomial models which involve the explicit
identification of infection paths. The thesis also examines how these models relate
to generalized linear models where statistical models are fitted to infection data
to estimate system parameters.
It is often the case that processes in the real-world that one wishes to investigate
are too complicated to fully understand. It is reasonable to strip such processes of
less important features and use models of the basic processes (Morgan, 1994, Sec¬
tion 1.2). For many epidemiological processes of interest, assumptions have to be
made about the way in which infections occur and develop. These assumptions,
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which usually take a mathematical form based on logical relationships, constitute
a model that can be used to try to gain more understanding of how the corre¬
sponding epidemiological process behaves (Law and Kelton, 2000, Section 1.2).
If the model can be understood, then it may provide insight into the process it¬
self. For some processes, the relationships that compose the model may be simple
enough to allow the use of analytical methods to obtain exact information about
questions of interest. However, most real-world processes are too complicated
to map to realistic models which can be evaluated analytically. Models for such
processes must be studied by means of simulation.
Often simulation can prove to be a useful tool, not only for describing the prop¬
erties of the model but also for investigating how the behaviour of the model
would change following a change in the model. Which in turn, maps to a possible
change in the epidemiological scenario. Features of the model in epidemiological
studies that had not previously been anticipated may emerge. In recent years,
there has been much interest in mathematical models of the spread of infection
(Morgan, 1994, Section 1.3; Renshaw, 1991, Section 10.1). Although the models
are often simple, their mathematical solution is not trivial and simulation of the
models has frequently been used.
Simulation models for epidemic data are usually constructed on basis of what are
commonly known as compartmental models. These models involve categorising
the states of individuals over time. Models of this class that will be explored in
this thesis are the SIR and SLIR models. These models, as opposed to alternatives
such as SIS (Susceptible-Infectious-Susceptible) model will be used on the basis of
the results of the FMD experiments. In these experiments there was no evidence
of recovered individuals being susceptible to re-infection and, indeed, when they
were tested for FMD virus antibodies at the end of the experiments, recovered
individuals showed signs of immunity (Hughes, 2001).
In the SIR models, the infectiousness period will be assumed to be negative expo¬
nentially distributed with mean where A is the transition rate to the recovered
state. This model is commonly known as the general epidemic model. For the
SLIR models, two sub-models will be considered, one which assumes fixed latent
and infectiousness periods and another where latent and infectiousness periods are
assumed to be variable and are modelled as gamma distributed random variables.
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2.2.1 The general epidemic model (SIR)
In the general epidemic model all individuals are initially assumed to be suscep¬
tible. Once infected, an individual becomes infectious for a period of time, and
is referred to as an infective, after which the individual stops being infectious,
recovers and becomes immune or dies. The individual is then said to be removed.
Models which assume that individuals pass in turn through the Susceptible, In¬
fective and Removed states are called SIR models and the general epidemic model
is defined in these terms. The general epidemic model was first studied in its de¬
terministic form by Kermack and McKendrick (1927) and in its stochastic form it
first received attention by Bartlett (1949). The general epidemic model is a mem-
oryless continuous time model describing the spread of a SIR infectious disease
in a population of homogeneous individuals that mix uniformly. The infection
process is illustrated in Figure 2.1. The model is formulated below, where the
Markovian nature of the process is illustrated in that instantaneous probabilities
depend only on the current state of the process.
Figure 2.1: The transition between states in the SIR infection process model, where
(3 is the rate of infection, j is the mean infectiousness period, S is the number of
susceptible individuals in a mixing group, I is the number of infectious individuals
and N is the total number of individuals in a mixing group. R is the number of
recovered individuals, and S + / + R = N.
Consider a closed community with N individuals. Let (3 denote the rate of infec¬
tion, A the recovery rate and S(t), /(f), and R(t) denote the number of susceptible,
infectious and removed individuals at time t respectively, R(t) + S(t) + I(t) = N
holds for all f, where N is the total number of individuals in the population under
study.
Under the pseudo mass-action formulation (de Jong et ah, 1995) or density depen¬
dency formulation of Begon et al. (2002), the general epidemic model is defined
by the transition probabilities:
Pr{dS{t) = -1, dl{t) = 1, dR(t) = 0} = 0S(t)I(t)dt
= Probability of one new infection in time
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Pr{dS(t) = 0 ,dl(t) = —1 ,dR(t) = 1}
Pr{dS(t) = 0, dl{t) = 0, dR{t) = 0}
= A I{t)dt
= Probability of one removal in time dt
= 1 - 0S(t)I(t)dt - XI(t)
= Probability of no change.
Under the true mass-action formulation (de Jong et ah, 1995) or frequency de¬
pendency formulation (Begon et ah, 2002), which will be used in the rest of the
thesis, the general epidemic model is defined by the transition probabilities:
Pr{dS(t) = -1, dl(t) = 1, dR(t) = 0} = PSW®dt
Pr{dS(t) = 0 ,dl(t) = — 1 ,dR(t) = 1} = A I(t)dt
Pr{dS(t) = 0, dl(t) = 0, dR{t) = 0} = 1 - PS^^dt _ XI(t). (2.1)
The choice of true or pseudo-mass action model may sometimes be justified by
improvements in fit to data. This will not be possible in this thesis, since the
population size is constant for most of the populations under study. The true-
mass action formulation will be preferred, on the ground that it has a more
intuitive interpretation. @I(t) is the force of infection associated with the infective
population. If this force is homogeneously distributed through the population,
^p- is the fraction of the force applying to susceptibles, the only class able to
make the specified transition.
2.2.2 The susceptible-latent-infectious-recovered model
In the SLIR model, the infection process is modelled using four states: the suscep¬
tible, latent, infectiousness and removed/recovered (SLIR) states as illustrated in
Figure 2.2. Once individuals are infected, they pass through a latent state fol¬
lowed by an infectiousness state and are then removed (no longer infectious with
no further effect on the force of infection, and not susceptible).
Figure 2.2: The transition between states in the SLIR infection process model
(Markovian true mass-action formulation).
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The model latent period corresponds to a period when viral load is low in the
animal following initial infection. Only individuals in the infectious state have the
potential to infect susceptible individuals. The infectiousness period corresponds
to the period when viral load is high and virus is being excreted or is present in
damaged epithelial cells at levels such that transmission can occur via physical
contacts between individuals. There is usually a rough correspondence between
the infectious period and the period during which clinical signs of infection are
apparent (Anderson and May, 1991, Section 2.1). End of latency marks the
beginning of the infectiousness state and end of infectiousness marks the beginning
of the removed state.
Under the Markovian (memoryless) true mass-action formulation the SLIR epi¬
demic model is defined by the following transition probabilities:
Pr{dS(t) = -1, dL{t) = 1, dl{t) = 0, dR{t) = 0} = PSWWdt
Pr{dS(t) = 0,dL(t) = —1, dl(t) = 1, dR(t) = 0} = pL(t)dt
Pr{dS(t) = 0, dL(t) = 0, dl(t) = -1, dR(t) = 1} = AI[t)dt
Pr{dS{t) = 0, dL{t) = 0, dl(t) = 0, dR(t) = 0} =
1 - PWWW _ n L(t)dt _ A I(t)dt
where p is the transition rate between the latency and infectiousness states and A
is the transition rate between the infectiousness and recovery states. It is assumed
that the transition times from L to I and from I to R are negative exponentially
distributed. This assumption is unrealistic for many applications, and a more
appropriate model, based on gamma distributed times to infectiousness and re¬
covery, will be defined in Section 2.4.2.
2.3 Previous applications of epidemic and sim¬
ulation models
This section will provide a brief review of some recent applications of epidemic
models and simulation modelling in the veterinary context. Leslie (1996) uses sim¬
ulation models to explore the transmission rate of Salmonella enteriditis phage
type 4 in a flock of laying hens given that experimental work to explore the epi¬
demiology of Salmonella enteriditis phage type 4 had left many question relating
to the transmission rate unanswered. French et al. (1999) use deterministic and
stochastic models to simulate the spread of Neospora caninum infection in cattle
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to try to understand the effect of various routes of transmission on the efficacy
of different control measures of the disease. The authors consider three possible
routes of transmission and they argue that the model results for one of the routes
of transmission are consistent with what is observed in the field. This highlights
the fact that simulation models can yield realistic results. Howard and Donnelly
(2000b) use simulations of a SLIR model to evaluate the control policy of slaugh¬
tering infected herds on the same day as disease confirmation in a FMD outbreak.
This model was also applied to study a classical swine fever outbreak in Taiwan
from which the authors concluded that implementation of the proposed policy
could have resulted in a smaller number of farms being affected by the outbreak,
van Nes et al. (1998) apply an SIR model to experimental and observational data
to evaluate the feasibility of eradicating pseudo-rabies virus by vaccination and to
determine which factors would hinder such an eradication, van Nes et al. (2001)
use SIR models to analyse data summarising a major outbreak of pseudo-rabies
virus in a vaccinated sow herd. Nodelijk et al. (2000) use a stochastic SIR model
to analyse observational data from a longitudinal study investigating the popula¬
tion dynamics of porcine reproductive and respiratory syndrome virus in a Dutch
breeding herd with the aim of quantifying transmission within the herd.
Haydon and Woolhouse (1997) use a SLIR model to generate a set of time varying
estimates for the transmission rate for the UK 1967-68 FMD outbreak. These
authors assume a fixed latent period and a fixed infectiousness period. Results
from their model confirmed the importance of the rapid and effective implemen¬
tation of control measures to reduce transmission rates during an outbreak. The
results in this paper were important during the 2001 UK FMD epidemic. Howard
and Donnelly (2000a) use an SLIR model to reconstruct the pattern of infection
and estimate a time-varying force of infection and R0 from observed epidemic
data summarising an outbreak of classical swine fever. These authors assume an
exponential distribution for the latent and infectiousness periods.
From the literature it is observed that many modellers tend to use the SIR model
even in situations where it is not realistic. For most infectious diseases, once
an individual is infected it does not become infectious immediately and use of
the SLIR model in such situations is more appropriate where the mean length
of the latent period is appreciable relative to the length of the mean infectious¬
ness period. However, even in situations where the SLIR model has been used to
model the infection process, many researchers have assumed a fixed latent and
infectiousness period or an exponential distribution for the latent and infectious-
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ness periods {e.g. Haydon and Woolhouse (1997); Howard and Donnelly (2000a)).
These distributional assumptions are likely to be extremely unrealistic for many
infectious diseases. Also, in a number of models, authors have assumed complete
observation of data {e.g. Becker and Hasofer (1997)). This is never likely to be
true in the case of infectious diseases and in some cases, the assumption will give
rise to misleading parameter estimates. In this thesis, where the simulation mod¬
els are used to explore the infection process of FMD in sheep, a random latent
period and infectiousness period will be assumed. The unobservable quantities
of the infection process will be recognised as such, estimated and not assumed
known.
In the next section, the general epidemic model and the SLIR model are described
in the context of the experimental FMD infection process.
2.4 Simulation models for experimental FMD
virus in sheep
In this section, the general epidemic model and the SLIR model are formulated as
applied to the FMD experiments, taking into account the experimental hypothesis
of decreasing rate of infection by infection generation. To model the decrease in
the rate of infection, a new parameter is introduced. This parameter consistently
will be referred to as the passage multiplier. It will usually be denoted by 7.
In this formulation, each infected individual has an infection generation number
assigned to it and the rate of infection for individuals of infection generation g is
given by f3g — (3 e~7S, where /3 is the rate of infection in the initial group of in¬
fectives and /3q = /3. Individuals are assigned infection generation numbers based
on the nature of the infection 'donor'. The initial infectives constitute infection
generation zero infectives, and an individual who becomes infected from contact
with a zero infection generation infectious individual is defined to be a generation
one infective. In general, an individual who becomes infected by a generation g
infectious individual is assigned an infection generation number of g + 1. This is
similar to the approach seen in the chain binomial models in Section 3.2 of this
thesis. The infection process for the FMD experiments will therefore be mod¬
elled based on the properties of individual infectious individuals in the simulation
models. Hence, the transition rate between susceptible and infectiousness states
in the case of the general epidemic model or between susceptible and latent states
for the SLIR model, due to a generation g infectious individual is given by ■
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Three models were considered for the infection process, namely:
1. A general epidemic model assuming no latent period and exponentially dis¬
tributed infectiousness period.
2. A model assuming fixed latent and infectiousness periods.
3. A model assuming a random latent period and infectiousness period. These
are modelled as independent gamma distributed random variables. The
gamma distributions for the two processes are different, with parameters
chosen for the latent period distribution to reflect the time elapsing (after
inoculation), before viraemia and those for the infectiousness period chosen
to reflect the number of observed viraemic days.
2.4.1 The general epidemic model
Each infected individual has a generation number. The generational rate of in¬
fection /3g depends on the generation number and is given by /3g = (3e~19, where
7 is the passage multiplier. Thus the epidemic model is considered separately
for each infectious individual such that, in a true-mass action formulation, the
transition probability of an infection of a given generation from a gth generation
infective individual in a small time period dt is given by ^j^-dt. The probability
of a removal is the same for each infectious individual and is given by Adt and
the probability of no change is given by 1 — ^-~dt — Adt. The general epidemic
model has two parameters, /?, the rate with which an infectious individual makes
an infectious contact with another member of the community and A, the removal
rate. The quantity -4^, measures the potential that an infective has for infect¬
ing a given susceptible. This quantity is called the basic reproduction number,
denoted by Rq, and it plays an important role in SIR models.
2.4.1.1 Inter-event times (time to next event)
In the general stochastic epidemic model, the latent period is zero i.e. once in¬
dividuals are infected, they become infectious immediately. The infectiousness
period is assumed to be negative exponentially distributed with parameter A and
hence mean infectious period A The removal rate is A/, where I is the number
of infectious individuals in the system. In the case of non-restricted mixing, there
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are two possible events, an infection or a removal. In the situation of restricted
mixing due to grouping of individuals, there are three possible events: a new
infection, a removal or a change of mixing pattern. Under the assumption of
non-restricted mixing, the inter-event times are based on the probabilities of a
new infection or a removal. At any moment in time during the infection process,
the next event to occur is either a new infection with probability or a removal
with probability where Tt = NI + RM, NI denotes the instantaneous total
infection rate and RM denotes the instantaneous total removal rate. The time to
next event, Te is exponentially distributed with mean ^ and random inter-event
times can be simulated from this distribution using standard methods (Morgan,
1994, Section 4.3).
2.4.1.2 Simulation of a random time to next event
Random variables from probability distributions can in principal be generated
by applying the inverse of the cumulative density function to a uniformly dis¬
tributed random variable (Morgan, 1994, Section 4.3). The general formula for
the probability density function of the uniform distribution is
f(x) = ——— for a < x < bb — a
where a is the location parameter and b — a is the scale parameter. The case where
a = 0 and b — 1 is called the standard uniform distribution with probability
density function given by
f(x) = 1 for 0 < x < 1
and cumulative density function given by
F(x) x for 0 < x < 1.
It is important that a reliable source of random uniform numbers is used. This
is essential for any kind of stochastic simulation (Press et ah, 1992, Section 7.1).
In this thesis, a uniform pseudo random number generator rani from Press et al.
(1992), Section 7.1, was used. According to Press et al. (1992), Section 7.1, the
routine rani passes various statistical tests for randomness that the alternative
routine ranO is known to fail. Press et al. (1992), Section 7.1, claim that rani
passes all the structural statistical tests for randomness except when the number
of calls start to become in the order of the generation period m, say greater than
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108. Given the total number of random numbers that will be required to simulate
the infection process in this thesis, using ronl we are assured of no recycling of
numbers, and of the random nature of pseudo random number stream.
To generate a random number from the exponential distribution, the following
process is carried out. From standard statistical theory it is known that if a
random variable X is uniformly distributed in the range (0, 1), then the random
variable Y = — A InX is exponentially distributed with mean A (Law and Kelton,
2000, Section 8.3.2).
To generate an inter-event time te, a uniform random number X, 0 < X < 1
is generated, such that te = — X [nx is the time to the next event. For each
infectious individual, te is calculated and the individual responsible for the next
event is chosen at random by following the following algorithm:
Algorithm 2.1
1. For each infectious individual generate a uniform random number X,
0 < X < 1 and calculate £e;
2. determine the minimum of the tes denoted min(te) and refer to the corre¬
sponding individual as the event individual;
3. determine the nature of the next event (refer to Algorithm 2.2 Section
2.4.1.4);
4. if next event is a removal then the event individual will be removed at
next time = current time + min(te)
else event individual will make an infectious contact and the new infected
individual will be of generation 'generation of event individual plus 1';.
5. if next event is an infection, use Algorithm 2.3 to choose an individual to
be infected;
6. return to step 1 until all infected individuals are removed.
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2.4.1.3 Probability of next event
0 sFor each infected individual, the force of infection is calculated as NI =
where S is the number of susceptible individuals mixing with the infected indi¬
vidual. The rate of removal is calculated as RM = A. Thus the rate of new
0 sinfection = and rate of removal = A.
0 s
Let Tt = NI + RM = + A; the probability of the next event being a new
0„ s
infection is equal to = j-f— and the probability of the next event being a
N +A
removal is equal to ^ . Based on these probabilities, a choice is made
of which event is to occur next.
2.4.1.4 Choice of next event under non-restricted mixing
At time t, the time of next event applying to an individual, it is known that the
rate of new infection is NI and the rate of removal is RM. The next event will
either be a new infection with probability or a removal with probability ,
where Tt = NI + RM.
The procedure to choose the next event involves the following steps:
Algorithm 2.2
1. calculate the rates NI and RM;
2. generate a uniform (0,1) random number x\
3. if 0 < x < then the next event is a new infection otherwise it is a
removal;
4. update 1 = 1 + 1 and S = S — 1 if the next event is a new infection or
R = R + 1 and 1 = 1 — 1 if the event is a removal, where I is the number
of infectious individuals, S is the number of susceptible individuals and R
is the number of removed individuals;
5. go to step 4 of Algorithm 2.1.
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2.4.1.5 Choice of individual to infect
The process of selecting the susceptible individual to become infected during the
next infectious contact is outlined in the algorithm below; where each susceptible
has an equal chance of being selected:
Algorithm 2.3
1. generate a uniform (0,1) random number x\
2. define tester = (int)(x x S) +1;
3. set j — 0 and sum = 0;
4. test whether sum < tester; if true go to step 5, otherwise go to step 7;
5. update j to j + 1;
6. iterate through the individuals sequentially, if individual with identity (ID)
number j is a susceptible, update sum to sum+1 and go to step 4, otherwise
go to step 5;
7. return individual with ID = j as new infection, and assign it a generation
number equal to generation number of event individual plus 1;
8. go to step 6 of Algorithm 2.1.
2.4.1.6 Restricted mixing in the general epidemic model
Within a model with restricted mixing, the rate of new infection NI from a single
infection of generation g depends on the number of susceptible individuals, Smix,
and the total number of individuals, Nmix, in the mixing groups and is given by
B S
aN mix. The daily change in the mixing pattern is another event in addition to
events of new infection and removal. The time to the next event is calculated as
in the non-restricted mixing situation. The event which may take place, however,
depends on whether the time tnext = current time t plus the time to next event is
less or greater than tm, the next time of change of mixing pattern. If tnext is less
than tm then the next event is either a new infection or removal (as specified in
earlier sections), otherwise the next event is the change of mixing pattern.
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If the next event is a removal, then the infectious individual associated with the
minimum time of next event is the one to be removed. If, however, the next
event is a new infection, then the individual associated with the minimum time
of next event is the one 'responsible' for the new infectious contact. The suscepti¬
ble individual which becomes infected is chosen randomly among the susceptibles
currently mixing with the 'donor' individual. The process of selecting a suscepti¬
ble to make an infectious contact is as described in Section 2.4.1.5 with S = Smix,
the number of susceptibles in the mixing group.
As discussed in Section 2.2.2, in so far as the general epidemic model does not
incorporate a latent state, it is unrealistic for many epidemics. For most diseases,
when an individual is infected, infectiousness does not start immediately. There
is a period when infected individuals are not yet infectious after acquiring the
infection i.e. the latent period. For a disease such as FMD, where this time
period is appreciable relative to the mean length of infectiousness period, such
a model is inappropriate. In the next section infection processes where infected
individuals pass through a latent state before becoming infectious are considered.
Two situations are considered:
1. latent and infectiousness periods are assumed to be fixed;
2. latent and infectiousness periods are assumed to be gamma distributed ran¬
dom variables.
2.4.2 Models incorporating a latent state in the infection
process
2.4.2.1 Structure
The experiments involved 32 sheep in 4 groups of 8 sheep. From the experimental
studies, sheep were not re-infected, thus it is assumed that removed/recovered
sheep have permanent immunity. Group 1 sheep which are infected at time t = 0,
the start of the epidemic (experiment) immediately enter the latent state. Sheep
in groups 2 to 4 are in the susceptible state at the start of the experiment (time
t — 0). Sheep in the latent state are infected but not infectious.
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2.4.2.2 The model
The rate of infection for an infected sheep is given by j3g where g is the infec¬
tion generation of the infected sheep. The overall transition rate from susceptible
O QJ
state to latent state is given by However, this is implemented on the ba¬
sis of individual infectious sheep, i.e. I—l such that the individual transition
a cj
rate arising from each individual of infection generation g is given by t-^~. The
transition rates from latent state to infectious state and from infectious state to
removed state could be thought of as time-dependent functions such that the
length of the latent period and infectiousness period are either fixed or gamma
distributed. A gamma or point distribution was used to model both the latent
and the infectiousness periods, and in practice, the algorithm was implemented
by assigning projected latency and infectious time periods with the associated
distributions to each individual on entry to the associated state.
2.4.2.3 Inter-event times
In addition to the events of infection i.e. transition to latent, infectious and re¬
moval states, the system incorporates an intrinsic mixing pattern. The change
of mixing groups occurs on a daily basis (every 24 hours), thus the maximum
inter-event period is 1 day. For each infectious individual, a uniform random
number is selected using the rani random number generator from Press et al.
(1992), Section 7.1, as discussed in Section 2.4.1.2 above, following which the
time the individual will make an infectious contact with a susceptible individual
is calculated as
. . — /n(uniform random number)
sheep-ml-time =
infection potential
Q 5*where the infection potential is given by * mix.Wmix
An individual could cease to be infectious before reaching its sheep-inf-time.
Hence the time at which the next infection event occurs due to a particular
infectious individual is calculated as
next-inf-time = current time (t) + sheep-inf-time.
The individual with the minimum next-inf-time among the infected individu¬
als, subject to it still being infectious by the associated next-inf-time is selected
as the one to make an infectious contact with a susceptible individual at time
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next-inf-time. Only the time of a hypothetical next infection event has been de¬
termined. Four possible types of events may take place. These are infection, end
of latency (start of infectiousness), removal (end of infectiousness) and change
of mixing pattern. The time for the next event (denoted next-event-time) and
the nature of the next event to take place are determined by choosing the min¬
imum of: next-inf-time, the time of the end of latency for all individuals in the
latent state in the mixing group and the time of the end of infectiousness for
all individuals in the infectious state in the mixing group. If the minimum of
these times, i.e. next-event-time is within the current day, then the next event is
the one determined by next-event-time, otherwise the next event is a change of
mixing pattern and the next-event-time is t — end of current day.
2.4.2.4 Model assuming fixed latent and infectiousness periods
The length of the latent period is based on expert knowledge which suggests that
the latent period for experimentally inoculated FMD virus in sheep is between 1
day (24 hours) and 2 days (48 hours). An average value of l| days was taken as
the fixed latent period for infected individuals. The length of the infectiousness
period was determined from the data, and assumed to equal the average length
of viraemic period, which was approximately 2.8 days.
Since the latent and infectiousness periods are fixed, the only random event which
is modelled is new infection. The other events namely transition from latency to
infectiousness, infectiousness to removed and change ofmixing pattern in the case
of restricted mixing, are not random. The time to a new infection event is based
only on the rate of infection NI. Thus, given a uniform (0,1) random variable X,
the random variable of the time to the next event Te = — Ay InX is exponentially
distributed with mean Ay. The time to the next event te is determined for each
infectious individual and the individual with minimum te is selected as the one
provisionally associated with the next infection. The time
current time t + te
is compared with the times of the end of latency for all currently latent individuals,
the times of removal for all infectious individuals and the time of the next change
of mixing pattern (at the end of the current day). The minimum of these times
is the time of the next event and determines the nature of the next event. This
procedure is repeated until there are no latent or infectious individuals remaining
in the system.
43
2.4.2.5 Infection event in model assuming random latent and infec¬
tious periods
A susceptible individual to become infected during the next infectious contact is
randomly selected as described in Section 2.4.1.5 with S = SmiX, the number of
susceptibles in the mixing group. Once a susceptible individual has been selected
to make an infectious contact i.e. to become infected, the 'donor' infectious in¬
dividual is already known and hence the infection generation is also known. To
each newly infected individual
1. an infection generation number is assigned;
2. a latent period is randomly generated as sheep-latent = Aiat x gamran(zqat),
a random variable generated from a gamma distribution with shape param¬
eter uiat and scale parameter A;ai;
3. an infectiousness period is randomly generated from a gamma distribution
with shape parameter i/jnf and scale parameter Xinf using sheep-inf-period
= \nf X gamran(r'in/).
gamran(^) is a function that generates random numbers from a gamma distri¬
bution with shape parameter v and scale parameter 1 (Law and Kelton, 2000,
Section 8.3.3).
Thus, once infected, an individual has all current and future transition time
points {i.e. time of infection (start of latency), start of infectiousness and time of
recovery) determined.
2.5 The effect of restricted mixing on infection
process
The effect of restricted mixing on the infection process in groups of sheep was as¬
sessed using simulations. Preliminary simulation studies were performed to iden¬
tify whether restricted mixing would have an effect on the progress of the infec¬
tion through groups of sheep. The simulations were performed for both restricted
mixing and non-restricted mixing. The assessment was based on the following
quantities estimated over 1000 realisations: the average number of secondary in¬
fections; the mean instantaneous force of infection and the average cumulative
number of secondary infections. Values for these quantities were compared for
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Figure 2.3: The effect of restricted mixing on an infection process in groups of
sheep based on (a) the average number of secondary infections, (b) the average
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both restricted mixing and non-restricted mixing. These results are summarised
in Figure 2.3 and these confirm that restricted mixing has an effect on the infec¬
tion process across groups. The distribution of the average number of secondary
infections and of the average force of infection has a much lower peak under re¬
stricted mixing than under non-restricted mixing (Figure 2.3(a) and (b)). The
plots also show that the epidemics, on average, tend to last longer under restricted
mixing. Figure 2.3(c) shows that the average cumulative number of secondary
infections is higher under non-restricted mixing than under restricted mixing.
2.6 Methods of parameter estimation for epi¬
demic models
Maximum likelihood estimation methods are widely used in parameter estimation
and hence would normally be the first method considered for parametric infer-
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ence. However, for epidemic models, parametric inference based on likelihood
is often difficult because the likelihood functions associated with epidemic data
are often very complicated as a consequence of the fact that the infection pro¬
cess is only partially observed. In particular, the epidemic pathway is unknown.
Likelihood-based inference would be more straightforward if there was a more
complete observation of the epidemic process. The complexity of likelihood-based
inference applied to incidence data has generated interest in alternative methods
of inference for epidemiological parameters.
For closed communities (i.e. those with a fixed population), likelihood inference
can be based on data summarising the size of independent outbreaks. The most
basic model for the size of an outbreak in a closed community is the chain binomial
model. However, Becker (1993b) warns that the probability distribution of the
size of epidemic is very complicated even under the simplest assumptions. Thus,
the method is tenable only in groups of very small sizes, e.g. household data.
The likelihood for chain binomial models rapidly becomes complicated as the
household size increases. These methods will be explored in Chapter 3.
Martingale methods of estimation provide an alternative to the complexity of
likelihood-based inference. These methods are derived from the theory of mar¬
tingales. Martingale theory applied to counting processes provides useful mathe¬
matical results to define estimating equations for some of the parameters which
define epidemic models (Becker, 1989, Section 7.1; 1993a). These methods will be
described in detail in Chapter 4. Under the assumptions of the general epidemic
model and SLIR model, martingales corresponding to the process that counts the
number of infection and removal events, can be constructed, from which estimates
of the desired parameters may be obtained.
Another estimation method which allows for the fact that infectious disease data
are typically incompletely observed is the Markov Chain Monte Carlo (MCMC)
method. The MCMC method is used to make inference about missing data as
well as parameters of interest. For example, Gibson and Renshaw (1998) present
MCMC methods used to estimate parameters in stochastic compartmental models
from incomplete observation of the corresponding Markov process. This thesis
will not investigate the MCMC methodology, but rather concentrate on classical
frequentist methods of inference.
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2.7 Approaches developed in this thesis
In exploring the infection process of experimental FMD virus in sheep, the main
emphasis in this thesis will be on estimating rates of infection in groups of sheep
and estimating unobserved infection process characteristics i.e. time of infection,
length of latent period and length of infectious period for infected individuals
(Chapters 5, 6 and 7). The distribution of time to infection will involve a hazard
function which depends on the average group rates of infection. The latent and
infectiousness period distributions will be assumed to be gamma distributed with
parameters estimated from the observed data. The expected times of infection
and expected lengths of latent period will be estimated jointly for each individual,
since, although the underlying random variables are independent, the inability to
observe the nature of the pre-infectious individuals creates a correlation in any
estimates. Estimation of the rate of infection in groups of sheep will use both
maximum likelihood and martingale methods. The expected time of infection,
expected length of latent period and expected length of infectious period based
on the assumed distributions and the observed data will be estimated alternately
with the average group rates of infection using an iterative scheme similar to the
EM algorithm. The EM algorithm is a method which may be used to obtain esti¬
mates of parameters and other quantities in situations where there is incomplete
data (Dempster et ah, 1977; McLachlan and Krishnan, 1997, Section 1.5).
2.7.1 The Expectation-Maximisation (EM) algorithm
The EM algorithm was formally defined by Dempster et al. (1977), although
the algorithm had been proposed many times previously to deal with particular
methodological problems. It provides a general approach to iterative computation
of maximum likelihood estimates where the data can be regarded, in some sense,
as incomplete. The concept of 'incomplete data' can be formally defined in terms
of two sample spaces y and X where the observed data y are a sample from y
and there is a corresponding set of observed and unobserved random variables
x which have been sampled from X. In general the set X is referred to as the
complete data. Different sets of complete values x can correspond to the observed
data set y, but it is assumed that there is a mapping x —> y(x) from X to y and
that x lies in X(y), the subset of X determined by the equation y = y(x). A
family of probability densities /(x|<p) is assumed for the complete data depending
on the vector of parameters cp £ £2. In general, the likelihood for the incomplete
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data g(y|<^>) is more complex than that for the complete data. However, given the
result g(y\4>) = Sx{y) f&lfydx, the EM algorithm proceeds to maximise g(y\<t>)
using the associated family of densities /(x|</>). It does this using a pair of iterative
procedures, one of which can be thought of as a conditional expectation, and the
other as a maximisation.
The general definition of the EM algorithm is based on the function
E[In /(x\4>')\y, 4>\, the expectation of the log-likelihood of the complete data, given
the observed data y and the current parameter estimates </> e Q. The algorithm




Chose cf)(p+^ to be a value (f> € H maximising
E[ln/(x|0)|y,^)]. (2.2)
(i!>(p) will converge to the parameter value which maximises g{y\(f>), although con¬
vergence may be slow (McLachlan and Krishnan, 1997, Section 4.1).
It will be useful at this point to define a more general class of algorithm. Where
M() is a mapping from H —» fl, and = M(0^), then if
£[ln/(x|M(0))|y, <j>] > .E[ln/(x|0)|y,0], V<f> e ft,
then the mapping defines a Generalized Expectation-Maximisation algorithm
(GEM). Intuitively, this represents a relaxation of the maximisation rule in the
EM algorithm, where </>(p+1) no longer needs to maximise Elfin/(x|</>(p+1)) |y, 4>^],
rather
^[ln/(x|</>(p+1))|y,(/)(p)] > ^[ln/(x|0(p))|y,(/>{p)].
Dempster et al. (1977) show that this is sufficient to ensure that the log-likelihood
on the incomplete data is also non-decreasing. They also propose a further pair of
constraints which they believed would guarantee convergence of ftP+1) to a single
point. In fact, these conditions are not sufficient (McLachlan and Krishnan, 1997,
Section 3.6).
The EM algorithm simplifies when applied to a complete-data likelihood de¬
rived from distribution functions in the regular exponential family. By definition
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(Dempster et al., 1977), the density for a data set x, with parameters </> G D, can
be written in the form,
t, lja 6(x) exp{</>t(x)r}f x ^ = 7777 'o(0)
where t(x) is a vector of sufficient statistics for </> (with the same dimensionality
as 4>), depending on the complete data x. In general, the EM algorithm simplifies
to an iterative estimation of the sufficient statistic with steps:
Expectation-step: Compute = £'[t(x)|y,
Maximisation-step: <^+0 js the solution of £'[t(x)|</>] =
The expectation step simplifies to the calculation of the expected value of the
sufficient statistics for the complete specification given the observed values and
the current parameter estimates. The maximisation step is identical to that
defined earlier. The maximisation will give a meaningful result whether or not
t(p) can actually be mapped to any complete data set x in the sample space X.
As long as the maximisation step is solvable for 4> 6 Q, this formulation of the
EM algorithm will be valid.
In the case where the sufficient statistic t(x) is linear in the unobserved terms,
this process is equivalent to calculating the expected values of each unobserved
term, given y and the current parameter estimate, and using these values in t(x)
instead of the unobserved terms.
In the case of the experimental FMD infection process, it will be shown (Section
4.4) that implementation of the EM algorithm would require use of the most
general definition (Equation (2.2)). The resulting algorithm would be computa¬
tionally prohibitive. Instead, a non-EM iterative algorithm is proposed in Section
4.4, which it is anticipated will give rise to acceptable estimates of the unknown
variables of interest, while not being computationally impractical.
2.7.2 Previous applications of the EM algorithm
Since the presentation of its general formulation by Dempster et al. (1977), the
EM algorithm has been used as a general-purpose algorithm for MLE in a wide
range of situations which are best described as incomplete-data problems. Exam¬
ples of fields where the EM algorithm has been employed as an estimation pro¬
cedure are survival analysis (Ng and McLachlan, 1998; Slasor and Laird, 2003),
studies involving genetic data (Shoukri and McLachlan, 1994) and medical image
49
processing (Liang et al., 1992) amongst others. When reviewing the literature
citing the EM algorithm, it is striking that the algorithm has mostly been used in
problems described by mixture distributions (Ng et ah, 1999; McLachlan et ah,
1996; Jones and McLachlan, 1991). In the context of epidemic data analysis,
however, a literature search does not identify much published work where the
EM algorithm has been used. Most of the literature appears only to have men¬
tioned that the EM algorithm could be used as a parameter estimation tool. Only
two papers, Becker (1993b) and Becker (1997), are relevant when reviewing the
use of the EM algorithm in the epidemic context. Becker (1993b) gives an illus¬
tration of how the EM algorithm can be used to simplify likelihood inference. The
author demonstrates how the algorithm can be used to estimate a parameter, q,
the probability of a susceptible escaping infection when exposed to an infectious
individual for the duration of the latter's entire infectious period. The analy¬
sis uses size of outbreak data modelled using the chain binomial model (Section
3.2). The E-step involves estimation of the number of outbreaks of a particular
epidemic size and in the M-step, the parameter q is estimated. The implemen¬
tation of the EM algorithm was possible in this context because ML estimates
corresponding to specific epidemic chains data had closed analytic forms. Becker
(1997) gives an illustration of how the EM algorithm can be used in the analysis
of HIV/AIDS data and other infectious diseases in general.
The analysis of infectious disease data is a natural setting for applications of the
EM algorithm because the infection process is only partially observed in practice
(Becker, 1997). However, the added complication of interactions between infective
and susceptible individuals whose numbers change over time make it difficult to
compute the expectation in the E-step of the EM algorithm (O'Neill, 2002). The
E-step is straightforward for epidemic chain binomial models, but for most trans¬
mission models no way has yet been found to effect the E-step directly (Becker,
1997). Instead, for example in applications of HIV/AIDS data in Becker (1997),
transmission models have been replaced by pragmatic models which capture only
part of the mechanism that generates the data and uses what he calls an EM
algorithm with smoothing. This enables reconstruction of the unobserved HIV
infection curve as well as the estimation of the distribution for the incubation pe¬
riod until AIDS, amongst other quantities. Due to the difficulties in the E-step,
for data on other infectious diseases other than AIDS data, application of the
EM algorithm has so far been restricted to the size of outbreaks in households
(Becker, 1993b, 1997). In general, for non-chain binomial models, any ML esti¬
mate for the parameters will have to be obtained numerically as the likelihood
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function becomes complicated. Similar issues apply to the experimental FMD
data, and these are discussed in Section 2.7.1, where a different iterative scheme
is proposed for the analysis of the experimental FMD data.
2.8 Summary
A review of epidemic models and simulation models has been provided. The SIR
and SLIR models have been described and their application to the experimental
FMD design has been described. The effect of the restricted mixing imposed by
the design of the experiments was explored and it was confirmed that this will
have an effect on the infection process across the groups when compared to the
equivalent non-restricted mixing model. A description of the EM algorithm has
been given and potential difficulties in its implementation in the epidemic context
discussed.
The SLIR model with random latent and random infectiousness periods will play a
large role in the exploration and evaluation of methods to model the experimental
FMD infection process. The model will be used to generate data to evaluate
inferential methods and to generate bootstrap epidemic realisations in Chapters
6, 7 and 8. The SIR model will be used to generate data in the simple case of
homogenous mixing with no restrictions or sub-groups, to explore the properties
of confidence intervals for infection process parameter estimates in Chapter 9.
These models have all been formally defined, and the methods used to produce
simulated realisations of the processes fully specified.
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Chapter 3
Modelling the FMD infection
process using infection generation
information
3.1 Introduction
In the current and subsequent chapters, specific models suited to the data gen¬
erated from the FMD experiments are explored. Two scenarios are considered,
the first involves modelling the infection process on the basis of infection path¬
ways, i.e. modelling the infection process by explicitly considering the likely de¬
velopment of the epidemic between different individuals across the groups. This
approach requires knowledge of individual infection generations. The second sce¬
nario involves modelling the infection process on the basis of 'average' infection
rates in groups of sheep, and this is the subject of Chapters 4, 5, 6 and 7.
Bearing the main objective of the experiments in mind, the infection pathway
models considered should aim to estimate infection rates for each infection gener¬
ation. Two types of model are considered to describe the infection process using
infection pathways. These are the chain binomial model (Becker, 1989, Section
2.3), and the generalized linear model (McCullagh and Nelder, 1983, Section 2.2).
3.2 Chain binomial models
Developing a model in terms of epidemic chains would suit the desired objective of
investigating whether there is an intrinsic diminution in the infectivity of infected
individuals during the course of successive naturally transmitted infections of
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FMD virus. These types of models are called chain binomial models. The models
are based on epidemic chains where, by specifying the chain type of an epidemic,
one specifies the progress of the disease spread among the susceptibles of a group.
This can be presented more precisely in terms of generations. Considering the
case of introduction of an infectious disease in a community, the first generation
of cases consists of those individuals infected by making an infectious contact
with one of the introductory cases (cases of generation 0). The second generation
of cases consists of those infected by making an infectious contact with one of the
first generation cases. The tth generation of cases consists of those individuals in¬
fected by making an infectious contact with one of the (t — l)th generation cases.
Thus an epidemic chain for an affected group is the enumeration of the number of
cases in each generation. For example, 1 —> 1 —» 2, denotes the chain consist¬
ing of 1 introductory case, 1 first generation case, 2 second generation cases and
no cases in third or later generations. Generally, io —» i\ —> ... —> ir has it
cases (infectives) in generation t, where t = 0,1, 2,..., r, and no cases thereafter.
In most cases the available data do not contain sufficient detail to enable the
classification of outbreaks into separate epidemic chains. However, it is useful
to formulate epidemic chain models as they lead to outbreak size distributions
in terms of parameters that have clear and useful interpretations (Becker, 1989,
Section 2.2). The chain binomial model is then formulated by attaching probabil¬
ities to each possible epidemic chain. This requires some additional assumptions.
Becker (1989), Section 2.3, outlines the necessary assumption namely:
1. Susceptibles make infectious contacts independently of one another and
each remaining susceptible has the same probability of making an infectious
contact with the infectives of a given generation.
2. The probability q% that a given susceptible escapes infection when exposed
to i infectives of a specific generation does not vary from generation to
generation.
For t = 0,1, 2,..., the probability that there are x infectives of generation £+1 in a
group, given that St, susceptibles have been exposed to It infectives of generation
t, is given by:
Pr (It+i = sis* = s,It = i) = -~r——r-p*Qi'x; x = 0,1,..., s
:r!(s — x)\
and pi = 1 — qi. Then the probability of a specified epidemic chain is the product
of probability terms from different binomial distributions.
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Generally, the probability of the complete epidemic chain i0 —> R —> ... —> ir
is given by:
! r
Pr (i0 —>ii —> ... —> ir) = ■ , II PuH+1 Qut+1%\.%2* • • • Ir-Sv f=Q
with ir+1 = 0 and sr+i = sr, i.e. there are no more infectives after the rth
generation of infectives.
Epidemic chain probabilities are conditional on the number of introductory cases.
In order to apply the chain binomial model in practice, the number of infectives
and the number of susceptibles present need to be known for each generation.
This can be ensured by making the further assumptions that all infectives can
be recognized and that, after their infectious period, the infectives are removed
or become immune for the remaining period of the epidemic. These assumptions
allow the deduction of the number of individuals who remain susceptible at the
end of each generation and this is given by St+1 = St — h+i, t — 0,1,2,..., with
the initial values 70 = io, and So = So assumed known.
Becker (1989), Section 2.4, emphasizes that whenever possible one should seek
to obtain data in sufficient detail to enable the epidemic chain to be identifiable.
In humans, where infectious disease data are generally observational, the most
readily available data are data on size of outbreak in, say, households or units
like schools and hospitals. These data do not enable the epidemic chain to be
identifiable. Epidemic models have been used in the analysis of the size of out¬
break (Bailey, 1953a; Longini and Koopman, 1982; Ball, 1986; Addy et ah, 1991;
Ball and Clancy, 1995; Ball and O'Neill, 1999). The probability of a given size
of outbreak can be expressed in terms of the qiS and the additional assumptions
made in the chain binomial model do result in some reduction in the number of
parameters to be estimated. Assuming data are sufficiently detailed to determine
the number of introductory cases and the initial number of susceptibles, the dis¬
tribution of the outbreak size can be determined by accumulating the appropriate
chain probabilities. However, Becker (1989), Section 2.4, points out that such an
analysis is more tedious and less effective than the analysis of epidemic chain
data.
There are two specific chain binomial models, the Reed-Frost model and the
Greenwood model. These models are obtained by being more specific about the
way in which the probability qi depends on the number of infectives i. Reed
and Frost in 1928 formulated a chain binomial model, making the assumption
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that qi = qi\ i = 1,2,.... This assumption stipulates that the event of escaping
infection when exposed simultaneously to i infectives of one generation is equiva¬
lent to escaping infection when exposed to a single infective in each of i separate
generations. In other words, each of the infectives of a group of i infectives from
the same generation creates infectious contacts independently. This assumption
is appropriate for diseases which are transmitted primarily by close individual-
to-individual contacts and hence is appropriate for diseases that are spread by
direct transmission.
Greenwood (1931) formulated an alternative chain binomial model by assuming
that qi = q, Mi > 1 and = 1- This assumption stipulates that the chance
of infection when exposed to 1 infective is identical to that when more than
1 infective is present. This assumption is appropriate when the environment
is saturated with infectious material even if only 1 infective is present and the
chance of a susceptible being infected depends more on the behaviour of the
susceptible individual in the environment. This assumption is appropriate for
diseases that are spread by indirect transmission. The two models represent
alternative extremes of the range of possible modes of infection. The advantage
of both models is that each contains only one parameter.
Chain binomial models have been used in the modelling of infectious disease data
for many decades now. Bailey (1953b), describes chain binomial models applied
to the analysis of intra-household epidemics involving households of size 3 and
4. Bailey (1956c), illustrates how significance tests can be performed to test for
variation in q^. Bailey (1956a,b), estimates the latent and infectiousness periods
of measles by constructing chain binomial models for 2 or 3 cases from families of 3
or more susceptibles, while in Bailey and Alff-Steinberger (1970), the authors give
an improved estimation method for latent and infectious periods of a contagious
disease by constructing chains from households of size 2 and 3. In general, chain
binomial models have mostly been applied to household data, the methodology
being easiest to implement when the populations are relatively small.
3.2.1 Application of chain binomial models to FMD ex¬
periments
Formulating the model in terms of epidemic chains for the FMD experimental
data, group 1 infectives constitute the introductory cases, i.e. cases of generation
0 with associated rate of infection /30. The first generation of cases consists of those
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individuals infected by making an infectious contact with one of the introductory
cases and their rate of infection is denoted by /3\. The second generation of cases
consists of those infected by making an infectious contact with one of the first
generation cases and their rate of infection is denoted by fa. The gth generation
of cases consists of those individuals infected by making an infectious contact
with one of the (g — l)th generation cases and their rate of infection is denoted by
/3g. The objective then is to estimate the different generation rates of infection.
A possible alternative would be to think of the problem in terms of a passage
multiplier, assuming a constant drop in infectivity on each passage, and hence
having only 2 parameters to estimate.
Let j3 be the rate of making an infectious contact for any infectious individual
and 7 be the passage multiplier. Then the rate of infection for a gth generation
infective is assumed to be:
/3g = /3e~19, 0 < 7 < oo.
The hypothesis to be tested would be whether 7 = 0 or whether 7 > 0.
However, there are potential difficulties with an epidemic chain based model.
For instance, observed infectious individuals in group 2 are not necessarily all
generation 1 cases as infection can also occur from a group 2 individual to another
group 2 individual and also from group 3 to group 2 individuals. However, the
first infection to occur in group 2 is definitely due to group 1 infectives and is
thus definitely a generation 1 case. For groups 3 and 4, the first infection to
occur is not necessarily of generation 2 and 3 respectively. However, group 3
has generation 2 as the possible lowest generation and group 4 has generation
3 as the possible lowest infection generation. For any group j,j 7^ 1, the first
infection to occur in the group must be due to contact with infectious individuals
in group j — 1. Other observed infections in group j could be due to contact with
infectious individuals of groups j — 1, j or j + 1. Thus at any given time when
two groups are mixing, the total hazard due to infectious individuals is a mixture
of that arising from different infection generations as the infectious individuals
will not necessarily all be of the same generation. The most crucial issue is that
the source of infection for each infected sheep will have to be known in order to
assign a generation to it. This issue makes inference for epidemic chain models
very complicated.
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3.2.1.1 Formulation of the likelihood function
Information about the times at which animals tested positive is used to model
and make inference about the characteristics of the infection. These character¬
istics include the duration of the latent period (time between infectious contact
and testing positive to infection), the duration of the infectious period and the
instantaneous rate of spread of disease f3g. It is assumed that for each infective,
the beginning and end points of the infectiousness period can be deduced. The
first point in time at which the animal tested positive is used to indicate the be¬
ginning of the infectiousness period and the first point at which it subsequently-
tested negative to indicate the end of the infectious period. The infectiousness
process is assumed to be fully specified. This will be a valid approximation if
the time between sampling is small, relative to the length of the infectious pe¬
riod. The analysis should make inference about the initial rate of infection, /?,
the passage multiplier, 7, and about the distribution function for the duration of
the latent period. Inference about the characteristics of the latent period is less
straightforward because the precise time at which the infectious contacts occur
is not observable except for individuals in group 1. It is assumed that the force
of infection associated with an infected individual takes non-zero values only on
the interval over which the individual is infectious.
The application of epidemic chain models to the FMD data requires consideration
of the mixing structures in the experiments. These complicate the equations
immensely, but a possible formulation is given below.
Let cij be an indexing variable for an infected individual in group j; aj may take
values from 1 to Ij, where Ij is the number of infectives in group j at a particular
time. Also, let (uja^,Wjaj) be the observed infectious period for infectious indi¬
vidual cij of group j, where Ujaj marks the beginning of the infectious period of
individual animal aj of group j and Wjaj marks the end of the infectious period
for individual aj.
Without loss of generality, individual aj = 1 will be the first animal in group j
to become infectious, aj = 2 will be the second, and so on. Individual Ij is the
Ijth animal in group j to become infectious, and hence Ujl < Uj2 < ... < Uj1^.
Let t denote the time of infection for a new infected individual by infectious
individual a0. For t in [uja', Wjaj], there exists a set Tjk = {£1, t2,..., tnjk}, of
Let
1 if group j and k are mixing at time t
0 otherwise
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size rijk, of transition time points indicating the time points during the infectious
period of individual aj when groups j and k start or cease to mix.
Let ajh9jk(t) be the hazard function at time t, posed by a gth generation infective
individual aj of group j, against susceptible individuals in groups j and k. Hazard
function, h(t), is the risk that an individual experiences an event (infection in
this case) in a small time interval given that the individual has survived up to
the beginning of the interval. /04 h(u)du is also known as the cumulative hazard
function and the survivor function, S(t), the probability that the time to infection
is greater than or equal to t is given by S(t) = exp{— Jq h(u)du} (Collett, 1994,
Section 1.3).
For an observed infectious period (uja>, Wjaj) of a gth generation infectious indi¬
vidual aj of group j and assuming that 8jk(ujaj) = 0, i.e. the groups j and k are
not mixing at the start of infectiousness period of individual aj,
a.j ug (f\ = / Pg{a})&jk{t) if Ujai < t < Wjai
J [0 otherwise
Using indicator function notation,
ajh9jk(t) = (3g(aj) 1[t2i-l,t2i] (0
2— 1
and the cumulative hazard function is given by:
r=i*i
ajH9jk(t) = f aih9jk(v)dv = /3g(aj) Y, f a. ffei-i.tw] (v)dvJuj J f= 1 Juj J
iPg{aj) E"ii/2(min{f2i, t} - mm{t2i-i, t}) when njk is even/3g(aj) i= :+1)/2(min{t2i, t} - min{t2i-i, t}) when j i odd.
Then given the set, Ijk(t) = Ij(t) U Ik(t), of infectious individuals in groups j and
k at time t, the total instantaneous hazard is given by:
hjk(t) = Y aj"h9jk(t)
tijk




The probability Pescape, that any individual remaining susceptible at time rx in
groups j and k escapes infection when exposed to the total hazard hjk(r2) up to
time r2 (rx < r2) is given by:
rm'm{wjaik ,T2}
Pescape = exp{ — E / ... ajkh9jk(t)dt}
ajkeljk(r2) 3"'T^
= exp{- J2 [ Pg{ajh) ( min{w^k, r2} - max{u/^, n} ) ] },
Cj kGIjk )
using the definition of the survivor function above.
Hence, the probability that an initially susceptible individual is infected when
exposed to the total hazard /i;fc(r2) up to time r2 is given by 1 — PeScaPe-
Suppose for a given path of infection, an individual ak is infected by individual
a,j when groups j and k are mixing. Let 2: be the time it takes for an individual
ak to be infected by individual a,j when groups j and k are mixing during the
infectiousness period of aj, i.e. z is measured from Ujaj. The time point when
infection takes place, z* = Ujaj + z.
It is desired to determine the conditional density of Z, the time to infection, given
that infection did occur and infectious periods {ujai,Wjaj) and (ukak, Wkak) were
observed. The conditional density of Z is given by:
fz(z | infection occurs) =
Zajkeijk(z*) aikh<>jk(z*)exp{- J2ajkeiJk(Z') fuj"J ajkWjk(t)dt}
1 - Px 1 escape
Let Xkak be the latent period for individual Oyt infected by individual aj and
fx{x) be the density of the latent period, then ukak — Ujai = z + xkak, the time
to infection plus the latent period of individual ak.
The distribution of Ukak — Ujaj given the infection path and the infectious periods
can be determined in terms of the density of Z and that of the latent period. This
is given by
rUkak — Uja3
/ fz(z)fx(ukak - Ujai - z)dz.J 0
Hence, an epidemic with a specific path of infection such that it is individual
aj that makes an infectious contact with individual ak and observed infectious
periods (ujkaik, Wjkaik) for all ajk G Ijk(t) makes a contribution to the likelihood
function of the form:
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rukak - Ujai
/ fz{z)fx(ukak - ujaj - z)dz X (1 - Pescape)J 0
ru/cak — Ujai rz*
= [ J2 ajkh9jk{z*)exp{- Y, / aikh9jk(t)dt} x
ajk£ljk(z*) ijktljki**) Uj 1
fx{ukak - Ujai - z) } dz.
To make inference about the infection rate /?, the passage multiplier 7 and the
characteristics of the latent period, all possible infection paths (epidemic chains)
for the observed infections must be considered. Infection in groups of size greater
than 1 have more than one possible infection path. Thus the likelihood function
will be a sum of contributions from all different paths. It is assumed that infec¬
tions within groups evolve independently of each other. Finally, the likelihood
function formulated must be maximized with respect to the parameters using an
appropriate computer algorithm. The EM algorithm (McLachlan and Krishnan,
1997, Section 1.5) is a possible algorithm particularly suitable for problems such
as this (Becker, 1993b).
3.2.1.2 The likelihood function
The contribution to the likelihood function of a given infection path can consist
of three types of factor. Each type equates to the contribution to the likelihood
of an individual which has a particular combination of status and observed data.
The factoring of the likelihood into components from single individuals is only
possible because of conditional independence. The infection times of individuals
are not independent because individuals in the same group are exposed to the
same infection challenge (same force of infection) and hence one will tend to
observe clustering of infections. However, conditional on the force of infection, the
chance of an individual becoming infected is independent of the other individuals.
The three classes of factor are:
1. A factor determined by the latent period of infectious individuals in group
1, since these latent periods are known.
2. A factor determined by probabilities of escaping infection for those individ¬
uals who were exposed to infection but did not become infected.
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3. A third factor determined by the convolution of the time to infection and
the latent period for individuals that became infectious after exposure to
the virus, coupled with a factor containing the probabilities that these in¬
fected individuals escaped infection from any other infectious individuals
with which they have been in contact.
Depending on the path of infection, the subset of the likelihood determined by
probabilities of escaping infection (2, above), consists of the product of these
probabilities over all exposed individuals who escaped infection in all groups.
These quantities, however, depend on the mixing pattern. The non-infection
probability for an individual depends on the number of infectious individuals to
which this individual was exposed, given the mixing pattern. The convolution
factor (3, above) is a product of these integrals over all individuals which were
infected by the end of the experiment. The limits of the component integrals
depend on the conditional path of infection, as will be explained below.
A mathematical formulation for the likelihood function for a given infection path
is now developed. Let Sj be the number of susceptible individuals in group j at
the end of the epidemic, m be the number of groups that were mixed during the
course of the epidemic, Ij be the number of infectives in group j, I be the total
number of secondary infections in all groups and aj E Ijk(t) be the individual
that makes an infectious contact with a susceptible individual a^ E Ijk{t), where
Ijk(t) is the set of infected individual in mixing groups j and k at time t.
Then the contribution to the likelihood function for a given path takes the general
form given below.
II /x(miQi) X H [ exp{— / a^h9jk{t)dt} ] x
<u=i group j = 2 ajkeijk(t) Juik 3
I rukak — UiaJ rUjai+z
II / [ E ajkh9jk(z*) exp{- E la. ajk h9jk(t)dt }x
ak=1 0 ajkeljk{z*) a,jkElik(z*) "•? 3
fx{ukak ~ ujai - z) } dz.
An illustration is given for 1 path of an observed epidemic in groups of size 2. This
is an outbreak in four groups of size 2 consisting of 2 initial (primary) infectious
individuals in group 1, 2 secondary infections in group 2, 1 secondary infection
in group 3 and no infections in group 4.
Consider an outbreak of the form given in Table 3.1.
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Table 3.1: An epidemic in four groups of size 2.
Group 12 3 4
Infections 2 2 10
This observed outbreak could correspond to three possible scenarios defining the
number of infected individuals in each infection generation, namely:
1. 2 infecteds of generation 0, 2 infecteds of generation 1, and 1 infected of
generation 2.
2. 2 infecteds of generation 0, 1 infected of generation 1, and 2 infecteds of
generation 2.
3. 2 infecteds of generation 0, 1 infected of generation 1, 1 infected of genera¬
tion 2 and 1 infected of generation 3.
The scenarios are illustrated in Figure 3.1. The second scenario could occur in
two possible ways, as illustrated in Figure 3.1(c and d). Each scenario can be
mapped to various pathways by which it could have arisen, as shown in Figures
3.2 and 3.3.
For instance, in the first scenario, with 2 infecteds of generation 0, 2 infecteds of
generation 1 and 1 infected of generation 2, there are 8 possible infection pathways
that could have yielded this realisation, considering choices of each individual as
a possible donor of infection. These pathways are given in Figure 3.2. In the
second scenario, with 2 infecteds of generation 0, 1 of generation 1 and 2 infected
of generation 2, there are four possible infection pathways that could have yielded
this realisation, as illustrated in Figure 3.3. In the last scenario, with 2 infecteds
of generation 0, 1 infected of generation 1, 1 infected of generation 2, and 1
infected of generation 3, there are eight possible infection pathways that could
have yielded this realisation, four for each of the two possible scenarios in Figure
3.1(c) and (d), and these are given in Figure 3.3.
For illustrative purposes, to explore the nature of the likelihood function, only
1 infection path from the scenario in Figure 3.1(d) is considered. The scenario
comprises 2 generation 0 infectives of group 1, 1 generation 1 infective of group
2, 1 generation 2 infective in group 3 and 1 generation 3 infective in group 2. It is
assumed that this realisation is associated with path number 5 from Figure 3.3,
which indicates that infection is from individual 1 of group 1 to individual 1 of
group 2 to individual 1 of group 3 and then to individual 2 of group 2, i.e Yu ->
Yi\ —■> T31 —> Y22 •
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Figure 3.1: Possible scenarios defining number of infecteds per generation. The
arrows indicate the infection process through the groups for chain types (a) 2 —>
2 —t 1, (6) 2 —^ 1 —^ 2 and (c) orui (d) 2 —1 —y 1 —^ 1.
Group Group
Gens 12 3 4 Infs Gens 12 3 4 Infs
0 2 2 0 2 2
\ \
1 2 2 1 1 1
\ t \
2 1 1 2 1 1 2
\ \
3 0 0 3 0 0
Total 2 2 10 Total 2 2 10
(a) (b)
Group
Gens 12 3 4 Infs Group
0 2 2 Gens 12 3 4 Infs
\ 0 2 2
1 1 1 \
1 1 1 1
2 1 1 \
\ 2 1 1
3 1 1 >/ \
\ 3 1 0 1
4 0 0 Total 2 2 10
Total 2 2 10
(c) (d)
The contribution of path number 5 for scenario 3 in Figure 3.3 to the likelihood
function is:
2 pujx PHJx riL)o
II fx(uiai)[ exp{- / 2 lhl23{t)dt- 3 lh233{t)dt - 2h323{t)dt j]1
a1= 1 2 •/«»
P{- f * 1h2M{t)dt} f
3
FL CU2a2—U I1 2 ^ /•"!* . -
E[ / ^ ai/i°12('"iai+^) exp{- J] aih\2(t)dt}fx{u2a2-u11-z)dz x
i2=l 0 ai = l ai=l l
1 ruza3 —U21 Cu2+z
11 / 1/i123(M21+'Z)exp{- 1h123(t)dt}fx{u3a3-u2 -z)dz x
13 = 1 ° U2
2 rU2a2-U3l , . 2 rup+z
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The likelihood function involves unknown components, in particular, the infec¬
tion path, and hence the generation number of infected individuals. The path can
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Figure 3.2: Possible infection pathways (paths) for scenario 1 given the number
of infecteds (Infs) in each infection generation (Gen). Ygi = infected individual i
of group g. Arrows indicate the 'donor' and 'recipient' infected individuals.
Figure 3.3: Possible infection pathways (paths) for scenarios 2 and 3 given the
number of infecteds (Infs) in each infection generation (Gen). Ygi = infected
individual i of group g. Arrows indicate the 'donor' and 'recipient' infected indi¬
viduals.
Scenario 2 Scenario 3
Gen 0 1 2 0 1 2 3
Infs 2 1 2 2 1 1 1
1 >1 i
Vl2
1 >21 - >22, >31
to<-■
- v2i -> v22 —i v3i
2 I'll
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either be 'made up' given the observed data or summed into the likelihood as an
unknown component. The distribution for the latent period has to be assumed in
order to be able to evaluate the likelihood function. In addition, it was assumed
that the infectiousness period is known precisely but there is a portion of un¬
observed infectiousness period prior to the first observed time and after the last
observed time of infectiousness. If the uncertainty in the infectiousness period is
also modelled, the likelihood function will become even more complicated.
It is noticeable that the number of possible infection pathways depends on the
group size and how many infected individuals are in each group. The higher the
number of infected individuals in each group, the higher the number of possible
infection pathways. In the example given above, with just 2 individuals per group
and with 2 infectives in group 1, 2 in group 2, 1 in group 3 and none in group 4, the
total number of possible infection pathways is twenty. In a situation with group
size 8 and with at least 4 infected individuals in each group, the number of possible
pathways is very high. For instance, in experiment 1 of the FMD experiments,
there are 8 infected individuals in group 1, 6 out of 8 infected individuals in
group 2, 8 infected individuals in group 3 and 7 infected individuals in group
4. Restrictions on possible sources of infection may be imposed, for example
an assumption of a fixed 1 day latent period would ensure that an individual
first observed to be shedding virus on, say, day 4 could not be a possible source
of infection for individuals first observed to be shedding on days beyond day 4.
Also we could take the mixing pattern into consideration, so that, for example,
an individual from group 1 could not be a possible source of infection for an
individual in groups 3 and 4. Nevertheless, the number of possible paths would
still remain very high.
Depending on the distribution assumed for the latent period, the likelihood func¬
tion could be complicated since it could involve integrals that are analytically
intractable. In the illustration above, it is assumed that the length of the infec¬
tious period is known, which is a major assumption. Even if one uses the observed
viraemic periods or duration of symptoms to signify the infectious period, there
is always an unobserved period of 'infectiousness' especially when sampling has
occurred at discrete times, which is usually the case when collecting infectious
disease data. The number of generations is also an unknown quantity because
the exact times of infection and source of infection are unobservable. It can be
appreciated that modelling the FMD experimental infection process using chain
binomial models would involve making so many assumptions that the results ob-
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tained would be unreliable. Therefore this thesis will not focus on models of in¬
dividual infection pathways; instead, the average infection process within groups
of sheep will be modelled. However, a published (de Jong et ah, 1996) approach
to modelling FMD experimental data while considering infection pathways using
generalized linear models is evaluated, since, of necessity, it incorporates many of
the simplifying assumptions listed above.
3.3 Generalized linear models
Generalized linear models (GLMs) are an extension of the classical linear model.
A GLM is made up of three components namely, the random component which
may be normally distributed (as in ANOVA) or may follow any distribution in the
exponential family; the systematic component which models the effect of covari-
ates; and the link function, a monotonic differentiable function which provides
the link between the random and systematic components (McCullagh and Nelder,
1983, Section 2.2).
The GLM approach is straightforward when all aspects of the infection process
are observable. However, in practice, no genuine infectious disease data set is ever
likely to be so complete. There are two sets of circumstances when the approach
can be applied, namely:
1. When the disease is such that the latent and infectiousness periods are
essentially of fixed duration, i.e. random variation in the duration of latent
and infectiousness periods is negligible.
2. When the infectiousness period is indicated by observable symptoms or
signs. Although there may be variation in the duration of infectiousness
period among infectives, one is able to determine the infectiousness period
for each infective by the show of symptoms or signs.
Thus, in order to apply the GLM approach to infectious disease data, a number
of assumptions have to be made. In particular, it is assumed that the numbers
of infectives and susceptibles are observable over time. This is a drawback in the
approach as it will limit the applicability of the method. However the method
may still answer important epidemiological questions even though the underlying
assumptions are only approximately true.
66
The GLM approach has been used by several authors to estimate infection process
parameters in epidemic studies. Becker (1989), Section 6.4, applies the approach
to data from a smallpox outbreak in a closed community of Abakaliki in south¬
eastern Nigeria to estimate the rate of infection, while assuming fixed latent and
infectious periods. Becker (1989), Section 6.5, also uses the approach to analyse
respiratory disease data to estimate the rate of infection both within a household
and between households. Nodelijk et al. (2000), use a GLM to estimate the
transmission parameter for respiratory syndrome virus in a Dutch breeding herd
of pigs, while van Nes et al. (2001) use a GLM to estimate the reproduction ratio
as a measure of transmission of pseudo rabies virus in a vaccinated sow herd.
3.3.1 Formulation of the GLM as applied to epidemic data
Suppose the duration of the latent period is fix for each infected individual and
that properties of the disease are sufficiently well known that a value can be as¬
signed a priori to the constant /rx, e.g. 1 day in the case of the FMD experimental
data. Suppose further that the infectious period can be deduced for each infected
individual. The aim of the analysis is to study the characteristics of the spread
of the disease through a population.
Let A denote the risk of infection for susceptible individuals due to infectious indi¬
viduals. Attention is focused on the form of A and inference about its parameters,
where in general,
Pr[S(t + 5) = s — l\I(t) = i,S(t) = s] — X(i,s)5 + o(5),
where S(t) is the number of susceptibles at time t, I(t) is the number of infectives
at time t and 5 is a small increment in time.
To introduce the generalized linear model, it is convenient to formulate the as¬
sumptions about the risk of infection in terms of the individual susceptibles. A
given individual, who is still susceptible at time t, may be infected during the
time increment (t,t + S) with probability A(I(t)) 6 + o(S), where A is a specified
function of I(t) and other epidemiological factors and is assumed to involve only
a small number of unknown parameters. It is assumed that each susceptible in¬
dividual is subjected to the risk of infection independently of other susceptibles,
with A(i) = z = 0,1,2,..., where (3 is the rate of infection, i is the number
of infectious individuals and N is the total number of individuals in the study
population.
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For the purposes of the present analysis, it is convenient to partition the continu¬
ous absolute time scale into a succession of time intervals, in this case, days, i.e.
to evaluate the process on a day-to-day basis. Partitioning of the time interval
is not merely a mathematical convenience but also a reflection of the nature of
infectious disease data. Such data are normally available in terms of discrete time
units. The time unit is usually chosen in such a way to ensure that only a small
number of cases occur in one unit of time. As a results, the conditional proba¬
bility of a given susceptible escaping infection during the time interval (t, t -1-1)
given X(I(u)) for u € (t, t + 1), is approximately equal to e~ft A(7("))rfw_ This
conditional probability may be approximated by e~x^^\ for some u £ (t,t + 1)
if the value of A does not vary appreciably during the time interval (t,t + 1).
3.3.1.1 Analysis of epidemic data based on the GLM approach
Assume that during a given time unit, susceptibles either escape infection or
become infected independently of each other. Let C(t) denote the number of
individuals infected (cases) during the time interval (t,t + 1], t = 0,1,2,....
The conditional distribution of C(t) given S(t) and X(I(u)) for u £ (t,t + 1], is
approximately a binomial distribution with index S(t) and parameter 1 — e~x^^\
i.e. conditional on S(t) and A(I(u)),
C(t) - Bin(S(t), 1 - e-A(/(i)))
and the expected value E(C(t)) = S(t) e~x^^ from which
«»--1. (.- «).
Although C(0), C(l), C(2),... are not independent random variables, it can be
claimed that the respective observations c(0), c(l), c(2),..., provide essentially
independent information about the parameters contained in the specification of
A, when they are treated as conditional on the size of the susceptible population
at the start of each day. Thus inference about these parameters should proceed
as though C(0), C(l), C(2),... were independent.
If A(I(t)) in Equation (3.1) can be linearized by log-transformation such that
ln[A(/(i))] = In [—In (l — is linear in the parameters defining A(/(t)),
then a generalized linear model for the number of new cases C(t) with a com¬
plementary log-log link function (McCullagh and Nelder, 1983, Section 2.2.3) has
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been specified and can easily be fitted in standard statistical packages, for exam¬
ple Genstat (Genstat 5 Committee, 1993) or S-Plus (MathSoft, 1999), to obtain
ML estimates for the parameters involved. Where A{I(t)) = this is indeed
the case.
3.3.2 GLMs applied to FMD experimental data
For the FMD experimental data, the aim is to estimate the rate of infection j8g
for each infection generation g. Thus the risk of infection at time t is given by:
ACM) = J5#. (3-2)
where G is the total number of infection generations, Ig(t) is the number of
generation g infectious individuals at time t and N(t) is the number of individuals
mixing in a given group at time t.
From Equation (3.2),
E(C(t))\In -In 1- ln[A(/(i))] = In f i>,mh ms(t)!\
However, ln[A(/(f))] is not linear in the parameters f3g hence a GLM can not be
fitted to generate estimates of (3g.
One alternative is to re-parameterise A in a way similar to that proposed by
de Jong et al. (1996). These authors set out to investigate population persistence
and recurrent outbreaks of bovine respiratory syncytial virus on dairy farms.
Based on the assumption that both seronegative and seropositive cattle can be¬
come infected, de Jong et al. (1996) investigate whether infectivity and rate of
recovery may differ depending on whether the animal was seronegative or seropos¬
itive when infected. They also investigate whether susceptibility to infection may
differ between seronegative and seropositive cattle. The authors use GLMs to es¬
timate the different rates of infection namely; /3nn, the rate at which seronegative
cattle become infected by seronegative infectious cattle, /3np, the rate at which
seronegative cattle become infected by seropositive infectious cattle, /3pn, the rate
at which seropositive cattle become infected by seronegative infectious cattle and
Ppp, the rate at which seropositive cattle become infected by seropositive infec¬
tious cattle. In order to be able to apply a GLM to the data, the following
expected value equation was used for the case of susceptible seronegative cattle:
E[dln\ = expja + bq] Sn(In + Ip)N
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where Sn is the average number of seronegative cattle, dln is the average daily
incidence of primary infections, In is the number of seronegative infectious cattle,
Ip is the number of seropositive infectious cattle, N is the total cattle population
under study, the covariate q = faction °f infectious animals that
are seronegative and where a and b are parameters to be estimated from the
GLM. Taking ln[5n(/n^/p)] as an offset, a and b were estimated and from these
the transmission rate parameters pnp and f3nn were computed by Pnp = ea and
Pnn = za+b yielding separate estimates for the rate at which seronegative animals
become infected by seronegative infectious animals and the rate at which seroneg¬
ative animals become infected by seropositive infectious animals. Similarly, the
corresponding estimates for seropositive animals were estimated. The technique
is exact if over the time period, there is only one category of infectious individuals
such that on each sampling day q is either equal to 0 or 1.
Formally, the method makes the approximation that
Pnn q + Pnp (l ~ 0) - PL Pup9
the equality being true iff q = 0 or q = 1. Hence the parameterisation assumes
that during any sampling day, q is consistently close to either 0 or 1. It is arguable
how valid this assumption might be in the original application; it is certainly not
especially credible when applied to the FMD experimental data, where there are
several generations to be modelled, and a relatively small group size.
Following the parameterisation in de Jong et al. (1996), A[/(f)] in Equation (3.2)
can be reparameterised such that
with
Po = ea°, f3g = eao + asi9j g > i anci qk = k > I. (3.3)
Then
E(C(t))\In -ln
'G mln[A(/(t))] = o0 + J2 akQk + In ( Al
k=0 \ 9=0
is linear in the parameters ag and hence a GLM with complementary log-log link
function and ln wp)) as an offset can be fitted to the data to yield the
estimates and estimates of standard errors for the ag.
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Estimates for the j3g are then determined from estimates of ag using Equation
(3.3) and estimates of the corresponding standard errors are calculated using
the S method (Becker, 1989, Appendix). The S method involves expansion of
a function of a random variable about its mean, usually with a one-step Taylor
approximation, and calculation of the variances of the approximation. For in¬
stance, if it is desired to approximate the variance of a function G(x), where X
is a random variable with mean (jlx and G(x) is differentiate, then
G{x7j — G((j,x) T fjjX^ G (/r^) — G(px) ~f~ xG (px) PxG (px)
such that
Var{G{x)) ~ Var(X G'(fix)) ~ [G'(px)]2 Var(X) (3.4)
where G'() =
For vector-valued functions of random variables,
Var{G{x)) = G'(p*) Var(X) [G'(px) ]T (3.5)
and this in fact is the basis for deriving the asymptotic variance of maximum
likelihood estimators. In Equation (3.5), X is a 1 x m vector, Var(X) its m x m
variance-covariance matrix, G(x) is a vector function returning alxn column
vector, G' (x) is its n x m matrix of first derivatives, T is the transpose operator
and Var(G(x)) is the resulting n x n variance-covariance matrix of G(x).
An alternative to the de Jong et al. (1996) parameterisation approach is the direct
maximization of the likelihood. The likelihood (L) and log-likelihood (I) functions
for the cases are given by:
AkT'-^n.-^n
'= El"(c)+ E (l-e-S,°-^) +
days \ ) days(t) \ g—0 /
(3.6)
where S, C, Ig, and N, all depend on the day t.
The re-parameterisation of the rate of infection proposed to allow fitting via a
GLM will yield estimates equal to the estimates obtained by direct maximisation
of the likelihood if at any one moment there is only one generation of infectious
individuals, i.e. infectious individuals in higher generations are detected only
when the preceding generation of infections has ceased to be infectious, so that if
Ik(t) > 0 then Ig(t) should be equal to zero for all g ^ k.
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3.3.2.1 The data
The de Jong et al. (1996) approach is applied to data from FMD experiment 1.
For each day between the start and the end of the experiment, the number of
sheep that were viraemic is noted. In this study viraemia is used as an indicator
for infectiousness. This is a major assumption, but studies have shown that peak
viraemia coincides with high infectiousness (Hughes et ah, 2002a). The data
extracted from the full experimental data as required to fit the model in Genstat
is presented in Table 3.2. Data are presented only for days where the mixing
groups have at least 1 infectious individual i.e I(t) > 0. The data required to fit
the GLM was extracted from the observed viraemia experimental data in Figure
1.3. The data previously have been described in Sections 1.3.1 and 1.3.3.
An individual was assumed to have become a case 1 day before it was observed
to be shedding virus, i.e., a 1 day fixed latent period was assumed. The basis
for this assumption was that if the individual had detectable viraemia on any
previous sampling day, then it would have been identified as being viraemic. The
assignment of cases to donors and hence cases to generation numbers, was done
by 'eye' depending on the most likely donor among the present infectives and the
mixing pattern. Four infection generations are assumed, such that all infected
individuals that would have been assigned infection generation numbers of 3 or
higher are all assigned to infection generation 3. This is on assumption that any
passage effects will have largely occurred by generation 3, and in practical terms it
ensures an adequate sample size of generation 3 observations. Thus there are four
rates of infection parameters to be estimated, i.e. Po, Pi, P2 and Pz for infection
generations 0 to 3 respectively.
3.3.2.2 Results from the analysis of experimental data
A GLM was fitted to the data in Genstat and the results presented in Table 3.3
were obtained. Group 1 infected individuals which are generation 0 infectives
have an estimated rate of infection of 0.14 (s.e = 0.147), generation 1 infectives
have an estimated rate of infection of 0.86 (s.e = 0.636), generation 2 infectives
have their rate of infection estimated to be 3.56 (s.e = 1.724) and generation 3
and higher infectives have an estimated rate of infection of 0.73 (s.e = 0.242).
It is observed that the initial infected individuals have a very low rate of in¬
fection. Indeed from the criterion used to define the cases, only 1 generation 1
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Table 3.2: Data from experiment 1 required to fit the generalised linear model
where Cg(t) is the number of generation g cases on day t, C(t) = Hg=oCg(t),
Igift) is the number of generation g infecteds on day t, I(t) = Hg=o and
R(t) is the number of recovered individuals on day t.
Day
t Room N(t) S(t) Cx(t) C2(t) C3(t) C{t) I0(t) hit) I2(t) I3(t) I(t) R(t)
1 1 16 11 0 0 0 0 5 0 0 0 5 0
2 1 8 1 0 0 0 0 7 0 0 0 7 0
3 1 16 9 1 0 0 1 5 0 0 0 5 2
4 1 8 1 0 0 0 0 1 0 0 0 1 6
4 2 16 15 0 0 0 0 0 1 0 0 1 0
5 1 16 8 0 0 0 0 0 1 0 0 1 7
6 2 16 15 0 2 0 2 0 1 0 0 1 0
7 1 16 7 0 0 2 2 0 0 1 0 1 8
7 3 16 15 0 0 3 3 0 0 1 0 1 0
8 2 16 8 0 0 2 2 0 0 2 5 7 1
9 1 16 4 0 0 0 0 0 0 1 3 4 8
9 3 16 11 0 0 3 3 0 0 1 4 5 0
10 2 16 4 0 0 1 1 0 0 0 8 8 4
10 4 8 7 0 0 0 0 0 0 0 1 1 0
11 1 16 3 0 0 0 0 0 0 0 1 1 12
11 3 16 8 0 0 5 5 0 0 0 4 4 4
12 2 16 2 0 0 0 0 0 0 0 5 5 9
12 4 8 3 0 0 1 1 0 0 0 5 5 0
13 1 16 3 0 0 0 0 0 0 0 1 1 12
13 3 16 2 0 0 0 0 0 0 0 7 7 7
14 2 16 2 0 0 0 0 0 0 0 1 1 13
14 4 8 2 0 0 1 1 0 0 0 4 4 2
15 3 16 1 0 0 0 0 0 0 0 2 2 13
16 4 8 1 0 0 0 0 0 0 0 1 1 6
17 3 16 1 0 0 0 0 0 0 0 1 1 14
18 4 8 1 0 0 0 0 0 0 0 1 1 6
infective was identified. 7 of the 8 initially inoculated sheep became viraemic,
but managed to generate only 1 secondary infection. These results do seem to
indicate that the inoculated sheep had very low potential to cause infection in
group 2 individuals. The estimated rate of infection increases between generation
0 and 1 and between generation 1 and 2 and drops in generation 3. Generation 2
infectives have the highest estimated rate of infection and this could be because
of the natural infection exposure from generation 1 infective. The estimated rate
of infection drops between generation 2 and 3 infectives and it could be possible
that this is associated with the hypothesis of rate of infection dropping through
passage. Performing an analysis with only two levels of rate of infection, i.e. one
rate of infection assumed for the generation 0 i.e. infection due to inoculation
and one infection rate assumed for all secondary infections (natural infections),
yielded an estimated generation zero rate of infection of 0.14 and rate of infection
for secondary infections of 1.06. Comparing the model with two levels of rate
of infection with a model where only one rate of infection is assumed for all in¬
fections, the two models were statistically significantly different (p-value = 0.03,
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Table 3.3: Results obtained from the generalized linear model fitted to data in
Table 3.2.
Infection
generation g ag s.e(ag) A s.e($g)
0 -1.96 1.04 0.14 0.147
1 1.81 1.28 0.86 0.636
2 3.23 1.15 3.56 1.724
3 1.64 1.09 0.73 0.242
based on the F test using the change in deviance). The model assuming three
different rates of infection, one rate for generations 0 and 1 combined, another
rate for generation 2 and one rate for generation 3 and higher generations, pro¬
vided a better fit to the data compared to the model with one rate of infection.
The results indicate that the rate of infection in inoculated sheep is lower than
the rate of infection in naturally infected sheep.
As pointed out earlier, the re-parameterisation of the rate of infection proposed in
the de Jong et al. (1996) parameterisation would yield estimates equal to estimates
obtained by direct maximisation of the likelihood if in any one time period there
is only one generation of infectious individuals. However, this may not be the
case and indeed from the FMD experimental data it is true for generation 0 and
1 but not for generations 2 and 3. The rates of infection estimates obtained
from the GLM have a similar trend to those obtained by direct maximisation,
however, the GLM yielded a higher generation 2 rate of infection and a lower
generation 3 rate of infection compared to the ML estimates. The estimates
obtained by direct maximisation of the likelihood are: A = 0.14 (s.e = 0.199),
A = 0.86 (s.e = 0.864), A = 2.58 (s.e = 1.480) and A = 0.77 (s.e = 0.364).
These differences are probably due to the inadequacies of the de Jong et al.
(1996) approximation in this application.
The GLM approach works on the assumption that the infection generation is
known for each infected individual. Generally, assignment of infection generation
number to individuals is very subjective. For the FMD experimental data, it was
assumed that individuals became cases on the day before they tested positive to
FMD virus and on that assumption, given the generation of infected individuals
with which any particular individual sheep was mixing when it is assumed to
have become a case, an infection generation number was assigned to it. In the
next section, therefore, the de Jong et al. (1996) approach as applied to data
from the FMD experiments is evaluated using simulated data from a model that
incorporates the design of the experiment.
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3.3.3 Evaluation of the GLM approach using simulated
data
Simulation models that reflect the design of the experiment, based on a susceptible-
latent-infectious-recovered (SLIR) infection process as described in Section 2.4
were used to generate epidemic data. Data were generated from two models,
namely:
1. A model assuming a gamma distributed latent period with distribution
mean equal to 1.5 days (based on a priori expert knowledge) and a gamma
distributed infectiousness period with distribution mean equal to 2.8 days
(calculated from the number of viraemic days observed in experiment 1).
2. A model assuming a fixed latent period of 1.5 days and a fixed infectiousness
period of 2.8 days.
The input parameters in the models were a rate of infection set equal to 0.86 for
the initially infected individuals of group 1 and a passage multiplier of zero such
that the true rates of infection for all infection generations were equal to 0.86.
0.86 is the /3q estimate from the GLM estimated in Section 3.3.2.2.
From each run of the model, two data sets were generated to evaluate the GLM
approach. One is where the analysis can be based on true infection generation.
Within the model, the 'donor' for each infected individual is known and hence the
true infection generation number will be known. The other data set, based on the
same realisation of the process, is the more realistic model of data, where analysis
would be based on assigning infected individuals infection generation numbers
(referred to as pseudo infection generations) using some criteria as though the
truth was not known. These models of infection assignment are outlined below.
Within realisation from the model assuming random latent and random infec¬
tiousness periods, an infected individual was identified as having become a case 1
day or 2 days before it was first observed to be infectious based on certain prob¬
abilities. Let p_T denote the probability of an infective being observed on day d
given that it became a case on day d — r, /_T denote the number of infectious
individuals on day d — r and /3 the rate of infection.
On making some simplifying assumptions we have:
Pr(individual became exposed on day d—r | individual was observed to be positive




The approximation is not particularly valid, but it is likely to correspond to the
type of simplifying assumption made by a person attempting mentally to assign
an infection path to an observed data set.
Restricting r to only 2 days before observation of infection yields:
Pr(individual became case on day d — r \ individual was susceptible prior to day
d — t and was observed to be infectious on day d)
P—T I—T
P-1 I—l +P-2I-
for r = 1, 2.
2
For the data modelled here, p-1 and p_2 were set equal to 0.5, i.e. equal proba¬
bilities of becoming a case either 1 or 2 days before being observed as infectious.
Within realisations from the model assuming fixed latent and infectiousness pe¬
riods, infection generation numbers for infected individuals were assigned on the
basis of when the individuals became infections. This was done by assuming that
individuals became cases 1 day before first being observed to be infectious and
randomly assigning an infection generation number calculated from the genera¬
tions of infectious individuals mixing on that day. However, due to the mixing
pattern, a situation frequently arose where on that day, the individual in question
was not mixing with any infectious individuals and hence it could not have be¬
come a case on that day. In such situations the individual was defined as having
become a case 2 days before it was observed as being infectious and a genera¬
tion number was assigned randomly calculated from the generation numbers of
infectives mixing on that day.
Thus four different categories of data were analysed, namely:
1. That based on true allocation of infection generation numbers, with random
latent and random infectiousness periods.
2. That with random latent and random infectiousness periods with allocated
pseudo infection generations based 011 probabilities.
3. That with fixed latent and infectiousness periods with true allocation of
infection generations.
4. That with fixed latent and infectiousness periods with pseudo infection gen¬
erations derived by assuming infection either 1 or 2 days previously, depend¬
ing on the presence or absence of candidate individuals.
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100 sets of epidemic data in each category were analysed using a GLM to yield es¬
timates for the rate of infection for different infection generations. 95% confidence
intervals for each f3g were constructed and the proportion of intervals, denoted by
P(fail), that failed to cover the true value /3g = 0.86 was determined. For each
P(fail), exact 95% confidence intervals were calculated based on the formulae in
Armitage and Berry (1994), Section 4.7, to determine whether the approach gave
rise to confidence intervals with 95% confidence. The results are summarised in
Table 3.4. For some realisations the total number of infection generations inferred
was as high as thirteen (generation 0 to 12), however, only results for the first
four generations are presented. For each of infection generations 0 to 3, results
presented include the mean of fig for the 100 realisations, P(fail) and the 95%
confidence intervals of P(fail).
Table 3.4: Summary of results for the power study of the GLM approach based on
simulated data.
True infection generation Pseudo infection generation
Lat/
InfP
type Gen (g) j3g mean P(fail) 95% CIs fig mean P(fail) 95% CIs
Random 0 0.902 0.117 (0.062, 0.195) 0.621 0.194 (0.123, 0.284)
1 0.897 0.107 (0.055, 0.183) 1.617 0.117 (0.062, 0.195)
2 0.975 0.097 (0.048, 0.171) 1.346 0.087 (0.041, 0.159)
3 0.976 0.126 (0.069, 0.206) 1.248 0.126 (0.069, 0.206)
Fixed 0 0.898 0.050 (0.018, 0.105) 0.393 0.481 (0.383, 0.580)
1 0.634 0.190 (0.125, 0.271) 1.553 0.038 (0.010, 0.094)
2 1.015 0.099 (0.052, 0.167) 1.523 0.123 (0.067, 0.201)
3 0.723 0.248 (0.174, 0.335) 2.210 0.057 (0.021, 0.119)
For all the four categories, apart from estimates of fii from the model with fixed
latent and infectiousness periods with pseudo generation infection, all estimates
have P(fail) greater than the notional 5%. The GLM approach performs poorly in
all categories. It is also notable that the pseudo infection generations have inflated
estimates of rate of infection compared to the true infection generation, except
estimates for the generation 0 parameter. P(fail) is higher for pseudo infection
generations for a majority of estimates than in the equivalent true infection gen¬
erations. However, this effect is not as pronounced as might have been expected.
Examining the confidence intervals for P(fail), it is clear that almost all of the
true generation infections based intervals do not cover the notional P(fail) of 5%.
Thus, it is concluded that the type of re-parameterisation proposed by de Jong
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et al. (1996) does not perform well in the particular situation of multiple genera¬
tion parameter estimation arising from the design of the FMD experiments. Also,
the use of informally inferred epidemic paths clearly produces inflated estimates
of infection parameters and conservative confidence intervals. The latter effect is
inevitable, given the failure to account for the potential variability in the infection
path.
3.4 Summary
The use of chain binomial models and generalized linear models as applied to epi¬
demic data have been reviewed and their application to the FMD experimental
data evaluated. It was concluded that the chain binomial model would be very
difficult to implement in this situation, where the group size is higher than the
usual household size in the context where the chain binomial model has been most
frequently applied. Evaluation of the GLM approach revealed that the method
performs poorly for these data and is highly sensitive to knowledge of individual
infection generation numbers. Thus modelling the infection process for the FMD
experiments based on individual infection pathways using classical methods ap¬
pears impractical given the obstacle of having to know the true infection paths.
An alternative to the models considered in this chapter is to model the infection
process on the basis of average infection rate in groups of sheep rather than in
individuals. This approach uses the fact that any decreasing rate of infection
across groups is most probably due to the presence of more higher generation in¬
fected individuals in higher groups. Modelling the infection process on the basis
of groups and the methods for estimating the associated parameters on are the




methods for FMD infection
process models
4.1 Introduction
In the analysis of the infection dynamics of experimental FMD in sheep, for the
rest of this thesis, the focus will be on modelling the infection process in groups of
sheep rather than in individual sheep. In the previous chapter it became appar¬
ent that formulation of models in terms of infection generations makes inference
difficult. The source of infection for each infected individual needs to be known
to determine the generation number of an infected individual. Only group 1 in¬
fected individuals which were artificially infected and the first group 2 infected
individual have a known generation. Modelling the infection process in groups
of sheep rather than individuals avoids the need to know individual infection
generations and full infection pathways. Models fitted at group level will aim to
estimate the typical infection rate, /3, acting upon different groups of sheep i.e.
the rates at which groups of sheep acquire infection. Once a set of /3 estimates
for each group has been calculated, if there is a genuinely decreasing trend, the
only possible cause is a drop in infectivity with increased generation. This fol¬
lows from the consideration that the mixing strategy ensures that an infection in
a higher numbered group will tend to be of a higher generation. In the current
chapter, methods for estimating /3 for groups 2 to 4 are described. These include
maximum likelihood and martingale estimation methods. /? estimates will be cal¬
culated together with estimates for the expected characteristics of the infection
process in an iterative scheme. The mechanism for the proposed iterative scheme
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is described and the justification, mentioned in Section 2.7.1, for using a non-EM
algorithm is given.
4.2 Maximum likelihood estimation methods
One of the methods that will be used to estimate the /3s is the maximum likelihood
estimation (MLE) method. The likelihood and log-likelihood functions are the
basis for deriving estimators for parameters from data. While the shapes of these
two functions are different, they have their maximum point at the same value of
the parameter. The value of the parameter that corresponds to the maximum
point of the log-likelihood function is defined to be the ML estimate. In other
words, the ML estimate of the unknown parameter in the model is the value that
maximizes the log-likelihood for the observed data. The log-likelihood links the
data, unknown model parameters and model assumptions and allows rigorous
statistical inference. It is of fundamental importance in the theory of inference
and in all of statistics.
Generally, calculus is used to find the maximum point of the log-likelihood func¬
tion and obtain ML estimates in closed form. However, in some cases a closed
form solution is unattainable and numerical methods have to be used in or¬
der to attain the desired ML estimates. Assuming a model has k parameters
6>i, d2, ..., 0k, then the log-likelihood Loge(L(9\, 92-, •••> #fc|data) = loge(L)
and k log-likelihood equations can be defined:
dlogL n dlogL n dlogL n
dOx = ' dO2 = ' "'' d9k = '
The solution of these equations gives ML estimates 9i, 92, • • ■ > Sk¬
in estimating parameters for the FMD infection process, two sets of estimates
of f3 will be considered using MLE methods applied to two different models,
namely, unrestricted ML estimates of /3 and restricted ML estimates of f3. For
the unrestricted model (also under martingale methods), the estimates of f3 in
groups 2 to 4 will be unrestricted in the sense that, for instance, the estimate in
group 2 can be lower or higher than the estimate in group 3. For the restricted
model, however, the estimates of (3 in groups 3 and 4 will be restricted to ensure
that the estimates are non-increasing with respect to increasing group number.
This restriction will increase the power to detect a decreasing trend in j3 if such
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a decreasing trend indeed is present. The restriction is justified by the nature of
the experimental hypothesis of decreasing infectivity due to passage effect.
4.2.1 Formulation
Let (3g denote the rate of infection to group g.
Ig denote the total number of infected individuals in group g.
Ng denote the total number of individuals in group g.
n(t) denote the total number of mixing individuals at time t.
I(t) denote the total number of infectious individuals in mixing groups at time
t.
Igi(t) denote the number of infectious individuals mixing with individual i of
group g at time t.
ngi(t) denote the total number of individuals mixing with individual i of group
g at time t.
The hazard to which an individual i of group g is exposed at a given time t is
given by:
h .(A = R Igi^
ngi(t)'
Then the probability that a susceptible individual i of group g becomes infected
at time tgi is given by:
Pr(z becomes infected at tgi) = hgi(tgi) e~fo9 hailt)dt = pg-LlA.e 09-To ngi(t)dt
n(tgi)
and the probability that a susceptible individual s of group g escapes infection
during the entire epidemic duration is given by:
Pr(s escapes infection) = e~^o9 hgs{t)dt _ g Pg f0 ngs(t)dt;
where t™ax is the time at which virus shedding ceases from the last shedding
individual mixing with individuals in group g.
Based on these probabilities, a likelihood function of the infection process given
the observed data is formulated and from it parameters will be estimated using
MLE.
Let L denote the likelihood function, then:
4 ( Ig Ng—Ig
l = n {n Pr(i becomes infected at tgi) JJ Pr(s escapes infection)
g=2 ^ i=l s=l
4 { Ia I(t ■) i rtai Iqi(t) -it Ng~l9 n rC°* Iqs(t)
= n i n/^-T^-e nai(t) n e Io ^




Note that the likelihood splits into factors corresponding to infected and non-
infected individuals. This arises due to the fact that although the infection times
of individuals are not independent, conditional on the force of infection, the prob¬
ability of an individual becoming infected is independent of that applying to all
other individuals.
4.2.2 The likelihood function for unrestricted model MLE
To ensure that the /? estimates are non-negative, a re-parameterisation for the
/3s is proposed such that f3g — ea\ g — 2,3,4, g indicating group number. The
likelihood function in Equation (4.1) then becomes:
L = n ( n I-^jAe~eag f°9i ^dtY e"6"9 ^aX Sttdt
g=2 ( i=l nV'gi) S=1
tt a2 —eQ2 f*2i ^jXdt Ni-J2 _e«2 f)™"1 'l*(l) dt= lie —— e Jo n2i(o Me Jo n2S(0 x
i= 1 nT2 i) S=1
J* a3l{t3i) _e«3 rf3. iliW dt ^3-/3 _ga3 tm.«^11 e 3 —;—r-e Jo "3.(0 e Jo "3S(0 x
1=1 S=1
tt tt4/(t4i) -e-4 rrx lA^idt11 e e Jo n4i(o || e Jo n4s(«) ,
l=i n(Ui) 5—1
where is the time of infection of individual % of group g, ngi(t) is the number of
individuals mixing with individual i of group g at time t and Igi(t) is the number
of infectious individuals mixing with individual i of group g at time t.
Taking natural logarithms of function L yields a log-likelihood function denoted
by I and is given by:
I = I2a2 + Y ln(^M) - e"2 Y ^Qdt - e"2V" ^rdt +I** ^r\dt-ea> Y [ti ri(t2i)> o n2l{t) stt Jo
h OC* + Y ln(^4) - e"3 Y r ^r\dt - eQ3 AE3 r™ —71n(t3i) Y\ J° n3i(t) Yl n3s(t)
n2s(t)
dt
IAaa + Y ln(^4) - eQ4 Y ~j\dt ~ ^ ^j\dt~i n(tAi) Yi ^ n4S(^)
, i)s , f (^4i)d2 Oil + f3 «3 + A «4 + 2^1n( / J + £ln( /+ 0 + ^ 0
1=1 n\hi) i-1 n(t3i) i—1 n\Jii)




£ rt3i hi(t) ^ , V3 r^ax hs{t) dt
n3s(t)£ f3i MEdt + [pi Jo n3i(t) p Jo
'A [*» Uitt) N-/4 ftr* i4s(t)
pJo n4i(t) ^ "4.W
= /2 a2 +/3 a3 +/4 a4 - eQ2 T2 - eQ3 T3 - eQ4 T4 + W, (4.2)
where
ti nfoi) p\ n(tsi) fr[ n{t4i)
Ig rhr I (t) N9~h ft™ax T (f)
T9 = E ^dt+ £ 9 JEJldt, g = 2,3,4.
1=1 ngi(j) S=1 do TlgS\t)
Tg is the total infection exposure time for group g, scaled by the number of mixing
individuals and W is a constant term, dependant only on the observed data.
4.2.2.1 Estimation of rate of infection
ML estimates for the rate of infection in terms of the as are obtained by equating
the first derivatives of the log-likelihood in Equation (4.2) to zero and solving for
the parameters. Taking derivatives of I in Equation (4.2) with respect to a yields:
dl d2l
T — p012 T ■ — — p"2 Tt-'2 ^ -^2j j2da2 ' da.2
dl d2l
h ~ e"3 T3; = — e"3 T3,
da3 ' da2
dl d2l





Equating the first order derivatives to zero yields ML estimators for the a pa¬
rameters i.e.
Jk= 0 = % * &2 = 1,1 (i
S| = ° =*•<=*■ = £=►*.= ln(|
dl - Ia ( Ia
d^=° ^ ' T< * ai = ln (Tt
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To ascertain that the estimates attained are unique estimates that give the ML,
second order derivatives of the log-likelihood function with respect to a2,a3 and
aq are obtained. The first order derivative with respect to each variable equating
to zero is a necessary condition for an extreme value. Each first order derivative
has a single zero, therefore the combination of these is the sole extreme value
in the space. It remains to show that the evaluated at the a ML estimates
are all less than zero, which will be sufficient to show that this extremum is a
maximum.
The log-likelihood in Equation (4.2) can be viewed as a sum of functions of one
variable.
Let I = l(a2,a3,a4) = l2(a2) + h(a3) + Z4(c^4), where 7(cq) = Acq - eaiTi, for
i = 2,3, 4, then
dl dli d2l d?li d2l
dcti dai' da2 da2 daidaj
Evaluating the second order derivatives ^ at the ML estimates, cq : ^ = 0
(cq), yields: ^ = —7$ V i. Thus each of the evaluated at cq is less than zero
implying that 7(cq) is at a maximum at cq, hence I = J2k(ai) is at a maximum
at on Mi, since I is a linear combination of l2(a2), l3(a3) and £4(0:4), each of which
is a function depending only on a2, a3 and 04 respectively. Hence the attained
ML estimates for a correspond to a unique maximum.
After calculating ML estimates for the parameters, it is important to form some
idea about the possible deviation between the estimate and the true parameter.
From theory by Cramer-Rao (Azzalini, 1996, Section 3.2), the observed informa¬
tion, 1(a) = — j4^r£(o:)|a = d can be used to estimate the standard error of the
parameter estimates, where a is the vector of parameters of interest and a is the
vector of the attained parameter estimates. Using Cramer-Rao's inequality, if
T(y) is an unbiased estimator for a and assuming that the expected information
matrix, 1(a) is positive definite, then
var[T(Y)] > [/(a)]"1.
The expected information matrix, 1(a) = — E d^aT £(o:)] > can be estimated by
the observed information matrix 1(a), such that
var[T(Y)] > [1(a)]-1 =
d2
U 11Rcr) \a = &dadaT
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If the estimator attains the minimum variance estimate, then
varlT(Y)] = ■
Information matrix
The information matrix is the matrix whose elements are the second order deriva¬
tives of the log-likelihood function evaluated at the ML estimates. It will be
denoted by H and its inverse denoted H~l such that:
00b?1 001
H = 0 1 0 and H 1 = 0 1 <bb 0
0 0 1 jb 0 0 1 bb
From the inverse of the information matrix, standard error estimates for the
parameter estimates are obtained.
Let a = (a2,a3,a4), then var(a) = - \d£^]a = & = ~ H~l
Thus standard error estimates for the as are given by:
s.e{6>2) = 1,1] =
5.e(d3) = 2,2] = ./I
s.e(d4) = y/-H~l[3,3]
Estimates for the rate of infection in terms of (3
The estimates for the /3g are as follows:






Standard error estimates for the fa are obtained based on the standard error
estimates of the as using the 8 method (Becker, 1989, Appendix). The 8 method
stipulates that if estimators Mj of parameter 6j have variances var(Mj), j =
1,..., r, then for M = 5(Mi,..., Mr),
var (M) - %r(w
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It follows that:
if r = 1, s.e{g(Mi)} ~ \g'(Mi)\ s.e(Mi), and
If r = 2,
var{g(MuM2)} ~ var(Mi) + var(M2)
Thus, using the S method, the standard error estimates for the /3s are as follows:
fig = ea° = y(ag), s.e(fig) ~ \y'{ag)\s.e{ag) = e&s
Hence
s.e{fi2) = s.e(fi3) = ^ and s.e(fi4) = ~J-2 J-3 J-4 (4.4)
4.2.3 Parameter estimates for restricted model MLE
When calculating ML estimates for the restricted model, the aim is to estimate
rates of infection acting upon groups of sheep while ensuring that these rates
decrease or stay the same across groups. Based on the experimental hypothesis
of decreasing infectivity due to passage effect, /3 estimates will not be allowed
to increase across groups. This is in contrast to ML estimates made for the
unrestricted model where the f3 estimates are unrestricted, which may potentially
result in for example, fi3 > (32-
The procedure to estimate parameters in the restricted model MLE situation is
as follows. Initially, estimate the unrestricted model parameters (4.3). If the
estimates are valid, i.e. /32 > /?3 > /34, then this point will be the maximum
in the parameter space. Refer to this as Case 1. If not, then the maximum
will be on the boundary of the restricted space (Hatton, 1977, Section 10.12)
and the resulting ML estimates may be any among: f32 — (33 > (Case 2)
or /32 > (33 = (34 (Case 3) or f32 = /?3 = (34 (Case 4). It is useful to think
in terms of a nested hierarchy of parametric models. Just as the maxima of
likelihoods with 2 effective parameters (with two parameters constrained to be
equal) are less than or equal to the maximum of a likelihood with 3 parameters
(with no constraints), the maxima of likelihood with 1 effective parameter (with
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all three parameters constrained to be equal: Case 4) must be less than or equal
to the likelihoods with 2 effective parameters (Cases 2 and 3). It is important to
understand that the extrema corresponding to both Cases 2 and 3 may be wholly
within the valid space.
Let 0:23 be the a parameter in Case 2 where 0:2 = <^3 (P2 = P3), <234 be the a
parameter in Case 3 where 0:3 = a4 (f33 = f34) and 0:234 be the a parameter in Case
4 where o2 = o3 = a4 (/32 = Ps = A). The following algorithm is appropriate:
Algorithm 4.1
1. Estimate a2, a3 and 04. If o2 > o3 > 04, use these estimates (Case 1).
Goto end.
2. Estimate o23 and o4 (Case 2).
3. Estimate 02 and o34 (Case 3).
4. If (o23 < o4) and (o2 < o34) goto 8.
5. If (o23 > 04) and (o2 < o34), use the o23 and o4 estimates (Case 2). Goto
end.
6. If (o23 < 04) and (02 > o34), use the o2 and o34 estimates (Case 3). Goto
end.
7. If (o23 > 04) and (02 > o34), evaluate the maximum log-likelihoods for
each pair of parameter estimates. Use the estimates which give rise to the
larger maximum log-likelihood (Case 2 or 3). Goto end.
8. Estimate o334 and use this estimate (Case 4). Goto end.
9. End.
For Case 1 i.e. (32 > /33 > f34, estimates of these parameters and their correspond¬
ing standard error estimates are equal to those estimated using unrestricted model
MLE. Now we proceed to determine expressions for the ag and f3g estimates and
their associated estimates of standard error for Cases 2, 3 and 4.
87
4.2.3.1 Case 2: fi2 = £3 > Pa
For Case 2, /?3 = p2 and a3 = a2, thus, the log-likelihood function in Equation
(4.2) becomes:
I = (I2 + h) a2 + I4a4 - eQ2(T2 + T3) - eQ4 T4 + W.
Taking first and second order derivatives of the log-likelihood with respect to a2
and aq yields:
M
= h + h ~ ea2 (T2 + T3); = e°4 /4 - e"4 T4,7 ' - O ^ \ 6 1 O / 1 J
dcx2 cL(X/±
d2l d2l d2l
—eQ2 (T2 + T3); = — e°4 T4; —— = 0.ala:2 ' da\ ' da2da4
Equating the first order derivatives to zero and solving for a2 and aq yields the
following likelihood equations and estimates of a:
dl
=0 => e4> = ^ d2= lnfA+A). (4,5)da2 T2 + T3 vT2 + 21
0 => eai — =>- aq = In (^-) . (4.6)
Ih
da4 T4 VT4
Evaluating the second order derivatives at d:9 gives:
r/2/ . rftl . (ft I
= _ea2 (Ta + Ts) = _(j2 + /8); = —e"4 T4 = —J4; -—-— = 0.
(2(^2 (10L± dOi2CL(X^
The information matrix, denoted i/2, whose elements are the second order deriva¬
tives of the log-likelihood evaluated at the ML estimates, and its inverse, H2 are
then given by:
~{h + h) 0 \ / ~ t^+T3 0
and 2/T1 — '
0 -h
and the determinant ofmatrix H2, denoted by det(772) is equal to /4 (/2+/3) > 0.
Each of the first derivatives has a single root and det(i72) is positive. Thus the
estimated parameters correspond to a unique maximum in the surface.
Standard error estimates for the estimates of the ag are determined from the
inverse of the information matrix based on Cramer-Rao's theory (Azzalini, 1996,
Section 3.2) as follows:




4.2.3.2 Estimates of fa for Case 2
From Equations (4.5) and (4.6) the estimates for the rates of infection are as
follows:
= ea2 = j**1,! = fa and fa = eQ4 = (4.8)
2 2 + +3 24
The standard error estimates for the j3s are determined based on the <5 method
(Becker, 1989, Appendix) as follows:
1. For fa = e&2 = g(a2) = fa,
s.e(fa) - Itf'M|s.e(d2) = e&']J j2 + j3 = ^2y j2 + /3' (4l9)
2. For /34 = eQ4 = <7(0:4),
s-e(fa) ~ 1^(04)|s.e(d4) = ea\[J- = faj-y-. (4.10)
4.2.3.3 Case 3: fa > fa = fa
By similar methods to those in Section 4.2.3.1 above, it is trivial to show that:
ft = s.e(k)- ft^/+ ft = ft = A±A, s.e(ft) =, ft^y.
(4.11)
4.2.3.4 Case 4: fa = fa = fa
Using similar methods to those in Section 4.2.3.1, the estimates obtained for the
fa are:
ft = ft = ft = = fa-h±k-t(ft) ~ ft,/ 1 . (4.12)22 + 43 + 24 V 22 + 23 + 24
4.2.3.5 Likelihood on boundary of parameter space
The properties of estimates of parameters under ML on a restricted parameter
space may be problematic. If the unrestricted estimates are outwith the allowable
parameter space, the restricted model ML estimates will be on the boundary of
89
the parameter space (Hatton, 1977, Section 10.12). In this situation, first or¬
der approximations to the properties of the likelihood will be invalid, since these
depend on the ability to generate valid Taylor Series approximations to the like¬
lihood at values of the parameter equal to the ML. However, the likelihood is
discontinuous at the boundary. If a confidence interval was required for the pa¬
rameter estimates, Barndorff-Nielsen and Cox (1994), Section 3.8, recommend
that the confidence interval from the unrestricted case be used, with regions out¬
side the restricted parameter space being made void. Hence, in principle, it would
be possible to generate a confidence interval for the ML estimates. However, the
dependence of these parameter estimates on a common inferred underlying in¬
fection history creates a lack of independence in the estimates, while variability
arising from the lack of knowledge of the infection path is not expressed in the
log-likelihood of the data. Where the standard EM algorithm has been used to
estimate parameters, methods have been proposed to allow the estimation of the
covariance matrix of the estimated parameter vector (McLachlan and Ivrishnan,
1997, Sections 4.2:4.5). However, it is not clear whether these methods will be
valid for non-EM iterative algorithms such as those in the current work. In addi¬
tion, these methods are based on the asymptotic properties of the complete-data
log-likelihood, and it seems likely that the relatively small numbers of animals in
the experiments will make such asymptotic arguments hard to justify. Because
of these factors, it was decided to base the testing of the alternative hypoth¬
esis on bootstrap methods (McLachlan and Krishnan, 1997, Section 4.6) rather
than on asymptotic likelihood theory. Although no confidence intervals are there¬
fore required for the estimated parameters, it would seem useful to incorporate
information about the apparent precision of the estimates into the bootstrap¬
ping procedure. Ideally, this requires a point estimate of the variability of the
estimates, and this can only be provided from an expected information matrix
evaluated at the point estimate. In the situation where the point estimates for the
restricted and unrestricted cases are identical, there is no problem: the standard
errors derived from the 3 by 3 information matrix are used. Where the point
estimates are on the boundary of the restricted parameter space, the appropriate
degenerate information (either a 2 by 2 matrix or scalar) is used, as presented in
previous Sections 4.2.3.1 to 4.2.3.4. In a sense, the resulting standard errors are
conditional on the parameter estimates being degenerate in that particular way
(i.e., either a2 = 0:3 or a3 = aq or a2 = 0:3 = aq). However, it is felt that the
resulting standard errors will provide an appropriate measure of the variability
of the parameter estimates within the bootstrap procedure.
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4.2.4 Estimation of the exposure time, Tg
For each individual the amount of time for which they were exposed to infection
is determined. The total group infection exposure time Tg which features in the
expression for the log-likelihood function in Equation (4.2) and in the expressions
for the estimates of the (3g, is determined by the length of infection exposure of
individuals mixing in group g i.e.
T = f f-LM dt + "y ['•" LM" hj" hi ■><• "rM
where
Ng is the total number of individuals in group g.
Ig is the total number of infected individuals in group g.
ngi{t) is the number of individuals mixing with infected individual i of group
g at time t.
Igi(t) is the number of infected individuals mixing with infected individual i
of group g at time t.
ngs(t) is the number of individuals mixing with susceptible individual s of
group g at time t.
Igs(t) is the number of infected individuals mixing with susceptible individual
i of group g at time t and
t™ax is the maximum of the time of end of experiment and the last time of
exposure to infection for group g.
Individuals from a single group that each escaped infection were exposed to the
same hazard and hence have the same exposure time. The length of exposure
time is estimated based on the infectiousness period of infected individuals. By
assuming a distribution for the infectiousness period and fitting the distribution
to data, the expected infectiousness period will be estimated.
For each infected individual i, the time between the start of the experiment
and the individual's expected time of infection tgi is partitioned into regions of
constant hazard while taking into account the re-mixing of groups every 24 hours.
Thus, the largest interval has a length of 1 day. The time points of change in
hazard will be referred to as transition time points.
Let pi denote the number of transition time points for individual i, and tki denote
the individual partition time points for individual i, k = 1, 2,... ,pi with tu — 0,
the start of the experiment and tPii = tgi, the expected time of infection for
individual i.
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The probability that an infected individual i of group g becomes infected at time
tgi is given by:
YJk=i1 n9'(tt') (fyfc+i)» ~ tki) in Equation (4.13) is the total expected scaled infec¬
tion exposure time (scaled by the total number of mixing individuals) for indi¬
vidual i of group g by the time it became infected.
Similarly, the time from the start of the experiment up to the time of the end
of the experiment or up to the time when a group ceased to be exposed to in¬
fection (i.e. when there were no more infectious individuals among those mixing
with the group), is partitioned into intervals of constant hazard, again taking the
group mixing times into consideration. The probability of an individual escap¬
ing infection throughout the experiment, is calculated based on these partitioned
intervals.
The probability that an individual escapes infection throughout the duration of
the epidemic is given by
The time period [0, t™ax] is partitioned into intervals of constant hazard.
Let pg denote the number of transition time points in the period [0, t™ax] for
group g individuals that escaped infection. Individuals in the same group that
each escape infection have the same transition time points during the period
[0, t™ax]. Also let tmg denote the individual transition time points for group g,
m = 1,2,...,pg, with tig = 0 and tVg9 = t™ax. Then the probability that an





P9~1 I s(tm )9S g (tm+ig — tmg) in Equation (4.14) is the total infection exposure
m=l ngs\Jmg)
time, scaled by the number of mixing individuals ngs(-), for a susceptible individ¬
ual that escaped infection in group g.
The total group infection exposure time Tg is therefore given by the expression
below:
' hi'o "»'(') hi
Igijtki) f.
_ , \ 9 P\r-^ Igsjtmg) (. __ , \
/Li 2-7 „ \ \C'+l) ® tki) + 2^ 2T „ fj. 1 ( (m+l)s tmg J
7=1 fc=l ngi\Lki) S=1 777=1 1 Lgs\Lmg)
= E E 0«>< -<«) + W " E " '•"») ■
7=1 fc=l ngi\iki) 771=1 il'g\Lmg)
(4.15)
/g(t) denotes the number of infectious individuals mixing in group g at time t and
ng(t) denotes the total number of individuals mixing in group g at time t.
The number of infectives at a given time t, and the transition points, are of
course, unobserved. Where these are replaced with estimated values derived from
an iterative algorithm, as described in Section 6.6, the resulting quantity is treated
as an estimator for E[Tg].
4.3 Martingale methods
As noted in Section 1.4, infectious disease data present several difficulties in their
analysis and in the estimation of parameters. The spread of infection through
a community (group in our case) is only partially observable. Relatively little
information is available about characteristics such as the duration of latent period
that are not directly observable making it difficult to formulate and fit parametric
models for the entire disease process. Also, the lack of independence in the data
usually leads to likelihood functions with an unmanageable form. To tackle some
of these difficulties, alternative methods to MLE have been developed to make
statistical inference about relevant epidemiological parameters. One such method
is the martingale method of estimation. Becker (1993a) points out that martingale
methods have provided methods of inference in a number of situations where no
satisfactory method of analysis was previously available. Martingale methods
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facilitate the construction of estimating equations and the derivation of parameter
estimates and associated standard error estimates.
4.3.1 Previous applications of martingale methods
The use of martingales as a tool to derive methods for nonparametric inference
was first illustrated by Aalen in a 1975 Berkeley PhD thesis (Becker, 1989, Section
7.7). Andersen and Borgan (1985) give a review of the methodology. The first
application to inference for parameters of an epidemic model is given in Becker
(1977). Other illustrations of the use of martingale methods in the analysis of
infectious disease data, particularly those involving two types of susceptibles, are
given by Becker and Angulo (1981) and Becker (1982). Martingale methods have
since been applied to the estimation of epidemiological parameters such as the
force of infection, the infection potential, the mean duration of the infectiousness
period, and the basic reproduction number, R0. Becker (1993a) uses martin¬
gale methods to estimate the mean infection potential for the general epidemic
where the infection process for an individual was defined by Susceptible-Infected-
Removed states and the time spent in the infected state was exponentially dis¬
tributed. Martingale methods have also been used to make inference in popu¬
lations with varying susceptibility, for instance, in vaccinated and un-vaccinated
individuals. This approach enables, for example, the estimation of the degree of
protection offered by a vaccine (Becker, 1993a). de Jong and Kimman (1994) use
martingale methods to generate estimates for R0 in vaccinated and un-vaccinated
Landrace pigs while investigating the experimental transmission of virus in a pop¬
ulation of pigs. The application of martingale methods to infectious disease data,
where the rate of infection is allowed to depend on time is discussed by Becker and
Yip (1989). Becker and Hasofer (1998) illustrate the use of martingale methods to
estimate the transmission rate in a situation where a disease is highly infectious
and hence the number of susceptible individuals at the end of the epidemic is
likely to be zero. The formulation of martingale methods presented in this thesis
develops ideas presented in Becker (1979, 1981); Becker and Hopper (1983) and
Becker (1989), Chapter 7.
4.3.2 Martingale methods for epidemic models




N = {N{t)-t> 0}
is a random process that counts the occurrence of certain events over time, where
N(t) is the number of events occurring in the time interval (0, t\. N is a piece-wise
constant function with jumps of size +1. In epidemic studies, the development of
the appropriate counting processes is governed by the following transition equa¬
tions:
Pr{dN(t) = 1| H(t)} = A(t)dt
Pr{dN(t) = 0| H(t)} = 1 — A(t)dt
where A(t) is the intensity process of N(t), itself often a random process, and
P(t) denotes the history of the process up to time t. Martingales are expressed in
terms of a counting process and the associated intensity process. A mathematical
definition of a martingale is given below.
Suppose that certain random processes are followed continuously over time be¬
ginning at time t — 0.
Then a martingale is a random process M = t > 0} such that for every
t > 0 :
1. The value of M(t) is determined by %{t)
2. E(\M(t)\) < oo
3. E(M(u)\7i(t)) = M(t) for every u > t.
Property 3 is referred to as the martingale property, which stipulates that the
expected value of a martingale at any future point in time is equal to its current
value. The concept of a zero mean martingale is then derived from this property:
E{M(t)|77(0)} = M(0) for all f > 0 and when M(0) = 0 this leads to
E{M(t) |-H(0)} = 0.
In this case M (t) is defined to be a zero mean martingale.
It is also possible to define a variation process on M(t) which describes the vari¬
ability present in M(t).
The martingale estimate for a parameter of interest is produced by setting the
value of an appropriate zero mean martingale at a specified observation time t
equal to zero. The resulting estimator is therefore a special case of the method
of moments estimator (Becker, 1989, Section 7.1). A useful estimator will be a
function of only observed quantities and the parameter(s) of interest.
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4.3.2.1 Formulation
Let N(t) denote the number of individuals infected during the time interval (0, f]
and assume that individuals are either susceptible, latent, infectious or removed
(SLIR) at any given moment.
Suppose at time t = 0 there are s susceptibles and % infectives in the community.
Using the true mass action formulation of an epidemic process (de Jong et al.,
1995), the intensity process of N(t) is given by:
where /(f) is the number of infectious individuals in the community at time f,
S(t) is the number of individuals still susceptible to infection and n(t) is the total
number of individuals mixing at time f.
It follows that the process M(t) specified by
is a zero mean martingale with respect to the history 7l[t).
Although the entire infection process is not observed, martingales can be defined
with reference to histories based on incomplete observations of the epidemic. The
aim is to develop methods of inference that depend only on observable aspects
of the epidemic. Estimating equations are therefore constructed involving only
observable aspects of the epidemic and the parameters of interest.
Martingale methods tend to involve only simple computations and often apply
in a general fashion as they can be derived to make statistical inference about
specific parameters without requiring a complete specification of the epidemic
process. In fact the attraction of these methods is that they require only partial
specifications of the model. The use of martingale methods is appealing since it
also allows derivation of estimates of the standard errors of the parameters and
hence construction of confidence intervals, however, these depend on the use of
the martingale central limit theorem and hence are only valid for large epidemics.
An important result from the theory of martingales is that integration of certain
random processes with respect to a zero mean martingale M leads to processes
which are also zero mean martingales. Predictable random processes i.e. processes
that can be forecast through observable quantities of the infection process, are
chosen for this purpose. The fact that a predictable random process can be
=mmm
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specified given observed properties of the infection process makes it possible to
evaluate the resulting integrals.
Let B be a predictable random process such that its history T-L(x) determines
B(x) for every x > 0.
The new process M* specified by the stochastic integral
M*(t) = f B(x)dM(x) = [ B(x)dN(x) — f B(x)A(x)dxJo Jo Jo
is a zero mean martingale with respect to Ji i.e. E [dM*\H(x) ] = 0, and
Var [/J B(x)dM(x) ] = E [/g B2(x)dN(x) ] (Becker, 1989, Section 7.1).
This result is used in formulating martingale estimates for the rate of infection
acting upon groups of sheep.
4.3.3 Martingale (5 estimates from experimental FMD data
It is assumed that the infection process is such that individuals are either suscep¬
tible, latent, infectious or removed (SLIR) at any given moment. The intensity
process for the epidemic is then given by:
A(t) n(t)
where /? is the infection rate, I(t) is the number of infectious individuals in the
community at time t, S(t) is the number of individuals still susceptible to infection
and n(t) is the total number of individuals mixing at time t.




w/x _ r. . ft pi(x)S(x) ,M(t) = N(t) - / H K , ' dx,Jo n[x)
is a zero mean martingale.
If the infection process was observable continuously over the duration of the
epidemic so that the number of individuals in each epidemic state was known, an
estimating equation for /? could be obtained by evaluating the martingale M at
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the precise end of the epidemic T and equating it to its mean of zero. This would
yield an estimate of (3:
0 =
jtix and s'e(^ = (4-16)JO „(x) ax JO n(x) aX
This estimator, which assumes complete information, is identical to the unre¬
stricted model ML estimator in Equation (4.3).
However, for the experimental FMD data, only daily observations of virus shed¬
ding or absence of shedding for any infected individual are available. The use of
a zero mean martingale M is proposed using an appropriate predictable process
£(.).
The zero mean martingale M{t) has been defined:
H /3I(x)S(x)M(t) = N(t) - f P [X [X)dx.Jo n{x)
Let B{x) = fjfzj where J(x) — |
with B(x) = 0 when J(x-) = 0.
1 S(x) > 0
0 S(x) = 0
Integrating B(x) with respect to the martingale M, the zero mean martingale
M*, specified below, is obtained:
M'(t) = /"' B(x)dN(x)—Jo Jo n[x)
ft rt /3I(x)J(x)f B(x)dN(x) - [ P [X ,[X)dx.Jo Jo nix)( )
x— used in the definition of B ensures predictability and hence in the computation
of integral /J B(x)dN(x) one inserts the values of S just prior to each of the jump
times.
An estimate for (3 is obtained by solving the method of moments estimating
equation for the martingale M*, namely E[M*(T)] = 0, giving:
-gB{x)dlV(«) (417)P '
where
[ B(x)dN(x) — - + t—-—e + ■ • ■ + andJo s
1 1
(s^Tj+ '"+S(T)"+l





Where S(x) > 0 for all x > 0, I(X) J(X) _ ancj hence
n(x) n(:r)
In a particular group where all individuals ultimately became infectious we define
Tfinal as the time at which the final susceptible became infected. It follows that
Sheep are observed to be shedding virus on a certain number of occasions. Where
an infective is identified as positive at the beginning and end of a period, it
is assumed that it is positive throughout this period (observed infectiousness
period), with probability 1. Hence, any problems in applying the expectation
operator only arise with respect to the unobserved 'excess' infectiousness periods
at the beginning and end of each observed virus shedding period.
The denominator in the expression for the estimator {3 (Equation (4.17)) is the
total expected infection exposure time for each group, where the total exposure
time is scaled by the total number of sheep mixing at any given time in the true
mass action formulation. Thus the martingale estimate for /? requires an estimate
for the expected total infection exposure time for each group. The length of time
for which susceptibles were exposed to infection is estimated through considera¬
tion of the infectiousness period of infected individuals and the mixing strategy.
The complete infectiousness period for any infected individual is, however, an
unobserved quantity which has to be estimated. The expected infectiousness pe¬
riod is one of the infection process characteristics which will be estimated via
the iterative scheme (Chapters 5 and 6). The estimated expected infectiousness
period for each infected sheep will be determined and the contributions of each
infected sheep to the total infection exposure time for the relevant group will be
summed.
Using both MLE and martingale methods, (3 estimates will be calculated within
an iterative scheme. Also calculated within this scheme are estimates for the ex¬
pected infection process characteristics, some of which will be required to obtain
the (3 estimates. Throughout the thesis, estimates of /3 based on expressions in
Equation (4.17) will be referred to as arising from the martingale estimator. The
martingale estimator for f3 in the situation with incomplete information (Equation
(4.17)) depends to a lesser extent on the estimated unobserved infection process
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information than the estimator based on Equation (4.16), which yields identical
estimates to the ML estimator obtained from Equation (4.2), which assumes com¬
plete observed information and hence uses all of the estimated infection process
information. The martingale estimator in Equation (4.17) might therefore be less
sensitive to any inadequacies in the estimated pattern of infection arising from
the non-EM algorithm nature of the iterative procedure. In contrast, martingale
estimates have generally been used where there is incomplete data (e.g. in Becker
(1993a); Becker and Hasofer (1997, 1998); Britton (1998)), and it is inevitable
that the performance of such estimates will be suboptimal when compared with
those using complete information such as Equation (4.16). Both approaches re¬
quire estimates from the iterative procedure, however, the martingale method
makes minimal use of the expected pattern of infection, while the MLE approach
makes heavy use of these data. In Chapter 7, comparisons of estimates based on
the martingale estimate in Equation (4.17) and the unrestricted ML estimates
will be made.
4.4 Proposed iterative scheme
Considering the log-likelihood for the complete data (assuming tgi known) in
Equation (4.1), it is not possible to formulate the function
I2a2 + I3a3 + /4a4 - eQ2T2 - ea*T3 - eQ4T4 (4.18)
in the form at(x)T -I- A(a), where A(a) does not contain any observed random
variables. The density for these data is therefore not a member of the exponential
family, and hence the formulation of an EM algorithm to maximise the likelihood
of the observed data would involve the maximisation of the expectation of the
function in Equation (4.18) conditional on the observed data. /2, I3 and J4 are
all observed quantities, so the expectation would apply to the function
—e"2T2(t2, t3) — eQ3T3(t2, t3, t4) — eQ4T4(t3, t4) (4-19)
where the dependence of the function on the unobserved times of infection in
each group tg is made explicit. The functions will also depend on the unobserved
full length of shedding times, but these estimates are assumed to be conditionally
independent of the times at which animals become infected, and will be esti¬
mated using the methods described in Sections 5.2, 5.2.1 and 5.2.2. Nevertheless,
calculation of the function in Equation (4.19), given the high dimensionality of
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the unobserved data, would be computationally prohibitive. Maximisation would
have to proceed by numerical means, which would make the entire process even
more computationally expensive (O'Neill, 2002). Even use of a GEM algorithm,
which would remove much of the computation consequent on a maximisation step,
appears to be computationally infeasible.
It should be noted that the log-likelihood (Equation (4.2)) for the complete data
set indicates that the vector of statistics (/2, /3, /4, T2, T3, T4) are sufficient for
the parameter (a2, cr3, a4). I2, h and h are observed quantities. If the likeli¬
hood had been in the regular exponential family form, the EM algorithm would
have involved estimation of the expectation values of T2, T3, and T4 given the
observed data. This, of course, still presents the same computational difficulties
as discussed previously, since T2, T3, and T4 are not linear functions of the un¬
observed variables tgi. However, it is possible to formulate a feasible, although
computationally expensive scheme in which each tgi is estimated by the associated
expected value, conditional on the expected shedding periods of those individuals
which have previously become infective. In a situation such as this, where the
latent period is fairly short with a low variability, and the shedding periods are
well defined through frequent sampling, it is hoped that the expected values of
T2, T3, and T4 will be well approximated by the proposed scheme. Estimates of
(ai2, ct3, cn4) are then made by maximising the 'complete' likelihood, with unob¬
served values replaced with their expected values.
It should be stressed that the resulting algorithm is not an EM algorithm. Hav¬
ing already abandoned the EM framework, it was considered useful to consider
whether other estimates for f3 might be incorporated. In particular, the mar¬
tingale estimator for (3 in the situation with incomplete information (Equation
(4.17)) uses much less of the unobserved information from the realisation than the
ML estimator obtained from Equation (4.2). It might therefore be less sensitive
to any inadequacies in the estimated pattern of infection arising from the expecta¬
tion step of the iterative procedure. Hence, another algorithm is proposed, where
the expectation step proceeds as outlined above, but where the maximisation step
is replaced with an 'estimation' step, where the martingale estimator is used to
generate an updated estimate for f3.
As stated above, neither of these algorithms are EM algorithms. Therefore, there
is no guarantee that they will converge to the parameter estimates corresponding
to the ML for the complete data.
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4.5 Conclusion
The methods that will be used to estimate (3 in groups of sheep have been de¬
scribed. An iterative scheme has been proposed where the infection process char¬
acteristics are estimated alternatingly with the /3 estimates. The maximisation
step in the EM algorithm will be replaced by an 'estimation' step, where the
ML or martingale estimator is used to generate an updated estimate for (3. The
resulting iterative schemes are not EM algorithms, but in a situation where the
(unobserved) latent periods are short and have low variability, and where fre¬
quent sampling defines the shedding periods fairly accurately, it seems reasonable
to believe that the algorithms will give reasonable estimates of the unobserved
variables. The experimental FMD infection process will be explored in two ways.
Firstly, in Chapter 5, the infection process will be partially modelled, considering
only the infectiousness period. In this chapter, only the martingale method of
estimation will be used to estimate /3 for groups of sheep. The second approach
will involve modelling the entire infection process where the time of infection and
latent period will also be considered in addition to the infectiousness period. The
aim here will be to estimate the expected infection process characteristics and
the rate of infection acting upon groups of sheep using both MLE and martingale
estimation methods (Chapters 6 and 7).
Although not pursued in this thesis, modelling of the infection process in groups
of sheep and indeed by individual sheep could be achieved using MCMC meth¬
ods. These are established Bayesian methods that enable samples to be drawn
from some target density that is only known up to an element of proportionality.
Introductions to the subject can be found in Gilks et al. (1996) and Gamerman
(1997). Brooks (1998) gives a comprehensive review of some of the common areas
of research in MCMC methods. Renshaw and Gibson (1998) investigate whether
MCMC methods can be usefully applied to stochastic processes with unobserved
birth times. O'Neill (2002) gives a tutorial introduction to Bayesian inference for
epidemic models using MCMC methods. Examples in epidemic modelling where
MCMC methods have been employed are: Gibson (1997), to fit spatiotemporal
stochastic models in plant epidemiology, Gibson and Renshaw (1998), for pa¬
rameter estimation in stochastic compartmental models and O'Neill and Roberts
(1999), for inference for partially observed stochastic epidemics applied to house¬
hold data from a smallpox outbreak. O'Neill et al. (2000), use MCMC to anal¬
yses infectious disease data from household outbreaks of influenza and measles
and O'Neill and Becker (2001), examine inference for epidemics with variable
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susceptibility. Britton and O'Neill (2002), use MCMC to fit models for stochastic
epidemics in populations with random social structure and Clough et al. (2003),
estimate pathogen prevalence within groups of animals from faecal-pat sampling
data. However, given the low volume of data available in the FMD experiments,




period of infected individuals
5.1 Introduction
The main objective of this chapter is to estimate the expected infectiousness
period of infected individuals given data defining the viraemic periods. The mod¬
elling here will be referred to as a partial model of the infection process where
information about the latent period or the force of infection is not taken into
account. Also estimated in this chapter is the martingale rate of infection (/?)
acting upon groups (2 to 4) of sheep, mainly with the purpose of highlighting the
importance of modelling the entire infection process which will be addressed in
Chapters 6 and 7. The martingale estimator (Equation (4.17)) requires only the
number of infections occurring in the group and an estimate of the total expo¬
sure time to infective individuals in the group to generate an estimate of (3. The
former quantity is immediately available from the data, the latter requires to be
estimated. In this chapter, a simple method to estimate the expected infectious¬
ness period for each infective is proposed, which, in principle, allows martingale
estimates for j3 to be calculated. This method assumes that the estimates of
infectiousness periods are conditionally independent of the infection process, and
hence of (3, given the observed data. This will be a reasonable assumption if the
period between observations is short relative to the length of infective periods,
since in this situation, knowledge of /5, and hence of the distribution of infection
times for an individual, is unlikely to change the estimate of total infectiousness
time by any great amount.
A gamma distribution is assumed for the infectiousness period and from the
observed data the parameters of the distribution are estimated. The expected
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infectiousness period is estimated conditional on r, the number of days for which
the individual infected sheep tested positive to FMD virus. From Chapter 4 it
was established that in order to be able to calculate a martingale estimate for
f3 for a given group, the expected time of infection exposure for that group has
to be estimated (refer to Equation (4.17)). Once an estimate for the expected
infectiousness period for each individual has been derived, the total expected time
of infection exposure for each group is estimated. This is attained by establishing
for how long infected individuals were infectious and how much of the infectious¬
ness period contributed to the time of exposure of infection in different groups.
A martingale estimate for (3 for each group is then calculated. These martingale
estimates derived on the basis of the partial information of viraemic periods will
be compared with the martingale estimate in Chapter 6 where estimated times
for the start of infectiousness are obtained. Considering the objective of the ex¬
periments, it is desirable to assess the trend in the estimates of (3 across groups.
This will be done in Chapter 6.
5.2 Distribution of infectiousness period
A gamma distribution with shape parameter vinj and scale parameter Ais
assumed for the infectiousness period, 77, with density given by:
fvinfXnfttl) - F (uinf)
It should be noted that the subscript 'inf' is used to reflect the fact that the
parameters, vinj and Adefine the distribution of the infectiousness period.
Parameters vinf and Ainf are to be estimated using maximum likelihood estima¬
tion by maximising the likelihood of the infectiousness period given the data.
Once the parameter estimates are calculated, expected values of the infectious¬
ness period can then be calculated, from which the amount of infection exposure
for a given group is determined.
Often an exponential distributed or a fixed infectiousness period is assumed (Hay-
don and Woolhouse, 1997; Howard and Donnelly, 2000a). However, for many
infection processes, the exponential distribution is not a realistic option for the
distribution of the infectiousness period. A gamma distribution is therefore as¬
sumed due its wider variability in shape depending on the value of the shape
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parameter. The exponential distribution is a special case of a gamma distribu¬
tion. Figure 5.1 shows different shapes of gamma distribution based on the same
value of the scale parameter (Ainj = 1).
Figure 5.1: Probability density function for a gamma variate for various values
of the shape parameter and scale parameter equal to 1.
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For any infected individual, let
ne be the number of daily observed test results that were positive [ne > 0),
t be the day of the first observed positive test,
lu be the day of the last observed positive test,
tj be the infectiousness period for an infected individual.
The aim is to determine the expected length of infectiousness period, t/, for an in¬
fected individual conditional on the number of times the individual tested positive
for FMD virus. Let Pr(f/|ne) denote the probability of length of infectiousness
period, tj, given ne. Using Bayes' rule,
rw, i.i Pr(ne|U) Pr(U)Pr(i'M = —pTM
=> Pr(ne) Pr(U|ne) = Pr(ne|f/)Pr(U)
where Pr(t/) is the probability density function of the infectiousness period and
Pr(?7.e|U) is the probability of detecting ne positive observed days given the length
of infectiousness period tj.
If ne > 0 then it is possible for the infectiousness period tj to have taken any
value between ne — 1 and ne + 1. However, conditional on U, there are different
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probabilities of ne positive observations having been detected. The distribution
of ne given the various ranges of tj is given below, assuming that the time of
observation and the infectiousness state are independent.
0 < tr < 1
Range of ti
1 < tr < 2 2 < tr < 3
Number 0 1 -h 0 0
of positive 1 ti to 1 C-+- 0
obs (ne) 2 0 ti — 1 3 — tj ...
3 0 0 tj — 2 ...
If ne — 1 < ti < ne, the probability of detecting ne positive tests is equal to
ti — (ne — 1) = tj — ne + 1 and if ne < tj < ne + 1, the probability of detecting
ne positive tests is ne + 1 — f/.
Hence,
Pr(ne) Pr(£/|ne) = Pr(ne|f7) Pr(f7)
'
{ti-ne + l)fUinf,Xinf{ti) if ne — 1 < tj < ne
> (ne + l-t/)/v.n/>Ain/(</) if ne < tj < ne + 1
and
J Pr(ne) Pr(tj\ne) dti
= [ (^/ _ ne + 1) Svinj,\in! i^l) dti + [ (TLe + 1 — tj) ) dtiJ fie — 1 "
=> Pr(ne) J Pr(t/|ne) dti
rne rne+l
— {tj — ne + 1) fvinf,xinf{ti) dtj + / (ne + 1 — tj) fvinf,xinf{pi) dti-
Jne — l J ne
But, by definition
J Pr(t/|ne)cft/ = 1,
hence
Pr(ne) = [ (tr -ne + 1) /„ A (tr) dU + f (ne + 1 - ti) f„inftXinf (tf) dtfJne — 1 Jne
allowing the formulation of a likelihood function given the data in the next section
and hence parameters Uinf and \nf can be estimated.
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5.2.1 Estimation of parameters uinf and Ainf
The likelihood function consists of different components which depend on whether
the infectiousness period, tj is between ne — 1 and ne or between ne and ne + 1.
For ne > 0, the contribution to the likelihood is:
f-ne frie+ l
I Tie — 1
rn rri 1
/ (ti-ne + l)/^n/lAin/(t/)clt/ + / K + lJ n J ne
For nP = 0 the contribution to the likelihood for an infected individual is:
/ (1 -*/)/<w,Ain/(*/)^/-
J 0
Therefore the full log-likelihood function is given by:





]T ("e freq) x In f (t/ - ne + 1) /(t/) dt/ + f (ne + 1 - f7) /(t7) dt/
, -v,n L •/72e — 1 J Tle
(5.1)
Maximisation of the log-likelihood is implemented in the Splus statistical package
using the nlminb in-built routine to yield the desired parameter estimates i>inf
and Xinf for the gamma distributed infectiousness period. Expected values of the
infectiousness period can then be estimated and this is performed in the next
section.
The above formulation assumes that infectiousness starts randomly during the
unobserved day prior to the day of the first observed positive test. This is not
strictly true since infectiousness period is a function of the past time of infection
and the latent period distribution but it will be very close to the truth, especially
given the relatively dense sampling strategy used in the FMD experiments. In
Chapter 6 the model for the entire infection process will address the above issue.
5.2.2 Expected infectiousness period
Once the parameters of the distribution of the infectiousness period have been
estimated, estimates for the expected infectiousness period for each infected in¬
dividual can be calculated.
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Let f(ti\ne) denote the density of the infectiousness period distribution given ne.
Then,
/(t7|ne) oc fUinft\inf(tI)Pv(ne\tI)
(f7 - ne + 1 )fuinf,\inf{tI) if ne — I < ti < ne




f*e_1(ti-ne+ l)f(ti)dti+ f"e (ne+l-ti)f(ti)dtj
if ne — 1 < tj < ne
^ne+1
y? n <tr<n +1
/n"e_ i (o -"e+i)/(o +/;; (ne+i-o)/(t/)dp e e
For (ne > 0), the expected infectiousness period for an infected individual is given
by:
E[Ti\ne] =
C-i - (ne - 1) /";_1 tif{ti)dtj + (ree + 1) /";+1 f//fa)^7 - f£+1 tjfjt^dtj
C-i tif(ti)dtr - (ne - 1) /(f/)df/ + (ne + 1) /„"e+1 /(t/)df/ - /"ee+1 hf^dtj
(5
For example, for ne = 2,
fi2t]f{tI)dti - + 3/23 - /23 t2jf{ti)dtjE[Ti\ne = 2] /i2 - f? /(ij)dt/ + 3/23 /(i/)dt/ - /2 tIf(tI)dtI
(5.3)
where /(£/) is the density for the distribution of the infectiousness period which
is gamma with shape parameter i/iny and scale parameter Ainj.
All integrals in Equation (5.2) can be expressed in terms of integrals of a gamma
density. For instance, for any arbitrary limits a and b, f(t) a density function and
F7(t; v, A) the cumulative distribution function for a gamma distributed random
variable T, with shape parameter v and scale parameter A;
fb /. / \ fb tXvtv-le~xt dt rb Xu u xt ,LtmM = L m = L wfe dt
T(u + 1) rb Xu+1t"e~Mdt
J a
= ~fXJa








rb t2\utu~le~xt dt rb A1' xt ,L —tm—=L wf e dt
T(v + 2) rb \v+Hu+le~Xtdt
A2I» Ja F(v + 2)
(u + 1 )v rb \v+2tv+le~xt
~~T2 Ja T{u + 2)
= ^ \l)V [ F7(fr ^ + 2, A) - F>; u + 2,X)}.
(5.5)
Hence the expression, in Equation (5.2), for the estimator of the expected infec¬
tiousness period given ne has components that are all analytically tractable and
once Oinf and D;n/ have been obtained, estimates for the expected infectiousness
period can be calculated.
The PCR technique used in detecting virus in the blood samples is considered
to be sensitive and specific (Reid et ah, 2001; Hughes et ah, 2002b). Using the
simplifying assumption that a positive test result indicates infectiousness, if sheep
had been infectious (had live virus in blood) on day r — 1, the day before the first
positive test was observed, these sheep should have tested positive. Similarly if
sheep were still infectious on day u> + 1, the day after the last observed positive
test, they should have tested positive to FMD virus presence. Thus infectiousness
begins sometime between day r — 1 and r and ceases sometime between day uj
and uj + 1.
If ne positive tests have been observed, the observed infectiousness period is
equal to ne — 1 days. Thus the expected unobserved infectiousness period, Tu,
is the difference between the expected and observed infectiousness periods i.e.
Tu = E[Tj\ne] — (ne — 1). The unobserved period is composed of a portion before
r and after u>. Half of the unobserved infectiousness period is assigned to each
portion, since the model provides no basis for preferring one portion over the
other.
After estimating the expected infectiousness period for each infected sheep, the
amount of expected infectiousness period that each contributes to the expected
total infection exposure time for each group can be determined. The expected
total infection exposure time is derived and estimates for the j3g can then be
calculated.
/ t2f(t)dt = IJ n .It
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5.3 Estimation of rate of infection
The rate of infection (/?) acting upon groups of sheep is estimated based on
expected infectiousness periods and the times when infected individuals test pos¬
itive. Martingale estimates for /3 for each group and their respective standard
error estimates are calculated based on Equation (4.17) of Chapter 4. Any trend
in the estimates of the f3s can only be attributable to a drop of infectivity with
increased generation, as infected sheep in higher groups will tend to have high
infection generations.
The use of the martingale estimates, based on modelling only the expected infec¬
tiousness times, depends on the assumption that there is at least one remaining
susceptible individual in each group at the end of the epidemic. However, if there
are no susceptible individuals left at the end of the epidemic in a group, the mar¬
tingale estimate for (3 is an underestimate. There will be an amount of infection
exposure time included in the total infection exposure time of the affected group
which should not be included because in actual fact this group will have ceased
to be influenced by any infection exposure after the infection time of the last
susceptible individual in the group.
Modelling only the infectiousness times yields inferential methods that are quite
easy to implement and in situations where the group susceptible population is not
exhausted, the resulting martingale estimate for /3 might be sufficient. However,
when analysing data from groups where all individuals are infected by the end of
the epidemic, it is necessary to use the more appropriate estimate for (3, based on
an estimate of the time of infection of the last individual to become infected in the
group. The problem of underestimation of the /3 parameters, which arises when
all individuals are infected, will be addressed through modelling of the entire
infection process. This is the subject of Chapter 6.
5.4 Application to experimental data
For each infected sheep the number of days that the animal tested positive, de¬
noted by ne, is known. Hence the infectiousness period for an infected sheep is
expected to be between ne — 1 and ne + 1 days given an observed infectiousness
period of ne — 1 days. Conditioning on the expected infectiousness period f/,
there are different probabilities of ne positive test days having been detected. If
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the infectiousness period, ti is between ne — 1 and ne i.e. Tu < 1, the probability
of detecting ne days of positive tests is equal to tj — (ne — 1). Alternatively if
t[ is between ne and ne + 1 i.e. Tu > 1, the probability of detecting ne days of
positive tests is given by ne + l — tj. Taking the different possibilities into account
yielded an estimator for the expected infectiousness period (Equation (5.2)), from
which an estimate for the expected infectiousness period for each infected sheep
is calculated.
5.4.1 Data from experiments 1 and 2
The experimental data are summarised in Table 5.1, in the form that is required
for analysis using a partial model of the infection process. These data consist of
the identity of the sheep, sheep ID, the number of days with positive test result
ne, the day of the first positive test result r, and the day of the last positive test
result ui. Sheep with ID 1 — 8 belong to group 1, ID 9 — 16 are group 2 sheep, ID
17 — 24 are in group 3 and sheep with ID 25 — 32 belong to group 4.
Table 5.1: Data from experiments 1 and 2 for each sheep indicating number of
days with positive test result, ne, the day of the first positive test result r, and the
day of the last positive test result u>.
Experiment 1 Experiment 2
ID r u> ne ID r u; ne ID T CJ ne ID T a> ne
1 2 4 3 17 11 13 3 1 2 3 2 17 11 13 3
2 1 3 3 18 9 10 2 2 1 4 4 18 11 12 2
3* - - - 19 9 11 3 3 2 4 3 19 10 12 3
4 1 3 3 20 11 13 3 4 2 4 3 20* - - -
5 3 4 2 21 9 11 3 5 2 4 3 21 12 13 2
6 2 4 3 22 10 13 4 6 2 4 3 22 14 15 2
7 3 4 2 23 8 10 3 7 2 5 4 23* - - -
8 2 5 4 24 13 15 3 8 2 5 4 24 10 11 2
9* - - - 25* - - - 9 5 7 3 25 15 16 2
10 8 10 3 26 11 14 4 10 7 10 4 26 15 16 2
11 5 7 3 27 13 14 2 11 9 11 3 27 12 13 2
12 9 11 3 28 16 18 3 12 9 10 2 28* - - -
13 12 14 3 29 13 15 3 13* - - - 29 13 15 3
14 9 11 3 30 13 15 3 14 17 19 3 30* - - -
15* - - - 31 13 16 4 15* - - - 31* - - -
16 10 11 2 32 14 15 2 16* - - - 32* - - -
*sheep did not shed virus, thus assumed not to be infected.
From experiment 1, in group 1, sheep 3 did not test positive for FMD virus
even though it was inoculated. In groups 2 to 4, sheep 9, 15 and 25 did not test
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positive for FMD virus. In group 2, 2 susceptible sheep remained at the end of the
epidemic, all group 3 sheep became infected and 1 susceptible individual remained
in group 4 at the end of the experiment. There were 21 secondary infectives in
groups 2 to 4 from 24 initial susceptibles. In experiment 2, there were 15 secondary
infectives from groups 2 to 4 with at least 2 susceptible individuals in each of these
groups at the end of the experiment. Sheep with no observed viraemic days were
confirmed as uninfected by serology at the end of the experiment (Hughes, 2001).
Sheep with at least 1 positive test result i.e. ne> 1, are considered to have been
infected. For both experiments, ne takes values 2, 3, and 4 in all groups. In
experiment 1 more than half of the infected sheep tested positive on 3 occasions
(ne = 3) and in experiment 2, about half of the infected sheep tested positive on
3 occasions. The distribution of ne is given in Table 5.2.
Table 5.2: Distribution of ne for sheep data in Table 5.1.
ne 2 3 4 Total
Frequency (exptl) 6 18 4 28
Frequency (expt2) 9 10 4 23
For each value of ne the expected value of the infectiousness period, E\Tj\ne], is
calculated from expressions in Equations (5.2), (5.4) and (5.5).
5.4.2 Estimates of Vinf and A,;Hnf
The log-likelihood function for the infectiousness process is as given in Equation
(5.1) in Section 5.2.1 i.e.
I = (freq for ne = 0) x In dti +/ (1-*/)/(*/)Jo
r fHe
22 (ne freq) x In (f/ - ne + 1) /(t7) dtr +
ne>0 L ■'"e-l
[ (rae + 1 — t/) /(£/) dtrJne
_
^ f rne rne
= ("e freq) x In tr f{tj) dtt - (ne - 1) / f(tr) dtt +
ne>o L Jne-1 Jne — l
rne +1 rne+l
(ne + 1) / /(t/)dt/ - / t//(t/)dtJJ Tie " Tie
Frequency for ne = 0 is zero for both experiments.
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Using the property of the gamma density as stated in Equation (5.4) and the fact
that the frequency for ne = 0 is zero, the expression for the full log-likelihood
function becomes:
I — ^ ) (ue freq) x In \ — - [F7(?re, i^inf T 1, Ainf) F7(ne 1, Vinf -1- 1, A^j)]
ne >0 I *inf
(j^e 1) [ Ey(71e; Vinf i Am/) F7(?Te 1, Vinf, ^inf)}
T- (ne T- 1) [F7(ne 4- 1, Ainf) F7(ne, Vinfi Ain/)]
Uinf
T [F7(7T.e-f- 1, Xinf) F7(ue, + l,Ajnj) j j.
"inf
(5.6)
The log-likelihood function was maximised using the nlminb routine in the Splus
statistical package yielding the estimates, below, for the parameters of the distri¬
bution of infectiousness period.
Experiment 1
The estimate for the shape parameter uinf = 12.6362 and the estimate for the
scale parameter Ainf = 4.4952. Thus the estimate for the mean of the distribution
of the infectiousness period for the infected sheep in experiment 1 given by
^inf
is 2.81 days, with standard deviation estimated by . jf1- = 0.791.
V inf
Experiment 2
The estimate for the shape parameter vinf — 22.7237 and the estimate for the scale
parameter Xinf = 8.1539. Thus the mean of the distribution of the infectiousness
period for the infected sheep in experiment 2 is estimated to be equal to 2.79
days, with an estimated standard deviation of 0.585.
From both experiments, results indicate that infected sheep have an estimated
infectiousness duration of 2.8 days on average with the variation in infectious¬
ness higher in experiment 1 than in experiment 2, but probably exhibiting no
statistically significant difference.
5.4.3 Estimates of expected infectiousness period
For every observed value of ne, a corresponding estimate for the expected in¬
fectiousness period is calculated. For ne = 2, the estimator for the expected
infectiousness period is as given in Equation (5.3). For ne — 3 and ne = 4 the
expressions are similar. The expressions are further simplified by substituting the
114
integrals by the equivalent quantities from Equations (5.4) and (5.5). Table 5.3
lists estimates for the expected infectiousness period given ne. For instance, the
results indicate that from experiment 1, if an individual sheep tested positive on
2 sampling days i.e. ne = 2, then its expected infectiousness period is estimated
to be equal to 2.18 days and from experiment 2, the respective estimate for the
infectiousness period is 2.28 days.
Table 5.3: Expected infectiousness period given ne for sheep data in Table 5.1.
Tle 2 3 4
expected inf period (exptl) 2.18 2.92 3.77
expected inf period (expt2) 2.28 2.90 3.65
The consequence of only partially modelling the infection process is that the
infectiousness period of a sheep is based on ne and the infectiousness period
distribution only. As a result sheep from the same experiment that have the
same ne be associated with the same estimate for the expected infectiousness
period.
Given that an individual sheep tested positive on ne days, the observed infec¬
tiousness period for such an infected sheep is ne — 1 days. Thus there is always
an amount of unobserved infectiousness period (Tu). The unobserved amount of
infectiousness is composed of a period before the first observed positive test and
a period after the last observed positive test. From the results in Table 5.3 giving
the estimated expected infectiousness period, E[T[\ne] is always greater than the
observed infectiousness period ne — 1. Thus Tu = E[Ti\ne] — (ne — 1) >0 and the
size of Tu for each ne for both experiments is presented in Table 5.4.
Table 5.4: Unobserved infectiousness period (Tu).
ne 2 3 4
Tu (exptl) 1.18 0.92 0.77
Tu (expt2) 1.28 0.90 0.65
Results indicate that the unobserved infectiousness period is higher for lower ne.
Sheep that tested positive on only 2 sampling days are estimated to have had
more than a day of their expected infectiousness period unobserved while sheep
that tested positive on 3 sampling days are likely to have had just under a day
of unobserved infectiousness. Sheep that tested positive on 4 sampling days, are
estimated to have less of their infectiousness period unobserved compared to those
with ne = 2 and ne = 3.
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Sheep start excreting virus at an unobserved point in time between day r — 1 and
day t and stop excreting virus sometime between day uj and day u + 1. In order
to assign the estimated expected infectiousness period of each infected sheep, it
has to be decided how much of the estimated unobserved expected infectiousness
period is before r and how much is after u>. There is no basis of weighting one
over the other, so half of the unobserved expected infectiousness period (Tu) is
assigned to the period before r and half to the period after u>. Thus for each
infected sheep, the estimated start of infectiousness is given by r — \TU and the
estimated end of infectiousness is to + \TU. For instance for sheep number 1 in
experiment 1, its ne = 3, r — 2, lo = 3 and its expected infectiousness period
is estimated to be 2.92 days. Therefore the unobserved expected infectiousness
period is estimated to be 0.92 giving § Tu = 0.46. Hence the estimated start of
infectiousness for sheep number 1 is at time — 2 — 0.46 = 1.54 and estimated end
of infectiousness is at time 4 + 0.46 = 4.46.
Tables 5.5 and 5.6 give estimates for the time of start of infectiousness and end
of infectiousness for each infected sheep from experiments 1 and 2 respectively.
Table 5.5: Estimates for the expected infectiousness process for infected sheep
(Experiment 1).
ID Inf.Start Inf.End Inf.Period ne ID Inf.Start Inf.End Inf. Period Tle
1 1.54 4.46 2.92 3 17 10.54 13.46 2.92 3
2 0.54 3.46 2.92 3 18 9.41 11.59 2.18 2
3* - - - - 19 8.54 11.46 2.92 3
4 0.54 3.46 2.92 3 20 10.54 13.46 2.92 3
5 2.41 4.59 2.18 2 21 8.54 11.46 2.92 3
6 1.54 4.46 2.92 3 22 10.62 14.39 3.77 4
7 2.41 4.59 2.18 2 23 7.54 10.46 2.92 3
8 1.62 5.39 3.77 4 24 12.54 15.46 2.92 3
9* - - - - 25* - - - -
10 7.54 10.46 2.92 3 26 10.62 14.39 3.77 4
11 4.54 7.46 2.92 3 27 12.41 14.59 2.18 2
12 8.54 11.46 2.92 3 28 15.54 18.46 2.92 3
13 11.54 14.46 2.92 3 29 12.54 15.46 2.92 3
14 8.54 11.46 2.92 3 30 12.54 15.46 2.92 3
15* - - - - 31 12.62 16.39 3.77 4
16 9.41 11.59 2.18 2 32 13.41 15.59 2.18 2
* These sheep did not shed virus, hence assumed not to be infected.
For both experiments, results indicate that group 1 sheep are estimated to have
been infectious between day 0 and day 6. The first group 1 sheep to shed virus is
estimated to have entered the infectiousness state at time 0.54 for experiment 1
(time 0.68 for experiment 2) and the last sheep from this group to shed virus is
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Table 5.6: Estimates for the expected infectiousness process for infected sheep
(Experiment 2).
ID Inf.Start Inf. End Inf.Period ne ID Inf.Start Inf.End Inf.Period ne
1 1.36 3.64 2.28 2 17 10.55 13.45 2.90 3
2 0.68 4.33 3.65 4 18 10.36 12.64 2.28 2
3 1.55 4.45 2.90 3 19 9.55 12.45 2.90 3
4 1.55 4.45 2.90 3 20* - - - -
5 1.55 4.45 2.90 3 21 11.36 13.64 2.28 2
6 1.55 4.45 2.90 3 22 13.36 15.64 2.28 2
7 1.68 5.33 3.65 4 23* - - - -
8 1.68 5.33 3.65 4 24 9.36 11.64 2.28 2
9 4.55 7.45 2.90 3 25 14.36 16.64 2.28 2
10 6.68 10.33 3.65 4 26 14.36 16.64 2.28 2
11 8.55 11.45 2.90 3 27 11.36 13.64 2.28 2
12 8.36 10.64 2.28 2 28* - - - -
13* - - - - 29 12.55 15.45 2.90 3
14 16.55 19.45 2.90 3 CO O * - - - -
15* - - - - 31* - - - -
16* - - - - 32* - - - -
* These sheep did not shed virus, hence assumed not infected.
estimated to have ceased being infectious at time 5.39 for experiment 1 (time 5.33
for experiment 2). For both experiments, only 1 sheep in group 2 was estimated
to be infectious during the estimated expected infectiousness period of group 1
sheep. In experiment 2, it is estimated that sheep 14 started shedding virus when
all sheep in groups 2 and 3 had ceased to be infectious. Thus, sheep 14 was
probably infected due to infected individuals in group 3 and not group 2. The
estimated pattern of virus shedding is presented in Figure 5.2.
5.4.4 Estimation of the rate of infection for each group
After deriving estimates for the expected infectiousness period for each infected
sheep, the expected total infection exposure time for each of groups 2 to 4 (which is
required for the martingale estimate of f3, as given in Equation (4.17)), can now be
estimated. Taking the mixing of groups into account, the appropriate contribution
of expected infection exposure from each infective sheep to the relevant group is
calculated.
For example, sheep 1 in experiment 1 is estimated to have excreted virus from
time 1.54 to 4.46. During day 1 i.e. between day 1 and day 2, group 1 and group
2 sheep were mixing. Thus during this time, any infectious individuals which are
present contribute to the expected infection exposure time of group 2. Sheep 1,
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during day 1, contributed 2 — 1.54 = 0.46 days to group 2 expected infection
exposure time. Again during day 3 i.e. between day 3 and day 4, group 1 and
2 were mixing during this period, sheep 1 was still infectious, so it contributed
a full day of infection time to the expected exposure time of group 2. For the
period between day 5 and 6, although group 1 and 2 were mixing, sheep 1 did
not contribute to the exposure time because it had ceased excreting virus at
the estimated time of 4.46 after the start of experiment. Thus in total, sheep
1 contributed an expected value of 1.46 days of infection exposure to group 2.
Because a true mass action model is assumed, the infection time is scaled by the
total number of sheep mixing during the contribution period.
For groups 2 and 3, the infection exposure time is divided by 16 because once
the experiment has started, these groups are always mixing with another group,
making the total number of sheep present always equal to 16. For group 4,
however, the scaling number depends on the day of mixing. If the day of mixing
is odd, say day 3 i.e. between day 3 and 4, then the estimated expected infection
time exposure during this period will be divided by 16, the total number of sheep
from group 3 and group 4, since on odd days groups 3 and 4 are mixing. However,
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if the mixing is on an even day, say day 4 i.e. between day 4 and 5, then the total
number of sheep will be 8 because group 4 sheep will not be mixing with any
other sheep from another group on these days.
All contributions of infection time exposure from each infected sheep are calcu¬
lated, scaled and summed, yielding an estimate for the total expected infection
exposure time for each of groups 2 to 4. The expected infection exposure times
for each group are given in Table 5.7 for both experiments.
Table 5.7: Estimates for expected total group infection exposure time, in days,
scaled by the number of mixing individuals.
group 2 3 4
exposure time (exptl) 2.3952 2.6452* 2.6423
exposure time (expt2) 2.1357 1.6829 1.4060
* all sheep in group infected
The numerator in the expression in Equation (4.17) for calculating (3 estimates
is given by:
I s(lWl1 = i+ ih.+" •+ sot +1
where s is the number of susceptibles in each group at the start of the experiments,
which is 8 in this case, T is the time of the end of the epidemic and S(T) is the
number of susceptibles remaining in the group at the end of the epidemic. For
experiment 1, the number of susceptibles remaining at the end of the experiment
(epidemic) are: 2 in group 2, 0 in group 3 and 1 in group 4. For experiment 2, the
number of susceptibles remaining at the end of the experiment are: 3 in group 2,
2 in group 3 and 4 in group 4. Thus the value for /0T B(x)dN(x) for each group
can be calculated and are presented in Table 5.8.
Table 5.8: Number of susceptibles at the end of experiments, S(T), and corre¬
sponding values for the integral of the B function for each group.
Experiment 1 Experiment 2
Group S(T) Integral of B S(T) Integral of B
2 2 1.2179 3 0.8845
3 0 2.7179 2 1.2179
4 1 1.7179 4 0.6345
The quantities required for the /3 estimate are now all known, and hence it is
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possible to calculate estimates for f3 for each group, 2 to 4, with corresponding
standard error estimates.
Recall that
2 ffB(x)dN(x) _ , {ff B*(x)dN(x)]U2
The numerator of $ is the value of the integral of the B function given in Table
5.8 and the denominator is the expected total infection exposure given in Table
5.7. The numerator for the standard error estimate of j3 is given by
= + + + <5-7>
and is calculated from the values of the number of susceptibles at the start and
end of the experiments.
The results for the estimates of (3 and the corresponding standard error estimates
for the three groups are presented in Table 5.9, for both experiments. Group 3
has the highest estimated rate of infection, followed by group 4 and then group 2
which has the lowest estimate for both experiments. It should be noted that in
group 3, all individuals became infected. As a result the rate of infection in this
group is underestimated because all of the estimated expected infection exposure
time was included in the calculation of the estimate and yet the group was only
exposed to infection up to the time of the infection of the last individual to become
infected in this group. Although underestimated, group 3 still has the highest
estimated rate of infection. In practice, such a risk of systematic underestimation
must be regarded as a serious drawback of this approach.




Experiment 1 /? 0.5085 1.0275* 0.6502
s.e(/3) 0.2199 0.4672 0.2749
Experiment 2 /? 0.4142 0.7237 0.4513
s-eC8) 0.1910 0.3130 0.2292
'all sheep in group became infected
Given the experimental hypothesis, it would be expected that group 2 would ex¬
hibit the highest rate of infection, followed by group 3 and then group 4. However,
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the results do not indicate this. One explanation could be that the inoculated
virus does not have as much infection potential as the naturally acquired virus.
This would lead to a lower force of infection acting upon group 2 individuals
which is the only group that is exposed to group 1 (inoculated) infection. There
is a decrease in the estimated rate of infection between groups 3 and 4 by contrast
to the increasing trend visible between groups 2 and 3. It would be interesting to
see what would happen if there were a greater number of groups to assess if the
rate of infection would continue to fall with higher group number. Investigation
of significance of trend is addressed in Chapter 6.
5.5 Summary
In this chapter a partial model of the infection process was considered where only
the infectiousness periods were modelled. A gamma distribution was assumed
to describe the infectiousness period and distribution parameters were estimated
conditional on the observed viraemic data. The expected duration of infectious¬
ness period given the number of viraemic days was estimated and hence the
infectiousness period for each infected individual was estimated. It was observed
that there was an appreciable expected unobserved infectiousness period and that
this varied depending on the number of observed viraemic days. Individuals with
observed viraemic period of 2 days had more than a day of the expected infec¬
tiousness period unobserved while those with 4 days of observed viraemic period
have slightly over half a day of unobserved expected infectiousness period.
The expected duration of infection exposure for groups 2 to 4 was estimated
and the martingale rate of infection acting upon groups 2 to 4 was estimated.
The method described provides an efficient way in which to calculate those /3
estimates applying to different groups of animals. However, the method has a
major drawback. In experiment 1, group 3 had all its members infected and as a
result, the martingale estimate for the rate of infection acting upon this group is an
underestimate. To correct this, the time of infection for last individual to become
infected in this group needs to be estimated so that the appropriate amount of
infection exposure is used in calculating the estimate for the rate of infection.
Therefore before formally testing whether there is a trend in the estimates for the
rate of infection, a more appropriate estimate of (3 in group 3 of experiment 1 is








In this chapter, the entire infection process is modelled i.e. for each infected
individual, the time of infection, latent period and infectiousness period are all
considered. Expected values for these quantities are estimated. The time to
infection and the latent period are modelled using a joint distribution of the two
infection process characteristics conditional on the time (day) of the first positive
test (r) for an infected individual. In Section 6.2, the distribution for the time
to infection is derived from survival analysis theory and in Section 6.3, a gamma
distribution is proposed for the latent period. Although these two quantities are
assumed to be independent, they are modelled jointly due to a correlation in their
estimates which arises from the inability to observe the nature of the pre-infectious
individuals. The estimates for the expected infection process characteristics are
calculated alternately with the rates of infection, (3g, acting upon groups of sheep,
using an iterative procedure as discussed in Chapters 2 and 4. In this chapter,
martingale based f3 estimates are calculated, while in Chapter 7, ML estimates
are calculated for two different models of (3g.
When all individuals in a group are infected, a cumulative amount of infection is
'wasted' as there are no susceptible individuals left to infect. When this fact is
ignored in determining a martingale estimate for the rate of infection for groups
where all individuals became infected, the result is an underestimate for the pa¬
rameter. Estimation of the expected time of infection enables allocation of the
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appropriate amount of infection exposure time to the martingale estimate for
groups where all individuals become infected. The process of determining esti¬
mates for the expected infection process characteristics is described in this chapter
in Section 6.4. It should be stressed that this procedure remains unchanged even
if the /? estimates are derived using MLE methods as in Chapter 7. It is just that
a different /3 estimation method is used in the 'maximisation step' of the iterative
scheme. Calculation of martingale /3 estimates is described in Section 6.5. The
algorithm that is used to implement the iterative scheme and to derive estimates
for the expected infection process characteristics and /? is outlined in Section 6.6.
The aim for the FMD experiments was to assess whether FMD infection is sheep
is self-limiting. With this aspect in mind, in Section 6.7, the trend in the esti¬
mated /3s is assessed. For the martingale /3 estimates, the trend is summarised
by a slope estimated using weighted linear regression. The Significance of the
estimated slope is tested using bootstrap methods, based on simulated epidemic
realisations. In Section 6.9, the proposed method is applied to the experimental
FMD data.
6.2 Distribution of time to infection
It is vital to estimate the time at which an infected individual is expected to have
made an infectious contact i.e. the time at which it became infected. Besides
having other uses, knowledge of this quantity, is crucial for martingale based
parameter estimation in groups where all sheep became infected. The time to
infection is modelled from the start of the experiment (epidemic). In this section
the distribution of time to infection for infected individuals is established.
Let X\ be the time to infection and f{x\) denote its density function.




S(xi) = Pr(T > x{) — / f(u)du = 1 — / f{u)du = 1 — F(xi).Jx i Jo
Let h(xi) denote the instantaneous force of infection at time x\ conditional on
survival to time x\.
From survival analysis theory (Collett, 1994, Section 1.3),
fX 1
S(xi) = exp{— / h{u)du}.Jo
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Therefore the density function for X\ is given by
f(xi) = h(xi)exp{—[ h(u)du}. (6.1)Jo
In our case,
A(t) = (6.2)
where lit) is the number of active infectives at time t, n(t) is the total number of
individuals in a mixing group at time t, j3 is the rate of infection and h{t) depends
on (5.
6.3 Distribution of latent period
It is necessary to model the latency process because for many infectious diseases
including FMD, infected individuals pass through a latent state prior to becoming
infectious. Proper understanding of this characteristic of the infection process
can have an impact on the control policies appropriate during an outbreak of
a particular infectious disease. For the FMD experimental infection, a gamma
distribution with shape parameter viat and scale parameter Aiat is assumed for
the latent period. The density is denoted by g^lat,\iat{x2), where X2 denotes the




For a group 1 individual, suppose rq negative tests were observed before the first
positive test after inoculation. The latent period for an infected individual would
be between rq and rq + 1 days i.e. x2 6 (rq, rq + 1).
Using MLE methods, estimators for parameters uiat and \lat are calculated by
maximising the log-likelihood function given in Equation (6.3) below.
If rq < x2 < ni + 1, consideration of all possible values of rq for all infected sheep,
yields a log-likelihood function given by:





The log-likelihood function is maximised using in-built routines in the S-Plus
statistical package, yielding the required parameter estimates for uiat and A/a(.
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6.4 Estimation of entire infection process
When modelling the entire infection process for experimental FMD, two cate¬
gories of individuals are considered viz. group 1 individuals and groups 2 to 4
individuals. Group 1 sheep were artificially infected with FMD virus at the start
of the experiment. The artificial inoculation was staggered, half of group 1 sheep
being inoculated on day 0, while 24 hours later the rest of the group 1 sheep were
inoculated with the virus. Time t = 0 (day 0) is regarded as the time of infection
for the first 4 group 1 sheep (ID numbers 1 to 4) and day 1 as the time of infection
for the other 4 group 1 sheep (ID numbers 5 to 8). Thus the time of infection
for group 1 individuals is known. For these individuals therefore, the aim is to
determine estimates for their expected length of latent and infectiousness peri¬
ods. For groups 2, 3, and 4, there is no explicit information about their time to
infection or latent period, all that is observed is the time at which any infected
sheep tested positive to FMD virus. Therefore for infected sheep in these groups,
the aim is to estimate the expected time of infection, expected latent period and
expected infectiousness period. The expected infectiousness period for infected
sheep from all groups is estimated as in Section 5.2.2.
6.4.1 Infection process for group 1 sheep
For group 1 sheep the time of infection is assumed to be known, based on the
inoculation times. Thus only the latent and infectiousness periods for these sheep
require to be estimated.
6.4.1.1 Estimation of expected latent period
Let Tl be the latent period with density given by
Ml) = lat Lv( * • (6-4)L\yiat)
If ni negative tests were observed before r then tL G (rq, rp + 1) i.e. if an individual
tested negative n; times (on rq days), then the length of the latent period is
between ni and ni + 1 days. In both experiments, group 1 sheep tested negative
for either 1 day after inoculation or never tested negative after inoculation, before
the first positive test was observed. So rp takes values 0 and 1 only, implying that
the length of the latent period is between 0 and 2 days. The expected length of
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the latent period is therefore calculated conditional on the number of negative
observed tests, n;.
After rescaling /(£l) in Equation (6.4), the conditional density of Ti given rq is
given by:




rni + l \lal"latf Ulat-le-\lattL (lfT '
Thus the expected latent period conditional on rq is given by:
771 frp I 1 Jn!+ltLf(tL)dtLE[TL\ni} = ' ■ (6.5)
In! fVLjatL
Once Aiat and z>;at have been estimated, estimates for the expected latent period
for each sheep in the group will be calculated depending on whether the sheep
had 0 or 1 negative tests observed prior to testing positive.
6.4.1.2 Estimation of expected infectiousness period
In Chapter 5, it was assumed that infectiousness started randomly some time
between day r — 1 and day r (r is the day of the first observed positive test)
and that infectiousness ceased between day ui and day u> + 1 (a; is the day of
the last observed positive test). However, with time of infection known and esti¬
mates for the expected length of latent period obtained, the expected time when
infectiousness started can be estimated. Based on the assumed distribution for
the infectiousness process, the expected length of the infectiousness period condi¬
tional on ne, the number of observed positive test results and the expected start
of infectiousness is estimated. It is known that the latent period ends sometime
between day r — 1 and day r. If the unobserved infectiousness period before r is
denoted by Tt and the time of end of latency (start of infectiousness) by z, then
Tt is equal to r — z. Thus the length of the infectiousness period, denoted by f/,
ranges between the observed period plus Tr and observed period plus Tr plus 1
day of unobserved potential infectiousness period after u>, i.e.
ne — 1 + Tr < tj < ne — 1 + Tt + 1
ne — 1 + Tr < tj < ne-\-Tr.
The process is illustrated in Figure 6.1.
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Figure 6.1: Figure to illustrate the infection process.
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Let T/ denote the length of infectiousness period. The unconditional random
variable Tj is gamma distributed with shape parameter Vinf and scale parameter
Ainf with density function given by
JVinfFnf\ I) - Y(umf)
Estimation of the length of infectiousness period is described in Section 5.2.2 and
estimation of parameters Uinf and Ainf is described in Section 5.2.1.
The rescaled density function for Tj conditional on the observed data and Tt is
given by:
r tu ' ne — 1 + Tt < ti < ne + TTf f(ti)dti
and hence the expected infectiousness period for an infected individual given that
it had rp negative tested days followed by ne positive tested days is given by
fnf-l+Tr tlf (tl)dti
C-1+7V !(ti)dt,
Comparing Equation (6.6) with Equation (5.2), one can observe the effect of
assuming a random start of infectiousness or of having a known start of infec¬
tiousness on the nature of the expression for the expected infectiousness period.
In Equation (5.2), the expected infectiousness period depends on whether tj lies
between ne — 1 and ne or between ne and ne + 1, however, in Equation (6.6), it is
known that t/ lies between ne — 1 + Tr and ne + Tr. In practice, Tr is estimated
using r — E[Tl\tii] and ne is observed. From these data and the estimated density
for the infectious period, the expected infectiousness periods for each infected
group 1 sheep can be estimated. Group 1 sheep will then each have a complete
set of estimates of the unobserved quantities which define the effect of the infec¬
tion process on each individual. The contribution of these sheep to group 2 total
expected infection exposure can then be determined.
mWe.M = Jnf-i++r; , (6.6)
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6.4.2 Infection process for group 2 to 4 sheep
For groups 2 to 4 the expected time to infection, expected length of latent periods
and expected length of infectiousness period need to be estimated for all infected
sheep. The expected time to infection and the expected latent period are esti¬
mated from the joint distribution of these two infection process characteristics,
conditional on r. The time period from the start of the experiment to the time
of infection for each infected sheep, is partitioned into intervals of constant force
of infection (hazard), h(t). The partitions are based on changes in hazard arising
from changes in the number of infectives (new infections and removals) and also
from the mixing patterns which change on a daily basis (every 24 hours). The
maximum range for any interval is therefore 1 day (24 hours). Once the partitions
are identified, estimates for the expected time of infection, aq, and expected latent
period, X2, are obtained by summing the components over all possible partitions.
Figure 6.2 demonstrates the partitioning.
Figure 6.2: Sketch of partitioned time scale, where tr is the time of the most
recent change in h(t) prior to the time of infection x\.
For any arbitrary time point t, between i; and U+i, a partitioned interval, the
force of infection h(t) is given by:
which is the instantaneous hazard at time ti.
Ii is the number of active infectious individuals in interval [ti, ti+1), which is equal
to the number of infectious individuals at the start of this interval of time, t{.
The density for the time to infection X\ can be given in terms of the hazard in
each partitioned interval up to time aq. The density /(aq), as given in Equation
(6.1), expressed in terms of these intervals becomes
h(t) = = h(ti).
n{t)










The hazard at time £i, h(xi), is the hazard that has given rise to a new infection
whose time of infection is x\. This is the hazard in interval [tr, x\) given by h{tT)■
Thus h(xi) = h{tT) and h{tT) will be denoted by hr for ease of notation. The
expression for f(xi) becomes:
/(xi) = h(tT) exp{-h(0)(ti - 0)} exp{-h(ti)(t2 - ti)} x ... x
exp{-h(tT-i)(tT - tT-i)} exp{—h(tT)(xi - tT)}
= hT exp -hi x (ti+i - ti) + hTtT^j exp{-hTxi}. (6.7)
6.4.2.1 Joint distribution of the time to infection, X\ and the latent
period, X2
Preliminary investigations showed that modelling the time to infection without
taking into account the latent period produced very unrealistic estimates of the
times of infection. The time of infection converged toward the first exposure time
for each individual. The two processes are therefore modelled jointly. A joint
distribution of the time to infection and the latent period, conditional on the
time of the first observed positive test for an infected individual is considered.
Figure 6.3 is a sketch of the infection process from the start of the experiment
i.e. time 0.
Figure 6.3: Sketch of infection process.
X, x2
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The time to infection (Ad) and latent period (X2) are assumed to be independent
i.e. the length of the latent period for an infected individual is not affected by the
time taken for the individual to be infected. However, as pointed out earlier,
the inability to observe the nature of the pre-infectious individuals creates a
correlation in any estimates of the two infection process characteristics. Thus
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the two quantities are modelled jointly. A joint distribution of X\ and X2 based
on partitioned intervals of constant force of infection is formulated below.
Let f(xi,x2) denote the joint distribution of X\ and X2, then
f(xi,x2) oc f(xi)g(x2)
rXl
\j \latUlat x2Ulat~l £~XlatX2\
= ^(aqjexp-f— / h(u)du}-Jo
oc /^aq) exp{— [ h(u)du}x2Ulat~le~XlatX2Jo
r iyiat)
rt i rt2
= /i(aq)exp{ — / h(u)du — / h{u)du — ...Jo Jti
- [ h(u)du - Aiatx2}x2Vlat~l
J tx
T-1
= h(xi) exp{— (ti+i - ti) - hT (x\ - tT) - kat^2}x2lat~l
i=0
T—l
= hT exp{— (U+i - ti) + hTtT}e~hTXle~x'atX2x2lat~l. (6.8)
i=0
Let A = hT exp{— K (tj+1 — ti) + hTtT}, which does depend on aq, since T
is defined as the initial time of the ultimate infection partition before time aq.
Then /(aq, x2) oc /(aq)g(x2) = Ae~hTXle~XlatX2x2l'lat~1.
After rescaling,
1 g ^lat"^2 rjQ^lat ^
//A e~hrXl e~x'atX2 x2riat~^ dx\dx2 ^ ^
The range of values of aq and x2, and hence the domain of integration, are dis¬
cussed in the next section.
6.4.2.2 Estimation of expected time to infection and length of latent
period
The expected values for X\ and X2 are estimated from the joint distribution
formulated above. Integrating with respect to aq first, the expected values are
given by:
E[Xi\ = JJxif(xi,x2) dxxdx2 , i = l,2
ff Xi A e~hrXl e~XlatX2 x2i/'at_1 dx\dx2
JJ A e~hrXl e~XlatX2 x2l,'at~l dx\dx2
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(6.10)
The domain of integration for the double integrals in the probability density
function in Equation (6.9) and for expectations in Equation (6.10) needs to be
determined. The time to infection, x\, for an infected individual can take any
value between 0 and r and the latent period X2 can take any non-negative value
between r — 1 — x\ and r — X\ i.e. infection could have taken place at any time
between the start of exposure to infection (a long latency) and a time just before
r (a short latency), hence, the length of latent period can be very close to r — x\
i.e. a long latent period with infectiousness starting just before r, or very close
to t — 1 — X\ i.e. a short latent period with infectiousness starting just after day
t — 1, the day prior to the first positive test, implying that infectiousness started
in the early hours of sampling day r — 1. The length of latent period has to be
non-negative and greater than r—l —Xi, otherwise a positive test would have been
obtained on day r — 1 but the latent period would not be longer than r — X\ since
otherwise the test on day r should have been negative. In summary, 0 < x\ < r
and max{0, r — 1 — xi} < X2 < r — X\. It is assumed that a positive test which
indicates presence of live virus implies that the individual is in an infectious state
(able to infect others).
Since the time between the start of experiment (t = 0) and the time of infection
for an infected sheep {t = xi) is partitioned into intervals of constant hazard, the
domain of integration is constructed in terms of these partitioned intervals.
Consider an arbitrary time interval (tx, t) with range less than or equal to 1
day. From the design of the experiment, the maximum range for any partitioned
interval is 1 day. Movement of sheep between groups is considered to be an event
starting a new interval. Thus in situations where no new infection or removal
has occurred over 2 days, the only event is the change of mixing groups which
happens on a daily basis.
Considering an infected individual which first tested positive at time r, assume
that its time to infection lies somewhere between time tx and time t, and then its
latent period can take any value between the maximum of 0 and r — 1 — t at one
extreme and t — tx at the other. That is, if tx < X\ < t, with t — tx < 1, then
max{0, r — 1 — t} < X2 < t — tx- Figure 6.4 gives a graphical representation of
the region of interest over which we have to integrate. The region of integration is
divided into 3 parts labelled Area 1, Area 2 and Area 3. The domain of integration





Figure 6.4: Sketch of the region of integration for interval (tr,t).
*-tT
T- t
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Domain for xx Domain for r2
t — 1 — x2 < xx < t \ max{0, r — 1 — t} < X2 < max{0, r — 1 — £r}
tT < X\ < t ; max{0, r — 1 — tT} < x2 < r — t
tT < x\ < t — x2 ; t — t < x2 < t — tr- (6-11)
For a given interval (tx,t), the appropriate domain of integration for each of the




r r rmax{U T-L-tT)
/ / f(xux2)dxxdx2 = / f(xux2)dxidx2 +J Jfl(tT x{0,r— 1—
rr—t rt rr—tx rr—x 2
/ / f(xi,x2)dxidx2+ / f(xi,x2)dxidx2, (6.12)
■/max{0,T—1—tr I J fa Jr—t Jtr
where f(xx,X2) is as in Equation (6.9) and t) = xi G (tT, t)+ x2 G (r - 1, r)
The 3 double integrals in Equation (6.12) will be referred to as integrals 1 to 3
over areas 1 to 3 respectively.
To evaluate the integral of the joint distribution between the start of the epidemic
experiment on day 0 and day r for a given infected individual, all integrals over
the partitioned intervals are summed.
Xi G (U, tj)
Xi + x2 E (t - 1, r) '
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Let Q(U, tj) =
then
/ / f(xx,x2) dxxdx2 = / / f(xi,x2) dxxdx2 +J in(o,r) J Ai(o,ti)
/ / f(xx,x2) dxxdx2 + ...+ / / f(xx,x2) dxxdx2. (6.13)
Each double integral in Equation (6.13), for a partioned interval, is composed of
3 double integrals as in Equation (6.12) for the different domains of integration.
For instance for interval (0, tx), where tx < r, tx = 0, and t = tx. Thus the limits
for the 3 regions for this partitioned interval are:
for Area 1: r — 1 — x2 < xx < tx and max{0, r — 1 — tx} < x2 < r — 1 — 0
0 < xx < tx and t — 1—0<x2<r — tx
0 < xx < r — x2 and r — tx < x2 < r — 0.











/ / Xi k(xx, x2) dxxdx2 + Xi k(xx, x2) dxxdx2 + ...+J Jn(o,ti) J Jn(ti,t2)
/ / Xi k(xx, x2) dxxdx2,
J Jn(tT,r)
/ / k(xx, x2) dxxdx2 + k(xx, x2) dxxdx2
/ / k(xx,x2) dxxdx2,J Jn{tT,T)
+ ... +
and ^(2:1,2:2) — A e hrXl e x'atX2 x2"lat 1.
Each of the 3 integrals 1 to 3 in Equation (6.12) representing the integrals over
the 3 areas 1 to 3 is considered separately. Also the denominator and numerator
in Equation (6.10) are considered separately for each integral in Equation (6.12)
for a given partitioned interval
Note that the denominator is the same in the expression for the expected time to
infection and the expected latent period, only the numerator differs.
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6.4.2.3 Expected time to infection, E[Xx]
The 3 areas 1 to 3 as outlined in Equation (6.11) are considered separately. Note
that for ease of notation, hr is denoted by h in the expression for the joint
distribution and r — 1 — tj will be used to denote max{0, r — 1 — tj}, where tj = t
or tT or x2.
Numerator integral 1 (for area 1)
In a given interval (tx,t), the contribution of integral 1 to the numerator N(xi)




XX A e hxi e XlatX2 x2u'at 1 dxxdx2
— 1—X2
rr— l—tx
/ T— l— t
e XlatX2 x2"lat 1




= — (- (ht + l)e ht [ e x,atX2 x2lat ldx2n2 I JT—i—t
+ (h(r - 1) + 1) e~h(-T-l) fT T X2^t-ie-{\iat-h)x2 dx2JT—l—t
— he~h{T-l) x2Ulate-{Xlat-h)x2 dx2 J , (6.15)
since A is a constant with respect to xx in the domain, it is taken outside the
integral. This is true for all intergals in this section.
The expression for Nn in Equation (6.15) is composed of integrals of gamma
densities.
Let F7(t; uiat, Aiat) denote the cumulative distribution function up to time t, of a
random variable which is gamma distributed with shape parameter uiat and scale
parameter Aiat, i.e.
F7(t; uiat, Xlat) = [ p'"' r x2Ulat~l e~XlatX2 dx2Jo I Wat)
==» [ x2Ulat~l e~XlatX2 dx2 = T}Ul^t F7(t; viatAiat)- (6.16)JO Alat
Substituting the integrals with the equivalent gamma cumulative distribution
functions, Equation (6.15) becomes:
A(ht+ l)e~ht T{yiat)Xli
h2 J^lat
x {F7(r - 1 - tT-Uiat, Xlat)-
F7(t 1 t, Uiat, ^lat)}
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+
A[h{r - 1) + l]e-h^T(ulat)
h2(Xiat - h)^
Ahe~h<-T-V T(ulat + 1)
x {F7(r - 1 - tT] Ulat, Xiat -h)~
F-y(T 1 t, Vlatt Xiat
w (\lat - hyiat+l x {Ft(t "1 ~ tT] Ulat + F Xlat ~h)~
F7(r - 1 -t; uiat + 1, Xiat ~ h)} .
(6.17)
Numerator integral 2 (for area 2)
In a given interval (tT,t), the contribution of integral 2 to the numerator N(xi)
of the expected value of Xx, denoted by NX2, is:
rT—t rt
N,12 = f f xi A e hxi e XlatX2 x2lat 1 dxxdx2
J T—l— tx J tx
e ~XlatX2 x2lat 1





= A /i r—1—ty
= {(hiT + 1) e_/ltT - (hi + 1) [ x2lat~1 e~XlatX2dx2.h2 1 J Jr—l—tT
(6.18)
Substituting the integral with the equivalent gamma cumulative distribution func¬
tion, Equation (6.18) becomes:
N12 =
A
{ {htT + 1) e~htT - (ht + 1) e~ht }
T {Ulat)
x
h2 >• - j A/aj,iot
{ > Xiat) ^7(T 1 txj liaij Xiat) } .
(6.19)
Numerator integral 3 (for area 3)
In a given interval the contribution of integral 3 to the numerator N(xi)
of the expected value of Xx, denoted by 7V13, is:
rT-t-r rr—x 2








rtT p~\atx2 xUlat-l ~Jr-t 2 [ h2
I (htT + 1) e~ht J xy^'1 e~XlatX2dx




(hr + 1) e-/lT T T xy^-1 e~^-h)x2 dx2Jr—t
h e~hT fT~tT xyat e-^-h)x2 dx2 J . (6.20)
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Integrals in the expression for iV13 in Equation (6.20) are integrals of gamma
densities. Substituting the integrals with the equivalent gamma cumulative dis¬
tribution functions, Equation (6.20) becomes:
Ar A(htT +1) e~ht r(uiat) fT? ^ x ^ ^ ^ uA^l3 — to \ viat Uie Ti ^lat) ^lat) F7(t ^lati Mat)}
"> Mat
A (hr + 1) e~hT T{ulat)
h2 (Ajflt _ X IF-r(r ^
F-y("r f, -^iai
A h e~hr r(flat + 1)
h2 (A, i - /i)iy'at+1 X ir' + F A/ai ^
F-y(T tj Vlat "b 1, A/at } •
(6.21)
Denominator integral 1 (for area 1)
In a given interval (tr, t), the contribution of integral 1 to the numerator D(xi)
of the expected value of Xx, denoted by Dx is:
fr—l—tr rt
Di = [ [ A e hxi e XlatX2 x2"lat 1 dxxdxJr—l—t Jt—1—X2
rr-l-tr . ,
_ a / x2l'lat e latX2Jr-l-t
_ & tlx i t
dx2
- r—1—12




£ 1 tTX2^ot_1 e~XlatX2 dx2J. (6.22)
The expression for Dx in Equation (6.22) is composed of integrals of gamma
densities. Replacing the integral functions with the equivalent expression in terms
of the gamma cumulative distribution function, Equation (6.22) becomes:
Ae^7"-1) T{yiat) i , \
1 =
h x (F7(r - 1 - T; - /i)-
F7(t 1 t, Vlati ^lat ^)}
Ae-ht T[ylat)
h A lat
— x {F7(r - 1 - tr; "iat, Mat) - F7(r - 1 - i; Aiot)} ■
(6.23)
Denominator integral 2 (for area 2)
In a given interval (tr,t), the contribution of integral 2 to the numerator D(xx)
of the expected value of Xx, denoted by D2 is:















'}rJr—l—tT "lat 1 g X'°-tX2dX9. (6.24)
The integral in the expression for D2 in Equation (6.24) is an integral of a gamma








x {F7(r - t; Aiat) - F7(r - 1 - fT; viaU \lat)} .
(6.25)
Denominator integral 3 (for area 3)
In a given interval the contribution of integral 3 to the numerator D(x\)






= f [ A e hxi e XlatX2 a;2l/'ai 1 dxxdx
Jr-t JtT
rT-t-r





x2Ulat 1 e A,atl2 dx2
--t
J T X2lat~l e-^t-h)x2 dX2^ . (6.26)
Replacing the integrals by the equivalent gamma cumulative distribution func¬
tions, Equation (6.26) becomes:
Ae~htT r(ulat)D
h \ ulat X {P7^ ^Tt Vlati A/ot) F7(r t, Vlati A;a/)}^ "lat
Ae r(^oi)-/it
(A, _/j)^ x {p7(r - A;at - A) - F7(r - Aiat - A)} .
(6.27)
The denominator and numerator integrals for each partitioned interval for the 3
areas are summed over all of the intervals and the expression for calculating the
expected time to infection is given by:





where i is any interval (A, tf+i) in (0,t)-
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6.4.2.4 Expected latent period, E[X2)
The denominator in the expression for calculating the expected value of the latent
period is the same as that in the expression for calculating the expected value of
the time to infection which is given by:
E Dx(i) + D2{I) + Dz{I).
all intervals i
The numerator in the expression for calculating the expected value of the latent
period is calculated in a similar way to the expectation of time to infection by
considering the 3 areas, 1 to 3, as outlined in Equation (6.11), separately.
Numerator integral 1 (for area 1)
In a given interval (tr,t), the contribution of integral 1 to the numerator N(x2)
of the expected value of X2, denoted by N2i, is:
PT— l—tT ft
JT—l—t JT—1—2
fT—1 — tf p tlX\
A
N,21 A e hxi e XlatX2 x21/'at 1 dx\dx2




[ x2Ulate (A,at h^X2dx2JT—\—t
J x2"late~XlatX2dx21. (6.29)
Replacing the integrals in 6.29 by the equivalent gamma cumulative distribution
functions yields:
Ae-h(r-i) T^lat +N,21
h (Xiat - hYlat+ 1 {F7(r — 1 — tx] Vlat + 1) Xiat — h)-
F7(r - 1 - t; I'lai + 1, Xiat -h)}
Ae ht T(uiat + 1)
h Xlat^+1 {F7(t 1 tx, Vlat T 1) Xiat)
F7(t 1 t, l^lat ~t~ 1) Xiat)} ■ (6.30)
Numerator integral 2 (for area 2)
In a given interval (tr,t), the contribution of integral 2 to the numerator N(x2)
of the expected value of X2, denoted by N22, is:
N22 — f f x2 A e hxi e XlatX2 x2I/,ot 1 dx\dx2










Replacing the integrals by the equivalent gamma cumulative distribution func¬
tions in 6.31 yields:
AT _ A (p~htT p~ht\ lat ^ XN" ~ h1-*~C > A,
{F7(r — t; uiat + 1, Xiat) — F7(r — 1 — tT] viat + R A/at)} . (6.32)
Numerator integral 3 (for area 3)
In a given interval (tr,t), the contribution of integral 3 to the numerator N(x2)
of the expected value of X2, denoted by N23, is:
N23 = [ [ x2 A e hxi e x'atX2 x2lat 1 dx\dx2Jr—t J tx
rT-tr
JT—t
= A / x2Ulate XlatX2
_e~hx 1 T—X2
h
= ^ \e'htT £~tT x2u,at e-x,atX2dx2 - e~hT£ * x2"lat e~^lat-h)x2dx2}.
(6.33)
Replacing the integrals by the equivalent gamma cumulative distribution func¬





Ae hT T(ulat + 1)
N2z — +1 {F7(r — tT] Utat + 1, A lat) — F7(t — t] Ulat + 1, A lat)}n "lat °
{F7(r - tT\ Ulat + 1, A lat - h)~h (Xiat - hyiat+1
F7(t — t) Ulat + 1, Xiat — h)} . (6.34)
The numerator in the expression for calculating E[X2\ is attained by summing
N2\, N22, N23 over all intervals and hence the expression for calculating the ex¬
pected value of the latent period is given by:




where i is an interval (tj, U+i).
6.4.2.5 Estimation of infectiousness period
Once estimates for the expected time to infection and the expected length of latent
period are obtained, estimates for the expected infectiousness period for each
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infected sheep can be calculated, based on the distribution of the infectiousness
period. From the estimates of the expected time of infection and expected length
of latent period, the time of start of infectiousness and the expected amount
of unobserved infectiousness period before r are estimated. Estimates for the
expected length of infectiousness period for infected sheep in groups 2 to 4 are
calculated in a similar way to the calculations for group 1 sheep in Section 6.4.1.2.
Let tj denote the expected infectiousness period. The expected infectiousness
period for an infected individual given ne is estimated by:
Jne+Tt tjf{tj)dtj
E[Tr\ne\ = "e~1+7V (6.36)L " eJ rne+Tr r(, v '
•*ne — l+TT J\ l) I
where /(f/) is the density of the infectiousness distribution which is gamma dis¬
tributed with shape parameter i>inf and scale parameter A;nf-
The unobserved infectiousness period before r, Tr, is the length of time between
the end of the latent period and r and is estimated by r — E[Xi + X2\. Thus for
each infected individual, ne is known and estimates for Tr and for the expected
infectiousness period are obtainable. Hence an estimate for the unobserved ex¬
pected infectiousness period after u, can also be calculated. Thus contributions
from each infected individual to the expected total duration of infection exposure
for groups of sheep can be calculated and a martingale estimate for obtained.
6.5 Estimation of rate of infection
In the current chapter, the rate of infection, (3g, acting upon groups 2 to 4 of sheep
is estimated using martingale methods. These methods are described in Section
4.3 and the expressions for the estimates of j3g and the corresponding standard
error estimates are given in Equation (4.17).
In order to be able to calculate a martingale estimate for f3g, the total expected
infection exposure time for each group has to be determined. The exposure time
depends on the length of infectiousness periods of infected sheep in a group. For
groups where all sheep became infected, an estimate for the expected time of
infection of the last sheep to be infected in the group is required to determine the
appropriate amount of infection exposure required for the estimate of f3g acting
upon such groups. Modelling the entire infection process makes this possible,
because estimates for the expected time of infection for all infected individuals
are obtained from the model. Thus, through knowledge of the expected times of
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infection, a cut-off point is attained for the infection exposure time necessary to
calculate the martingale estimate for /3 acting upon groups where all individuals
became infected.
The hazard function, h(-), in the density function for time to infection (Equation
(6.1)) involves (3. Thus, estimates for the expected infection process character¬
istics and for the /3g have to be obtained via an iterative scheme as outlined in
Section 4.4. The proposed scheme is analogous to the EM algorithm, where in the
expectation step, the unobserved infection process characteristics are estimated
by expected values conditional on previous estimates, and the equivalent of the
maximisation step is an 'estimation step' where the j3g are estimated using either
MLE or martingale methods. The scheme is outlined in Algorithm 6.1 below.
6.6 Algorithm for the iterative scheme
Algorithm 6.1
1. Assume the latent period distribution to be a gamma distribution with
parameters z>/at and Aiat as previously estimated.
2. Assume the infectiousness period distribution to be a gamma distribution
with parameters and Ainj as previously estimated.
3. Initialise the rates of infection, /?2, @3 and /?4, applying to groups of sheep,
to the estimates from the partial model (Chapter 5).
4. Estimate the expected time to infection, expected latent period and ex¬
pected infectiousness period for each infected individual, according to Equa¬
tions (6.28), (6.35) and (6.36) respectively, starting with those animals
which earliest became infective, and using estimates (from this iteration)
of these values where required in the calculations for individuals with later
infections.
5. Calculate the estimate for the expected total infection exposure, for each
group, by summing the relevant contributions of the estimated expected
infectiousness periods.
6. Calculate new martingale based estimates for /52, /33 and f3± according to
Equation (4.17).
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7. Compare estimates in steps 4 and 6 with estimates from previous iteration
or with initial values in the case of the first iteration, if the difference is
greater than 10~7 go to step 4, else go to step 8.
8. Use the estimates in step 4 and step 6 as the final estimates for the expected
infection process characteristics and for the @g.
9. End.
6.7 Investigation of trend in the rate of infection
The aim of the experiments was to assess whether the rate of infection decreases
across groups. The trend in /3 across groups is measured by a slope calculated
from weighted linear regression analyses (Freund and Wilson, 1998, Section 4.3).
The /3 estimates are regressed against the group numbers, with weights given by
the square of the reciprocal of the estimated standard error of /3 i.e. weight =
(g q0})2• With the estimate for the slope, the regression analysis also gives an
estimate of statistical significance (p—value). However, because the estimates for
the group /3s are not independent, due to their underlying dependence on the
expected infection process, the p—value given by the regression analysis will not
be valid. Therefore to test whether the estimate for the slope is significantly
less than zero, bootstrap methods (Efron and Tibishirani, 1993, Section 16.2) are
employed to calculate a valid p—value.
6.7.1 Bootstrap methods
Bootstrap methods involve resampling from the original data either directly or
via a fitted model to create replicate data sets from which the variability of
the estimates of interest can be assessed. The approach is a computer-intensive
method because it involves repeating the original data analysis procedure with
many replicate sets of data. In the simplest nonparametric problems, sampling is
done from the observed data. A wide range of statistical problems can be tack¬
led this way, rescuing the investigators from the need to over simplify complex
problems (Davison and Hinkley, 2000, Chapter 1). Bootstrap methods can also
be applied to simple problems to check the adequacy of standard measures of un¬
certainty, to relax assumptions and to give quick approximate solutions. Even in
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situations where one is fairly confident in the suitability of a particular parametric
model and the associated standard analysis, it can still be useful to see what can
be inferred without making the assumption of a specific parametric model. 200
bootstrap epidemic samples are generated from the simulation model described
in Section 2.4.2. In addition to the parameters for the distributions of latent and
infectiousness periods and the rate of infection, the model also involves a param¬
eter termed the passage multiplier, which describes the passage effect. For the
latent and infectiousness distribution parameters, the parameters estimated from
the experimental epidemic data are used. For the rate of infection, a global rate
of infection (assuming the same (3g for all groups 2 to 4) is estimated from the
experimental data. The passage multiplier is set to 0, since the aim is to generate
epidemics under the null hypothesis i.e. that the rate of infection is the same for
all infected individuals regardless of how far down the infection chain they may
be.
6.7.1.1 Global rate of infection (/3gi0bai)
Under the null hypothesis of equal rate of infection acting upon groups of sheep,
an equal (3g is assumed for all groups. This is referred to as the global rate of
infection, denoted by /3giobai- To estimate f3gi0bai, information from all groups is
combined. A martingale estimate for f3gi0bai is calculated from the expected total
infection exposure time for all groups 2 to 4 and the corresponding values of the




J24g=2 total expected infection exposure time for each group g'
(6.37)
where T is the stopping time of the experiment, Ig(x) is the number of infectious
individuals in group g at time x, sg(T) is the number of susceptible individuals
remaining in group g at the end of the epidemic and ng(x) is the total number of
sheep in the mixing group containing group g at time x.
global and the expected infection process characteristics are estimated iteratively
using Algorithm 6.1, with the different group /3g replaced by /3gi0bai-
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6.7.1.2 The simulation model
Formulation of the simulation model is based on a Susceptible-Latent-Infectious-
Removed (SLIR) infection structure, modelling the generational infection of in¬
dividual sheep (Section 2.4.2) rather than groups of sheep. Group 1 sheep are
generation zero infectives and these have an infection potential when exposed to
group 2 sheep proportional to the rate /30 = (3gi0bai ■ Since the bootstrap epidemics
are to be generated under the null hypothesis of no reduction in infectivity with
respect to generation number, all infected individuals are assumed to have the
same rate of infection, equal to /3gi0bai-
If the alternative hypothesis that the rate of infection drops with respect to infec¬
tion generation number is true, then infected individuals in higher groups which
will tend to be of higher infection generation number will potentially have lower
rate of infection. Thus although it is infection generations of sheep that are be¬
ing modelled by the simulation model, the alternative hypothesis is equivalent
to the rate of infection acting upon groups of sheep dropping across groups. For
instance, group 3 individuals are exposed to infected individuals of generation 1
(from group 2) and above and group 4 individuals are exposed to infected indi¬
viduals of generation two (from group 3) and above.
The simulation model reflects the nature of the experiment, with groups of size 8
and restricted mixing among groups of sheep. A gamma distribution is assumed
for the latent and infectiousness processes and the parameters for the distributions
are as estimated from the experimental data.
6.7.1.3 Bootstrap epidemic samples
200 bootstrap epidemic samples are generated using the simulation model de¬
scribed in Section 6.7.1.2 above. Using only the information as was observed in
the experimental data i.e. ni, r, ne, and u> for each individual (refer to Section
5.2), the simulated epidemic data are analysed using methods to model the entire
infection process to obtain estimates for /3S, in each of groups 2 to 4. Weighted
linear regression analyses are performed by regressing the estimates of f3 on group
number to produce an estimate of the slope as a measure of the trend in the /3S.
From the distribution of the 200 estimated slopes, a bootstrap p—value (Efron
and Tibishirani, 1993, Section 16.2) is obtained. The null hypothesis is equivalent
to the estimate of the slope being equal to zero i.e. no trend in the (3 estimates,
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and the alternative hypothesis is that the slope is less than 0. If the estimated
slope from the experimental data is significantly less than 0, it will be expected to
fall outside or at the extreme left of the distribution of the slopes estimated from
the bootstrap samples. The p—value is formally calculated as follows: Based on
the alternative hypothesis of slope decreasing with higher group, the p—value is
given by:
#{bootstrap slopes < observed (estimated) slope} . .
p—value = — , (6.38)
total number of bootstrap samples
i.e. count the bootstrap slopes where the slope is less than the estimated slope
from the experimental data and divide by the total number of bootstrap samples.
6.8 Implementation of methods
The inferential methods described in previous sections are implemented by pro¬
gramming in C (Kernighan and Ritchie, 1988) and S-Plus (Venables and Ripley,
1994). Programs were developed to model the infection process and the methods
were applied to experimental data generated from two identical experiments car¬
ried out at the Institute of Animal Health in Pirbright and to simulated data. The
experimental data are described and presented in Section 1.3.3 and the simulation
models used to generate the simulated data are described in Section 2.4.
6.9 Application of methods to experimental data
6.9.1 Estimates of viat and Aiat
Information about group 1 sheep (see Table 5.1) was used to estimate the pa¬
rameters uiat and Xiat of the latent period distribution. Group 1 sheep provide
more information about the latent period. The time at which these sheep were
inoculated is considered as the time of infection. Based on rp, the number of days
that these sheep tested negative after inoculation prior to r, ML estimates for
the distribution parameters were obtained.
Given n/, for an infected individual, the length of latent period is between rp and
ni + 1. Recall from Section 6.3: if rp < x2 < ni -1- 1, where x2 is the length of
latent period, the log-likelihood function for the latent period is given by:





l+ l \latUlatX2U'at XlatX2
P iyiat)
dx9 (6.39)
In both experiments, group 1 sheep are observed to have first tested positive
either on the first day after inoculation, i.e. ni = 0, or on the second day after
inoculation, i.e. rp = 1. The value of 7p for each of the group 1 sheep from
both experiments is given in Table 6.1. In experiment 1, sheep number 3 did
not test positive to FMD virus throughout the experiment despite having been
inoculated. Therefore in that experiment only data on the remaining 7 sheep are
used to model the latent period.
Table 6.1: Number of negative tests after inoculation prior to the first observed
positive test, ni.
Sheep ID 1 2 3 4 5 6 7 8
ru (exptl) 1 0 -* 0 1 0 1 0
ri; (expt2) 1 0 1 1 0 0 0 0
* Sheep did not shed virus
Using these data the full log-likelihood function given in Equation (6.39) is max¬
imized with respect to uiat and Aiat, yielding the following estimates:
Experiment 1
The estimate for the shape parameter hiat = 32.26 and the estimate for the scale
parameter A[at = 32.95. Thus the estimate for the mean of the distribution of the
latent period for the infected sheep in experiment 1, given by is 0.98 days
*lat
with the standard deviation of the distribution given by equalling 0.172.
V lat
Experiment 2
The estimate for the shape parameter 0iat = 29.99 and the estimate for the scale
parameter Xlat = 31.43. Thus the estimate for the mean of the distribution of the
latent period for the infected sheep in experiment 2 is 0.95 days with the standard
deviation of the distribution equalling 0.174.
From both experiments, the mean of the distribution for the latent period for
infected sheep was estimated to be approximately 1 day (0.98 for experiment
1, 0.95 for experiment 2) with similar variability in latency being seen in both
experiments.
The fact that in both experiments there are more sheep that did not test nega¬
tive after inoculation prior to first testing positive than sheep that tested negative
once prior to the day of the first positive test has an effect on the resulting es¬
timate for the mean latent period. Due to the discretization of the time scale,
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because sampling is done on a daily basis, ni takes only values 0 and 1. The
resulting likelihood function for the latent distribution is flat and hence there is
a wide range of possible values for parameter estimates that maximize the log-
likelihood function to a specified tolerance. Different estimates for vtat and Aiat
were obtained depending on the choice of initial values. However, the maximum
value of the likelihood was always the same and all values of the estimates gave
similar estimates for the mean and standard deviation of the latent period distri¬
bution. Only one set of parameter estimates is presented since practical interest
is primarily in the mean of the distribution. These estimates are the ones at¬
tained after using moment estimates as the initial values for uiat and Aiat. Using
simulated epidemics with an increased group size (i.e. 20 sheep per group) simi¬
lar problems with convergence were encountered for the estimates of the latency
parameters. The latent period would still be expected to be between 0 and 2
days, with many individuals presenting at 1 day of latency, assuming that the
individuals that test negative once became viraemic shortly after the time of the
first negative test and that those that never tested negative before the first posi¬
tive test started shedding virus shortly before the test was done on the day after
inoculation. The use of lognormal and normal distributions (Johnson and Kotz,
1970, Section 4.3) to model the latency variable, did not solve the convergence
problem. Sampling more frequently, say on a half day (12 hours) basis would
provide more information about the latent process, resulting in an improvement
in convergence and possibly better parameter estimates. There is a need to in¬
vestigate the appropriateness of the gamma distribution as a model for the latent
period and further investigation of other choices of distributions for the latent pe¬
riod should be considered, if the experiment is repeated, with a shorter sampling
cycle.
6.9.2 Infection process for group 1 sheep
6.9.2.1 Expected latent period
The expected latent period for an infected sheep was estimated conditional on
ni. From Equation (6.5), the expression for the estimate of the expected latent
period is given as
I 1 Jn!+1 tLf(tL)dtLEl™ = Jr/TTT ( '
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Using the properties of the gamma distribution as outlined in Equations (5.4) and
(5.5), the expression for the estimate of the expected latent period, in Equation
(6.40), becomes:
E[TL\m] cr
[F7(rq 4- 1; zqai + 1, Aiat) — F7(zq; zqai + 1, A;at)]
F7(ri; + 1, flat, Alat) F7(rq, f;a(, Aiat) (6.41)
where fviat+i,\lat[tL) is the density function of a gamma distributed random vari¬
able with shape parameter uiat +1 and scale parameter Aiat. F7(rq + 1; viat+ l, Xiat)
is the cumulative distribution function up to the point rq + 1 of a gamma dis¬
tributed random variable with shape parameter uiat + 1 and scale parameter Aiat.
From the expression in Equation (6.41), the estimate for the expected latent pe¬
riod for an infected sheep given rq was calculated. Sheep with rq = 0 have an
estimated expected latent period of 0.86 days for experiment 1 and 0.85 days for
experiment 2. Sheep with rq = 1 have an estimated expected latent period of
1.14 days for experiment 1 and 1.13 days for experiment 2. Table 6.2 presents
the estimated expected latent period for each of the sheep in group 1 for both
experiments. In experiment 1, sheep in group 1 have an estimated average ex¬
pected latent period of 0.98 days with standard deviation of 0.149. In experiment
2, sheep in group 1 have an estimated average latent period of 0.95 with standard
deviation of 0.148. Thus, for both experiments sheep were, on average, estimated
to be in the latent state for a period of approximately 1 day.
Table 6.2: Expected latent period for group 1 sheep given
Experiment 1
Sheep ID m Latent period
Experiment 2
Sheep ID rq Latent period
1 1 1.14 1 1 1.13
2 0 0.86 2 0 0.85
3* - 3 1 1.13
4 0 0.86 4 1 1.13
5 1 1.14 5 0 0.85
6 0 0.86 6 0 0.85
7 1 1.14 7 0 0.85
8 0 0.86 8 0 0.85
sheep did not shed virus
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6.9.2.2 Expected infectiousness period
The expression for calculating the expected infectiousness period given ne is de¬
rived from Equation (6.6), where
infectiousness (end of latency) and r, and Tj is the expected length of infectious¬
ness period which is assumed to be gamma distributed with shape parameter
vinf and scale parameter Ainf (see Section 5.4.2), and f(tj) is the corresponding
density function.
From the properties of a gamma distribution as outlined in Equations (5.4) and
(5.5), the above expression is equivalent to:
The expected infectiousness period for group 1 sheep is determined conditional
on ne and rq. Thus sheep with the same rq and same ne will have the same
expected length of infectiousness period. Using data about rq and ne from both
experiments, the estimate for the expected length of infectiousness period for each
infected sheep in group 1 was calculated based using Equation (6.42). The results
are presented in Table 6.3. The estimate for Tt depends on rq. In the data set,
rq takes values 0 and 1 (see Table 6.2).
For rq = 0, the estimate of Tr for experiment 1 is 0.14 days (3.36 hours) i.e. in
experiment 1, it is estimated that sheep that tested positive on the first day after
inoculation were first observed to be excreting virus 3.36 hours after the expected
start of virus shedding. For sheep with rq = 1, the estimate of the expected length
of unobserved infectiousness before r is 0.86 days (20.64 hours). It is estimated
that these sheep were only observed to be excreting virus more than 20 hours
after the expected start of virus shedding.
where Tr is the estimated unobserved infectiousness period between the start of
F-y(&, Ainf ) F\(&, Vinf i Ainf )
(6.42)
where the limits a = ne — 1 + Tr and b = ne + Tr.
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In experiment 2, the results are similar to those of experiment 1, sheep with 7p = 0
had an estimated 0.15 days (3.60 hours) of their infectiousness period unobserved
before r. These sheep were first observed to be excreting virus less than 4 hours
after the estimated start of virus shedding. Sheep with rp = 1 had an estimated
0.87 days (20.88 hours) of their estimated infectiousness period unobserved.
In summary, for both experiments, sheep that tested positive on the first testing
day after inoculation are estimated to have started to shed virus on average within
4 hours of the test being done. On the other hand, it is estimated that sheep that
tested negative once before the first positive test, on average became viraemic
within less than 4 hours after the first testing day after inoculation.
With the values of Tr calculated, the limits of the integrals in the expression for
the expected infectiousness period are fully specified. Table 6.3 lists expected
lengths of infectiousness period conditional on rp and ne.
Table 6.3: Estimates of the expected lengths of infectiousness period for group 1
sheep given ni and ne.
Experiment 1 Experiment 2
ne nt =0 m = 1 m = 0 ni = 1
2 1.82& 2.40 1.92& 2.45
(0.68)* (0.54) (0.77) (0.58)
3 2.64 3.28 2.66 3.24
(0.50) (0.42) (0.51) (0.37)
4 3.54 4.22& 3.49 4.15&
(0.40) (0.36) (0.34) (0.28)
f^- 0.14 0.86 0.15 0.87
+Tt is the estimated unobserved shedding time before r given ni.
* value in brackets is the estimate of the length of unobserved shedding time
after to.
&calculated, although no sheep from either experiments was in this category.
In both experiments, sheep with rp = 0 tested as positive for 3 or 4 days and
sheep with rp = 1, tested as positive for 2 or 3 days. This is presumably due to
the fact that sheep with rp = 1 had a large portion of their infectiousness period
(estimated at 20.60 hours for experiment 1 and 20.88 hours for experiment 2)
unobserved before r Sheep with rp = 0 had a smaller estimated portion of the
expected infectiousness period unobserved before r (3.36 hours for experiment
1 and 3.60 hours for experiment 2). The period of 24 hours between sampling
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therefore favoured the observation of positives from sheep that tested positive on
the first day of testing. Sheep with a short latent period (less than 24 hours) had
their infectiousness observed on the first day of testing after inoculation. However,
sheep whose latent period was slightly longer than 1 day (over 24 hours) and
became infectious shortly after the first day of testing, because of the 24 hour
period between sampling, tended to have fewer positive samples recorded. By
the time of next sampling, these sheep were well into their infectiousness state.
Comparing columns 2 and 3, for experiment 1 and columns 4 and 5, for experiment
2, of Table 6.3, sheep with the same ne but with n; = 1, are estimated to have
excreted virus, on average, for longer periods than sheep with rp = 0. Thus,
given a fixed number of positive observations, ne, sheep that had an estimated
shorter expected latent period (less than 1 day) had a shorter estimated expected
infectiousness period.
With estimates for the individual expected infectiousness periods obtained, the
expected total unobserved infectiousness period can be obtained. So far, attention
has focussed on Tt, the unobserved infectiousness period before r. However, after
ij, the day of the last positive test, there is an amount of unobserved infectiousness
period. It is known that a sheep last tested positive on day co and tested negative
thereafter from day co + 1 on wards. At some point between day co and day co +1,
infected sheep ceased shedding virus. From the estimates for the expected total
infectiousness period and expected start of infectiousness, the expected amount
of unobserved infectiousness period after co can be estimated. This is obtained by
subtracting the observed (ne — 1) infectiousness period and Tr from the estimated
expected infectiousness period. Thus Tu — E[Ti\ne,ni] — (ne — 1) — Tt and the
estimates corresponding to each combination of ne and n; are given in Table 6.3.
For both experiments and for both n/ = 0 and ni = 1, sheep had average estimates
of between 8 and 14 hours of unobserved infectiousness after co. The estimated
expected amount of unobserved infectiousness after co was slightly higher for sheep
with rti = 0 when compared to that for sheep with rp = 1.
Table 6.4 shows the estimated total expected unobserved infectiousness period
i.e. the expected infectiousness period (E[T\ne, n/]) minus the observed period
(ne — 1), conditional on ne and rp. In general, for rp = 1, the estimate is of
more than 1 day (between 1.14 and 1.44 days) expected unobserved infectiousness
period. Sheep with ni = 0 gave rise to an estimate of less than 1 day (between
0.49 and 0.92 days) of total expected unobserved infectiousness period. In future
experiments of this type, the duration between sampling should be smaller to
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Table 6.4: Estimated total expected unobserved infectiousness period (in days) for
group 1 sheep.
Experiment 1 Experiment 2
ne n; = 0 nt = 1 71; = 0 n; = 1
2 0.82 1.40 0.92 1.45
3 0.64 1.28 0.66 1.24
4 0.54 1.22 0.49 1.15
reduce the amount of unobserved infectiousness period. It appears that a 24 hour
sampling interval was not appropriate given the short observed latent periods,
and relatively short viraemic periods. In particular, sheep that have an expected
latent period of more than a day will have much of their expected infectiousness
period unobserved. The results also indicate that for both ni = 0 and ni — 1, the
estimated expected unobserved infectiousness period decreases with increasing
ne, as illustrated in Figure 6.5.
Figure 6.5: Comparison of estimated length of unobserved infectiousness by ne
and ni.
Experiment 1 Experiment 2
Estimates of the expected infectiousness period for group 1 sheep are included in
Table 6.5 for both experiments. In this table, estimates for the entire histories
of infection for group 1 sheep, including the expected time of infection (time of
inoculation) denoted by 'Inf T', the expected length of latent period, the expected
time of start of infectiousness denoted by 'Start inf', the expected time of end
of infectiousness denoted by 'End inf' and the expected length of infectiousness
period denoted by 'Inf Period' are presented.
152
Table 6.5: Estimates for group 1 infection history characteristics, for experiment
1 and 2.
Experiment ID Inf T Latent Start inf Inf Period End Inf
1 0 1.14 1.14 3.28 4.42
2 0 0.86 0.86 2.64 3.50
3* - - - - -
4 0 0.86 0.86 2.64 3.50
5 1 1.14 2.14 2.40 4.54
6 1 0.86 1.86 2.64 4.50
7 1 1.14 2.14 2.40 4.54
8 1 0.86 1.86 3.54 5.40
1 0 1.13 1.13 2.45 3.58
2 0 0.85 0.85 3.49 4.34
3 0 1.13 1.13 3.24 4.37
4 0 1.13 1.13 3.24 4.37
5 1 0.85 1.85 2.66 4.51
6 1 0.85 1.85 2.66 4.51
7 1 0.85 1.85 3.49 5.34
8 1 0.85 1.85 3.49 5.34
* sheep did not shed virus
Modelling the entire infection history enables appropriate allocation of the con¬
tribution of the estimated infectiousness period of each sheep to the respective
estimate of the group infection exposure time. For the partial model of the in¬
fection process, where only the infectiousness period was modelled, the estimated
unobserved infectiousness period was divided into two equal portions, one for the
period before r and the other for the period after oj. By modelling the entire
infection process, there is an estimated variable for each of these periods. For
instance, sheep number 1 in experiment 1, has an estimated start of infectious¬
ness at t = 1.14 i.e. after 1 day and 3.3 hours from the start of the experiment;
the first observed positive test is on day 2 (r = 2), the last positive test is on
day 4 (u> = 4) and its estimated end of infectiousness occurs at t = 4.42, with
an expected infectiousness period estimate of 3.28 days. The estimate for Tr is
equal to 2 — 1.14 = 0.86 days and the estimate for Tu is 4.42 — 4 = 0.42 days.
The estimate for the total unobserved infectiousness period is 0.86 + 0.42 = 1.28
days. The equivalent estimate for the unobserved infectiousness period when only
the infectiousness period is modelled is 0.92 days, giving 0.46 days to each por¬
tion of unobserved infectiousness period before r and after oj. This implies that
infectiousness starts at time 1.46 and ceases at time 4.46, estimating 2.92 days
as the expected infectiousness period. The entire infection process model yields
estimates with 0.36 days (8.64 hours) of additional infectiousness time compared
to the partial model of the infection process.
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When estimating the expected total exposure time in order to calculate the es¬
timate for the rate of infection acting upon group 2 sheep, using the full model
of the infection process, sheep number 1 from experiment 1 contributes 0.86 days
during day 1 when groups 1 and 2 are mixing, compared to 0.46 days estimated
from the partial model. The total contribution of sheep number 1 to the esti¬
mate for the expected infection exposure time of group 2 in the entire model is
0.86 + 1 = 1.86 days as compared to 1.46 days. Although the estimate for the
total contribution to the expected infection exposure time is not very different,
the estimates for Tr and/or Tu may be appreciably different as is the case for the
estimate of Tt for sheep number 1, experiment 1. Modelling the entire infection
process enables allocation of the appropriate estimated amount of unobserved
infectiousness period before r and after cu, rather than having to assign half of
the estimated expected total unobserved infectiousness period to each portion as
for the partial model of the infection process. This is no surprise, since the full
model takes account of the force of infection applying to individual animals in
the run-up to infection.
The infection process for group 1 sheep is now fully specified. Estimates for the
expected times at which sheep start and cease to shed virus have been calculated.
Using this information plus the observed data i.e. r, ne and u>, the expected
infection history characteristics for sheep in the remaining groups are estimated.
6.9.3 Infection process for sheep from groups 2 to 4
Unlike group 1 sheep, where the time of infection was known (time of inoculation),
for infected individuals in the other groups, the time at which infection occurred
is not known. The process of time to infection together with the latency process
are modelled via a joint distribution of the two variables. From the fully specified
infection history for group 1 sheep and using the properties of the latent period
distribution estimated from group 1 sheep data, estimates for the expected time
to infection and expected latent periods for the infected sheep in groups 2 to 4
are calculated using the expression in Equation (6.14). After deriving estimates
for the expected time to infection and the expected latent period, the expected
infectiousness period is estimated based on the distribution already fully specified
in Section 5.4.2 and Equation (6.36).
For each infected sheep, the period between the start of the experiment and the
possible time of infection AT is partitioned into intervals with constant hazard,
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while taking mixing events into account as described in Section 6.4.2.
Estimates for the expected time to infection X\ and the expected latent period X2
are calculated using contributions from all of the partitioned intervals, conditional
on r and ne and past estimates of infection history from other infective individuals.
When calculating estimates for Xi and X2, it can be assumed that sheep with the
lowest value of r were the first to be infected. Thus, calculations were done in an
ordered way based on the value of r. In a situation where there was more than 1
sheep with the same value of r (ties), if the sheep are from the same group, then
estimates for X\ and X2 will be the same for these sheep (experiment 1: sheep
nos. (12 and 14); (18, 19 and 21); (27, 29, 30 and 31)) and if the sheep have the
same ne, they will also have the same estimate for the expected infectiousness
period. Because the same distributions for time to infection, latent period and
infectiousness period were assumed for every sheep, it is assumed that sheep
from the same group with the same r are unlikely to have contributed to each
other's infection exposure. If, however, tied sheep are from different groups,
a criterion based on the cumulative force of infection is formulated to choose
the group of animals whose infection history components should be calculated
first. The cumulative force of infection acting upon each group, using previously
estimated infection histories for other infective individuals, is calculated and the
group with the largest cumulative force of infection exposure is chosen for initial
calculation. If within the chosen group there were more than 1 sheep with the
same critical value of r, then the calculations were performed for one individual
and the resulting values adopted for all sheep with the same value of r and ne in
this group.
After calculating estimates for the expected infection process characteristics, the
expected total infection exposure time for each group is calculated by summing
contributions from individual infected sheep throughout their estimated expected
infectiousness histories. Finally, an estimate for /3 for each group was calculated
based on Equation (4.17), Section 4.3, i.e.
- Sl B[x)dN(x) , _ [/„T BHx)dN(x)X
P /WJWi , a 01 S'e\P)Ell^)dx EU^^dx) ■
The numerator of /? is the value of the integrals of the B function given in Table 5.8
in Section 5.4.4 and the denominator is an estimate for the expected total infection
exposure determined from estimates of the expected infectiousness periods. The
numerator for the standard error estimate of /3 is calculated from Equation (5.7)
of Section 5.4.4.
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The procedure of estimating the expected infection process characteristics and
the (3g was repeated iteratively until convergence, as outlined in Algorithm 6.1 in
Section 6.6.
6.9.3.1 Expected time of infection, latent period and infectiousness
period
In Tables 6.6 and 6.7, results for experiments 1 and 2 from the last iteration of the
full model of the infection process are presented. The results include estimates for
the expected time of infection denoted by 'InfT', expected length of latent period
denoted by 'latent', the expected start of infectiousness denoted by 'Start Inf', the
expected end of the infectiousness period denoted by 'End Inf', the time of the
first positive test r, the time of the last positive test u and the expected length
of infectiousness period denoted by 'Inf Period'. The estimated entire infection
history is presented graphically in Figure 6.6 for the two experiments.
Table 6.6: Estimated infection process for sheep from groups 2 to A (Experiment
!)■
Sheep ID InfT Latent Start inf r Inf Period End Inf Ul
9*
10 6.52 0.98 7.50 8 2.96 10.45 10
11 3.46 0.99 4.45 5 3.00 7.45 7
12 7.56 0.97 8.53 9 2.93 11.46 11
13 10.48 0.99 11.46 12 2.99 14.45 14
14 7.56 0.97 8.53 9 2.93 11.46 11
15* - - - - - - -
16 8.65 0.95 9.61 10 2.02 11.62 11
17 9.48 0.99 10.48 11 2.98 13.45 13
18 7.73 0.94 8.67 9 1.97 10.64 10
19 7.73 0.94 8.67 9 2.80 11.47 11
20 9.48 0.99 10.47 11 2.98 13.45 13
21 7.73 0.94 8.67 9 2.80 11.47 11
22 8.63 0.96 9.59 10 3.79 13.38 13
23 6.50 0.98 7.48 8 2.97 10.45 10
24 11.37 1.02 12.39 13 3.05 15.44 15
25* - - - - - - -
26 9.52 0.98 10.50 11 3.88 14.38 14
27 11.46 0.99 12.44 13 2.15 14.59 14
28 14.43 1.00 15.43 16 3.02 18.45 18
29 11.46 0.99 12.44 13 3.00 15.45 15
30 11.46 0.99 12.44 13 3.00 15.45 15
31 11.46 0.99 12.44 13 3.93 16.37 16
32 12.64 0.96 13.60 14 2.02 15.62 15
* sheep did not shed virus
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Table 6.7: Estimated infection process for sheep from groups 2 to 4 (Experiment
2).
Sheep ID Inf T Latent Start inf r Inf Period End Inf (x)
9 3.49 0.96 4.46 5 2.97 7.43 7
10 5.43 0.98 6.40 7 3.90 10.30 10
11 7.45 0.98 8.42 9 3.00 11.42 11
12 7.45 0.98 8.42 9 2.24 10.66 10
13* - - - - - - -
14 14.89 1.23 16.11 17 3.26 19.37 19
15* - - - - - - -
16* - - - - - - -
17 9.78 0.91 10.69 11 2.78 13.47 13
18 9.78 0.91 10.69 11 2.04 12.73 12
19 8.61 0.94 9.55 10 2.89 12.44 12
20* - - - - - - -
21 10.54 0.95 11.49 12 2.19 13.68 13
22 12.47 0.97 13.44 14 2.22 15.66 15
23* - - - - - - -
24 8.61 0.94 9.55 10 2.14 11.69 11
25 13.46 0.97 14.43 15 2.23 16.66 16
26 13.46 0.97 14.43 15 2.23 16.66 16
27 10.86 0.87 11.73 12 2.01 13.74 13
28* - - - - - - -
29 11.56 0.95 12.51 13 2.93 15.44 15
30* - - - - - - -
31* - - - - - - -
32* - - - - - - -
* sheep did not shed virus
From Figure 6.6 and Table 6.6, it is observed that for experiment 1, only sheep
number 11 is estimated to have been infected during the estimated infectiousness
period of group 1 sheep. The rest of group 2 infected sheep are estimated to
have been infected after all group 1 sheep had ceased to shed virus. Thus even
with 7 infectious sheep in group 1, estimates for the expected infection process
characteristics would suggest that only 1 group 2 sheep managed to make an
infectious contact with group 1 sheep even though these two groups mixed for
a total of 2 days during the estimated expected infectiousness period of group
1 sheep. For experiment 2, the results are similar (Figure 6.6 and Table 6.7);
only sheep number 9 from group 2 is estimated to have been infected during the
estimated expected infectiousness period of group 1 sheep.
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6.9.3.2 Estimates for rate of infection
Estimates of the expected scaled total infection exposure time and estimates for
the rates of infection and the corresponding standard error estimates, all derived
from the final iteration of the analysis procedure, are presented in Table 6.8.
Results from both experiments indicate that the highest rate of infection occurs
in group 3 sheep followed by group 4 and then group 2 (the same pattern as was
observed for the partial model). It should be noted that the estimate for /33 in
experiment 1 increases relative to the estimate made under the partial model. In
this group all sheep were infected, and thus a sizeable amount of infection exposure
in this group was 'wasted'. Estimating the expected time of infection for all the
sheep enabled identification of the likely last sheep to be infected and the expected
time of infection. The estimate for the total expected infection exposure for group
3 was then calculated only up to the estimated expected time of infection of the
last sheep in the group to become infected (sheep number 24). After rescaling,
the estimated total infection exposure time for group 3 while modelling the full
infection process was 1.33 days as compared to 2.65 days under the partial model.
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The partial model yielded a severe underestimate for /?3, since all of the time that
sheep contributing to the group 3 expected infection exposure time were shedding
virus, was included in the estimate for the total expected infection exposure, but
the full model would suggest that there were no remaining susceptible sheep to
infect in this group after time t = 11.37 days. Some individuals in groups 2 to
4 (which contribute to the estimate for the expected exposure time of group 3)
were still shedding virus until much later in the experiment with the last sheep
shedding virus up to an estimated time of t = 18.45, but only time up to 11.37
should contribute to the estimate for the total expected infection exposure for
group 3.
Table 6.8: Estimates for the expected scaled exposure time (in days) and (3 esti¬
mates (per day), from the final iteration of the analysis procedure.
Experiment 1 Experiment 2
Expected Expected
Group Exposure time p estimates s.e(/3) Exposure time /? estimates s.e(fi)
2 2.38 0.5116 0.2213 2.16 0.4087 0.1884
3 1.33 2.0469 0.9308 1.68 0.7256 0.3138
4 2.69 0.6377 0.2696 1.36 0.4655 0.2364
Estimates of /?2 and (34 acting upon groups 2 and 4 of experiment 1 and for all
/3g groups in experiment 2, are similar for both the partial and the entire models.
For experiment 2, results indicate that the estimated expected scaled exposure
time decreases across groups (2.16 days for group 2, 1.68 days for group 3 and
1.36 days for group 4).
Under the experimental hypothesis of reduction in infectivity across groups, group
2 would be expected to have the highest estimate for the rate of infection followed
by group 3 and then group 4. However, the results for both experiments indicate
a lowest estimated rate of infection applying to group 2, and a highest estimated
rate of infection applying to group 3. The estimated rate of infection for group
4 is higher than that for group 2 but lower than that for group 3. Thus, there is
an apparent reduction in the estimates for the rate of infection between group 3
and group 4 and as mentioned before it would be interesting to see what would
happen if there were to be more than 4 groups. It could be possible that the virus
in group 1, which is taken from laboratory stocks, although able to cause infection
in group 1 sheep, may lack some factor which promotes infectivity. By contrast,
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group 3 and group 4 sheep are exposed only to a natural virus. In Section 6.9.4,
a formal test of trend in the rate of infection across groups is performed.
Modelling the entire infection process enabled the expected time of infection for
the last sheep in group 3 of experiment 1 to be estimated. The improvement on the
P estimate for this group is remarkable. Even though estimates in the other groups
are similar for the two methods, modelling the entire infection process allows the
use of more information from the experimental data in estimating the rate of
infection and in estimation of the expected infection process characteristics i.e.
time of infection, time of start of infectiousness and removal time for the infection
process. Modelling the entire infection process is however, more computationally
intensive, whereas modelling of the partial infection process could be implemented
using a hand calculator. In Figure 6.7, comparisons of the scaled total time of
infection exposure and (3g estimates obtained from both experiments are presented
graphically. The graphs indicate that the estimate for the scaled total time of
infection exposure and f3g estimates are similar for both methods except in group
3 of experiment 1.
Figure 6.7: Estimated expected total exposure time (in days) and @ estimates (per






Tables 5.5 and 5.6 present the estimated infectiousness history inferred from the
partial model, which can be compared with Tables 6.6 and 6.7 respectively. There
is no consistent pattern apparent when comparing the inferred histories from the
two models. Estimated infectiousness start times in group 2 individuals tend
to be earlier in the full model, but there is one animal where the infectiousness
start time comes later. Infectiousness periods vary marginally, but no clear trend
is apparent. This is clear from the estimated total exposure times presented
in Figure 6.7, where, with the exception of group 3, experiment 1, there are
only marginal changes in the summed estimates between the two models. Given
the differences seen, for group 3, experiment 1 arises from the imposition of an
earlier cut-off point in the full model calculations, rather than from any systematic
differences in the estimated infectiousness periods.
6.9.4 Assessment of trend in the rate of infection
To estimate the trend in the rate of infection across groups, weighted linear regres¬
sion analyses were performed. /3g estimates were regressed against group numbers
2 to 4 with weights given by (s e(/3))2, m°dcl was fitted in the Splus statistical
package and the results from both experiments are presented in Table 6.9.
Table 6.9: Regression results for trend test for both experiments.
coefficients:
value std error t-value Pr(> |t|)
Expt 1 intercept 0.4060 0.8053 0.5045 0.7026
groups 0.0728 0.2709 0.2686 0.8330
Expt 2 intercept 0.3699 0.3680 1.0052 0.4984
groups 0.0405 0.1246 0.3251 0.7999
The regression analysis results indicate a non-zero positive slope for both exper¬
iments. Give the p—values, there is no evidence of any significant trend in the j3
estimates. However, because the /? estimates are not independent, these regres¬
sion analysis p—values are not correct. It is necessary to calculate a valid p—value
to test whether the slope for the (3 estimates is significantly less than that arising
under the null hypothesis of no change in infection rate with increased infection
generation. This is carried out using bootstrap methods.
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6.9.4.1 Testing trend
Bootstrap epidemic samples were generated using the simulation model described
in Section 6.7.1.2. For both experiments, a global rate of infection is estimated
and this estimate is used as the rate of infection for all infected individuals. 200
bootstrap epidemic samples were generated from the simulation model assuming
no trend in the rates of infection i.e. the passage multiplier was set to zero.
6.9.4.2 Estimate of global rate of infection ((3gi0bai)
Information from all groups is combined to calculate a martingale based estimate
for /Sgiobai as described in Section 6.7.1.1 using Equation (6.37). Using estimates
for the expected total infection exposure for each group (Table 6.8), and values
for the B integral (Table 5.8), an initial value for f3giobai is calculated.
For experiment 1 the initial estimate is given by:
- 1.2179 + 2.7179 + 1.7179
Pgiobai 2.38 + 1.33 + 2.69
and for experiment 2 the initial estimate is:
3 0.8845 + 1.2179 + 0.6345 n coco
Palobal — — 0.5263.h'global 2.16 + 1.68 + 1.36
global is then estimated iteratively using Algorithm 6.1, Section 6.5. Estimates for
Pgiobai and the corresponding estimates for the scaled expected infection exposure
time, derived from the final iteration of the fitting procedure, are presented in
Table 6.10. For experiment 1, Pgiobai is 0.8818 per day and for experiment 2, f3gi0bai
is 0.5258 per day.
Table 6.10: Estimates for global rate of infection for experiments 1 and 2.
B-Integral Overall exposure time Global /? estimate
Experiment 1 5.6537 6.4111 0.8818
Experiment 2 2.7369 5.2056 0.5258
6.9.4.3 Bootstrapping results
Using the estimated latent and infectiousness period gamma distribution parame¬
ters for each experiment (i.e. estimated mean latent period of 0.98 and estimated
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mean infectiousness period of 2.81 days for experiment 1 and estimated mean
latent period of 0.95 and estimated mean infectiousness period of 2.79 days for
experiment 2), and the estimated global rate of infection for each experiment
(0.8818 for experiment 1 and 0.5258 for experiment 2), 200 bootstrap epidemic
samples were generated from the simulation model. The resulting epidemic data
were analysed using the full model of the infection process, yielding estimates
for f3g for groups 2 to 4 for each epidemic realisation. Weighted linear regression
analyses were performed on each set of f3 estimates and estimates for the slopes
obtained. Descriptive statistics of the slope distribution are presented in Table
6.11 and histograms of the slopes simulated for each experiment are presented in
Figure 6.8.
The aim of the bootstrap exercise was to calculate a p—value to test whether
the estimated slopes from the experimental data are significantly less than those
arising from the null hypothesis. For experiment 1 a total of 139 slopes were less
than 0.0728, the estimated slope from the experimental data, yielding a p—value of
Hjj = 0.695. For experiment 2, 143 slopes were less than 0.0405, the estimated
slope from the experimental data, yielding a p—value of 0.715. Thus for both
experiments, the estimated slope was not significantly less than those generated
under the null hypothesis, leading to the conclusion that there is no significant
decreasing trend in the estimated rates of infection across groups. Rather, the
estimated slopes from both experiments fall well within the distribution of the
bootstrap estimated slopes. For experiment 1, the estimated slope of 0.0728 lies
in the right tail of the distribution of the bootstrap slopes at the 70% point.
For experiment 2, the estimated slope of 0.0405 also lies in the right tail of
the distribution of the bootstrap slopes at the 72% point. If the slopes were
significantly less than those arising under the null hypothesis, they would fall
at the extreme left ends or outside the distribution of the bootstrap estimated
slopes. Hence it is concluded that there is no significant decreasing trend in the
estimates for the rates of infection across groups in either experiment.
Table 6.11: Descriptive statistics for bootstrap slopes.






















Figure 6.8: Histograms of slopes from the bootstrap epidemics, the dashed lines
denote the observed (estimated) slope of 0.0728 for experiment 1 and the observed
(estimated) slope of 0.0405 for experiment 2.
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6.10 Summary
Full modelling of the infection process is of crucial importance. Time of infection,
length of latent period and length of infectiousness period are all very important
components of the infection process as far as infectious diseases are concerned.
It is always of interest to know whether individuals have been at high risk of
contracting infection when they have been exposed. The methods described in
this chapter can be used to model infectious disease data effectively, estimating
aspects of the infection history and all of the parameters involved.
Through full modelling of the infection process, estimates for the expected values
of the infection process characteristics for each individual were obtained. Us¬
ing the estimated expected times to infection, a cut-off point was estimated for
the expected infection exposure time as is necessary for the calculation of the
martingale estimate for /3 in groups where all individuals become infected. Also,
the model no longer necessitated the assignment of an equal amount of estimated
unobserved infectiousness period to the two portions of the unobserved infectious¬
ness period before r and after u>. The results indicate that the expected values
of the unobserved infectiousness periods were typically not equal and varied ac¬
cording to the number of observed negative days rii and the number of positive
days ne.
Considering the results from this analysis, the conclusion may be that there is no
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significant trend in the rate of infection across groups. As mentioned previously,
it would be of great interest to discover what would happen if there were more
than 4 groups, whether the decreasing trend in infectivity would become apparent
in later groups (group 3 onwards). Taking into account Home Office regulations,
laboratory facilities and other logistic constraints, it unlikely to be feasible to
have more groups. An alternative may be to increase the number of sheep in each
group, provided that this is logistically possible for the laboratory and acceptable
to the regulatory authorities, given the size of the rooms in which sheep are
housed.
It could be that a significant trend was not detected because:
1. It did not exist.
2. The inferential methods were not appropriate to the nature of the data.
3. The number of sheep in each group was too small to yield a significant
trend, given the size of effect present.
These options are investigated in Chapter 8.
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Chapter 7
Full modelling of the infection
process: ML estimation methods
7.1 Introduction
As in the previous chapter, the aim of the current chapter is to model the entire
infection process by estimating the unobserved infection process characteristics,
i.e. the times of infection, the length of latent period, the length of infectiousness
period and the rate of infection, /3g, acting upon step group g (g = 2, 3, 4). In this
chapter, the (3g are estimated using MLE methods, in contrast to the martingale
methods used in the previous chapter. Two sets of f3g estimates are considered
using MLE methods applied to two different models, namely, the unrestricted and
restricted models (refer to Section 4.2). Full modelling of the infection history is
therefore carried out separately for the two MLE models.
The difference between Chapter 6 and the current chapter lies in the method of
estimating f3. The assumed distributions for the latent and infectiousness periods
and the corresponding parameter estimates, as defined in the previous chapter,
will still be utilised. Estimates for the infection process characteristics for group 1
sheep will also be retained, since these are unaffected by the method of estimation
of f3. The infection process in groups 2 to 4, which is affected by (3, will be the
considered in this chapter. Using an algorithm similar to Algorithm 6.1, the
process of obtaining estimates of the infection process characteristics and of the
fig is carried out with the martingale estimator replaced by the ML estimators.
The ML estimators use more of the estimated infection history than was required
for the martingale estimators in Chapter 6. It is of interest to see how the two
classes of estimator compare.
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7.2 Estimation of entire infection process
The model distributions for the length of the latent and infectiousness periods,
the corresponding distribution parameter estimates and the estimated infection
process characteristics for group 1 sheep, obtained in Chapter 6, are retained.
Here, therefore, the focus is on the infection process of sheep in groups 2 to 4.
7.2.1 Infection process for group 2 to 4 sheep
For groups 2 to 4, the time to infection, the length of latent period and length of
infectiousness period for all infected sheep are to be estimated. Estimates for the
infection process characteristics of any infected animal are obtained conditional
on the time of the first observed positive test, r and the time of the last observed
positive test, u, and on estimates of the infection process characteristics of an¬
imals whose infection preceded that of the subject. Estimates of the expected
time of infection and expected length of latent period are calculated from a joint
distribution of the two variables conditional on r and the past history of the
epidemic, as described in Section 6.4.2.2. Following the calculation of estimates
for the expected time to infection and expected length of latent period, estimates
for the expected length of infectiousness period are obtained for each infected
sheep based on the infectiousness period distribution conditional of the observed
number of positive samples (refer to Equation (6.36), Section 6.4.2.5).
7.3 Estimation of rate of infection
In the current chapter, the rate of infection acting upon groups 2 to 4 is to be
estimated using MLE methods. These methods are described in Section 4.2. Two
sets of ML estimates (unrestricted model and restricted model) are determined.
Expressions for the unrestricted model estimators for the /3g and the correspond¬
ing standard error estimates are given in Equations (4.3) and (4.4) respectively.
The restricted model ML estimates of the (3g depend on whether the estimates fall
within or on the boundary of the restricted parameter space, and correspond to
distinct scenarios. If the estimates fall within the restricted parameter space, i.e.
P2 > @3 > At (Case 1), then the estimates for the (3g are the same as those obtained
for the unrestricted model MLE. If, however, the ML estimates fall on the bound¬
ary of the parameter space, then there are three possible cases (Cases 2 to 4), to
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which the estimates may correspond (Section 4.2.3). In Case 2 (/32 = $3 > $4),
expressions for the f3g are given in Equation (4.8) and the corresponding standard
error estimates are given in Equations (4.9) and (4.10). In Case 3 (/32 > $3 = $4),
the estimators for the f3g and the corresponding standard error estimates are as
given in Equation (4.11). In Case 4 (/}2 = $3 = $4), the estimator for the single
value of ft and the corresponding standard error estimate are given in Equation
(4.12). ML estimates for the fig from the restricted model are obtaining using
Algorithm 4.1, Section 4.2.3.
The objective is to estimate the fig and to investigate whether or not there is
a significant decreasing trend in the estimates for fig across groups. To be able
to calculate these estimates, the expected total duration of infection exposure,
Tg, for each group of sheep has to be estimated. Modelling the entire infection
process makes this possible, because from the estimates of the expected length
of infectiousness period, estimates for the durations of infection exposure due to
specific infected sheep can be obtained. As a result, Tg, which depends on the
expected length of infectiousness period of infected sheep, can be estimated using
Equation (4.15).
However, the hazard function, h(-), in the density function for the time to infection
(Equation (6.1)) involves ft. Thus, estimates of the (3g are obtained alternately
with estimates of the expected infection process characteristics, via an iterative
scheme. The estimates of Tg required to calculate estimates of the f3g are obtained
from the estimated length of infectiousness periods. Taking into account the
different estimation method for the Pg and the need to estimate Tg, the equivalent
iterative scheme to Algorithm 6.1 is given in Algorithm 7.1 below.
Algorithm 7.1
1. Assume the latent period distribution to be a gamma distribution with
parameters i>iat and Aiat as previously estimated.
2. Assume the infectiousness period distribution to be a gamma distribution
with parameters zA„y and Aas previously estimated.
3. Initialise the estimates for the rates of infection, /?2, @3 and @4 applying to
groups of sheep to the martingale (3g estimates from Chapter 6.
4. Estimate the expected time to infection, expected latent period and ex¬
pected infectiousness period for each infected individual, according to Equa¬
tions (6.28), (6.35) and (6.36) respectively, starting with those individuals
168
which earliest became infective, and using estimates (from this iteration)
of these values where required in the calculations for individuals with later
infections.
5. Calculate the estimate for the total infection exposure, Tg, for each group,
according to Equation (4.15).
6. Compute new ML estimates for /?2, P3 and /?4 using Equation (4.3) (unre¬
stricted model MLE) or using Equations (4.3) or (4.8) or (4.11) or (4.12)
within Algorithm 4.1 depending on whether the (3g estimates fall within or
on the boundary of the parameter space (restricted model MLE).
7. Compare the estimates in Steps 4 and 6 with estimates from previous itera¬
tion or with initial values, in the case of the first iteration. If the difference
is greater than 1CT7 go to Step 4, else go to Step 8.
8. Take the estimates in Step 4 and Step 6 as the final estimates of the expected
infection process characteristics and of the (3g.
9. End.
7.4 Investigation of trend in ML f3 estimates
The aim of the FMD experiments was to assess whether or not the rate of infection
decreases across groups. For the ML estimates, the method used to assess the
trend in the /3g estimates will differ for the two models.
7.4.1 Investigation of trend in the unrestricted model ML
(3 estimates
As in the equivalent case where the (3g are estimated by martingale methods, the
trend in the unrestricted model ML /3g estimates is measured by a slope attained
from weighted linear regression analysis (Freund and Wilson, 1998, Section 4.3),
where the /3g estimates are regressed against group numbers. The significance of
the trend is tested using bootstrap methods (Efron and Tibishirani, 1993, Section
16.2), since, as explained in Section 6.7, the p-values obtained from the regression
analysis are not valid.
Bootstrap methods involve resampling from the original data either directly or via
a fitted parametric model to create replicate data sets from which the variability
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of the estimates of interest can be assessed. The methods have been described
in Section 6.7.1. Bootstrap epidemic realisations are generated from a simulation
model, described in Section 6.7.1.2, based on the estimated infection process pa¬
rameters and the properties (such as parameters for the latent period) estimated
from the experimental data. In particular, the simulation model requires a rate
of infection at which infectious individuals make an infectious contact. Since it
is necessary to simulate epidemics under the null hypothesis of no trend in the
rate of infection, a constant rate of infection acting upon groups of sheep is esti¬
mated from the experimental data and used in the simulation model as the rate
of infection for infectious individuals.
7.4.1.1 Global rate of infection (Pgiobai)
Given the null hypothesis of an equal rate of infection from all infected sheep,
an equal rate of infection is assumed for all groups and this is referred to as the
global rate of infection, denoted by Pgiobai■ To estimate Pgi0bai, information from
all groups is combined. The assumption that p2 = Pz = Pa corresponds to case
of estimates for the restricted model MLE. Hence
a _ h + ^3 + h a „„(Q \ _ Vh + h + h !n t ^
Pgiobai — rp . rp . rp and S.eyPgiobal) — — I'-tJ
-12 + -*3 + -*4 -*2 + -*3 + -Li
Pglobal is obtained alternately with estimates of the expected infection process
characteristics, using the iterative scheme outlined in Algorithm 7.1, with all
values of Pg replaced by Pgiobai-
7.4.1.2 Bootstrap epidemic samples
200 bootstrap epidemic realisations are generated using the simulation model
described in Section 6.7.1.2, using model parameters estimated from the experi¬
mental data. The generated epidemic realisations are analysed using the methods
described in this chapter, to obtain both unrestricted and restricted model ML
estimates for the Pg.
Considering the unrestricted model ML estimates, weighted linear regression anal¬
yses are performed by regressing the P estimates against group number to generate
an estimate of the slope as a measure of the trend in the estimated Pg. From the
distribution of the 200 estimated slopes, a bootstrap p-value is obtained. The
null hypothesis states that the slope is equal to 0, i.e. there is no trend in the
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P estimates, while the alternative hypothesis is that the slope is less than 0, i.e.
there exists a decreasing trend in the ft estimates. If the estimated slope from the
experimental data is significantly less than 0, it will be expected to fall to the left
end of the distribution of the slopes estimated from the bootstrap samples. The
one-sided significance probability for the unrestricted model MLE is given by:
#{bootstrap slopes < observed (estimated) slope} . .
p-value = r — . (7.21
total number of bootstrap samples
7.4.2 Investigation of decrease in the restricted model ML
/3 estimates
With the restricted model, a non-increasing trend is assured for the estimated
Pg. The objective of the analysis is to investigate whether there is a significant
decrease in the estimated Pg across groups. The size of the decrease in P will be
measured by d23 = In(^2) ~ ln(/53), the estimated decrease between the infection
rate acting upon group 2 sheep and the infection rate acting upon group 3 sheep
and by d34 = ln(/33) — ln(/?4), the estimated decrease between infection rate acting
upon group 3 sheep and the infection rate acting upon group 4 sheep. Estimates
of the size of any decrease are calculated on the log scale, since the Pg were
estimated on a log scale in terms of the ag (Section 4.2.3), in fact ^23 — a2 —
and d34 = 0:3 — 0:4. In many cases these estimated decreases will equal zero, which
would tend to give rise to a poorly fitting regression line. Hence the use of this
alternative approach. The statistic selected to summarise the overall decrease will
be chosen the more significant of the two quantities d23 and d34. The significance
is assessed by comparing the quantities
s^ ^ and The larger value is
the more significant and the decrease in P by group will then be summarised
by ^23 or d34, depending on which quantity corresponds to the more significant
effect. The decrease in P is also estimated by the sum of d23 and d34. The need
to choose between the two measures arises only in Case 1 situations where all the
three Pg (P2, P3, Pa) are estimated. Both measures will be used in assessing the
decrease in P across groups. In Case 1 situations, use of the first measure will
require standard error estimates for d23 and d34. These are calculated, based on
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In Case 2 situations (P2 — P3 > Pa) the decrease in (3 is estimated by ^34 and the
associated standard error is estimated by + 7hTP
In Case 3 situations (p2 > P3 = Pa) the decrease in P is estimated by d23 and the
associated standard error is estimated by R+7R
In Case 4 situations 02 = $3 = Ai) the decrease in P is zero.
7.4.2.1 Testing the significance of a decrease in the restricted model
ML P estimates
To test whether an observed decrease in P is significantly greater than 0, bootstrap
methods are used. 200 bootstrap epidemics are simulated using the simulation
model described in Section 7.4.1.2. The data from each bootstrap epidemic reali¬
sation are analysed based on the established model of the entire infection process
incorporating restricted model MLE for the Pg. For each bootstrap realisation,
the estimate for the decrease in the estimated Pg is determined. The estimated
decreases in P are sorted and compared with the estimate of the decrease from
the experimental data. If the decrease in P from the experimental data is signifi¬
cantly greater than 0, it lies in the tail/outside the distribution of the estimated
bootstrap decreases. The test of significance of decrease is one sided and the
p-value for testing the significance of any decrease in P is given by:
j #{bootstrap decreases > observed (estimated) decrease} ^ ^
total number of bootstrap samples
7.5 Application to experimental data
The inferential methods described in the current chapter are implemented by pro¬
gramming in C (Kernighan and Ritchie, 1988) and S-Plus (Venables and Ripley,
1994). Programs were developed to fully model the infection process and the
methods were applied to the experimental data generated from the two identical
FMD experiments and to simulated data.
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The results presented in the current chapter will initially describe the estimated
infection histories for group 2 to 4 individuals. Comparisons by method of estima¬
tion / choice of model for f3 (martingale - ML / unrestricted - restricted) will be
made for the estimated infection process characteristics and for the j3 estimates.
7.5.1 Estimates of infection history for sheep from groups
2 to 4
Estimates for the expected infection process characteristics and for the f3g are
obtained as described in Sections 7.2.1 and 7.3 respectively. The results from the
final iteration of the analysis process are presented.
7.5.1.1 Estimated infection process characteristics
In Table 7.1, estimates of the expected time to infection, expected length of latent
period and expected length of infectiousness period for both experiments are
presented. Also presented in the same table are the equivalent martingale based
estimates. The results presented are: the sheep identity number, 'Sheep ID',
estimates of the expected time of infection, 'Exp Inf T', estimates of the expected
length of latent period, 'Exp Latent' and estimates of the expected length of
infectiousness period, 'Exp Inf P'. To highlight the differences in the estimates,
results are presented to 3 decimal places. The estimated entire infection history
for both experiments are presented graphically in Figure 7.1 (unrestricted model
for (3) and Figure 7.2 (restricted model for (3).
In experiment 1, from both unrestricted and restricted models, only sheep number
11 has its expected time of infection estimated as occurring during the estimated
infectiousness state of group 1 sheep. This is in spite of the fact that, in total,
groups 1 and 2 are mixed for an estimated 2.4 days during the estimated typical
infectiousness period of group 1 sheep. Hence, it is likely that only 1 group
2 sheep became infected due to group 1 infectious sheep (refer to Table 6.5).
Similarly, in experiment 2, only 1 sheep (number 9), has its expected time of
infection estimated as occurring during the estimated infectiousness period of
group 1 sheep. It appears that the choice of the model for /3g has made little
appreciable difference to the estimated expected infection process characteristics,
even in group 2 of experiment 1 where it might have been expected that a switch
to restricted model MLE would result in changes to the expected pattern of
infection. The differences which are present will be discussed in Section 7.5.1.3.
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Table 7.1: Estimates for the expected, infection process characteristics, for infected
individuals of groups 2 to 4, based on restricted model ML, unrestricted model ML
and martingale estimation for (3. Sheep numbers 9, 15, 25 (experiment 1) and




















































































































































































































































































































































































































7.5.1.2 Estimates of rate of infection
Recall from Section 4.2.2 (Equation (4.3)) that the estimates for the f3g acting
upon groups of sheep from the unrestricted model MLE are given by:
A> = 4, 9=2,3,4.
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For the restricted model MLE, the expressions for the estimates of 0 depend on
the particular case. For the experimental data, the 0 estimates correspond to
Case 2 (02 = 03 > 0a) and the 0g estimates are given by:
02 = 0S = j8 + (L3 and 0A = if,^3 T2 + T3 ^ T4'
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where Ig is the total number of infected individuals in group g and Tg is estimated
by the expected total duration of infection exposure determined from Equation
(4.15).
Tables 7.2 and 7.3 present estimates for the expected total infection exposure time,
estimates for the (3 acting upon groups 2 to 4 and the corresponding standard error
estimates. It should be remembered that these estimates of standard error are
likely to be unreliable. For comparison purposes, the corresponding martingale
estimates are also included.
Table 7.2: Estimates of the expected total scaled group exposure time in days
(time) and the estimated group rate of infection (0) per day for experiment 1.
Restricted ML estimates Unrestricted ML estimates Martingale Estimates
Group Infs Time (3 s.e(P) Time P s.e0) P s.e(p)
2 6 9.88 1.0881 0.2908 9.92 0.6051 0.2470 0.5116 0.2213
3 8 2.98 1.0881 0.2908 2.92 2.7388 0.9683 2.0469 0.9308
4 7 7.74 0.9046 0.3419 7.75 0.9032 0.3414 0.6377 0.2696
Table 7.3: Estimates of the expected total scaled group exposure time in days
(time) and the estimated group rate of infection (f3) per day for experiment 2.
Restricted ML estimates Unrestricted ML estimates Martingale Estimates
Group Infs Time P s.e0) Time P s.e0) P s.e0)
2 5 11.86 0.6220 0.1875 11.86 0.4217 0.1886 0.4087 0.1884
3 6 5.83 0.6220 0.1875 5.82 1.0303 0.4206 0.7256 0.3138
4 4 6.98 0.5728 0.2864 6.99 0.5722 0.2861 0.4655 0.2364
Unrestricted ML estimates
For experiment 1, the results for the unrestricted model ML estimates indicate
a similar trend to that seen in the martingale estimates, i.e. group 2 has the
lowest estimated rate of infection of 0.605 per day with a standard error estimate
of 0.247, followed by group 4 with an estimate of 0.903 per day (s.e = 0.341) and
group 3 has the highest estimate of 2.739 per day (s.e = 0.968). The unrestricted
model ML estimates are, however, higher than the corresponding martingale es¬
timates (Table 7.2). The martingale estimator in Equation (4.17) which uses less
information from the inferred historical infection characteristics, produces lower
estimates of (3g.
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Similarly, the (3g estimates from experiment 2 also depict a trend similar to that
seen in the martingale based estimates, with group 2 having the lowest estimated
rate of infection of 0.422 per day (s.e = 0.189), followed by group 4 with an
estimated rate of infection of 0.572 per day (s.e = 0.286) and group 3 having
the highest estimate of 1.030 per day (s.e = 0.421). The estimates for the /3g,
as in experiment 1, are consistently higher than the corresponding martingale
estimates (Table 7.3).
Restricted ML estimates
For experiment 1, the restricted model MLE results show that group 2 and group
3 have the same estimated rate of infection: /?2 = Pz = 1.088 per day (s.e = 0.291).
Group 4 has an estimated rate of infection [34 — 0.905 per day (s.e = 0.342). The
results indicate a slightly higher rate of infection acting upon groups 2 and 3
sheep than that acting upon group 4 sheep. However, the difference is unlikely
to be statistically significant. The results of experiment 2 depict a similar trend
to that displayed by experiment 1 results. Here, /32 = 03 = 0.622 per day (s.e
= 0.188) and $4 = 0.573 per day (s.e = 0.2864). These result indicate a slightly
higher estimated rate of infection acting upon groups 2 and 3 sheep than that
acting upon group 4 sheep, but again this is unlikely to be statistically significant.
7.5.1.3 Comparisons of estimated times for the three methods
In the two experiments analysed, the effect using restricted model MLE has been
to increase the estimated rate of infection acting upon group 2 sheep from to
t2Xt3 ' ^,e- ky a quantity of ^(r^+C)' ^he es^mate for the rate of infection acting
upon group 3 sheep is, however, reduced from ^ to . Thus the resulting
estimate for /32 from the restricted model is higher than the corresponding /32
estimate from the unrestricted model. The effect of the restricted model is also
reflected in the estimates for the expected infection process characteristics. Al¬
though not very different in either experiment, the estimated times of infection
for group 2 individuals using the restricted model are earlier than those obtained
from the unrestricted model. This is due to the fact that (32 from the unrestricted
model MLE is lower than that from restricted model MLE. Hence individuals in
group 2 are estimated as becoming infected earlier in time using the restricted
model than when using the unrestricted model estimates. For group 3, the re¬
verse is true; /33 is higher from unrestricted model MLE than from restricted
model MLE. The estimates of the expected times of infection for individuals in
this group are earlier using the unrestricted model than when using the restricted
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model. For example, in experiment 1, individual number 10 of group 2 has an
estimated time of infection of 6.517 days using the unrestricted model compared
to 6.513 days using the restricted model, whereas individual number 17 of group
3 has an estimated time of infection of 9.452 days using the unrestricted model
compared to 9.520 days using the restricted model. For group 4, the estimates for
the expected times of infection are the same for both restricted and unrestricted
models except for very minor differences due to the effect of group 3 individuals
that contribute to the estimates of group 4 expected infection exposure time.
It should be noted that the differences discussed here generally arise only at third
decimal place, i.e. in terms of (1001Qt/t of a day). In general, because the martingale
method yields the lowest /3 estimates for all groups, it leads to later estimates
for the expected times of infection. For group 2 individuals, the estimated times
of infection are latest using martingale methods, followed by those using the un¬
restricted model MLE, with those using the restricted model MLE yielding the
earliest times. Considering the expected length of latent period and expected
length of infectiousness period, the martingale method is associated with the
shortest estimates, followed by the unrestricted model, with the restricted model
being associated with the longest lengths of time. For group 3 individuals, the re¬
stricted model MLE gives rise to the lowest estimates in both experiments, and
is associated with the latest estimates for the expected times of infection, followed
by martingale based estimates, while the unrestricted model is associated with
the earliest times. The restricted model gives rise to the shortest estimates for the
expected length of latent and infectiousness periods, followed by the martingale
method, with the unrestricted model generating the largest estimates. Estimates
for the three expected infection process characteristics using the unrestricted and
restricted models are identical for group 4 individuals. The martingale method
gives the lowest /34 estimates and hence is associated with the latest estimates for
the expected times of infection and the shortest estimates for the expected length
of latent and infectiousness periods.
7.5.2 Assessment of trend in estimated rates of infection
7.5.2.1 Unrestricted model MLE
The trend in the j3g estimates from unrestricted model MLE is assessed using
weighted linear regression. The (3„ estimates, with ( l,^)2 as the weights, areo.c(p)
regressed against group numbers. The results are presented in Table 7.4.
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Table 7.4: Weighted linear regression analysis results for experiments 1 and 2.
coefficients:
value std error t-value Pr(> \t\)
Experiment 1 intercept 0.3125 1.2027 0.2599 0.8381
groups 0.1771 0.4210 0.4206 0.7465
Experiment 2 intercept 0.2573 0.5558 0.4629 0.7240
groups 0.1052 0.1990 0.5287 0.6904
The regression analysis yielded an estimated slope of 0.1771 for experiment 1 and
0.1052 for experiment 2. For both experiments, the results indicate an increasing
trend in the f3g estimates across groups as opposed to the anticipated decreasing
trend. If the alternative hypothesis of decreasing infectivity with higher infection
generation were true, a negative estimate for the slope would be expected. There
is a need to formally test if the estimated slopes from the experimental data
are significantly less than those arising under the null hypothesis. The p-values
obtained with the slope estimate are not valid because the /3 estimates are not
independent. Bootstrap methods are used to determine valid p-values.
7.5.2.2 Testing the significance of the estimated slope
Bootstrap epidemic realisations were generated using the simulation model de¬
scribed in Section 6.7.1.2. A global rate of infection, (3gi0bai, is estimated and the
estimate is used as the rate of infection for infected individuals in the simulation
model, together with the estimated parameters Xiat, 0inj and Ainf for the
distributions of latent and infectiousness periods. The parameter for the passage
effect, the passage multiplier, is set to zero, corresponding to a null hypothesis
of no effect of infection generation on infectivity, and hence no trend in the /3g
estimates across groups.
7.5.2.3 Estimate of the global rate of infection (/3gi0bai)
Assuming that the rate of infection in groups of sheep is the same regardless of
group, information from all three groups can be combined to determine an esti¬
mate for (3gi0bai- For both unrestricted and restricted model MLE, the expression
for (3gi0bai is given by Equation (7.1). An initial value for (3gi0bai was calculated
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from the values of Ig and the final iteration expected values of Tg, g = 2, 3, 4,
from the unrestricted model MLE. The values for Tg were 9.92, 2.92 and 7.75
days for groups 2, 3 and 4 respectively in experiment 1 and 11.86, 5.82 and 6.99
days for groups 2, 3 and 4 respectively in experiment 2. Thus, for experiment
1, the initial value of Pgi0bai was 1.0199 per day and for experiment 2, 0.6080
per day. $gi0bai was obtained alternately with estimates of the expected infection
process characteristics, using the iterative scheme outlined in Algorithm 7.1, with
all values of j3g replaced by f3gi0bai-
For experiment 1, the estimate for figi0bai from the final iteration was 1.0195 per
day (s.e = 0.2225), with a corresponding estimated total scaled exposure time of
20.60 days (9.89 days for group 2, 2.98 days for group 3 and 7.73 days for group
4). For experiment 2, the estimate for /3gi0bai from the final iteration was 0.6081
per day (s.e = 0.1570) with an estimated total scaled exposure time of 24.67 days
(11.86 days for group 2, 5.83 days for group 3 and 6.98 days for group 4).
7.5.2.4 Bootstrap results
Using /?giobai as the rate of infection, 200 bootstrap epidemic realisations were
generated from the simulation model for each experiment. The bootstrap samples
were analysed using the full model for the infection process, yielding estimates
for {3 applying to each group.
Weighted linear regression analyses were performed by regressing the (3g estimates
against the group number and estimates for the slope were attained. Descriptive
statistics for the slopes are presented in Table 7.5 and histograms are presented
in Figure 7.3.
Table 7.5: Descriptive statistics for bootstrap slopes, where Qi and Q3 are the
first and third quantiles.





















The estimated slopes from the experimental data, 0.1771 for experiment 1 and
0.1052 for experiment 2, do not fall in the tail of the distribution of the bootstrap
slopes. If these estimated slopes were significantly less than those arising under
the null hypothesis, they would fall in the left end of the distribution of the
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Figure 7.3: Distribution of slopes from the bootstrap epidemic realisations for
experiments 1 and 2. The dotted lines indicate the observed (estimated) values
for the slopes of 0.1771 (experiment 1) and 0.1052 (experiment 2).
Experiment 1 Slopes Experiment 2 Slopes
bootstrap slopes which were estimated from realisations assuming zero trend.
However, for experiment 1, the slope of 0.1771 falls at the 74.5% point in the
right tail of the distribution of bootstrap slopes and for experiment 2, the slope
of 0.1052 falls at the 76.5% point in the right tail of the distribution of bootstrap
slopes. The observed slopes are well within the distribution of the bootstrap
slopes. More formally, the significance of the slopes from the experimental data
is tested based on a p-value obtained from Equation (7.2).
For experiment 1, a total of 148 out of 200 estimated bootstrap slopes were less
than 0.1771, the estimated slope from the experimental data, giving a p-value
200 = 0.74. For experiment 2, a total of 152 out of 200 estimated bootstrap
slopes were less than 0.1052, the estimated slope from the experimental data,
giving a p-value of 0.76. It is therefore concluded that the estimated slopes from
the experimental data are not significantly lower than those arising under the null
hypothesis for both experiments, and hence there is no evidence of any decreasing
trend in the estimated rates of infection across groups.
7.5.2.5 Assessment of trend in restricted ML estimates of /?
For restricted MLE, two measures of decrease in the (3g were proposed, one being
a choice of d23 or f734, whichever was the more statistically significant of the two,
and the other being d23 + d34. For the experimental data from both experiments,
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d23 = 0. Thus the decrease in the estimated rate of infection is measured by d34
with corresponding standard error estimate given by \Jl2l+Ii +
For experiment 1, the decrease in the estimates for the rate of infection across
groups is equal to d34 = ln(/?3) — ln(/34) = 0.1847, with a standard error estimate
of 0.4629. In experiment 2, the decrease in the estimates for the rate of infection
across groups is equal to d34 = 0.0823 (s.e = 0.5839).
7.5.2.6 Testing the significance of a decrease in the /3g
For both experiments the estimated decrease in /3 was greater than zero, i.e.
0.1847 for experiment 1 and 0.0823 for experiment 2. It was necessary to test
whether these estimated decreases in (3 were statistically significant. This was
done using bootstrap methods. Data from the 200 bootstrap epidemic realisations
generated from the simulated model were analysed, with the /3g estimated using
restricted model MLE. Estimates for the f3g and estimates for the decreases in /3
were recorded. Descriptive statistics for the decreases in f3 for both measures are
presented in Table 7.6 and the accompanying histograms are presented in Figure
7.4.
Table 7.6: Descriptive statistics for the estimated decreases in f3 from bootstrap
epidemic realisations.
variable N mean median st dev se mean min max Q i Q 3








































The estimated decreases in f3, 0.1847 for experiment 1 and 0.0823 for experiment
2, fall well within the distribution of the decreases from the bootstrap samples
for both experiments and for both measures of decrease (see Figure 7.4). The
decrease of 0.1847 lies at the 55% point for the first measure and at the 53%
point for the second, and 0.0823 lies at the 43% point for both measures. If the
estimated decreases from the experimental data were significantly greater than
those arising under the null hypothesis, they would fall at the extreme right of
the distribution of the decreases estimated from the bootstrap realisations. The
p-values are calculated using Equation (7.3) to formally test the significance of
the estimated decreases in /?.
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Figure 7.4: Histograms for the estimated decrease in /3 estimates, for both mea¬
sures, from the bootstrap epidemic samples. The dotted lines indicate the observed
(estimated) decreases of 0.1847 (experiment 1) and 0.0823 (experiment 2).
Experiment 1
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Experiment 2
first measure second measure
For experiment 1, the following p-values were obtained: ^ = 0.46, for the first
measure of decrease, and ^ = 0.48 for the second measure. For experiment 2,
the corresponding values are 0.575 for both measures. The p-values from both
experiments indicate that the estimated decrease in (3 is not significantly greater
than those arising under the null hypothesis. Thus, even with a non-increasing
model imposed on the estimates, the resulting estimates for the rate of infection
do not indicate a significant decreasing trend in (3 across groups. Indeed, in both
experiments, the estimate for group 2 and group 3 is estimated to be identical
and the estimate for group 4 is not appreciably smaller than that of groups 2 and
3 (compare 1.0881 versus 0.9046 for experiment 1 and 0.6220 versus 0.5728 for
experiment 2).
7.6 Summary
In this chapter, using a full model of the infection process, the expected time
of infection, the expected length of latent period, and the expected length of
infectiousness period for all infected animals and the rate of infection acting upon
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groups of sheep were all estimated. The rate of infection was estimated for both
an unrestricted model and a restricted model using MLE methods. Using the
unrestricted model MLE, analysis yielded a highest estimated rate of infection
acting upon group 3, followed by group 4, with group 2 sheep estimated as having
experienced the lowest rate of infection. The restricted model MLE yielded equal
estimates for the rate of infection acting upon groups 2 and 3 and this estimate was
higher than the estimate acting upon group 4. A test of significance of decreasing
trend in the estimated rate of infection was not statistically significant. Hence
the MLE based analyses led to the same conclusion, of no significant trend in the
estimated rate of infection across groups, as seen in the martingale based analyses.
Estimates for the expected infection process characteristics were similar for the
restricted and unrestricted models with /3 fitted using ML estimation methods,
with small differences only observed at the 3rd decimal place in the estimates for
groups 2 and 3. These differences arose from the nature of the restricted model
MLE, where estimates for f32 and /?3 were effectively pooled, leading to higher
estimates in group 2 and lower values in group 3 when compared to those arising
from the unrestricted model MLE analysis.
In the results from the analyses for both experiments, the estimates for /3g using
the martingale estimator were lower than those for the maximum likelihood esti¬
mator from the equivalent (unrestricted) model. This could indicate the presence
of a systematic bias in one (or both) of the estimators arising from the depen¬
dence on the estimated infection process characteristics. An investigation of the
sampling distributions of these estimators would shed light on the matter, but
the extensive computing which would be involved places such a project beyond
the scope of this thesis.
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Chapter 8
Illustrative study based on
simulated data
8.1 Introduction
The issues posed in the discussion in Section 6.10, regarding the inferential meth¬
ods developed in Chapters 5, 6 and 7, are addressed in this chapter. Initial
investigations are carried out to find out whether or not the methods are capable
of detecting a genuine trend in the rate of infection, /3. Using the martingale
and restricted model ML estimates of (5gi0bai obtained from experiment 1 data,
two epidemic realisations are generated from the simulation model described in
Chapter 2. A passage multiplier of 0.15 is used to produce a decreasing trend
in the rate of infection. The generated data are analysed using the methods de¬
veloped in Chapters 5, 6 and 7. The martingale approach is used to exemplify
the properties of unrestricted model estimators, and the restricted model ML is
used as being the more powerful maximum likelihood methodology. Parameters
uiat and Xiat for the latent period and uinf and Afor the infectiousness period
distributions, expected values of the infection process characteristics and (3g, the
rates of infection acting up on groups of individuals, are estimated from the data.
Trends in the (3g martingale estimates are summarised using weighted linear re¬
gression analysis (Freund and Wilson, 1998, Section 4.3), while those in the (3g
restricted model ML estimates are summarised using measures of decrease as in
Chapter 7. Bootstrap methods (Efron and Tibshirani, 1993, Section 16.2) are
used to test the statistical significance of the estimated summaries of trend.
Further assessment of the methods is performed based on the assumption that the
methods developed are appropriate for the data and that it may be a small group
size, a small decrease in the f3g and/or a low reproduction ratio (i?0) that is/are
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responsible for the failure to reject the null hypothesis of no trend in the (3g in
the analysis of the experimental data. For this task, epidemic data are simulated
under three scenarios using martingale estimates of /3. One scenario models the
situation where the passage multiplier is increased to ensure a large decrease in
the f3g. Another models the situation where /3 is boosted from (3gi0bai to a higher
value with a value of R0 approximately equal to 10, but with only a small decrease
(passage multiplier = 0.15) imposed on the /?9, while a third scenario describes
the event where the group size is increased from 8 to 20, retaining a moderate
value of f3giobai and a passage multiplier of 0.15. For each of the three scenarios,
the parameter estimates for the latent period and infectiousness distributions
obtained from experiment 1 data are assumed. The full model for the infection
process using the martingale estimation method for the (3g is applied to the data
to calculate estimates of the expected infection process characteristics and of the
/3g. Trends in the are summarised and the statistical significance evaluated.
8.2 Ability of methods to detect trend
Two data sets, one based on the martingale (3giobai estimate and the other based
on the restricted model ML Pgi0bai estimate, are generated using the simulation
model described in Section 2.4.2. The data sets will be referred to as 'martingale
based' and 'MLE based' respectively. The specifications of the simulated data
are summarised below:
1. Four groups each of size 8 with restricted mixing as in the FMD experiments
and as described in Section 2.4.2.
2. The rate of infection for the initial infectives, fio, set to either the martingale
ftglobal estimate of 0.8818 per day (corresponding to R0 — 2.48) or to the
restricted model ML $gi0bai estimate of 1.0195 per day (R0 = 2.86), as
estimated from experiment 1 data.
3. A passage multiplier of 0.15 is used to define a trend in f3 with respect to
generation of infection (higher values for the passage multiplier resulted in
the failure of the epidemic to reach group 4).
4. A gamma distributed latent period with mean 0.98 days and a gamma
distributed infectiousness period with mean 2.81 days are used in the model,
the parameters are derived from the experiment 1 data (Sections 5.2.1 and
6.9.1).
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Each data set will be analysed using the full model of the infection process us¬
ing both martingale and restricted model ML estimation methods to generate
estimates for the f3g. The simulated data will be analysed as if it were partially
observed, making the properties of the simulated data equivalent to those of the
experimental observed data.
8.2.1 The data
The martingale based data are presented in Table 8.1, columns 2 to 4 and the MLE
based data are presented in Table 8.2, columns 2 to 4. Also presented in these
tables are the corresponding estimates of the infection process characteristics
obtained from the full model using the two estimation methods for f3. Only
data from infected individuals is presented. As before, all group 1 individuals
(ID numbers 1 to 8) are assumed to be infected at time t — 0, the start of the
epidemic, and all individuals in the other groups are susceptible at time t = 0.
In the martingale based data, there were 7 infecteds in group 2 (ID numbers 9 to
16), 5 in group 3 (ID numbers 17 to 24) and 2 in group 4 (ID numbers 25 to 32).
The true infection history for the simulated epidemic is presented graphically in
Figure 8.1. The data suggest that if individuals were to be tested for the presence
of an infectious agent, the first positive individuals in group 2 would be detected
on day 3 (ID 9, 13, 16) and the last positive in this group would be detected on
day 10. The respective times are day 6 and 14 for group 3 and day 9 and 14 for
group 4. Overall, the last infectious individual ceased to be infectious at time
14.66 (individual 28) and thus the epidemic lasted for a total of 15 days.
In the MLE based data, there were 7 infecteds in group 2, 5 in group 3 and 1 in
group 4. The infection history for the simulated epidemic is displayed in Figure
8.2. From these data, assuming the testing of an infectious agent was done on a
daily basis, infectious individuals would be detected between day 3 and day 9 for
group 2, day 5 and day 17 for group 3 and day 14 and day 16 for group 4. The
epidemic lasted up to day 17.9 when individual 23 ceased to be infectious.
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Table 8.1: Martingale based data; the information presented for infected indi¬
viduals is: ID, time of infection (InfT), latent period (LatP) and infectiousness
period (InfP). The table also includes the estimates for these variables from the
full model of the infection process using both estimation methods for /3.
True simulated values Martingale method Restricted MLE
ID InfT LatP InfP InfT LatP InfP InfT LatP InfP
1 0 1.06 2.46 0 1.13 2.43 0 1.13 2.43
2 0 0.94 2.00 0 0.85 1.87 0 0.85 1.87
3 0 0.80 2.12 0 0.85 1.87 0 0.85 1.87
4 0 0.86 2.76 0 0.85 2.67 0 0.85 2.67
5 0 0.85 3.46 0 0.85 3.56 0 0.85 3.56
6 0 1.22 1.82 0 1.13 2.43 0 1.13 2.43
7 0 1.09 2.74 0 1.13 2.43 0 1.13 2.43
8 0 0.95 4.11 0 0.85 4.50 0 0.85 4.50
9 1.98 0.91 3.30 1.51 0.96 3.91 1.51 0.96 3.91
11 3.78 0.80 1.91 3.45 0.97 2.20 3.44 0.97 2.21
12 4.97 0.85 2.74 4.56 0.96 2.96 4.55 0.96 2.96
13 1.44 1.12 3.02 1.51 0.96 3.00 1.51 0.96 3.00
14 4.24 0.77 3.37 4.56 0.96 2.96 4.55 0.96 2.96
15 5.85 1.12 3.57 5.53 0.96 3.89 5.52 0.96 3.90
16 1.37 0.77 3.86 1.51 0.96 3.00 1.51 0.96 3.00
17 6.09 0.98 4.56 6.50 0.96 3.92 6.50 0.96 3.92
18 4.61 1.02 2.32 4.54 0.95 2.14 4.54 0.95 2.14
19 4.09 0.99 3.58 4.54 0.95 2.97 4.54 0.95 2.97
20 7.83 1.15 2.67 7.56 0.95 2.96 7.56 0.95 2.96
24 9.60 0.94 3.83 9.54 0.96 3.89 9.53 0.96 3.89
28 11.05 1.11 2.50 11.35 1.00 2.26 11.35 1.00 2.26
31 7.05 1.22 3.53 7.52 0.96 3.00 7.52 0.96 2.99
8.2.2 Parameter estimates for latent and infectiousness
period distributions
Using MLE methods, the scale and shape parameters {uiat and Aiat) of the dis¬
tribution of the length of latent period were estimated from n/, the number of
occasions on which group 1 individuals would test as negative after the start of
the epidemic before they were first observed to be infectious. Given ni, parameter
estimates were obtained by maximizing the likelihood in Equation (6.3). For both
data sets, group 1 individuals had the same generated infection history. Thus the
estimates of the parameters for the latent period distribution were the same for
both data sets. The distribution of rp was such that 5 of the 8 group 1 individuals
would on no occasion test as negative after time 0 hence the frequency of n/ = 0
was 5. The remaining 3 would test as negative once and thus the frequency of
ni = 1 was 3.
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Table 8.2: MLE based data; the information presented for infected individuals is:
ID, time of infection (InfT), latent period (LatP) and infectiousness period (InfP).
The table also includes the estimates for these variables from the full model of the
infection process using both estimation methods for f3.
True simulated values Martingale method Restricted MLE
ID InfT LatP InfP InfT LatP InfP InfT LatP InfP
1 0 1.06 2.46 0 1.13 2.43 0 1.13 2.43
2 0 0.94 2.00 0 0.85 1.86 0 0.85 1.86
3 0 0.80 2.12 0 0.85 1.86 0 0.85 1.86
4 0 0.86 2.76 0 0.85 2.67 0 0.85 2.67
5 0 0.85 3.46 0 0.85 3.55 0 0.85 3.55
6 0 1.22 1.82 0 1.13 2.43 0 1.13 2.43
7 0 1.09 2.74 0 1.13 2.43 0 1.13 2.43
8 0 0.95 4.11 0 0.85 4.49 0 0.85 4.49
9 1.88 0.91 3.30 1.51 0.96 3.90 1.51 0.96 3.91
11 3.53 0.97 2.12 3.45 0.97 2.20 3.44 0.97 2.20
12 5.09 1.12 3.57 5.49 0.97 3.00 5.48 0.97 3.01
13 1.41 1.12 3.02 1.51 0.96 2.99 1.51 0.96 3.00
14 4.78 0.95 4.10 4.59 0.95 3.84 4.58 0.95 3.84
15 3.46 0.94 3.46 3.45 0.97 3.03 3.44 0.97 3.04
16 1.35 0.77 3.86 1.51 0.96 2.99 1.51 0.96 3.00
17 4.65 1.17 2.30 4.59 0.94 2.93 4.59 0.95 2.93
19 6.61 1.18 1.91 6.50 0.96 2.16 6.50 0.96 2.16
20 2.83 1.31 2.86 3.69 0.93 2.86 3.69 0.93 2.86
22 9.35 0.84 4.06 9.24 1.04 4.08 9.24 1.04 4.08
23 14.23 1.04 2.63 14.32 1.01 2.26 14.32 1.01 2.26
31 11.94 1.11 3.35 12.69 0.93 2.86 12.69 0.93 2.86
Considering the distribution of the length of infectiousness period, the scale and
shape parameters and Aj„y) were estimated from ne, the number of times
on which infected individuals would be observed to be infectious. The parameter
estimates were obtained by maximising the likelihood in Equation (5.6). The
distribution of ne for both data sets is presented in Table 8.3.
Table 8.3: Distribution of ne, the number of times on which individuals would
test positive in the simulated data.
7Te 2 3 4 5 Total
Frequency (martingale based data) 8 8 5 1 22
Frequency (MLE based data) 8 8 4 1 21
The parameter estimates for the latent period and the infectiousness period dis¬
tributions are presented in Table 8.4. Also presented in the same table are the
true parameters which were used in the simulation model when generating the
data.
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The estimates for the mean and standard deviation of the latent period distri¬
bution for both data sets were 0.95 days and 0.175 respectively. These estimates
compared well with the true mean of the distribution, 0.98 days, and the true
standard deviation, 0.172. The estimated means for the infectiousness distribu¬
tion from the simulated data (2.96 days for the martingale based data and 2.91
days for the MLE based data) were slightly higher than the original distribution
mean of 2.81 days. In general, the latent and infectiousness period distribution
parameter estimates were in good agreement with the true parameters, estimat¬
ing a mean period of approximately 1 day for the latent period and 3 days for
the infectiousness period.
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Table 8.4: Estimates for the latent and infectiousness period distribution param
eters from martingale based and MLE based simulated data.
True data Martingale based data MLE based data
Latent Infectious Latent Infectious Latent Infectious
Scale parameter 32.2594 12.6362 29.5951 14.6637 29.5951 14.7012
Shape parameter 32.9544 4.4952 31.0183 4.9594 31.0183 5.0573
Distribution mean 0.98 2.81 0.95 2.96 0.95 2.91
Distribution SD 0.172 0.791 0.175 0.772 0.175 0.758
8.2.3 Estimated infection process
Using the methods described in Chapter 6 for the martingale estimates and Chap¬
ter 7 for the restricted model ML estimates, the simulated data were analysed
to yield estimates for the expected infection process characteristics and of the
/3g. The estimates of the expected infection process characteristics based on the
two jd estimation methods are presented in Table 8.1, columns 5 to 10 for the
martingale based data and Table 8.2, columns 5 to 10 for the MLE based data.
The true and estimated infection histories based on the martingale /? estimation
method are displayed in Figures 8.3 and 8.4 to allow comparison of the true and
estimated values. The summarised averages for the expected lengths of latent
and infectiousness period by group are presented in Table 8.5.
Table 8.5: Mean true and estimated expected length of latent and infectiousness
period.
Martingale based data MLE based data
Martingale Restricted ML
True means estimated means True means estimated means
Group Latent Inf Period Latent Inf Period Latent Inf Period Latent Inf Period
1 0.97 2.68 0.95 2.72 0.97 2.68 0.95 2.72
2 0.90 3.11 0.96 3.13 0.97 3.35 0.97 3.14
3 1.02 3.39 0.96 3.18 1.11 2.75 0.98 2.86
4 1.17 3.02 0.98 2.64 1.11 3.35 0.93 2.86
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Figure 8.3: Comparison of true and estimated infection histories for the martin¬
gale based data, for groups 1 and 2.
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Figure 8.4: Comparison of true and estimated infection histories for the martin¬




17T 17E 18T 18E 19T 19E 20T 20E 24T 24E 28T 28E 31T 31E
ID Number
E = Estimated, T = True value
The estimates for the expected infection process characteristics, using both (3
estimation methods, were comparable to the true simulated data with minor dif¬
ferences. For the martingale based data, the expected length of latent period for
group 1 individuals, using the martingale estimation method for /3, were slightly
underestimated for individuals with n( = 0 and slightly overestimated for indi¬
viduals with ni = 1. Estimates of the expected length of infectiousness period in
group 1 were such that individuals with true infectiousness period greater than
3 days had the expected length of infectiousness period slightly overestimated,
while individuals with true infectiousness period between 2 and 3 days had the
value underestimated. However, the average estimated length of infectiousness
period for group 1 individuals of 2.72 days was very similar to the true average
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of 2.68 days (Table 8.5). Examining the plots in Figures 8.3 and 8.4 comparing
the estimated to the true infection process characteristics, the length of latent
periods were in fairly good agreement while there were only minor differences
in the length of infectiousness periods. The average estimated length of latent
and infectiousness periods for group 1 individuals were in very close agreement
with the average of the true values from both the martingale based data analysed
based on martingale (3 estimation method (Table 8.5, columns 4 and 5) and the
MLE based data analysed based on restricted model ML (3 estimation method
(Table 8.5, columns 8 and 9).
For group 2 individuals, estimates of the expected length of latent period from
the martingale based simulated data analysis using the martingale estimator for
/3 were slightly higher than the true values except for those from individuals with
true length of latent period greater than 1 day (see Table 8.1, column 3 and Figure
8.3). This was reflected in the average length of latent periods. For group 3 and
4 individuals, however, the results indicated slightly lower estimates than the
true simulated values. For the infectiousness period, the average of the estimated
lengths were similar to the true averages except for group 4 individuals where
the average of the estimated lengths was lower than the true average (Table 8.5,
column 5).
For the MLE based data, using the restricted model MLE for /3, the estimates for
the expected length of latent period for group 2 individuals were slightly higher
than the true values except for those from individuals with length of latent period
greater than 1 day. The mean of the estimated length of latent period was,
however, equal to the mean of the true values. For group 3 and 4 individuals, the
mean of the estimated lengths of latent periods was lower than the true mean.
Considering the infectiousness period, the mean of the estimated periods for group
2 and 4 individuals were lower than the true mean, however, the reverse was true
for group 3 individuals.
In general, the means of the estimates of the lengths of latent period were less
variable across groups than the true means. The mean estimates of the length
of infectiousness periods did not appear to be more or less variable than the
true averages on a group-by-group basis, but it is true that the estimates and
true means could, on occasion be quite different. More frequent sampling of
individuals should reduce the size of these discrepancies (Table 8.5).
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8.2.4 Estimates of the rate of infection, [3
8.2.4.1 Estimates for the martingale based data
Martingale and restricted model ML estimates for the (3g obtained from analysing
the martingale based data are presented in Table 8.6. Also presented in these ta¬
bles are (3g estimates obtained from the true simulated data. For both estimation
methods, the results indicate a consistent drop in the rate of infection across
groups.
Table 8.6: Estimates for expected duration of exposure time (Expo time) and
rate of infection ((5) using both the martingale estimation method for (3 and the
restricted model MLE method for /3, for the martingale based data.
Martingale method
True simulated data Estimated history
Group Infs B Integral Expo time P s.e(P) Expo time P s.e(P)
2 7 1.7179 2.56 0.6709 0.2836 2.62 0.6558 0.2772
3 5 0.8845 1.86 0.4754 0.2192 1.83 0.4823 0.2224
4 2 0.2679 1.17 0.2291 0.1623 1.00 0.2668 0.1891
Restricted MLE
True simulated data Estimated history
Group Infs Expo time P s.e{P) Expo time P s-e(P)
2 7 8.05 0.8696 0.3287 7.80 0.8974 0.3392
3 5 8.33 0.6001 0.2684 8.52 0.5872 0.2626
4 2 7.78 0.2571 0.1898 6.82 0.2932 0.2073
The analysis using the martingale estimation method for the f3g yielded a con¬
sistent decreasing trend for both the ftg and the estimated scaled total infection
exposure time by increasing group number. The j3g estimates obtained from the
estimated infection history compare well with estimates obtained from the true
infection history. The /?2 estimate from the true infection history was slightly
higher than the estimate from the estimated infection history. The /?3 and /34
estimates obtained from the estimated infection history were higher than those
obtained from the true data. Note that the /32 estimate in both cases (0.6558
from the estimated history and 0.6709 from true history) was lower than 0.8818,
the basic rate of infection which was used to generate the data. This was to be
expected where there is reduction of infection potential by increasing generation
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of infection, as assumed in the model. It is notable that the martingale estimator
for the /3g in Equation (4.17) which uses partial information consistently gave rise
to an estimate of /32 which is less than 0.8818 using both the estimated and true
infection histories. However, the ML $2 estimates were more consistent with the
true parameter value.
The restricted model ML /3g estimates obtained from the martingale based data
decreased by increasing group number. These estimates were constrained to de¬
crease or stay the same across groups, i.e. a non-increasing trend was imposed
on them. The estimates from the estimated infection process were in good agree¬
ment with those obtained from the true infection history. The restricted model
ML estimator (which uses complete information) gave rise to a /32 estimate close
to ftgiobai using the estimated history (compare 0.8974 and 0.8818).
The trend in the martingale /59 estimates was summarised via a slope estimated by
weighted linear regression where the estimates were regressed against group num¬
bers with a weight (s e(/3))2, The analysis yielded an estimated slope of —0.1973
(s.e = 0.0124). For the restricted model MLE f3g estimates, where a non-increasing
trend was imposed, a decrease in the (5g was estimated. As described in Chapter
7, the decrease in the f3g was summarised based on two measures: measure 1 be¬
ing equal to the more significant quantity of d23 (the estimated decrease between
/32 and /33) and d34 (the estimated decrease between /53 and /34) and measure 2
being the sum d23 + d34 (refer to Section 7.4.2). From the martingale based data,
the analysis yielded an estimated decrease of 0.6894 for measure 1 and 1.1187 for
measure 2. The statistical significance of the estimated slope and of the estimated
decreases was tested using bootstrap methods as described in Chapters 6 and 7.
8.2.4.2 Assessing the significance of the trend in the f3g estimates
To generate bootstrap epidemics to be used in testing the statistical significance
of the estimated slope and of the estimated decreases, a martingale estimate and
a restricted model ML estimate of /3giobai were obtained from the simulated data
using methods from Sections 6.7.1.1 and 7.4.1.1 respectively. The martingale
estimate for $gi0bai was 0.5261, corresponding to a scaled total expected exposure
time of 5.46 days and a sum of the B integral equal to 2.8702. The restricted
model ML estimate for f3gL0bai was 0.6050. Using the estimates of /3giobai and the
estimates for the parameters of the latent and infectiousness period distributions
for the martingale based data (Table 8.4), for each of the /3 estimation methods,
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200 bootstrap epidemic realisations were simulated under the null hypothesis of
no trend in the f3g. The bootstrap samples were analysed to yield martingale
and restricted model ML (3g estimates for groups 2 to 4. For each data set, for
martingale /3 estimation, a slope was estimated by weighted linear regression and
for restricted model ML f3 estimation, the decrease in the f3g was estimated based
on the standard measures. Descriptive statistics for the estimated slopes and
decreases are presented in Table 8.7 and the histograms of the slopes and of the
decreases are presented in Figure 8.5.
Table 8.7: Descriptive statistics for the estimated slopes from the bootstrap epi¬
demic realisations, where Q\ is the first quartile and Qy, is the third quartile.































Figure 8.5: Histograms for estimated slopes and decreases from the bootstrap
epidemic samples, the dotted lines indicate the estimated slope of —0.1973 and
estimated decrease 2 of 1.1187 from the martingale based data.
The estimated slopes from the bootstrap samples are fairly symmetrically dis¬
tributed about 0, with most slopes lying between —0.72 and 0.86, with a mean of
—0.0463 and a standard deviation of 0.1762. If significantly less than that arising
under the null hypothesis, the estimated slope of —0.1973 from the martingale
based data would be expected to fall at the extreme left end of the distribution
of the bootstrap estimated slopes. The estimated slope, however, falls at the
12% point in the left tail of the distribution of the bootstrap slopes. A formal
test of significance is done through a p— value. 24 of the 200 bootstrap slopes
were less than —0.1973, yielding a p—value of 0.12. For the restricted model ML
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based estimates, the estimated decrease in the (3g for both measures of decrease
were not statistically greater than those arising under the null hypothesis with
p-values of 0.165 (33 decreases greater than 0.6894) for measure 1 and 0.065 (13
decreases greater than 1.1187) for measure 2. Thus, for the martingale based
data, it was concluded that the estimated slope was not statistically significantly
less than those arising under the null hypothesis and the estimated decreases were
not statistically greater than those arising under the null hypothesis at the 5%
significance level. Even though a decreasing trend was imposed on the rates of in¬
fection across groups, it was not possible to reject the null hypothesis of no trend
in the f3g based on either the martingale or the restricted model ML estimation
methods for the rate of infection.
8.2.4.3 Estimates for the MLE based data
Martingale and restricted model ML estimates for the /3g obtained from analysing
the MLE based data are presented in Table 8.8. Also presented in these tables
are f3g estimates obtained from the true simulated data. For both estimation
methods, the results indicate a consistent drop in the rate of infection across
groups.
Table 8.8: Estimates for expected duration of exposure time (Expo time) and
rate of infection (f3) using both the martingale estimation method for /3 and the
restricted model MLE method for [3, for the MLE based data.
Martingale method
True simulated data Estimated history
Group Infs B Integral Expo time /3 s.e0) Expo time P s.e(P)
2 7 1.7179 2.64 0.6519 0.2756 2.56 0.6704 0.2834
3 5 0.8845 1.68 0.5265 0.2427 1.68 0.5252 0.2421
4 1 0.1250 0.72 0.1744 0.1709 0.73 0.1709 0.1709
Restricted MLE
True simulated data Estimated history
Group Infs Expo time $ s.e0) Expo time P s.e0)
2 7 7.63 0.9175 0.3468 7.52 0.9303 0.3517
3 5 8.66 0.5776 0.2583 8.71 0.5741 0.2567
4 1 5.27 0.1898 0.1898 5.44 0.1838 0.1838
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The analysis using the martingale estimation method for the (3g yielded a con¬
sistent decreasing trend in both the f3g and the estimated scaled total infection
exposure time by increasing group number. Also, the j3g estimates obtained from
the estimated infection history compare well with estimates obtained from the
true infection history. However, the resulting estimates probably underestimate
the true rates of infection in all groups.
The restricted model ML estimates for the @g in groups 2 to 4 were calculated
to ensure more power in detecting a genuine trend in the rate of infection across
groups. Results from the analysis (Table 8.8) indicate a decreasing trend in the
Pgiobai by increasing group number. The estimates obtained from the estimated in¬
fection history compared well with those obtained from the true infection history.
The fa estimate obtained from the estimated infection history is slightly higher
than the estimate from the true infection history, though smaller than the basic
infection rate used to simulate the data (0.9393 versus 1.0195). The discrepancy
can be explained by the presence of generation 3 infections in group 2.
The trend in the martingale (3g estimates was summarised via a slope estimated
using weighted linear regression. The analysis yielded an estimated slope of
—0.2653. For the restricted model MLE using decrease measure 1, the analy¬
sis yielded an estimated decrease of d34 = 1.1383, which was the more significant
estimated decrease. The second measure of d23 + d34 yielded an estimated de¬
crease of 1.6216. The estimated slope and the estimated decreases indicate that
there was a decreasing trend in the j3g, however, it was still necessary to formally
test whether or not the estimated trend summaries were statistically significantly
different to those arising under the null hypothesis.
8.2.4.4 Assessing the significance of the trend in the fig estimates
To test whether the estimated slope and the estimated decreases were statisti¬
cally significantly different to those arising under the null hypothesis, bootstrap
methods were used. A martingale estimate and a restricted model ML estimate of
Pglobal were obtained from the simulated data using methods from Sections 6.7.1.1
and 7.4.1.1 respectively. The martingale estimate for (3gi0bai equal to 0.5481 per
day and the restricted model ML estimate for $gi0bai was 0.5996 per day. Using
the estimates of Pgi0bai and the estimates for the parameters of the latent and
infectiousness period distributions for the MLE based data (Table 8.4), for each
of the 0 estimation methods, 200 epidemic realisations were simulated under the
null hypothesis of no trend in the j3g. The data sets were analysed to yield esti-
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mates for the $g for both estimation methods. Slopes from the weighted linear
regression were obtained from the martingale jd estimates and decreases were esti¬
mated from the restricted model ML f3g estimates. Descriptive summary statistics
for the estimated slopes and estimates of the decreases using both measures are
presented in Table 8.9 and the histograms for the slopes and measure 2 decreases
are presented in Figure 8.6.
Table 8.9: Descriptive statistics for the estimated decreases in [3 from the boot¬
strap epidemic realisations, where Qi is the first quartile and Qj, is the third
quartile.































Figure 8.6: Histograms for estimated slopes and measure 2 decreases from
the bootstrap epidemic samples, the dotted lines indicate the estimated slope of
—0.2652 and estimated decrease measure 2 of 1.6216 from the MLE based data.
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The estimated slope of -0.2653 from the martingale /3g estimates falls at the 6%
point in the left tail of the distribution of the bootstrap slopes with 12 of the
bootstrap estimated slopes being less than -0.2653. Thus the bootstrap analysis
yielded a p-value of 0.06. Thus at a 5% significance level, the results imply that
there is no significant trend in the martingale (3g estimates across groups. For the
restricted model ML jdg, the estimated decrease of 1.1383 arising from measure 1
lies at the 97% point of the distribution of the bootstrap decreases with only 6
of the 200 decreases being greater than 1.1383, which yields a p—value of 0.03.
For measure 2, the estimated decrease of 1.6216 lies at the 98% point of the
distribution of the bootstrap decreases, with a p—value of 0.02. The estimated
decreases based on both measures lie at the extreme right end of the distribution
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of bootstrap decreases. Both measures of decrease are significantly greater than
those arising under the null hypothesis, at significance level greater than 3%.
Using the restricted model MLE, which is proposed as increasing the power of
the test, the methods are able to detect a decrease in the rate of infection when it
does indeed exist. Using the martingale methods, however, it was not possible to
detect a known existing decrease in the rate of infection at a level of significance
less than 5% (although the significance level was very close to 5%, and a greater
number if bootstrap realisations might allow a more precise estimate of the p-
value). The restricted model MLE yielded p—values of 0.02 and 0.03 compared
to the martingale methods (unrestricted) which yielded a p—value of 0.06. Thus
it is evident that the restricted model MLE may have more potential to detect a
genuine decreasing trend in the rate of infection than the martingale estimation
method for /3.
Since the martingale estimation methods for f3 were unable to formally identify a
significant decreasing trend when it indeed existed, for both the martingale based
data 0g^bai = 0.8818) and the MLE based data 0giobai — 1-0195), it appeared
worthwhile to investigate the effect of other factors which might influence the
power if the test (discussed in Section 6.10). These were, that possibly the de¬
crease was too small to be detected given the group size of 8 or that the group
size of 8 was not large enough to enable detection of a significant trend given the
specified value of R0 (which is less than 3). These issues are addressed in the
next section.
8.3 Ability of martingale based methods to de¬
tect changes in f3g: effect of passage, R0 and
group size
After attaining a non-significant test result for a genuine trend based on martin¬
gale estimates, further investigations regarding the appropriateness of the pro¬
posed methods are required. In this section, investigations are carried out to test
whether or not the developed methods using martingale method of estimation for
/3, are appropriate for the nature of the data. One would want to know whether
it is the smallness of the decrease in the f5g or low value of Rq or the group size or
a combination of these factors, that is responsible for a genuine trend not being
detected as significant. Thus, investigations are carried out for three scenarios,
namely:
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1. To explore whether a significant trend was not attained because the genuine
effect was too small, the passage multiplier is increased from 0.15 to 1.5 to
ensure a large decrease in the rate of infection by infection generation. For
this purpose, data are generated based on four groups of size 8 (group 1:
ID numbers 1 to 8; group 2: ID numbers 9 to 16; group 3: ID numbers
17 to 24 and group 4: ID numbers 25 to 32), with a rate of infection for
infected individuals of 0.8818 and passage multiplier of 1.5. These data will
be referred to as data set A.
2. To test whether a significant trend was not attained due to a low R0 in the
initial group of infectives, and that a decrease in j3 corresponding to passage
multiplier of 0.15 could have been detectable if R0 in the initial group of
infectives was big enough, R0 is boosted from 2.48 to approximately 10,
corresponding to a rate of infection of 3.57. Data are generated based on
four groups of size 8, with a rate of infection for infected individuals of 3.57
and passage multiplier of 0.15. These data will be referred to as data set
B.
3. To test whether it was because of small group size that a significant trend
was not attained, the group size is increased from 8 to 20. Data are then
generated based on four groups of size of 20 (group 1: ID numbers 1 to 20;
group 2: ID numbers 21 to 40; group 3: ID numbers 41 to 60 and group
4: ID numbers 61 to 80), with a rate of infection for infected individuals
of 0.8818 and passage multiplier of 0.15. These data will be referred to as
data set C.
For all scenarios, a gamma distributed latent period with mean 0.98 days (scale
parameter equal to 32.26 and shape parameter equal to 32.95) and a gamma
distributed infectiousness period with mean 2.81 days (scale parameter equal to
12.64 and shape parameter equal to 4.50) were assumed in the simulation model
which was used to generated the data. Also, all group 1 individuals are assumed
to be infected at the start of the epidemic, t = 0.
8.3.1 The simulated data
Data sets A and B (for infected individuals only) are presented in Table 8.10 and
data set C is presented in Table 8.11. For data set A, the epidemic lasted up to
day 7 and there were 3 (out of 8) infecteds in group 2 and no infected individuals
in groups 3 and 4. For data set B, the epidemic lasted up to day 11 and had all
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24 initially susceptible individuals in groups 2 to 4 infected. For data set C, the
epidemic lasted up to day 20 and had 19 (out of 20) infecteds in group 2, 14 in
group 3 and 6 in group 4.
The three data sets were analysed using methods developed in Chapters 5 and 6
where the fig were estimated using martingale methods. Parameters for latent and
infectiousness period distributions, the expected values of the infection process
characteristics and the /3g were estimated from the data. The trends in the j3g were
estimated and bootstrap methods were used to test whether or not the estimated
trends were statistically significant.
Table 8.10: Simulated epidemic data about infected individuals from data set A
and data set B, presented is data about identity number (ID), time of infection
(Inf time), latent period (Latent) and infectiousness period (Inf period).
Data A Data B
ID Inf time Latent Inf period ID Inf time Latent Inf period
1 0.00 1.07 2.46 1 0.00 0.77 3.34
2 0.00 0.94 2.00 2 0.00 1.41 1.57
3 0.00 0.80 2.12 3 0.00 1.00 4.11
4 0.00 0.86 2.76 4 0.00 0.84 3.21
5 0.00 0.85 3.46 5 0.00 0.94 3.23
6 0.00 1.22 1.82 6 0.00 1.11 3.17
7 0.00 1.09 2.74 7 0.00 1.03 2.80
8 0.00 0.95 4.11 8 0.00 0.88 3.83
9 1.98 0.91 3.29 9 1.10 0.96 1.75
13 1.44 1.12 3.02 10 1.58 0.93 4.05
16 1.37 0.77 3.86 11 3.60 0.95 3.42
12 1.35 1.03 4.18
13 1.08 1.10 3.29
14 1.13 1.44 4.17
15 1.14 0.96 3.50
16 3.01 1.23 2.76
17 3.98 1.10 2.37
18 3.39 0.79 2.35
19 2.14 1.20 1.97
20 2.53 1.22 1.67
21 2.99 0.80 1.88
22 3.75 0.74 4.18
23 2.70 0.89 2.98
24 2.90 0.84 3.43
25 3.87 0.89 1.24
26 3.80 1.06 3.14
27 4.00 0.98 2.66
28 4.76 1.15 2.58
29 6.11 0.95 3.02
30 5.33 1.11 3.72
31 5.22 0.83 2.94
32 5.41 0.76 2.64
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Table 8.11: Simulated epidemic data about infected individuals from data set
C, presented is data about identity number (ID), time of infection (InfT), latent
period (Latent) and infectiousness period (InfP).
Group 1 Group 2 Group 3 and 4
ID InfT Latent InfP ID InfT Latent InfP ID InfT Latent InfP
1 0 0.78 1.83 21 1.22 1.28 2.88 41 4.29 0.92 1.78
2 0 1.07 2.29 22 3.34 1.18 2.38 42 4.87 1.07 1.98
3 0 0.79 2.05 23 1.15 1.18 3.37 43 2.87 0.95 3.18
4 0 0.90 1.36 24 3.36 0.73 3.02 45 8.61 0.74 4.31
5 0 0.87 4.18 25 2.63 1.27 3.40 46 4.59 0.88 1.42
6 0 0.96 4.10 26 1.55 0.76 2.88 47 8.15 0.87 3.57
7 0 1.13 2.13 27 3.60 0.98 3.58 50 13.79 1.14 1.87
8 0 1.02 1.91 28 6.95 1.09 1.91 51 16.61 0.83 1.95
9 0 1.17 2.59 29 1.52 1.08 1.89 52 10.26 1.29 1.20
10 0 1.03 3.01 31 1.70 0.97 1.78 53 10.73 0.94 1.89
11 0 1.32 3.31 32 3.76 1.03 1.96 55 6.66 0.74 3.23
12 0 0.96 3.62 33 1.81 0.92 2.56 57 15.62 0.88 3.47
13 0 1.12 2.35 34 5.03 1.04 1.77 58 7.95 1.06 1.54
14 0 0.99 3.25 35 4.84 1.23 3.04 60 6.21 1.13 2.97
15 0 0.75 3.07 36 1.35 1.06 2.18 63 11.39 0.93 2.37
16 0 0.78 2.12 37 1.91 0.90 2.81 67 13.53 0.65 1.92
17 0 0.93 2.51 38 1.36 0.80 2.33 68 8.70 1.18 2.38
18 0 0.80 3.28 39 1.17 0.89 3.27 69 5.53 0.92 2.60
19 0 1.15 2.56 40 4.03 1.03 3.46 74 10.25 0.99 3.00
20 0 1.17 2.18 76 11.11 1.23 2.16
8.3.2 Parameter estimates for latent and infectiousness
distributions
Using MLE methods, the scale and shape parameters (uiat and Xiat) of the distri¬
bution of the length of latent period were estimated from the n/, the number of
times that group 1 individuals would test negative after the start of the epidemic
before they are first observed to be infectious. For the distribution of the length
of infectiousness period, the scale and shape parameters (^n/ and \nf) were esti¬
mated from ne, the number of times that infected individuals would be observed
to be infectious. The data for n; and ne are presented in Table 8.12. For all three
data sets, nt was either 0 or 1, implying that the length of the latent period was
between 0 and 2 days. From the distribution of ne (Table 8.12), it was observed
that for data set A, infected individuals would be observed to be infectious at
least twice and at most 5 times. For data set B, infected individuals would be
observed to be infectious at least once and at most 4 times and for data set C,
individuals would be observed to be infectious between 1 and 5 times.
203
Table 8.12: Distribution of ni, the number of times that group 1 individuals
would test negative after the start of the epidemic before they are first observed
to be infectious, and of nc, the number of times that infected individuals would be
observed to be infectious, for data sets A, B and C.
Data
ni
0 1 1 2
ne
3 4 5 Total
A 5 3 0 5 3 2 1 11
Frequency B 4 4 3 8 9 12 0 32
C 11 9 7 23 20 7 2 59
Given the data for ni and ne, the log-likelihood functions for the latent and
infectiousness periods in Equations (6.3) and (5.6) respectively, were maximized
to yield estimates for the latent and infectiousness period distribution parameters.
The resulting estimates are presented in Table 8.13. From data set A, a mean
of 0.95 days and standard deviation of 0.175 was obtained for the distribution of
the length of latent period and a mean of 2.91 days for the distribution of the
length of infectiousness period. For data set B, a mean of 1.01 days was obtained
for the distribution of the length of latent period and a mean of 2.94 days for the
distribution of the length of infectiousness period. For data set B, a mean of 0.99
days was obtained for the distribution of the length of latent period and a mean
of 2.56 days for the distribution of the length of infectiousness period.
Table 8.13: Estimates for latent and infectiousness period (Inf period) distribu-










scale 32.26 12.64 29.60 10.53 67.24 9.47 59.80 8.60
shape 32.95 4.50 31.02 3.62 66.90 3.22 60.44 3.36
mean 0.98 2.81 0.95 2.91 1.01 2.94 0.99 2.56
SD 0.172 0.791 0.175 0.897 0.123 0.955 0.128 0.873
For each of the three data sets, estimates for the mean of the distribution of the
length of latent period were in good agreement with the model mean of 0.98 days.
The estimated means for the distribution of the length of infectiousness period
from data set A and data set B were slightly higher than the model distribution
mean of 2.81 days. For data set C, the estimated mean of the distribution was
lower than the assumed mean and this is mainly because 30 out of the 59 infected
individuals in this data set, would have been observed to be infectious on less
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than three occasions, forcing the overall estimated mean to drop.
8.3.3 Estimates of the infection history and (3
The simulated epidemic data sets A, B and C presented in Tables 8.10 and
8.11 were analysed using the proposed methods of full modelling of the infection
process based on martingale estimation methods for fa Estimates for the expected
infection process characteristics were calculated alternately with the estimates of
the /3g using Algorithm 6.1. The resulting estimates for the /3g from the last
iteration are presented in Table 8.14. Also presented in the same table are the fa
estimates based on the true simulated infection history.
Table 8.14: Estimates for expected duration of exposure time (Time) and the
rate of infection (/3) for data set A, B and C.
True simulated data Estimated history
Data Group Infecteds B Integral Time P s.e0) Time P s-e(P)
A 2 3 0.43 1.37 0.32 0.185 1.37 0.32 0.184
3 0 0.00 0.29 0.00 0.000 0.31 0.00 0.000
4 0 0.00 0.00 0.00 0.000 0.00 0.00 0.000
B 2 8 2.72 1.21 2.25 1.021 0.94 2.90 1.314
3 8 2.72 0.37 7.41 3.370 0.47 5.74 2.609
4 8 2.72 0.80 3.41 1.551 0.97 2.81 1.277
C 2 19 2.60 2.44 1.06 0.316 2.43 1.07 0.318
3 14 1.15 1.70 0.68 0.191 1.64 0.70 0.197
4 6 0.35 0.98 0.35 0.145 0.95 0.36 0.149
For data set A, the infection did not go beyond group 2, thus the martingale
estimate for fa and fa was 0. For group 2, fa was estimated to be 0.32 (s.e —
0.184) in good agreement with the estimate based on true infection history but
well below the model rate of infection of 0.8818. This appeared to be anomalous,
since it could be assumed that many of the infections occurring in group 2 were
generation 1 infections. The martingale estimator underestimates the rate of
infection. The slope in the /3s across groups was estimated to be equal to —0.1583
(s.e = 0.0914) from regressing the /3 estimates against the group numbers but with
weights of 1 in all groups (since weights defined in terms of s.e(/3) could not be
assigned for groups 3 and 4). If however, the slope had been estimated based
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on comparing the estimated rate of infection in group 2 with that in group 3
only (since ft estimates in groups 3 and 4 are 0), then the slope would have been
estimated to be equal to —0.3165.
For data set B, all individuals in all groups became infected. The results were such
that 04 < fi2 < fiz- However, from the true simulated infection history, results
indicated that fi2 < fiz < fi\- It was observed that fig estimates from the estimated
infection history were different from those obtained from the true infection history.
One explanation is that many individuals became infected during the same day
and under the estimated infection history, if these individuals had the same value
of ne then their estimated time of infection, estimated length of latent and of
infectiousness periods would be the same. Hence the estimated durations of group
infection exposure were bound to be different to the true durations. In general,
the more vigorous the infection process, the more frequent sampling requires to
be, so as to generate enough detail in the data to model fine distinctions in
the infection process. In this case, the sampling regime was probably deficient.
Again, since all individuals in all groups became infected, a cutoff time based
on the time of the last susceptible to become infected had to be determined for
the appropriate martingale estimate. In group 2, for example, the true time
of infection for the last susceptible was 3.60 whereas the estimated expected
time of infection for this individual was 3.31. This imposed a further effect on
the resulting estimates compared to estimates based on true data. However, in
analyses based on both the true and estimated infection processes, group 3 was
estimated to have experienced the highest rate of infection. The weighted linear
regression analysis was performed to summarise the trend in the fig estimates and
an estimate for the slope of —0.0143 (s.e = 0.4042) was obtained. The estimate
for group 3 was given a very low weight.
For data set C, the results indicated a decreasing trend in the fig estimates across
groups. These estimates were comparable with those obtained from the true
infection history. An estimated slope of —0.5242 (s.e = 0.0742) was obtained for
the trend in the fig estimates.
The significance of the estimated slopes was tested using bootstrap methods as
described previously. An martingale estimate for figi0bai was obtained from each
data set A, B and C. The aim was to generate bootstrap epidemics from each
of the three simulated epidemics based on the figi0bai estimate and the parameter
estimates for the distributions of the length of latent and infectiousness period for
these epidemics. The figi0bai estimate was calculated as in Section 6.7.1.1 based
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on Equation (6.37). For data set A, the resulting estimate for f3gi0bai was 0.26
corresponding to overall scaled total expected infection exposure time of 1.68
days. For data set B, the estimate for (3gi0bai was 3.39 and an overall scaled total
expected infection exposure time of 2.41 days. For data set C, the estimate for
ftglobal was 0.82 and an overall scaled total expected infection exposure time of
5.02 days.
8.3.3.1 Assessing the significance of the trend in the j3g estimates
From each of the simulated epidemics A, B and C, based on the infection process
characteristics (latency and infectiousness) for the simulated epidemic and a con¬
stant rate of infection equal to the estimated Pgi0baU 200 bootstrap epidemics were
generated under the null hypothesis that there is no trend in the f3g estimates.
For each of the 200 bootstrap data from epidemics A, B and C, estimates for the
fig were obtained. Weighted linear regression analyses were performed yielding
estimates of slopes for each epidemic sample. In Table 8.15 descriptive summary
statistics for the slopes are presented and in Figure 8.7 the histograms for the
estimated bootstrap slopes are presented.
Table 8.15: Descriptive statistics for estimated bootstrap slopes from data sets
A, B and C, where Q\ and Q3 are the first and third quartiles respectively.
Slopes
for data N mean median st dev se mean min max Qi Qi
A 200 0.007 -0.005 0.101 0.007 -0.268 0.281 -0.068 0.082
D 200 0.288 0.281 0.419 0.030 -1.005 1.287 -0.041 0.593
C 200 -0.023 -0.006 0.226 0.016 -0.881 0.548 -0.149 0.127
For data set A, the bootstrap slopes fell between —0.268 and 0.281 and were
fairly symmetrical about the mean of 0.007. For data B, the bootstrap slopes
were between —1.005 and 1.287 and were fairly symmetrically distributed about
the mean of 0.288. For data set C, the bootstrap slopes were between —0.881
and 0.548 and were fairly symmetrically distributed about the mean (—0.023).
It was curious that the mean slope simulated for data set B had a positive value
significantly different to zero.
For data set A, 7 out of the 200 bootstrap estimated slopes were less than —0.1583,
the estimated slope from data set A, yielding a p—value of 0.035. Thus the
estimated slope from these data was statistically significantly less than 0 at the
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Figure 8.7: Histogram for estimated bootstrap slopes from data sets A, B and
C, the dotted lines indicate the estimated slopes from the original data set A of
—0.1583, data set B estimated slope of —0.0143 and data set C estimated slope
of -0.5254.
-1.2 -0.9 -0.6 -0.3 0.0 0.3 0.6 0.9 1.2
Data A slopes Data B slopes
5% significance level. It can therefore be concluded that a genuine decrease in the
rate of infection can be detected under the estimated Ro of 2.48 from experiment
1 and group size of 8 if the decrease was reasonably large.
For data set B, 56 out of the 200 estimated bootstrap slopes were less than the
estimated slope of —0.0143, yielding a p—value of 0.28. Thus the estimated slope
was not statistically significantly less than 0 implying that, with a genuine small
decrease in the f3g, with groups of size 8, boosting the value of Ro in the initial
group of infectives would probably not increase the probability of detecting a
significant trend.
The effect of a larger value of R0 on the ability to detect a genuine decrease in
the rate of infection was investigated further by considering a larger decrease.
A passage multiplier of 1.5 was used in the simulation model, to effect a larger
decrease in the rate of infection by generation of infection. Data were generated
based on rate of infection of 3.57 (corresponding to R0 — 10), passage multiplier
equal to 1.5 and group size 8. The generated data had all 8 group 2 individuals
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infected, 4 infecteds in group 3 and 1 infected in group 4. Analysis of these data
resulted in a decreasing trend in the estimated j3g where Pi = 3.38 (s.e = 1.538),
Pz = 0.41 (s.e = 0.209) and P4 = 0.20 (s.e = 0.197). Weighted regression analysis
was performed and an estimated slope equal to —1.6643 was obtained. Based on
the Pgi0bai estimate from these data of 1.14, bootstrap epidemics were generated
and analysed to yield bootstrap slope estimates. The estimated slope from the
original data of —1.6643 was less than all the 200 bootstrap estimated slopes
(p—value < 0.005). Leading to the conclusion that the estimated slope was
statistically significantly less than 0 at the 1% confidence level. Thus, large
values of R0 with groups of size 8 would enable detection of a genuine decrease in
the rate of infection, but only if the decrease was substantially large. The larger
change in decrease was probably the key factor.
For data set C, 3 out of the 200 estimated bootstrap slopes were less than the
estimated slope from data set C of —0.5242 yielding a p—value of 0.015. Thus
the estimated slope was statistically significantly less than 0 at the 5% confidence
level, leading to the conclusion that increasing group size would enable the pro¬
posed methods to detect a genuine small decrease in the rate of infection given
Ro < 3 in the initial group of infectives.
8.4 Discussion
In the experimental data, the group size of 8 may not have been big enough given
the initial dose of virus infection introduced in the group 1 individuals. From
both experiments, results showed that the rate of infection for group 2 (the only
group that was exposed to group 1 infection) was the lowest of all the three groups
(2 to 4). It could be that the amount of infection that group 1 individuals were
able to pass on to group 2 individuals was really minimal and/or that group size
of 8 was not big enough. It is also possible that a genuine decreasing trend did
not actually exist in these data.
In the evaluation of the appropriateness of the proposed methods, simulation
methods were used. Data were generated on the basis of the infection process
characteristics as estimated from experiment 1. When a small decrease was im¬
posed on the rate of infection, the restricted model MLE based methods were able
to detect the decrease as statistically significant for the data set simulated un¬
der (3global > 1- However, the martingale based methods resulted in the estimate
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of a non-significant decrease at the 5% level of significance. This result was in
line with the underlying motivation for the development of the restricted model
MLE, that this approach would increase the power of the methodology to detect
decreases in /3 with increasing group number. The experiment was designed to
investigate a drop in infectivity with increased passage: as discussed earlier, this
should be associated with a sampling distribution of decreases with more support
on positive variables than the distribution of slopes arising from the null hypoth¬
esis of no drop in infectivity. The distribution of decreases arising from the null
hypothesis is used to define a critical region for rejection of the hypothesis. A
one-sided test for decreased infectivity will equate to a critical region of decreases
greater than a particular critical value. It is anticipated that estimating these
decreases under the null hypothesis using restricted model ML will give rise to
less variable estimates than those arising from unrestricted model ML. Hence, the
critical value for the test is likely to be lower in the restricted case than in the
unrestricted scenario. By contrast, any test statistic generated under the alterna¬
tive hypothesis has a high chance of being unaffected by the choice of restricted
or unrestricted estimates. If there is a sufficiently large decrease in infectivity,
the restricted and unrestricted estimates are likely to be identical. An unchanged
test statistic and a lower critical value will give rise to a reduction in the type 2
error. Treatment of restricted estimates (nature of maxima).
The non-significant result for a decreasing trend for the martingale /3 estimate,
prompted further investigations on the martingale based methods. Three situa¬
tions were considered as discussed in Section 8.3. In investigating whether the
martingale based methods would detect a genuine decrease in the rate of infection
but that the decrease imposed by initial passage multiplier of 0.15 was too small,
a large decrease (multiplier of 1.5) was imposed on the rate of infection and anal¬
ysis of data based on this criterion yielded a significant decrease. To investigate
whether the problem was the initial value of R0, the value of Ro in the initial
group of infected individuals was boosted to approximately equal to 10, while
maintaining use of the other parameters of the infection process, but the analysis
of data based on these conditions yielded a non-significant trend. The rate of
infection is so high that the decrease is effectively negligible. All individuals still
become infected very quickly. More individuals would be required to detect such a
trend. When, however, the decrease was increased, the martingale based method
was able to detect the decreasing trend in the rate of infection across groups. In
the third scenario, the group size was investigated on the assumption that even a
small decrease would have been detected if the group size had been greater than
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eight. Analysis of data based on group size 20 but with the other infection process
characteristics as estimated from experiment 1 yielded a significant decrease in
the rate of infection.
In conclusion therefore, the proposed inferential methods have inferential power
for the type of epidemic data. The restricted model MLE method is able to detect
a small genuine decrease in the rate of infection for groups of size 8. The mar¬
tingale based methods, however, appear to be able to detect a genuine decrease
in the rate of infection in groups of size 8 only if the decrease was reasonably
large. Hence, as long as a sizeable decrease is indeed present in the rate of in¬
fection across groups, groups of size 8 will probably suffice for the method to
formally detect the decrease. Martingale based methods would also be able to
detect a small genuine decrease in the rate of infection when Ro < 3 in the initial
group of infectives if the group size was large. However, if R0 was large (~ 10), a
small decrease in the rate of infection would not be detected by martingale based
methods, but a large decrease would be detectable.
The results seem to indicate that a group size of 8 is sufficient to detect a genuine
existing trend if R0 in the initial group of infectives is big enough. In Section
8.2, where data were generated based on group size 8 with R0 < 3, martingale
based analyses yielded a non-significant trend at a level of significance less than
5%. Boosting R0 to 10 and imposing a large decrease in the rate of infection
but maintaining the group size yielded very significant trend at a 1% level of
significance. The results therefore suggest that a genuine trend would be detected
in group sizes of eight provided R0 in the initial group of subjects is big enough
and the decrease is large. Increasing the group size to 20 for example, even with
a low value of R0, would allow the methods to detect even a small decrease in the
rate of infection. As always, the larger the experiment, the more power it will
have to detect an effect of any specified size. Where the alternative hypothesis
describes a consistent decline or rise in infectivity, it is probably optimal to use
a restricted model MLE method to test the hypothesis. It may be worthwhile to
investigate whether the properties of the martingale methodology can be improved
through the use of some other summary statistic to summarise any pattern in the
/3s. Certainly, a more detailed power study is required before it can be stated
with confidence that the restricted model MLE based method has more power to
detect an effect of a given size than the martingale based method. Given sufficient
power, both methods have the potential to successfully fit models to this class of
data. The results suggest that the major factor influencing the properties of the
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estimators is not the use of the estimated infection history, but the choice of the
estimator. It is possible that the martingale estimator consistently underestimates
the infection rate.
Any tendency for the distribution of slopes (in the case of unrestricted estimates)
under the null hypothesis of no passage effect to exhibit a differential number of
negative than positive slopes is very important. In the restricted model ML case,
such an effect would correspond to a distribution of drops with a heavier or lighter
tail, even under the null hypothesis, and hence, in both cases, a lower or higher
power to detect genuine passage effects than might have been expected. Before
the analyses were completed, it seemed likely that there might be a tendency of
negative slopes, arising from a tendency of the stochastic process to generate less
vigorous epidemics in higher number mixing groups. It is possible that such a
tendency might arise from threshold properties of non-linear stochastic epidemics.
It is well known that the SIR model exhibits threshold behaviour with respect to
the reproduction ratio 9 (Bailey, 1975, Section 6.5). Where 9 > 1, there is a finite
probability (1 — of a major rather than a minor outbreak, while for 9 < 1, all
outbreaks are minor. The current model incorporates a latent period, but in so far
as this property merely delays the onset of infectivity, it will not greatly affect the
stochastic properties of the final size of the epidemic. In the simpler case with no
restricted mixing structures, and homogeneous mixing of all individuals, there will
be no effect. As discussed in Diekmann and Heesterbeek (2000), Exercise 1.40, for
final size, it does not matter by whom an individual is infected, but only whether
an individual is infected. In this context, it is easy to formulate an equivalent
process, where 'infection' events occur from infectives individually to all other
individuals (some of these being so called 'ghost' infections), where it is obvious
that the event of any individual being infected at least once in a realisation, is not
affected by the latency model. By contrast, the interplay between latency and
restricted mixing makes the outcome of a particular realisation dependent on the
mixing status of the individual when it becomes infective. The main effect of this
will be to increase variability in the final size distribution, the system should still
exhibit major and minor outbreaks. Similarly, the use of a gamma distribution
to describe the length of infection period will not affect the conclusions.
If each mixing group is thought of as a discrete entity, which is exposed to 'ini¬
tial' infectives primarily from the preceding mixing group, then the probability
of a major outbreak occurring in the group will depend both on the rate of in¬
fection f3 and the mean infectiousness time, but also on the number of 'initial'
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infectives. Obviously, if a major outbreak occurs in each mixing group, then the
estimates for in each case will be unbiased and the overall analysis of the 3
estimates will provide information only about the passage parameter. However,
should one of the mixing groups undergo only a minor outbreak, /? will be under¬
estimated for this group. This in itself has potential to produce a heavy tailed
distribution of drops from the restricted model ML case. However, since a mi¬
nor outbreak, by definition, will be associated with a small number of infectives,
the next mixing group will be exposed to a smaller number of 'initial' infectives,
with a correspondingly higher probability of a minor outbreak ensuing. Hence,
a drop in the perceived value of /3, arising only from the stochastic properties of
the epidemic in one mixing group, has an enhanced chance of being propagated
to subsequent mixing groups, and hence of being summarised by a slope with a
negative coefficient.
Examination of the results from Experiment 1 and Experiment 2 suggested that
this effect was not having a large effect on the bootstrap estimates. The median
of the bootstrap estimated slopes (Table 7.5), although negative in each case, was
very close to zero. Examination of the slope distributions for the simulated data
provides further evidence that this factor has had little or no effect on the results
presented in this chapter. For data set A and C, the distributions are clearly
distributed around zero, with medians extremely close to zero. Curiously, the
one bootstrap distribution which is clearly not distributed around zero, that for
data set B, has a tendency of positive slope values. However, the effect of a minor
outbreak may explain the apparently anomalous results presented in Table 8.15,
where the estimates for data set A showed a very small estimated infection rate in
group 2, followed by extinction. It is, of course, possible that the minor outbreak
effect would be more salient in another situation, perhaps where /3 is small. The
tendency of positive slopes in data set B requires a different explanation. It
presumably arises from some property of the estimation procedure which fails
particularly badly in the case where infectivity is very high and hence all animals
become infected very quickly. This is, of course, a particularly difficult situation
to model where only partial data is available. Consideration of these possible
patterns in f3 arising under the null hypothesis leads to an important conclusion.
It is even more essential that the relationship between the different estimates of /3
be evaluated using a bootstrap-type approach. Any correlation between epidemics
in different mixing groups will give rise to correlations between /3 estimates which
must be allowed for in any hypothesis test.
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Further work is required to investigate the potential impact ofminor outbreaks on
estimates of /?. However, if this aspect of the stochastic process does under some
circumstances have a large impact on estimates of /3, it might be concluded that
the bootstrap simulations should perhaps not be based on an estimated (3gi0bai
value, if this may indeed be affected by the inclusion of minor epidemics. The
mixing group which is least likely to be subject to a minor outbreak is group
2, and it is arguable that a restricted model ML estimate of the infection rate
applying to group 2 is therefore the best estimate of the global infection rate, even
when working under the assumption that there is no systematic passage effect.
The nature of estimates for the infection and removal rates of the SIR model
arising from minor and major outbreaks is discussed further in Chapter 9.
214
Chapter 9
Coverage properties of confidence
intervals for the reproduction
ratio
9.1 Introduction
In the analysis of epidemic data, estimates for infection process parameters (for
example the rate of infection, /?, and the removal rate, 7), depend on whether the
epidemic results in a minor or major outbreak (Bailey, 1975, Section 6.5). In gen¬
eral, for minor outbreaks the size of the population is largely irrelevant because
there will be little information regarding infected individuals and, by definition,
estimates derived from small outbreaks will tend to underestimate f3. For major
outbreaks, however, there will be a substantial amount of information regarding
the infection process if the population size is large. In parameter estimation, it
is crucial that estimated parameters are accompanied by estimates of standard
errors and confidence intervals. For a given parameter estimate, once an estimate
for the standard error is calculated, a confidence interval can be constructed, jus¬
tified by Asymptotic Likelihood Theory (ALT), using the central limit theorem
(CLT) to approximate the distributional properties of the estimate. Asymptotic
ML and martingale estimation methods both give rise to estimates for the stan¬
dard error of estimates of a given parameter. As a result, the construction of
confidence intervals justified by the CLT is very appealing (and is discussed fur¬
ther in Section 9.2). Becker (1989), Section 7.2, uses ALT to construct confidence
intervals justified by what he terms the martingale CLT.
Unfortunately, confidence intervals based on ALT are only valid for large epi¬
demics and large population sizes. In many cases this fact has, however, been
ignored and researchers have proceeded to construct ALT-based confidence inter-
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vals regardless of the epidemic and population sizes. The results obtained from
such approximations may be invalid and conclusions based on such results are
likely to be unreliable.
In this chapter, the properties of confidence intervals based on ALT will be eval¬
uated. Since it is believed that ALT is not appropriate in situations with small
populations or small outbreaks, ways to improve ALT-based confidence limits
are discussed and alternative methods of constructing confidence intervals are
proposed and evaluated. The properties of ALT-based confidence intervals are
compared with those of the percentile based confidence intervals generated by
parametric and semi-parametric bootstrap methods. A calibration process is
applied to each of these methods with the objective of improving the basic con¬
fidence intervals. Simulated data are used to explore the coverage properties of
the different confidence intervals for the reproduction ratio, denoted by 9, of a
susceptible-infectious-removed (SIR) infection process. The parameter 6 equals /3
times the mean duration of infectiousness period, i.e. 9 = (3x and measures the
average potential of an infective to infect a susceptible. Properties of confidence
intervals are assessed with respect to the susceptible population size, the number
of secondary infections and the size of the epidemic (minor or major). If the
susceptible population is small, there is a limited amount of information avail¬
able to make inference about the infection process mechanism. If, in addition,
the resulting epidemic is minor, there is very little information available regard¬
ing the infection process. A strategy to address the effect of minor outbreaks
on confidence intervals is proposed, based on the use of a beta-binomial mixture
distribution.
Since the main aim of this chapter is to explore the properties of confidence
intervals, a simplified SIR simulation model, as described in Section 2.4.1, is used
to generate data which is then analysed under the assumption that the infection
process is fully observable. The SIR model assumes that there is no latent period
and that the length of infectiousness period is exponentially distributed with mean
i. The model further assumes a uniformly homogeneous mixing population. The
simulated infection process starts with 1 infectious individual and the rest of
the population susceptible. Once an individual becomes infected, it becomes
infectious immediately and stays in the infectious state for a random period of
time generated from the exponential distribution with mean equal to K after
which it is removed, i.e. it is no longer infectious and is not susceptible to re¬
infection.
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9.2 Estimation of parameters
When generating estimates for /3 and 7, different methodologies are available to
calculate confidence intervals. Those discussed at most length in the statistical
literature are those based on the Neyman-Pearson likelihood ratio statistic, those
based on the Rao score statistic and those based on the Wald, or maximum
likelihood (ML) estimate statistic. These are presented in their multi-dimensional
and scalar forms in Barndorff-Nielsen and Cox (1994), Section 3.2. These methods
are all equivalent to the first order of approximation, but they have subtly different
properties in terms of ease of calculation and of suitability in specific situations.
In each case, the calculation of the confidence interval is based on a proof that the
distribution of the test statistic converges in probability to a chi-square (multi¬
dimensional parameter) or normal (scalar parameter) distribution as the size of
the data set tends to infinity. The key issue when calculating confidence intervals
for (3 and 7 is the fact that the likelihood for these parameters is non-zero only
on the positive axis. When calculating confidence intervals for 9, it should be
noted that these estimates are not estimated directly from the data, but rather
as a function of estimates of /3 and 7. Confidence intervals derived from the
critical region of the Neyman-Pearson statistic automatically exclude any regions
where the likelihood is zero (such as those corresponding to negative values of
the parameter). This is not true of the other two statistics (Barndorff-Nielsen
and Cox, 1994, Section 4.2). Hence, everything else being equal, a confidence
interval based on the chi-square approximation to the log-likelihood ratio might
be preferred. However, the ML estimate statistic has computational advantages,
since if the information matrix is evaluated at the ML estimate, the confidence
interval is fully defined by the point estimate and the second derivatives of the
log-likelihood (as illustrated in Section 4.2). In the case of 9, this computational
advantage is compounded by an overwhelming practical issue. Both the Neyman-
Pearson and Rao methods require direct knowledge of the likelihood function. In
the case of 9, no such function is available. However, the use of the ML estimates
for p and 7 and hence the direct calculation of their estimated variances will allow
the calculation of a point estimate and variance for the associated estimate of 9.
Hence, for 9, the use of the ML estimate is unavoidable. For ease of computation
and comparison, the same methodology is used for ft and 7, although it should be
stressed that the log-likelihood ratio approach would give better results for these
two parameters.
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9.2.1 Estimation of rate of infection, /3
Let N denote the total number of individuals in the simulated epidemic,
Io denote the number of initial infectives, Jq = 1,
Is denote the total number of secondary infectives in a simulated epidemic,
such that N — 1 — Is is the total number of individuals still susceptible
at the end of the epidemic,
I(t) denote the number of infectives at time t,
ti denote the time of infection of infected individual i, and
tmax denote the time of the end of the epidemic.
The likelihood function L from which P is to be estimated is given by
i=i I N J J=l
= pis jj fomax^dt-
The log-likelihood I is given by
( . /. HP) + g In (fl) - P | f-f dt - 0 (N - 1 - /.) /;~f «.








where Te=Y 4/ dt
is the total scaled exposure time for the N — 1 initially susceptible individuals.
It should be noted that individuals that remain susceptible at the end of the
epidemic have a notional time of infection beyond the time of the end of the













From the first order derivative of the log-likelihood, the estimate for (3 is deter¬
mined:
I = ° - * = £• <9-2>








Assuming the asymptotic normality of the estimator, the (1 — a) 100% confidence
interval for P is given by
[P- s.e(P) zi_|, P + s.e0) 2i_| ],
where za is the standard normal value such that <f>(zQ) = a.
9.2.2 Estimation of rate of removal, 7
The SIR model assumes a negative exponentially distributed infectiousness pe¬
riod with mean Thus the length of infectiousness period for the ith infected
individual, denoted by Xi, is negative exponentially distributed with mean for
all i. The aim is to estimate 7.
Let It denote the total number of infected individuals during the epidemic i.e.
It = Iq + Is, and 7) denote the probability density function of Xi, then
fx(xit 7) = 7e~7Xi-
The likelihood function of the infectiousness period of infected individuals is given
by
h j
L = JJ 7 e~~1Xi = 7/ie-7^=iXi
and the log-likelihood function is given by
h
I = ln(L) = Itln(7) - 7
i= 1
Taking first and second order derivatives of I with respect to 7 yields:
dl It A , dH It
- = and (9.4)
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Estimates for 7 and the associated standard error are determined from the log-
likelihood derivatives as follows:
dl It












where Tp = aq is the total infectiousness period of all It infectives.
i= 1
Assuming the asymptotic normality of the estimator, the (1 — a)100 % confidence
interval for 7 is given by
[7-s.e(7)zi_a, 7 + s.e(7)^r_f ]•
9.2.3 Estimation of the reproduction ratio, 9
Since 9 is given by an estimate of 6 and an estimate of the standard error
of 9 can be determined from the estimates of 9 and 7 and the corresponding
estimates for their standard errors. From expressions for the estimates of f3 and
7 in Equations 9.2 and 9.5, the estimate for 9 is given by:
n P h Tp Is Tp . T , t fnc\9 = - = —f = , since It = Is + J0. 9.6
7 ItTe [Is + 1) Te
Examining the estimator of 9, simulation results suggest that minimal non-zero
values of 9 will occur where Is — 1. Let aq denote the infectiousness period of the
initial infective, x2 denote the infectiousness period of the only secondary infection
and E2 denote the scaled duration of exposure for the secondary infection. It
X*
should be noted that E2 = where x\ (x\ < aq), is the duration of exposure
that caused the secondary infective to became infected. Then the total duration
of infection exposure Te is given by:
Te = (JV_/,_i)hi±£2) + £ = (Ar„2)hi47h +
and
9 =
N N K ' N N
xi + x2 N (aq + x2)
2 [{N - 2)^±^ + f ] 2 [(N - 2)(aq + x2) + x\]
> N(Xl+x2) = H . f9.7)
2 [(N — 2)(aq + x2) + (aq + 2:2)] 2 [N — 1]
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Hence, 9 is bounded below by 2(n-\) ' a rnonotonically decreasing function in N.
As N —> oo,
iV
2(N—1) 2'
Using the 5 method (Becker, 1989, Appendix), the variance of 9 can be estimated
as follows:



























var0) + (ruar(7) conditional on cov(j3, 7) = 0
thus s.e(0) = \/var(9) = —^J[var((3) + 02uar(7)j. (9.8)
The joint likelihood for /3 and 7 can be factored into two parts, one a function
of (3 alone and the other a function of 7 alone. Hence the ML estimates are
independent. Assuming the asymptotic normality of the estimator, the confidence
interval for 9 is given by
9 - S.e{9) 2i_a, 0 + S.e(0)2i_a]. (9.9)
9.3 Evaluation of confidence intervals based on
the asymptotic properties of the ML esti¬
mate statistic
ALT-based confidence intervals for 9, which are based on the standard error
estimates for 9, depend on the variance estimates of j3 and 7. It is therefore
important to explore the properties of f3 and 7 and their variance estimators
to evaluate their effect on estimates of the standard errors of 9. For this task,
epidemics are simulated assuming a SIR infection process with parameters /5 and
7. Estimates of (3 and 7 and their corresponding standard errors are determined
for each simulated epidemic sample. Epidemics are repeatedly simulated based
on population sizes (n) of 10 and 50, each with [3 — 2 and 7 = 1. It is well known
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that the SIR model exhibits threshold behavior with respect to the reproduction
ratio 9 (Bailey, 1975, Section 6.5). Where 9 > 1, there is a finite probability
(1 — |) of a major rather than a minor outbreak, while for 9 < 1, all outbreaks
are minor. It therefore seems reasonable to attempt to fit a model to the observed
(simulated) number of secondary infections which assumes the existence of two
separate underlying distributions, one of which can be thought of as arising from
minor outbreaks, and the other from major outbreaks. For each population size,
outbreaks are categorized into minor and major outbreaks using a beta-binomial
mixture distribution as described below.
Let s denote the number of initial susceptibles in the population and Is the
number of secondary infectives, with is the observed value of Is. The probability
density function of Is assuming a beta-binomial mixture distribution, is given by:
P (Is = is) = P (minor)
+ (1 — P(minor))
s \ r(a?i + Pi) r(i6 + Qi)r(s — is + Pi)
is J r(c*i)r(/?i) r(ax + P\ + s)
s \ r(a:2 + /32) r(is + cr2)r(s - + p2)
r(a2)ro?2) r(a2 + ^2 + s)
(9.10)
where P(minor) is the probability of Is arising from a minor outbreak, 1 - P(minor)
is the probability of Is arising from a major outbreak, aq and P\ are the scale and
shape parameters respectively for the minor outbreak beta distribution, and a2
and fa are the scale and shape parameters respectively for the major outbreak
beta distribution.
For an observed outbreak with is observed secondary infectives, the quantity
-l
r(e*i + Pi) T(is + ai)T(s — is + ^i) 1 f r(a2 + /32) T(is + o:2)r(s — is + f32)
r(a1)r(A) r(ai + Pi + s) J \ r(a2)r(p2) r(a2 + p2 + s)
(9.11)
is used to categorize is as a minor or major outbreak, depending on whether this
function is greater than or less than unity.
The likelihood of Is for each class of simulated data sets (specified by popula¬
tion size and parameter choice) was maximised and estimates of parameters for
the beta-binomial mixture distribution were obtained. It was then possible to
obtain critical values of Is against which to classify epidemics as minor or major
outbreaks. For the n = 10 epidemics, the partition was taken to be such that
outbreaks with 1 to 3 secondary infectives are minor outbreaks and outbreaks
with 4 to 9 secondary infectives are major (on the balance of likelihood). For
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n — 50 epidemics, the partition was taken to be such that epidemics with 1 to
20 secondary infectives are minor outbreaks while the observation of 21 to 49
secondary infections implies a major outbreak.
The first and second order properties of (3 and 7 estimators are explored based
011 the simulated epidemics. For n = 10, 3249 non-trivial epidemic samples (i.e.
with Is > 0) were generated and from these, 984 were categorized as minor
outbreaks. For n = 50, 3285 non-trivial epidemic samples were generated and
1064 were categorized as minor outbreaks. These data are used, in a later section,
to explore the properties of (3 and 7 and the associated standard errors. For each
epidemic sample, [3 and 7 and the associated standard errors are estimated based
011 Equations 9.2, 9.3 and 9.5.
The goodness of fit of the beta-binomial mixture distribution was assessed by
fitting the model to smaller simulated data sets containing 100 realisations, for
populations sizes 10 and 50 and parameters 9 = 2 ((3 = 1, 7 = 0.5). These
realisations were all non-trivial and hence the likelihood was conditioned 011 the
observation of non-zero random variables. For both population sizes, the analysis
showed good fits of the beta-binomial mixture distribution to the data; chi-square
values of 2.7903 with 8 degrees of freedom (p-value = 0.947) for n = 10 and chi-
square values of 11.5476 with 14 degrees of freedom (p-value = 0.643) for n — 50.
The fitted distributions are displayed in Figure 9.1.
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Examining the plots for the fitted mixture distributions, it is clear that the clas¬
sification of epidemics as minor and major outbreaks is possible and that the
distinction between these classes becomes more obvious with increased popula¬
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number of secondary infections, there is an appreciable probability of an outbreak
arising from either category. Where n — 50 there is a very clear partition between
the two categories of outbreak.
9.3.1 Exploring the properties of the estimate of (3
To explore the properties of the estimated (3, the estimates of /? are plotted against
the number of secondary infections Is as is the mean of (3. The plots are displayed
in Figure 9.2 for population sizes 10 and 50.
Figure 9.2: Plot of estimates of (3 ((3 = 2) and the mean of estimates of (3 against
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The plots indicate a non-linear relationship between estimates of /? and the
number of secondary infections. This is to be expected from the nature of
the estimator for (3 0 = —), since the expected value of (3 given by
Z^i=l T•
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E(P) = I, E
tion exposure
is non-linear in Is, where Tj is the duration of infec-
or individual i. From the plots it is observed that variability first
decreases and then increases with Is (this is more obvious in the case n — 10).
There is more information in the data as the epidemic size increases, however,
for large Is, there is scope for more variability in the estimators as the epidemic
exhausts itself and changes in the observed exposure durations are not matched
by changes in Is. For small Is, infection exposure is calculated by summing a
small number of random variables, with an associated lack of ability to average
out variability in Tj. Hence variability will be high in f3 estimates for small and
large values of Is but lower for median values of Is. It is also notable that the
mean of /5 increases with Is and it is consistently below the true value for small
values of Is, i.e. for all minor outbreaks.
To explore the properties of the variance estimator, estimates of standard errors
for P are plotted against the number of secondary infections (Js). The plot is
displayed in Figure 9.3. The figure also includes plots of estimated standard
errors derived from the standard deviation of the simulated estimates (blue line),
the asymptotic standard error of the ML estimator conditional on the number
of observed infections (green line) and the asymptotic standard error of the ML
estimator in the case of a large outbreak (red line).
The asymptotic variance estimate for (3 is derived from the second order derivative
























where E(IS\major) is estimated from the simulated data.
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Figure 9.3: Plot of estimates of standard errors of /3 against the number of sec¬
ondary infections Is for (a) population size 10 overall, (b) population size 10
major outbreaks (Is > A), (c) population size 50 minor outbreaks (Is < 20) and
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For outbreaks for population size 10, the calculated estimates of the standard
errors (termed observed SEs on the plot) have a high variability for lower values
of Is but this decreases as Is increases, for Is < 7 but increases again for larger
Is. For population size 50, the trend in variability of estimates of standard errors
of f3 is similar to that for population size 10 where variability tends to be high
for small values of Is but tends to decrease with increasing Is in minor outbreaks
(see Figure 9.3(c)). For major outbreaks (Is > 20), the variability in calculated
estimates of standard errors seems to slightly increase with increasing Is. The
explanation for this is as earlier given, that changes in the infection exposure time
will not necessarily be matched by changes in Is where the epidemic exhausts the
susceptible population.
When Is is very small, comparing the 'observed' standard errors with the theo¬
retical standard errors (asymptotic SEs and estimates from standard deviations)
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is inappropriate. This is because the theoretical values plotted are not valid since
they are based on asymptotic large sample properties of the likelihood. Compar¬
isons between the calculated estimates and estimates of standard error calculated
from the standard deviation of the simulated values of (3, suggest that there is no
consistent bias in the calculated standard error estimators. This is true for both
the large and small population scenarios. However, estimates of /3 from small
outbreaks will tend to be biased downwards. For larger outbreaks, the calcu¬
lated ('observed') standard errors tend to overestimate the theoretical variability
of the estimator, and the resulting confidence intervals will therefore be liberal.
It should be noted that for cases with large numbers of secondary infections,
the theoretical (ML-based) values (red) are close to the estimated values (blue),
indicating that the ML estimates are a good approximation. However the esti¬
mates of these values are poor. The combination of these effects ensures that it
is unlikely that the true coverage of a notional confidence interval will be correct.
This is reflected in an evaluation of the coverage properties of the nominal 90%
confidence intervals for /3 derived from ALT.
For the n = 10 epidemic, the number of confidence intervals containing the true
value of f3 = 2 was 2996 out of 3249 yielding an estimated confidence of 92% with
a 95% confidence interval for the true confidence of (0.91,0.93). This estimated
coverage probability is statistically significantly greater than 0.90, but not very
different in absolute terms. However, as might be expected, this global estimate
is misleading given the divergent behavior of the estimates in the two under¬
lying groups. Out of the 3249 simulated epidemics, 984 were classed as minor
and of these, 777 confidence intervals contained the true value of (3, i.e. an esti¬
mated confidence of 79% with a 95% confidence interval for the true confidence
of (0.76, 0.81). Hence the true confidence in this class is much less than 90%. By
contrast, among the 2265 major epidemics, the number of confidence intervals
containing the true value of /3 was 2219, giving an estimated confidence of 98%
with a 95% confidence interval for the true confidence of (0.97, 0.99). As expected,
the notional 90% confidence interval is extremely liberal for major outbreaks.
For the n = 50 epidemic, the number of confidence intervals containing the true
value of /3 was 3011 out of 3285, i.e. an estimated confidence of 92% with a
95% confidence interval for the true confidence of (0.91,0.93). This estimated
coverage probability is again statistically significantly greater than 0.90, but not
very different in absolute terms. However, once again, this global estimate is
misleading given the divergent behavior of the estimates in the two underlying
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groups. 1064 simulated epidemics out of 3285 were classified as minor and of
these, 831 gave rise to confidence intervals containing the true value of /?, i.e. an
estimated confidence of 78% with a 95% confidence interval for the true confidence
of (0.75,0.81). Hence the true confidence in this class is much less than 90%. By
contrast, among the 2221 major epidemics, 2180 confidence intervals contained
the true value of /3 giving a 98% estimated confidence with a 95% confidence
interval for the true confidence of (0.98, 0.99). Thus, the notional 90% confidence
interval is consistently liberal for major outbreaks. These results are consistent
with the earlier review of the properties of standard errors for j3.
9.3.2 Exploring the properties of the estimate of 7
Estimates of 7 and the mean of these estimates are plotted against the number of
secondary infections Is, and the plots are displayed in Figure 9.4 for population
sizes 10 and 50.
For population size 10, variability in the estimates of 7 is high in minor epidemics
(/.s < 4) but is smaller in major outbreaks. This can be explained from the
definition of the estimator. The bigger Is is, the more information is present in
the data regarding the infection process. It can indeed be observed from the plots
that variability in the estimates decreases with increasing number of secondary
infections. The mean of 7 decreases with increasing Is and there seems to be a
nonlinear relationship between 7 and Is. It should be noted from the equation
for the estimator of 7 (7 = =7^—), that the expected value of 7 (E{fy) =
2^i=1Xi
It E =77— ) is not linear in It. The trend is similar for population size 50 with
-2^i=iXi J
variability in estimates being higher for minor outbreaks (Is < 10). For larger
outbreaks, the variability in the estimates is minimal and most estimates are
tightly concentrated around the mean for each Is and around the true value of
7=1. In general, the variability in the estimates is higher for those simulated
with population size 10 compared to those with population size 50.
To explore the properties of the estimator of the standard error for 7, estimates
of the standard errors of 7 are plotted against the number of secondary infections
(/s) and these are displayed in Figure 9.5 for populations of size 10 and 50. Also
included on the plots are estimated standard errors derived from the standard
deviation of the simulated estimates (blue line), the asymptotic standard error of
the ML estimator conditional on the number of observed infections (green line)
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Figure 9.4: Plot of estimate of removal rate 7 (7 = 1) and the mean of estimates
of 7 against the number of secondary infections Is for (a) population size 10 and
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and the asymptotic standard error of the ML estimator in the case of a large
outbreak (red line).
The asymptotic variance estimate of 7 is derived from the second order derivative














The asymptotic standard error of 7 conditional on the number of observed infec¬
tions It = it is therefore given by:
^var{f\it) 7E{h)
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Figure 9.5: Plot of estimates of standard errors of 7 against the number of sec¬
ondary infections Is for (a) population size 10 overall, (b) population size 10
major outbreaks (Is > A), (c) population size 50 minor outbreaks (Is <21) and
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and the asymptotic standard error of 7 in case of a large outbreak is given by:
\Jvar(f\major) = , /-yZ 7E(It\major) (Jt|major)'
where E(It\major) is estimated from the simulated data.
For all classes of outbreaks, the calculated estimates of the standard errors of
7 (termed 'observed' standard errors in Figure 9.5) decrease with increasing Is.
When comparing these estimates with the theoretical standard errors, the pattern
is clearest in the case of n = 50. Where Is is very small, the theoretical values
plotted are meaningless as they assume asymptotic large sample properties of the
likelihood, however, comparisons between the calculated estimates and estimates
of standard errors calculated from the standard deviation of simulated values of 7,
suggest that there is no consistent bias in the variance estimator, and if anything,
there is a tendency for the asymptotic standard errors to underestimate the vari-
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ability in the simulated estimates in minor outbreaks. However, as Is increases,
the calculated standard errors tend to overestimate the theoretical variability of
the estimator. Hence, even in the situation where we have a large outbreak, and
might have thought that there was a sufficient volume of information to allow
the use of the ML estimates and the use of ALT-based on a large sample, the
coverage properties of the confidence intervals may be poor.
The properties of the estimator can be explored by evaluating the true coverage
properties of the notional 90% confidence interval. For the n = 10 case, out of
3249 simulated epidemics, 3036 of the estimated confidence intervals contained
the true value of 7 = 1, i.e., a 93% confidence with a 95% confidence interval of
the true confidence of (0.93,0.94). For the case where n = 50, from 3285 sim¬
ulated epidemics, 3146 of the estimated confidence intervals contained the true
value of 7, i.e., an estimated confidence of 96% with a 95% confidence interval
for the true confidence of (0.95, 0.96). The results indicate some liberality in con¬
fidence interval coverage relative to the notional 90% confidence level. However,
it is more informative to consider the results for minor and major outbreaks sep¬
arately. For the n — 10 case, from 984 minor outbreaks, 982 of the estimated
confidence intervals contained the true value i.e an estimated confidence of 99.8%
with a 95% confidence interval for the true confidence of (0.99,0.9998). From
2265 major outbreaks, 2054 of the estimated confidence intervals contained the
true value, i.e., a 91% estimated confidence with a 95% confidence interval for
the true confidence of (0.89,0.92). For the n — 50 case, from 1064 minor out¬
breaks, 1035 of the estimated confidence intervals contained the true value of 7,
i.e., an estimated confidence of 97% with a 95% confidence interval for the true
confidence of (0.96,0.98). In 2221 major outbreaks, 2111 of the confidence inter¬
vals contained the true value of 7, giving a 95% estimated confidence with a 95%
confidence interval for the true confidence of (0.94,0.96).
From the above results it can be concluded that the use of asymptotic results, as
applied to the estimation of 7, may produce appreciably liberal or conservative
confidence intervals. Minor outbreaks seem likely to give rise to liberal confidence
intervals, while major outbreaks may give rise to conservative results.
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9.3.3 Exploring the effect of variance estimates of (3 and
7 on the properties of 9
The estimate of the standard error of 9 is calculated on the assumption that the
correlation between (3 and 7 is zero. Again, this is a large sample assumption,
and it is typical to observe correlation between the two parameter estimates.
Estimated values of /3 are plotted against values of 7. The plots are displayed in
Figure 9.6 for all epidemics, for minor outbreaks and for major outbreaks based
on population sizes 10 and 50.
Figure 9.6: Plot of estimates of 7 against estimates of (3 for (a) population size
10 overall, (b) population size 10 minor outbreaks i.e. Is < 3, (c) population size
10 major outbreaks i.e. Is > 3, (d) population size 50 overall, (e) population
size 50 minor outbreaks i.e. Is < 20 and (/) population size 50 major outbreaks
i.e. Is > 20. Note: Different colours indicate different values of Is, with blue
indicating the smallest Is value.
For small values of Is, the linear nature of the relationship between (3 and 7 is
obvious with correlation coefficient r = 0.999 (p-value < 0.001) for Is = 1, n = 10
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and r = 1 (p-value < 0.001) for Is = 1, n = 50. The correlations are appreciable
for the ((3, 7) pairs as a whole (r = 0.298 (p-value < 0.001) for n = 10 and r = 0.38
(p-value < 0.001) for n = 50) although it should be stressed that in these cases,
given the clear non-linear structures present in the data, the actual correlation
values are meaningless. Considering only major outbreaks, the correlation is
significantly greater than zero (r = 0.226 (p-value < 0.001) for Is > 3, n = 10
and r = 0.083 (p-value < 0.001) for Is > 20, n = 50). The correlation for n = 50
is small in absolute terms, however, for n = 10, r = 0.226 is still an appreciable
correlation. Thus the assumption that the correlation between (3 and 7 is zero is
likely to be inaccurate, and this assumption will affect the coverage properties of
the confidence intervals for 9.
The ALT-based confidence interval for 9 is calculated using Equation (9.9) where
s.e(9) depends on the variance estimates for f3 and 7 and the assumption that
cov((3,7) = 0. Hence underestimates or overestimates of the true variability
of (3 and 7 and the assumption of non-zero correlation between j3 and 7 will
affect the coverage of the resulting confidence interval for 6. The properties of
the interval will also be affected by the accuracy of the 8 method approximation
which is used to estimate the variance of 6 and the variability of the assumption of
asymptotic normality for 9. The exact effect of underestimates and overestimates
in estimating the second order properties of j3 and 7 011 s.e(9) will depend on the
means of the estimates and the relative sizes of the variance estimates. Hence,
these will vary for different values of (3 and 7. The effect of inadequacies in
the estimation of f3, 7 and the associated variance estimates on 9 and s.e{9) is
evaluated using simulations.
The 3249 and 3285 epidemic samples for n = 10 and n — 50 analysed in the
previous sections were evaluated relative to the true parameter value of 9 = 2
((3 = 2,7 = 1). Estimates of 9 and estimates of the standard errors of 9 were
obtained and ALT-based confidence intervals constructed. In Table 9.1, results
for the estimated confidence of the confidence intervals for all epidemics and for
categorised minor and major outbreaks are presented.
The results indicate that the true confidence for non-categorised epidemics (over¬
all) decreases with increased population size with a 90% estimated confidence for
n = 10 and a 74% estimated confidence for n = 50, which is a curious result. It is
therefore vital to review the properties of the confidence intervals separately for
minor and major outbreaks. It should be stressed that the fact that the overall
coverage may occasionally be close to 90% (as in the case of n = 10) does not
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Table 9.1: Summary of results for ALT-based confidence intervals for 0.




/3 confidence 7 confidence
10 overall 0.90 (0.89, 0.91) 0.92 0.93
minor 0.67 (0.64, 0.70) 0.79 0.998
major 1.00 (0.95, 1.00) 0.98 0.91
50 overall 0.74 (0.73, 0.76) 0.92 0.96
minor 0.21 (0.19, 0.24) 0.78 0.97
major 0.997 (0.995, 0.999) 0.98 0.95
imply that the statistical methodology is working well, when this is the average
of two distinct populations with very different properties. This explains the ap¬
parently paradoxical result that the overall coverage properties become poorer as
the population size increases. Considering the coverage properties of confidence
intervals for 0 separately for minor and major outbreaks, the results reveal that
minor outbreaks consistently have poor coverage, with estimated confidences well
below the nominal 90% confidence level and with properties which deteriorate
with increasing population, given the 21% estimated confidence for n = 50. For
major outbreaks, however, coverage is very high as can also be observed from
Figure 9.7, with a 100% estimated confidence for n = 10 and 99.7% for n = 50.
For n = 10, all of the confidence intervals that did not include the true value
of 9 were from minor outbreaks. For n = 50, 99% of the confidence intervals
that did not include the true 9 were from minor outbreaks. Thus, the overall
poor estimated confidence is largely due to the effect of minor outbreaks. From
the previously estimated confidences for and 7 (refer to columns 5 and 6 of
Table 9.1), it should be noted that though the methodology provides reasonably
good estimates for ft, s.e0), 7 and s.e(7), this is not reflected in the confidence
estimates for 6, particularly for minor outbreaks.
From the plot of confidence intervals against 9 presented in Figure 9.7, it can
be observed that there is a consistent trend for confidence intervals from major
outbreaks to be wide and those for minor outbreaks to be narrower, illustrating
the liberal and conservative nature of the confidence intervals arising from major
and minor outbreaks respectively. Hence, estimates of 9 from minor outbreaks
are unlikely to cover the true value with the specified, notional confidence. The
true confidence is likely to be much less. This may be due to the properties of
the estimator of the standard error, especially the biased nature of (3 estimates
from minor epidemics. Confidence intervals from major epidemics, by contrast
are likely to be liberal.
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Figure 9.7: Plots of 90% confidence intervals of 6 against 6 from population sizes
(a) 10 and (b) 50.
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In conclusion, results from the use of the maximum likelihood estimate statis¬
tic, assuming asymptotic normality of the estimator, indicate that it is a poor
methodology for the construction of confidence intervals in the context of the epi¬
demic data. Therefore, alternative methods of constructing confidence intervals
are explored, using bootstrap methods which have the advantage of not depending
on large sample assumptions about the nature of the likelihood.
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9.4 Epidemic bootstrapping and calibration
9.4.1 The procedure
In this section bootstrap methods, as applied to the epidemic simulations, are
described. Two methods are used, namely, the parametric bootstrap (Efron and
Tibshirani, 1993, Sections 6.5) and the semi-parametric bootstrap. From the sim¬
ulated epidemics, confidence intervals are constructed based on ALT, percentile
parametric bootstrap and percentile semi-parametric bootstrap methods. Cali¬
bration is performed on the confidence limits generated by the three methods.
Below is an outline of the procedure that will be followed in simulating and boot¬
strapping epidemics and calibrating the resulting parameter estimates.
Step 1: Generate an epidemic based on the SIR infection process, this requires
parameters /3 and 7.
Step 2: Check if realization is non-trivial, i.e., whether the number of secondary
infections is greater than zero, if non-trivial go to step 3 otherwise go to step 1.
Step 3: Calculate parameter estimates (3, 7, 9 and the associated standard errors
using the expressions outlined in Equations (9.2), (9.3), (9.5), (9.6) and (9.8) and
an construct ALT-based confidence interval for 9 as in Equation (9.9).
Step 4: Generate 200 valid bootstrap epidemics using both parametric and semi-
parametric bootstrap methods. The bootstrap methods are described in the next
section.
Step 5: Calculate parameter estimates (3, 7, 9, and the associated standard errors
as in step 3 for the 200 bootstrapped epidemic samples based on both parametric
and semi-parametric bootstrap methods.
Step 6: Construct confidence intervals based on the percentiles of the 200 9
bootstrap estimates from Step 5, for each of the parametric and semi-parametric
approaches.
Step 7: Perform calibration of confidence points for ALT-based confidence points,
parametric bootstrap percentile confidence points and semi-parametric bootstrap
percentile confidence points.
9.4.2 Bootstrap methods
Parametric and semi-parametric bootstrap methods are used to generate epidemic
samples based on the observed infection history of the simulated epidemic from
Step 1 of Section 9.4.1.
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9.4.2.1 Parametric bootstrap methods
During the parametric bootstrap procedure, epidemics are generated by simula¬
tion of the SIR infection process as in Step 1 but with the $ and 7 obtained in
Step 3 as the input parameters.
9.4.2.2 Semi-parametric bootstrap methods
From the infection process generated by the SIR simulation model based on pa¬
rameters (3 and 7, it is possible to generate bootstrap infection processes (epidemic
pseudo-realisations) using semi-parametric methods. For each individual in the
initial infection process, an infection profile is created, i.e, the duration of in¬
fection exposure (exposure threshold), the time of infection if it were infected,
and its duration of infectiousness period are calculated. Based on these profiles,
bootstrap epidemics may be generated. There may be up to are three types of
individual in the observed process, namely, the initial infective, any secondary
infectives and any susceptibles at the end of the epidemic. The bootstrapped epi¬
demics are generated based on one initial infective, i.e., Iq = 1, as in the 'parent'
epidemic process. For the initial infective, all that is required for the simulation is
a length of infectiousness to specify a removal time, since the time of infection for
this individual is set to zero, the start of the epidemic. An infectiousness period is
randomly assigned to the initial infective from the existing pool of infectiousness
periods from the profiles of infected individuals from the initial infection process.
For the remaining N — 1 individuals, a new infection profile is determined by
assigning exposure thresholds. These will be used to determine any times of in¬
fection. The process of generating a new infection profile and creating a bootstrap
epidemic realisation is described.
From the initial generated epidemic, the number of secondary infectives, Is, is
determined. The infection exposure thresholds for all N — 1 individuals are de¬
termined from the initial epidemic as follows:
Let Ei denote the exposure threshold for infected individual i, then
*-r f*
where U is the time of infection for individual i, I(t) is the number of infectious
individuals at time t and N is the total number of individuals.
For individuals that remain susceptible at the end of the epidemic, the exposure
threshold is unknown, but will be greater than /0<ma:c 7^ dt.
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Sampling with replacement from the Is observed infection exposure thresholds
Ei associated with the infected individuals in the parent epidemic, would give
rise to an epidemic with a bias towards individuals which became infected easily.
Rather, an individual among the N — 1 is assigned an exposure threshold based
on the following criteria:
For each individual i of the N — 1 initial susceptibles, generate a uniform random
variable itj from the uniform distribution U(0, 1).
• If Ui < j-, sample from the exposure thresholds of infected individuals
and assign the threshold to this individual. This corresponds to a non-
parametric sampling of a threshold from an infected individual.
• If Ui > do not assign a threshold from the pool of Ei, instead calculate
a new Ei as follows:
Generate a further uniform U(0,1) random variable Ui2 and scale this to a
a rtmax I(t)
uniform random number Uj from the uniform distribution U(0, e~p Jo n )
such that
-$ rtmax tgi m
Uj — u^e Jo n
Based on Uj, the exposure threshold for the individual is given by
E ln(uj)
P
This corresponds to a parametric sampling of a threshold for an individual
that had not become infected by the end of the epidemic.
With each of the N — 1 individuals assigned an exposure threshold Ei, each in¬
dividual is randomly assigned an infectiousness period from the set of observed
infectiousness periods, sampling with replacement. The new infection process is
sorted by exposure threshold. From the sorted exposure thresholds and corre¬
sponding infectiousness periods, where these become relevant, a new epidemic is
generated where individuals become infected and infectious if and only if the asso¬
ciated threshold is surpassed by the summed scaled exposure. The new epidemic
is analysed from which parameter estimates (3, 7 and 9 are to be generated.
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9.4.2.3 Generation of epidemic realisations by the semi-parametric
bootstrap
Based on the sorted exposure thresholds and corresponding infectiousness periods,
new epidemics are generated in what is termed the semi-parametric bootstrap.
It is semi-parametric because it involves f3 in the calculation of the exposure
thresholds for individuals with is greater than rather than merely sampling
with replacement from the generated exposure thresholds.
At time 2 = 0, the start of the infection process, the number of initial infections
is set to 1 where the initial infective has an exposure threshold of zero (E(p = 0)
and a randomly assigned infectiousness period from the pool of infectiousness
periods from the infection process of the original (simulated) epidemic. The
removal time, R\, of the initial infective is given by infection time 0 plus the
infectiousness period. From E@), the first non-zero exposure threshold among
the sorted thresholds, f(2), the time of infection for the individual associated with
exposure threshold E@), is calculated as follows:
Hence the time of the next event, whether a new infection or a removal is deter¬
mined by the minimum of Ri and f(2). If Ri is the minimum of the two quantities,
then the next event is a removal of the initial infective at time Rx. In this case the
epidemic ends with no secondary infectives. If t(2) is the minimum, then the next
event is a new infection with time of infection t(2) and removal time R2 equal to
t(2) plus the associated infectiousness period. The number of individuals in each
state of SIR is updated at the times 0, f(2) and a cumulative exposure denoted
by CumE{2) is determined up to time t(2). For the next step, the minimum re¬
moval time, minn, among the removal times for currently infected individuals is
determined. Then the next time of infection, corresponding to the next exposure
threshold, E(next), is determined as follows:
The time of next event is determined by the minimum of miriR and tnext. If minR
is the minimum, then the next event is a removal occurring at time mirtR. If tnext




its removal time given by tnext plus the length of the corresponding infectiousness
period. The number of individuals in each of the SIR states at the next event time
is updated and the cumulative exposure threshold up to this time is determined.
Subsequently, the time of infection corresponding to the next exposure threshold
(which could be the same exposure threshold as in the previous iteration if the
preceding event was a removal) is determined. It is compared with the minimum
among the current non-zero removal times and the time of the next event and
the nature of the event are determined. The process is repeated until there are
no infectious individuals remaining in the system i.e. I(tmax) = 0. If there are
any susceptibles left at the end of the epidemic, their exposure threshold is equal
to the cumulative exposure threshold at the end of the epidemic, at time tmax.
Hence, a new epidemic has been generated and the parameters of interest can
then be estimated based on the infection history of the generated epidemic for
those non-trivial epidemic realisations having at least 1 secondary infection.
9.4.3 Calibration of confidence points
In this section, the method of calibration of confidence points is described (Efron
and Tibshirani, 1993, Section 18.3). Consider a statistical estimator 9\(x) which
depends on an adjustable parameter A. In order to apply the estimator to data,
a value of A is needed. Bootstrap methods can be used to assess the performance
of 9\(x) for each fixed value of A and based on the assessment, the value A that
optimizes the performance of 9\(x) can be chosen. This process is called adaptive
estimation. If the process is applied to confidence interval procedures, it is re¬
ferred to as calibration. In this thesis the calibration process will be applied to the
ALT based confidence points, and both the parametric and the semi parametric
bootstrap percentile confidence points. This process will result in calibrated con¬
fidence points for each of the three types of confidence intervals. Theory suggests
that such calibrated confidence points will be second order accurate, improving
the performance of the confidence intervals relative to the uncalibrated intervals.
9.4.3.1 Calibration of a confidence point




For a maximum likelihood estimate statistic, assuming asymptotic normality
of the estimate, the confidence interval 9[a] is the standard normal point 9 —
zi-2. s.e(9) and in the case of a bootstrap percentile-based confidence interval,
9[a] is the bootstrap percentile point at the f% point in the sorted list of es¬
timated values of 9 derived from the bootstrap realisations. Since the actual
confidence of a confidence procedure is rarely equal to the desired confidence a
and is sometimes even substantially different, one way to think about the prop¬
erties of a confidence procedure is in terms of a calibration . That is, for each a,
if Pr{# < 0[a]} 7^ a, perhaps the equality will hold for #[A] where A ^ a. For
example, if the desired a in Equation (9.12) is 5 % perhaps it can be achieved
by using the 3 % confidence point. If the mapping a —>• A was known, then
a confidence procedure with exactly the desired property could be constructed,
but the mapping is not known, hence the need to perform a calibration. The
bootstrap is used to carry out the calibration as follows.
Let 0[A] denote a family of confidence points, where the objective is to find a
value A such that
p{A) = Prob{0 < <9[A]} = a. (9.13)
If the procedure is calibrated correctly, then (9.13) holds exactly with A = a. Let
p(A) denote the bootstrap estimate of p(A) and let p(A) be equal to Prob{(? <
#h[A]} where 9 is the estimate for which a confidence interval is required and 9b
is the estimate of 9 calculated from bootstrap sample b. To approximate p(A),
a number of bootstrap realisations (200 in this case) are generated. For each
realisation 9b is determined and p(A) is given by
#{<? < ft [A]}
number of bootstrap samples
The process of estimating p(A) is carried out over a wide range of values of
A using the same bootstrap samples. The calibrated confidence point is then
given by 0[AQ], where Xa is the value of A satisfying p(A) = a. In this project
a range of A values in the interval (0,1], in steps of ^ used, such that A
takes values 0.005, 0.01,..., 0.995,1. The algorithms for the calibration process of
the ALT-based confidence points and the bootstrap percentile confidence points
are outlined in the following sections. 200 bootstrap realisations are used as
the minimum required to give rise to reasonable results. The decision to use
only 200 bootstrap realisations was driven by the use of the double bootstrap
in the calibration of bootstrap confidence intervals, where the total number of
bootstrap realisations required, at 2002, is already extremely large. In practice,
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higher numbers should be used. In each case the aim is to construct a calibrated
confidence interval for 9 = estimated from the 'parent' simulated epidemic
sample.
9.4.3.2 Calibration of an ALT-based confidence point via the boot¬
strap
The ALT-based confidence interval is calibrated as follows:
Step 1: Using and 7 estimated from a 'parent' simulated epidemic sample,
generate 200 bootstrap samples b = 1,2,..., 200 and for each sample, estimate
9b and the associated standard error.
Step 2: Sort the set of 200 9b.
For the lower confidence point , p(A) is computed from
#{9 <9b-\z£_x\s.e{9b)}p(A) = 200 •
and the aim is to find A such that p{\) —
For the upper confidence point p(A) is computed from
#{9<«*+|zF-Alse(»i)}P(A) = 200 '
with the aim of finding A such that p(A) = 1 — |.
Evaluation of p(A) requires a 2i_a value. The computation of p(A) is equivalent to
determining a zi_a value (zf_A for the lower limit and z\_x for the upper limit) for
which p(A) is equal to the desired a-level confidence probability. The calibrated
confidence interval will then be given by [9 — \z[_x\ s.e(9), 9 + \z^_x\ s.e(^)].
For the lower confidence point, the threshold occurs at 9 = 9b — \z[_x\ s.e(9b)
1 L \ & — 9b ili 9b — 9 ~
=» - W-X\ = 7TT => 1^1-AI = 7X~\ ' Wheie 9b y °-s.e(9b) s.e(9b)
Calculate zf = 6h7/. from the 200 estimated values of 9b.i_A(i>) s.e(eb)
It should be noted that the expression is only meaningful in cases where it gives
rise to a positive value. The required z\_x value, equivalent to p(A) = a, can be
determined from the sorted list of the calculated Zi-X(b) values, by choosing the
(1 — f) 100% point value in the list, conditional on it being positive.
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For the upper confidence point, the threshold occurs at 9 = 9b + I^aI s-e(@b)
7 i /ol \ ^ •
s.e(9b)
Again, calculations of are only meaningful in cases where they give rise to
S.G^Ufj)
a positive value. The zx_x^ va-lues are computed from the bootstrap samples ,
yielding z-values corresponding to the 200 realisations. The required value
equivalent to p(A) = a is determined from the sorted list of the calculated zx_x
values by choosing the (1 — f) 100% point value in the list, conditional on it being
positive.
In practice, it is easier to operate simply in terms of Zi_a = For instance,
for a 90% confidence interval, the lower confidence point will require a zx_\ value
which corresponds to p(A) = 0.05, i.e. 20.95- This 2-value is the 2i_a value in
the 10th position from the bottom i.e. the 191th ranked 2i_a value, conditional
on this value being negative. Then the lower calibrated confidence point is given
by 9 + 2i_a[191] s.e(9). The upper confidence point will require a zX-\ value
which corresponds to p(A) = 0.95, i.e. zq.05. This z-value is the 2i_a value in
the 10th ranked value in the list of the 2i_a sorted values, conditional on this
being positive. Thus the resulting upper calibrated confidence point is given by
9 + 2i_a[10] s.e(9).
9.4.3.3 Calibration of a bootstrap percentile confidence point
Percentile confidence intervals are calibrated as follows:
Step 1: Generate 200 bootstrap samples based on (3 and 7 (the same realisations
as used for calibration of the ALT-based confidence point) and for each realisation
b obtain estimates 7^, 9b and the associated standard errors.
Step 2: For each bootstrap realisation 5= 1,2,..., 200, using (ib and % generate
200 calibration bootstrap samples c = 1,2,..., 200 and obtain estimates fibc, %c,
9be and the associated standard errors.
It should be noted that calibration of a bootstrap percentile confidence point will
require bootstrap sampling making the overall calibration a nested computation,
sometimes called a "double bootstrap " (Efron and Tibshirani, 1993, Section
18.3). Construction of a calibrated bootstrap percentile confidence interval for
a single estimate of 9, will require a total of 200 x 200 = 40,000 bootstrap
realisations each for both parametric and semi-parametric methods.
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Step 3: Sort the 200 calibrated 9bc estimates and denote the sorted estimates by
91(b), corresponding to bootstrap realisation b. Each of the 9x(b) corresponds to
a value of A in 0.005,..., 1.
Step 4: For each A, compute the number of estimated bootstrap 9b that are greater
than or equal to 9, for b = 1, 2,..., 200 and define
(A) = #{*<»>(»»J 200
The computation of p(A) is illustrated in Table 9.2.
Table 9.2: Illustration of a computation of p(A) for calibration of a bootstrap
percentile confidence point. The body of the table contains the output of indica¬
tor functions, specifying whether or not 9 < 9*x(b) for sample b and confidence
coefficient A.
A
bootstrap sample b 0.005 0.010 0.015 . 0.990 0.995 1
1 0 0 0 0 1 1
2 0 0 1 1 1 1
3 0 0 1 1 1 1
200 0 0 1 1 1 1
#{e < e\(b)) 0 0 3 199 200 200
P(A) 0 0 0.015 . 0.995 1 1
Step 5: Find the value of A (XL = lower, Av = upper confidence points) satisfying
p(A) = a, for each of the lower and upper confidence points.
The calibrated confidence interval for 9 is given by 9[X]f\, 0[A[/]J. For a 90 %
confidence interval, it is necessary to find A such that p(A) = 0.05 for the lower
confidence point and p(A) = 0.95 for the upper confidence point. The 200 boot¬
strap 9^ in Step 1 are sorted and a 90% confidence interval is determined by
selecting the XL% and Au% points (rather than the 5% and 95% points) of the
bootstrap distribution for 9.
However, because a discretised set of A is used, it is possible that there will be no
value of A for which p(A) = 0.05 or p(A) = 0.95 exactly. Various other situations
may instead arise, for instance, there may be several A for which p(A) = 0.05
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or p(A) = 0.95. Alternatively, there may be a situation where p(A(i)) < 0.05
and p(A(i) + 200) > 0.05. Another situation that might arise due to the number
of calibrated samples being insufficient is a situation where p(A(p) > 0.05 or
p(A(200)) < 0.95, or even situations where all of the estimated calibrated 9bc are
greater than the original 6, such that p(A) = 1 for all values of A. The following
criteria to select A will therefore be followed:
For the lower confidence point choose A such that
.
_ f maxA{p(A) < 0.05} if p(A(!)) < 0.05
\ A(1) if 0.05, < p(A(1)) < 1
and for the upper confidence point, choose A such that
_ f minA{p(A) > 0.95} if p(Ap)) < 0.95, and p(A(2oo)) > 0.95,
\ A(2oo) if P(A(200)) < 0.95.
In situations where all the calibrated 9bc are greater than 9, such that p(A) = 1
for all A, both the lower and upper limits of the confidence interval of 9 will
be set to the estimated value of 9, to indicate that in this pathological case the
methodology has failed.
The advantage in calibration of confidence points is that it produces confidence
intervals that are second order accurate provided that the confidence points being
calibrated are first order accurate. This is true of both the asymptotic likelihood
and the bootstrap percentile point methods. Hence, the calibrated interval will
enjoy the same accuracy as the BCa procedure which is recommended for the
improvement of accuracy of confidence intervals in many cases (Efron and Tib-
shirani, 1993, Section 18.4). The BCa methodology was believed inappropriate in
the epidemic bootstrap case, since it relies on an assumption of smoothness in the
functional relationship between the estimator (9) and the underlying data. Small
changes in the data (i.e., times of infection and removal times) should result in
only a small change in 9. This is not true in this case, hence the use of bootstrap
calibration as an alternative. Because of the property of second order accuracy,
calibration should produce superior confidence points.
9.5 Evaluation of bootstrap confidence intervals
Bootstrap methods do not depend on large sample assumptions, and hence where
data is lacking, they should generate better estimates of variability in estimates.
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However, these methods can do nothing about any bias arising in estimates from
minor outbreaks. When calibrating ALT-based confidence points, the effect of
simulated minor outbreaks will be to create problems caused by spurious values
of A which will tend to suggest that the confidence intervals need to be wider. This
is illustrated by the diagram in Figure 9.8. If the distribution of the bootstrapped
9b is as in Figure 9.8(a), the estimate of the upper ALT-based confidence limit
9b + s.e(Ob) zi_a will have a high proportion of cases which fail to cover 9 because
of the presence of the minor outbreaks. Hence the notional value of A which gives
the desired a level will tend to be reduced inappropriately, giving rise to wider
confidence intervals.












In the case of bootstrap percentile confidence intervals, the effect of minor out¬
breaks will be to extend the basic percentile confidence intervals by the inclusion
of results from minor outbreaks, while the calibration which follows will be af¬
fected by the generation of Xb associated with the properties of estimators of 9
from minor epidemics. Focusing only on major outbreaks, the bootstrap confi¬
dence intervals should be as specified by the V values in Figure 9.8(6). If minor
outbreaks are, however, included in the process, the estimated confidence inter¬
vals will potentially move to the alternative values indicated by on the same
figure. Hence the effect will be to spuriously increase the width of the confidence
interval and in particular to make the lower limit much lower. The calibration
scheme will not succeed in improving these confidence intervals since many of the
values of A will be calculated based on simulations of sub-threshold epidemics
which will have properties different to those of major outbreaks. There is no
reason to believe that these will be identical to the properties of those from ma¬
jor epidemics, leaving aside the particular issues which arise in the estimation
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of small values of 9 to be discussed in a later section. First, however, results
obtained from the calibration process are examined.
9.5.1 Evaluation of ALT-based confidence intervals
In the calibration process for the ALT-based confidence limits, 100 initial sim¬
ulated epidemics are generated with f3 = 1 and 7 = 0.5 i.e. with 9 = 2, for
population sizes n = 10, 30 and 50. It should be noted that the simulated epi¬
demics analysed here are different from those analysed in earlier sections. Based
on estimates of (3 and 7, from the simulated epidemics, for each realisation, 200
bootstrap epidemic realisations are generated. Basic ALT-based and ALT cali¬
brated confidence intervals for 9 are constructed for each of the 100 9 estimates.
The results, presented in terms of all epidemics (overall) and of epidemics clas¬
sified as minor or major outbreaks, are presented in Table 9.3. Partitioning was
carried out for the cases n = 10 and n = 50 on the same basis as described in
Section 9.3. In the case of n = 30, a beta-binomial mixture distribution was
fitted and 011 the balance of likelihood, outbreaks with fewer than 10 secondary
infections were defined as minor, while those with 10 or more secondary infections
were defined to be major.














10 Overall 0.84 (0.75, 0.91) 0.66 (0.56, 0.75)
Minor 0.43 (0.24, 0.63) 0.00 (0.00, 0.12)
Major 1.00 (0.95, 1.00) 0.92 (0.83, 0.97)
30 Overall 0.65 (0.55, 0.74) 0.60 (0.50, 0.70)
Minor 0.00 (0.00, 0.11) 0.00 (0.00, 0.11)
Major 0.96 (0.88, 0.99) 0.88 (0.78, 0.95)
50 Overall 0.64 (0.55, 0.74) 0.59 (0.49, 0.69)
Minor 0.03 (0.001, 0.16) 0.00 (0.00, 0.11)
Major 0.96 (0.87, 0.99) 0.88 (0.78, 0.95)
The results for the basic ALT-based confidence intervals are comparable with
earlier results (refer to Table 9.1), but have wider confidence intervals for the
true confidence due to the smaller number of realizations. Minor outbreaks give
rise to estimates with poor confidence intervals for all population sizes. For major
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outbreaks, for population size 10, basic ALT-based confidence intervals are liberal,
while for larger population sizes, the point estimate for the coverage is always
greater than 90%, and the failure for the estimated coverage to be statistically
significantly different to 90% (see the 95% confidence intervals for the estimated
confidences) can be explained by the smaller number of realisations.
Considering the ALT-based calibrated confidence intervals, the properties of con¬
fidence intervals arising from minor outbreaks are still poor (coverage less than
90%) for each of the three population sizes. This is inevitable given the bias in
the estimates. Among major epidemics, the estimated confidence has consistently
moved to be closer to 90%.
The significance of the improvement in the confidence interval through calibration
was assessed by fitting a generalized linear mixed model (GLMM) (Brown and
Prescott, 1999, Section 3.2). The response variable was a binary random variable
indicating whether a confidence interval did or did not cover the true 9 for both the
basic and calibrated ALT-based intervals. For major epidemics with population
size n = 10, modelling the responses as Bernoulli random variables with a logit
link function and fitting epidemic realisation as a random effect with dispersion
fixed to one, yielded an estimate of —3.052 (s.e = 1.163); p—value < 0.01, for
the difference in the calibrated and basic confidence intervals. Hence, for n —
10, the estimated confidence for the calibrated ALT-based confidence intervals
in major outbreaks is significantly lower than the estimated confidence of the
basic ALT-based confidence intervals. For n = 30 and n = 50, results from
the GLMM indicated drops in the estimated confidence of the calibrated ALT
compared to those from the basic ALT confidence intervals for major outbreaks,
but the differences were not statistically significant.
Where n = 10, plotting the basic and calibrated ALT based confidence intervals
against 9 estimates (Figure 9.9(a)), shows that the calibrated intervals are mostly
wider, although their estimated confidence is lower. It is also observed that
although the lower limits of the calibrated scheme may be rather low, they are still
being adjusted upwards relative to the basic ALT-based limits. In particular, the
calibration removes the spurious negative values of the basic confidence intervals.
Plotting the basic and calibrated ALT-based confidence points against each other
(Figures 9.9(5) and 9.9(c)), the plots indicate that there is a smooth relationship
between the associated confidence points. Hence, for this case (n = 10, /3 =
1, 7 = 0.5) there is some evidence that the calibration method does improve
the properties of the ALT-based confidence intervals, and that it operates in a
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Figure 9.9: Comparison of basic ALT and calibrated ALT-based confidence inter¬
vals for the case of n — 10, (a) Confidence points plotted against 6 estimates, (b)
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consistent fashion. However, the fact that one can be fairly sure that the calibra¬
tion procedure is not working properly (Section 9.5) means that this observation
should not be generalised in an assumption that this result applies for any values
of [3 and 7. Before examining the effect of calibration on the bootstrap percentile
confidence points, the effect of an estimation problem on the calibration of ALT-
based confidence points in situations where the true 6 is below the lower bound
of 0 is examined.
9.5.1.1 Evaluation of the calibration method for ALT-based confi¬
dence intervals when the true value of 9 = 0.5
A problem will arise in the calibration of the ALT-based confidence points in the
case where the true 0 is below the lower bound for 9 (refer to Equation (9.7)),
since it immediately follows that the true value of 9 will be consistently lower than
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all of the bootstrap estimates that are generated. This will clearly have an effect
on the coverage properties of the confidence interval. However, 9 cannot be lower
than all the bootstrap estimates which are generated since, by definition, 9 and
9b are all estimated. Hence, the bootstrap calibration is incapable of modelling
an important component of the relationship between 9 and 9 which must cast
doubt on the ability of the procedure to recalibrate the confidence interval in an
appropriate fashion.
Using 9 = 0.5 (/3 = 0.167 and 7 = 0.334), epidemics were simulated with n =
10, 30 and 50. The resulting data were analysed and 90% basic and calibrated
ALT-based confidence intervals were constructed for 9. The estimated properties
of the confidence intervals are presented in Table 9.4. It should be noted that
since the true value of 9 was small, categorizing of epidemics was not necessary
as the generated epidemics would, by definition, result in minor outbreaks.
Table 9.4: Summary of results for 100 ALT-based confidence intervals for 9 when
the true value of 9 = 0.5 i.e is below lower bound for 9.
Size(n) Estimated 95% CI Estimated 95% CI for
basic for basic calibrated calibrated
confidence confidence confidence confidence
10 1.00 (0.96, 1.00) 0.98 (0.93, 0.998)
30 0.98 (0.93, 0.998) 0.98 (0.93, 0.998)
50 0.99 (0.95, 1.00) 0.92 (0.85, 0.96)
The estimated confidences for both basic and calibrated confidence intervals are
greater than the notional 90% with the basic ALT-based intervals being con¬
sistently liberal for all three population sizes. The calibration procedure gives
rise to a drop in the confidence estimate towards the theoretical value of 90%
for n = 50 but not where n = 10 or n = 30 where the estimated calibrated
confidences are significantly higher than 90%. Fitting a generalised linear mixed
model to examine the effect of calibration for n = 10 and n = 30 confirmed that
the drop in confidence due to calibration was not statistically significant (p—value
= 0.29). For n = 50, the GLMM fit indicates a significant drop in coverage, of
— 1.52 (s.e = 0.6171) with a p-value = 0.01, due to the calibration relative to the
basic ALT method.
It was observed that the realisations which generated ALT-based confidence in¬
tervals which covered the true value of 9 but calibrated ALT-based confidence
intervals which did not cover 9 (and hence are causing the drop in confidence
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level), were exclusively those with observed 6 > 1. The bootstrap calibration
for these intervals was therefore based on values of A which were generated from
distributions for 6 which contained a sizeable number of estimates derived from
major outbreak data, and as established earlier, the bootstrap calibration has
some ability to recalibrate major outbreaks. However, it seems unlikely that
these A will be particularly appropriate for use in calibrating the estimate for a
minor outbreak. Hence, it is likely that the apparent drop in the true confidence
level is not based on any reliable re-calibration and would therefore be unlikely
to be a general result for all ft and 7.
9.5.2 Evaluation of percentile bootstrap confidence inter¬
vals
The bootstrap percentile confidence points, based on the 100 test simulations and
the associated 200 bootstrap epidemic realisations for each of the 100 initial sim¬
ulations (as in Section 9.5.1), were calibrated. For each of the 200 bootstrapped
realisations, 200 calibration realisations were generated. Bootstrap percentile
confidence intervals were obtained for both parametric and semi-parametric boot¬
strap methods. From the calibration samples, values of A were obtained, from
which calibrated percentile confidence intervals were constructed for both boot¬
strap methods and for population sizes of 10, 30, and 50 individuals. Estimated
confidences were generally poor and only confidence intervals for major outbreaks
are presented in Table 9.5.
Table 9.5: Summary of results for major outbreaks from 100 bootstrap based con¬
fidence intervals for 6 where 9 = 2.
Semi-parametric bootstrap estimates Parametric bootstrap estimates
95% CI 95% CI for 95% CI 95% CI for
Basic for basic Calibrated Calibrated Basic for basic calibrated calibrated
Size (n) confidence confidence confidence confidence confidence confidence confidence confidence
10 0.97 (0.90, 0.997) 1.00 (0.95, 1.00) 1.00 (0.95, 1.00) 1.00 (0.95, 1.00)
30 0.98 (0.90, 1.00) 0.98 (0.90, 1.00) 0.98 (0.90, 1.00) 0.96 (0.90,1.00)
50 1.00 (0.95, 1.00) 1.00 (0.95, 1.00) 0.94 (0.85, 0.98) 1.00 (0.95,1.00)
The basic bootstrap confidence intervals are liberal, and the calibration process
shows no signs of improving their properties, as might have been expected from
the theoretical consideration of the effects of minor outbreak realisations on the
exercise. Reviewing the properties of the calibration process, it is noticeable that
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many of the A which were applied to the calibration of major outbreak estimates
were pathological i.e. A = 1. Many of the upper limit A were set to one, which
corresponds to a case where it was impossible to set the upper value of A equal
to any of the (discrete) A values available because the largest available value
of A, A(2oo) corresponded to p(A) being less than the desired a value of 0.95.
Most typically, this problem would be associated with the use of an overly small
number of bootstrap samples and hence an unacceptably crude discretisation of
A. However, in this case, it is more likely that the problem is associated with
minor outbreaks skewing the distribution of the estimated A.
It has been observed from earlier analyses that the properties of all methods
are distorted and in some cases ruined by the occurrence of minor outbreaks in
the bootstrap realisations of epidemics. The problems that arise due to minor
outbreaks can potentially be addressed by what we term the weighted bootstrap
approach.
9.5.3 The weighted bootstrap approach
If the data suggest that 9 is greater than one, one solution might be to condition
on the occurrence of large outbreaks, using bootstrapped information only in so
far as it is consistent with having arisen from a major outbreak. Two quantities
are readily available to assess whether a simulated epidemic falls into the minor
or major class. These are the number of secondary infections and the estimated
value of 9. It might seem attractive to use the estimated value of 9, but the
true (unknown) sampling distribution for this variable, although dependent on 9,
is complicated by its functional dependence on discrete and continuous random
variables. A simple distributional model for 9 would be unlikely to adequately
fit this complex distribution. By contrast, the number of secondary infections is
a discrete distribution on a bounded set of integers. It seems likely that a fairly
simple model for this class of data might suffice to summarise the differences
between minor and major outbreaks. As described in Section 9.3 (Equations
(9.10) and (9.11)), a beta-binomial mixture distribution can be used to define
epidemics as major or minor outbreaks.
Thus the bootstrap approach could be extended to what we term the weighted
bootstrap to condition on the presence of major or minor outbreaks. The stan¬
dard bootstrap approach works on the basis of an equal weighting of jj, where
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B is the number of bootstrap samples, in the construction of percentile confi¬
dence intervals, and in the calibration process, p(A) increases in steps of 4. The
weighted bootstrap approach would instead give a weight (summing to one over
the distribution) which reflected the relative likelihood of an observation com¬
ing from a major or minor outbreak (Equation (9.11)). In the case where every
observation is assumed to come from the distribution of interest, the standard
bootstrap method is recovered. In the theoretical case, where a perfect partition¬
ing is possible, minor epidemics will not affect the calculations and the weighted
approach is equivalent to a standard bootstrap applied only to the major out¬
breaks. In reality, where no such perfect partitioning is possible, it is hoped that
the weighted bootstrap would allow bootstrap confidence intervals to be calcu¬
lated and bootstrap calibration to be applied successfully.
9.6 Summary
The initial exploration of the properties of bootstrap confidence intervals and
bootstrap calibrated intervals indicates that the effect of minor outbreak realisa¬
tions severely undermines the approach in most cases. There is weak evidence
that when analysing a major outbreak it might be worthwhile to apply bootstrap
calibration to any confidence intervals estimated using ALT. However, this latter
conclusion is provisional and would require to be tested against a wider range of
super threshold values of (3 and 7. The problems all arise from the occurrence of
minor outbreaks. If the data suggest that 9 is greater than 1, a solution might be
to condition on large outbreaks, using bootstrapped information only in so far as
it is consistent with having arisen from a major outbreak.
Should the weighted bootstrap prove successful in facilitating the calculation of
valid bootstrap confidence intervals and valid calibration, the resulting confidence
intervals will, of course, not be useful in establishing whether 9 is significantly
greater than 1. The weighted bootstrap, by conditioning on the existence of
major outbreaks, implicitly assumes that 9 is greater than 1. However, where
there is a super-threshold outbreak, the methodology outlined in this chapter
could give better bounds on the range of likely values of 9, and hence facilitate




Conclusions and further work
10.1 Methods employed
The main aim of this thesis was to investigate methods of statistical inference for
veterinary infectious disease data. This was pursued by fitting epidemic models
to data obtained from experimental FMD virus infections in sheep and simulated
data. The main contribution of this work is the estimation of expected infection
history characteristics for infected individuals. To investigate the experimental
hypothesis of intrinsic diminution in the infectivity of infected sheep during the
course of successive naturally transmitted infections of FMD virus, the infection
process for FMD virus in sheep was modelled in two ways: one based on infection
generation information for individual sheep and the other based on the estimated
infection rate applying to groups of sheep. Considering infection generation mod¬
els, chain binomial and generalised linear models were used to estimate the rate
of infection from each generation of infectives. In the analysis based on groups
of sheep, an iterative algorithm was used to estimate values for the unobservable
aspects of the infection history and the rates of infection acting upon groups 2 to
4 of sheep under a SLIR infection process. A gamma distribution was assumed
for the latent and infectiousness periods and the distribution parameters were
estimated from the observed experimental data. The rates of infection acting
upon groups of sheep were estimated based on maximum likelihood and martin¬
gale estimation methods. The former approach being applied to two models: an
unrestricted model, where the estimated rates of infection could take any values,
and a restricted model, where the estimated rates of infection were constrained to
be non-increasing. The trend in the estimated rates of infection was summarized
by a slope in the case of the martingale and unrestricted model ML estimates and
by a measure of decrease between groups 2 and 3 and between groups 3 and 4 in
case of the restricted model ML (5g estimates. The significance of any decreasing
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trend in the estimated rates of infection was tested using bootstrap methods. An
illustrative study using simulated data was carried out to investigate the appro¬
priateness of these methods to the observed type of highly structured epidemic
data. Finally, the coverage properties of confidence intervals for the reproduction
ratio were explored using simulated SIR infection processes.
10.2 Conclusions for analyses using infection
generations
A re-parameterisation proposed (in a different context) by de Jong et al. (1996),
was used to describe the infection model. The method also assumes that the
infection pathway is known: in practice, it is assumed that the analyst can 're¬
construct' a likely path, which is then used as the basis of the analysis. Together,
the re-parameterisation and the specification of an infection pathway allow infec¬
tion rate parameters to be estimated from a standard Generalised linear model.
Generalised linear model
• The results indicated that the inoculated sheep had a low potential to cause
infection in group 2 individuals.
• The estimated rate of infection increased by infection generation from gen¬
eration 0 to generation 2, but a drop in infectivity was observed between
generations 2 and 3, suggesting a possible drop in infectivity in naturally
infected sheep.
• Evaluation of the method using simulated data led to the conclusion that
the proposed re-parameterisation was not appropriate for epidemic data
where there are likely to be more than one infection generation of individ¬
uals in the system on any day during the experiment. In particular, the
re-parameterisation was not appropriate for the particular situation aris¬
ing from the experimental design and especially not where the aim was to
estimate more than 2 parameters.
• The method relies heavily on the assumption of knowledge of the infection
pathway.
Chain binomial model
The chain binomial formulation of infection models, as presented in the literature
was reviewed, and extended to apply to the type of structured mixing seen in the
experimental data.
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• The chain binomial model formulation yielded a complicated likelihood be¬
cause of the many unobserved aspects of the infection process. It was appre¬
ciated that such a likelihood would be difficult to be maximise in a situation
involving groups of size 8.
10.3 Conclusions for analyses using infection
rates applying to groups of sheep
The latent and infectiousness periods of individual sheep were modelled as gamma
random variables, and parameters for these distributions were estimated from the
observed data set using maximum likelihood
Latent and infectiousness periods
• For both experiments, the mean length of latent period was estimated to be
equal to approximately 1 day and the mean length of infectiousness period
was estimated to be 2.9 days.
Rate of infection acting upon groups of sheep
The estimation of the (3g was done using unrestricted and restricted models. For
the unrestricted model, both the martingale and the unrestricted ML estimation
methods were used. For the restricted model, the /39 were estimated using MLE
methods. The estimation of the /3g requires unobserved information about the in¬
fection history. The unobserved history was estimated using conditional estimates
of the expectation of unobserved quantities, followed by estimation of the (3g, us¬
ing an iterative procedure to convergence. Trends in the /3g were summarised and
their significance tested using bootstrap methods.
• Martingale and unrestricted model ML-based estimates suggested that group
2 experienced the lowest rate of infection, while group 3 experienced the
highest rate of infection, with an observed decline in the rate of infection
between group 3 and 4.
• f3g estimates based on the restricted model MLE suggested that groups 2
and 3 experienced an equal estimated rate of infection (estimates on the
boundary of restricted parameter space) and that there was a lower esti¬
mated rate of infection in group 4.
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• The martingale and unrestricted model ML estimates yielded positive esti¬
mated slopes, contrary to the experimental hypothesis of a decreasing trend.
The restricted model MLE method yielded estimated decreases greater than
zero. However, these estimates were not found to be statistically significant
(p-value = 0.46 for experiment 1, and p-value = 0.48 for experiment 2).
• In analysis the experimental data, the conclusion was that there was no sig¬
nificant trend in the rate of infection across groups. For both experiments,
the results suggested that the rate of infection for group 2 was the lowest
of that from all the three groups, 2 to 4. It could be that group 1 indi¬
viduals were able to pass on only a limited amount of infection to group 2
individuals. Alternatively, the group size of 8 may not have been sufficient,
given the initial dose of virus infection inoculated into group 1 individuals,
to enable the detection of a significant trend in the rate of infection acting
upon the groups of sheep.
• The martingale estimator used in this thesis is of interest because it makes
minimal use of the estimated infection history characteristics, when com¬
pared to the ML estimates for the unrestricted /3g model. However, the
results of Chapters 6 and 7 are consistent with the hypothesis that the
martingale estimator consistently produces lower estimates of (3g than the
ML estimator.
Illustrative study based on simulated data
Using the martingale and restricted model ML estimates of figi0bai obtained from
experiment 1 data, two epidemic realisations were generated. The initial aim was
to find out whether or not the methods arc capable of detecting a genuine trend in
the rate of infection, /3. A passage multiplier of 0.15 was used to produce a small
decreasing trend in the rate of infection. The generated data were analysed using
the martingale approach to exemplify the properties of unrestricted estimators,
and the restricted model ML as the more powerful maximum likelihood method.
• From the data generated using (3gi0bai = 0.8188 (the martingale estimate
from experiment 1), both estimation methods resulted into a non-significant
decrease. From the data generated using the restricted model ML estimate
°f Pglobal — 1-0195, the restricted MLE based methods were able to detect
the small decrease. However, the martingale based methods resulted into a
non-significant decrease.
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The properties of the martingale-based methodology were illustrated using further
simulated data sets.
• A data set was simulated assuming a large decrease in the rate of infec¬
tion with successive infection generations. The martingale analysis yielded
evidence of a significant decrease in infectivity.
• A data set was simulated assuming a large Ro and a small decrease in the
rate of infection on each infection generation. The martingale analysis esti¬
mated a non-significant trend. A further data set was simulated assuming
a large R0 and a large decrease in the rate of infection on each infection
generation. The martingale analysis detected a statistically significantly
decreasing trend in the rate of infection across groups.
• A data set was simulated assuming group size of 20. The martingale analysis
yielded evidence of a statistically significant decrease in the rate of infection
across groups.
General conclusions
• The inferential methods were appropriate for the type of highly structured
epidemic data.
• MLE based methods for the restricted model have some ability to detect a
small genuine decrease in the rate of infection for groups of size 8. Martin¬
gale based methods (unrestricted model) may detect a genuine decrease in
the rate of infection in groups of size 8 if the decrease is reasonably large.
• As long as a sizeable genuine decrease is present in the rate of infection
across groups, a group size of 8 is likely to suffice for the methods to be able
to detect the decrease.
• Results using the martingale estimator suggest that it would be desirable
to increase the group size as this would enhance the ability of the method
to detect a small genuine trend in the rate of infection across groups.
10.4 Conclusions from the review of properties
of asymptotic likelihood-based confidence
intervals
In exploring the properties of confidence intervals for the reproduction ratio based
on the asymptotic properties of the maximum likelihood estimate statistic, it was
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concluded that:
• Construction of confidence intervals for R0 based on the asymptotic prop¬
erties of the likelihood is likely to yield overly wide confidence intervals.
A methodology was proposed to produce semi-parametric and parametric boot¬
strap realisations of an epidemic. These bootstrap realisations were used to gen¬
erate bootstrap confidence intervals and for calibration purposes.
• Both the bootstrap confidence intervals and the calibrated intervals exhib¬




After analysing data from simulated experiments, the results indicated that a
group size of 8 is likely to be sufficient to detect a genuine trend if R0 in the
initial group of infectives is large and the decrease in the rates of infection is
substantial. In practice, these are properties of the infection, rather than of the
experiment. Increase in group size is proposed, as the results indicated that a
larger group size would be likely to increase the power of the methodology to
detect a genuine trend even if the decrease in the rates of infection with increased
infection generation number was small.
Analyses from experimental data yielded a lower estimate for the rate of infection
in group 4 compared to that applying to group 3. It would be worthwhile to
investigate any decrease in rate of infection by comparing only the estimates for
groups 3 and 4 since only sheep in these groups were only exposed to naturally
acquired infection. When evaluating the rate of infection estimates from the
unrestricted model, another summary of trend other than the slope could be
investigated. It would be interesting to investigate if the decreasing trend between
groups 3 and 4 is maintained in further groups by increasing the number of groups
of subjects in the study.
The maximisation of the latent period likelihood suffered from convergence prob¬
lems. Although the estimated mean and standard deviation of the distribution
was stable, individual shape and scale parameter estimates varied substantially
during the estimation process. More detailed data must allow some exploration
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of which distributions, other than gamma, are suitable models for the length of
latent period.
Before any further experiments which are similar in structure to the FMD ex¬
periments are carried out, substantial work should be carried out to evaluate the
design of the experiments. The statistical design of studies involving infectious
diseases is an important topic, especially when the results from the experiments
are of vital importance in understanding the infection mechanisms. There is a
need for a power study to consider the effect of group size, number of groups, the
sampling time scale (which should probably be less than 24 hours) and also the
mixing pattern and length of time for which groups should mix. It is important to
ensure that the design, both in structure and size is suitable given the objectives
of the study. It is possible that, for some infections, small and relatively inexpen¬
sive changes (such as a shorter sampling time scale) could dramatically increase
the information available from the experiment. Considerations of cost-efficiency
and of ethics necessitate an attempt to maximise the output of information while
minimising the number of animals used in the experiment. In an extreme case,
where power calculations suggest that more animals are required in an exper¬
iment than can logistically be included, the experiment should not proceed at
all. Only a thorough power study can justify the choice of animal numbers and
experimental design in such an extensive experiment.
10.5.2 Methodological work
Application of MCMC methods to model the infection process is a possible area of
further research for these data. Previously studies where these methods have been
applied to epidemic modelling have been discussed in Section 4.5. These methods
could be used to model the individual based infection process, for example, by
modelling the epidemic chains so that infection pathways are estimated along
with the other unobserved infection process characteristics. MCMC methods
could also be used to model the infection process based on groups of sheep to
explore how the results compare with those obtained in this thesis.
It is arguable that the characteristics of the infection process in group 1 individ¬
uals is different to that in individuals from groups 2 to 4, however, estimation of
the latent period distribution parameters was based only on data summarising
the number of occasions on which group 1 individuals tested negative before the
first positive test after inoculation (rq). MCMC methods would facilitate the esti¬
mation of the latent period distribution separately for the two categories of sheep,
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i.e. inoculated and natural infectives, although estimates of the latent period for
natural infectives would be likely to be somewhat variable. The assumption that
all inoculated animals become infected as a result of their inoculation could also
be relaxed, with the model allowing infections between group 1 individuals. In
general, it would be useful to investigate the use of MCMC methods, even when
applied to the group rate estimation problem, since use of this methodology would
avoid many of the ad hoc assumptions required in Chapters 6 and 7 to estimate
the aspects of the unobserved infection history. It might also be useful to revise
the model for the infection process by allowing individuals to exhibit variability
in susceptibility.
The martingale estimator consistently produced lower estimates of f3g than the
ML estimator, It would therefore be of interest to study the sampling distribu¬
tion of the two (martingale and ML) estimators to investigate what bias may be
present in the estimators and how this may relate to the dependency of the f3g
on the infection history characteristics, given the ad hoc nature of the iterative
estimation process.
Statistical significance of trend was tested using bootstrap methods, however,
further work is required to investigate the potential impact of simulated minor
outbreaks on estimates of the rate of infection. If this aspect of the stochastic
process does, under some circumstances, have a large impact on estimates of
the rate of infection, it might be concluded that the bootstrap simulations should
perhaps not be based on an estimated /3giobai, if this may indeed be affected by the
inclusion of minor epidemics. The mixing group which is least likely to be subject
to a minor outbreak is group 2, and it is arguable that a restricted model ML
estimate of the infection rate applying to group 2 is therefore the best estimate
of the global infection rate, even when working under the assumption that there
is no systematic passage effect.
In chapter 9, the nature of estimates of the rate of infection, removal rate and R0
of the SIR model arising from realised minor and major outbreaks was explored.
The results suggested that the presence of realised minor outbreaks affected the
estimated confidence intervals of these parameters. To address this problem, a
weighted bootstrap approach was proposed. It would be worthwhile to carry
out to carry out further work using the weighted bootstrap approach to estimate
confidence intervals conditional on observations coming from major outbreaks.
It is hoped that the weighted bootstrap would allow the bootstrap calibration
method described in Chapter 9 to be applied successfully.
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